%PDF-1.3 % 15 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 9 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 13 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 3 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 6 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 16 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 11 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 4 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 7 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 14 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 17 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 8 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 18 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 10 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 12 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 5 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 1 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T0WI2P0T5TR Ɩf !\!Y\ !p o endstream endobj 20 0 obj <>stream 2021-11-20T17:14:29+05:30 Arbortext Advanced Print Publisher 9.0.114/W 2021-12-17T04:31:13-08:00 Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT application/pdf NEU-2021-0116-ver9-Mikolic_4P 3315..3331 uuid:4619f257-c4c8-4d00-a199-231676255019 uuid:2dc653cf-444e-44b4-9453-bc3eb5e43c8a endstream endobj 21 0 obj <>stream x+| endstream endobj 22 0 obj <>stream xS**T0T0Biye( endstream endobj 23 0 obj <>stream x+| endstream endobj 24 0 obj <>stream xS**T0T0BihW endstream endobj 25 0 obj <>stream x+| endstream endobj 26 0 obj <>stream xS**T0T0Biyw* endstream endobj 27 0 obj <>stream x+| endstream endobj 28 0 obj <>stream xS**T0T0BiyJ% endstream endobj 29 0 obj <>stream x+| endstream endobj 30 0 obj <>stream xS**T0T0Biy+ endstream endobj 31 0 obj <>stream x+| endstream endobj 32 0 obj <>stream xS**T0T0BihlT endstream endobj 33 0 obj <>stream x+| endstream endobj 34 0 obj <>stream xS**T0T0Biy, endstream endobj 35 0 obj <>stream x+| endstream endobj 36 0 obj <>stream xS**T0T0Biy8# endstream endobj 37 0 obj <>stream x+| endstream endobj 38 0 obj <>stream xS**T0T0Biy\' endstream endobj 39 0 obj <>stream x+| endstream endobj 40 0 obj <>stream xS**T0T0BihX endstream endobj 41 0 obj <>stream x+| endstream endobj 42 0 obj <>stream xS**T0T0BihY endstream endobj 43 0 obj <>stream x+| endstream endobj 44 0 obj <>stream xS**T0T0Bih~V endstream endobj 45 0 obj <>stream x+| endstream endobj 46 0 obj <>stream xS**T0T0BihuU endstream endobj 47 0 obj <>stream x+| endstream endobj 48 0 obj <>stream xS**T0T0BiyS& endstream endobj 49 0 obj <>stream x+| endstream endobj 50 0 obj <>stream xS**T0T0BihZ endstream endobj 51 0 obj <>stream x+| endstream endobj 52 0 obj <>stream xS**T0T0BiyA$ endstream endobj 53 0 obj <>stream x+| endstream endobj 54 0 obj <>stream xS**T0T0Biyn) endstream endobj 56 0 obj <>stream /GS1 gs BT /F7 1 Tf 10.4607 0 0 10.4607 72.9637 722.0974 Tm 0 0 0 rg 0 Tc 0 Tw [(Biological)-395.5(\()48.2(sex)47(\))-390.8(and)-395.7(sociocultural)-393.7(\()48.2(gender)49.1(\))-390.8(as-)]TJ -1.046 -1.1869 TD [(pects)-525.1(strongly)-524.5(interact)-527.4(in)-525.1(humans,)-522.8(and)-525.7(differences)-527.6(in)]TJ 0 -1.1923 TD [(the)-316.6(context)-317.4(of)-316(health)-318.8(outcomes)-315.8(in)-313.8(humans)-317.6(are)-317.6(rarely)-320(the)]TJ T* [(product)-472.6(of)-473.1(exclusively)-471.2(sex)-478.1(or)-473.1(gender,)-469.8(but)-474.9(rather)-477.2(their)]TJ 0 -1.1869 TD [(combined)-271.3(effect.)]TJ 7.8454 0 0 6.9729 132.7748 676.9698 Tm (6)Tj 10.4607 0 0 10.4607 139.5779 672.321 Tm [(To)-273.4(emphasize)-268.7(that)-274(it)-272.6(is)-271.6(difcult)-271.8(to)-270.4(dis-)]TJ -7.414 -1.1923 TD [(en)14.8(ta)18(ng)13.6(le)-215(bi)16.8(ol)16.8(og)13.6(ic)18(al)-215(an)14.8(d)-226.2(s)11(oc)14.8(io)16.8(cu)14.8(lt)14.6(u)12.2(r)0(a)15.8(l)-228.4(co)20.3(mp)12.8(o)12.2(n)0(e)14.8(n)0(t)16.8(s)0(,)-215.9(w)0(e)-217(w)0(i)18.1(l)0(l)]TJ T* [(us)17.9(e)-295.5(t)0(h)16.8(e)-290.1(te)12.6(rm)-284.3()56.6()0(s)18.9(e)0(x)14.8(/)0(g)16.8(e)0(n)14.8(d)0(e)14.8(r)0()64.4()-290.3(an)14.8(d)-291.3()56.6(m)13.8(en)20.3()51.2()-290.3(an)14.8(d)-291.3()56.6(w)15.9(o)12.2(m)0(e)14(n)0(.)18.4()51.2()]TJ 1.046 -1.1869 TD [(The)-276.2(existence)-275.5(and)-276.4(the)-273.2(extent)-275.5(of)-272.6(the)-278.6(differences)-272.9(in)-275.8(out-)]TJ -1.046 -1.1923 TD [(comes)-328.6(after)-326.8(TBI)-321.8(varies)-327.6(between)-323.6(studies)-326.4(and)-325.2(depends)-325(on)]TJ T* [(TBI)-273(severity,)]TJ 7.8454 0 0 6.9729 117.5811 614.6644 Tm (7-9)Tj 10.4607 0 0 10.4607 130.9039 610.0156 Tm (age,)Tj 7.8454 0 0 6.9729 148.0818 614.6644 Tm (10,11)Tj 10.4607 0 0 10.4607 168.6047 610.0156 Tm [(and)-276.4(type)-271.8(of)-272.6(outcomes.)]TJ 7.8454 0 0 6.9729 261.9212 614.6644 Tm (7,12)Tj 10.4607 0 0 10.4607 278.4755 610.0156 Tm (Stud-)Tj -20.6921 -1.1869 TD [(ies)-507.5(exploring)-504.5(sex/gender)-505.1(differences)-511.3(in)-503.4(outcomes)-510.9(fol-)]TJ 0 -1.1923 TD [(lowing)-829.4(TBIs)-831(classied)-832.9(as)-831.8(moderate/severe)-832.5(mainly)]TJ 0 -1.1869 TD [(showed)-516.1(absence)-512.3(of)-516.5(differences)-516.7(or)-516.5(better)-512.9(outcomes)-516.3(in)]TJ 0 -1.1923 TD (women.)Tj 7.8454 0 0 6.9729 95.4708 564.8881 Tm (7,8,13)Tj 10.4607 0 0 10.4607 118.7716 560.2393 Tm [(Following)-358.1(mild)-357.3(TBI,)-359(the)-359.9(majority)-357.2(of)-359.3(stud-)]TJ -5.425 -1.1923 TD [(ies)-339.4(indicate)-338.7(worse)-343(psychological)-332.9(and)-341.5(global)-336.3(functioning)]TJ 0 -1.1869 TD [(outcomes)-380.8(in)-378.8(women.)]TJ 7.8454 0 0 6.9729 151.7102 539.9999 Tm (7,9,10)Tj 10.4607 0 0 10.4607 175.2944 535.3511 Tm [(In)-381(a)-382.2(European)-375.4(cohort)-381.8(of)-381(TBI)]TJ -10.8284 -1.1923 TD [(patients)-574.1(\(Collaborative)-576.4(European)-575.9(Neurotrauma)-577(Effec-)]TJ T* [(tiveness)-497.2(Research)-495.6(in)-498(TBI)-495.2([CENTER-TBI]\),)-500.4(we)-493.4(found)]TJ 0 -1.1869 TD [(worse)-343(functional)-346.9(outcomes,)-342.2(generic)-340.1(and)-346.9(specic)-344.5(health-)]TJ 0 -1.1923 TD [(related)-369.4(quality)-369.6(of)-370.1(life)-370.6(\(HRQoL\),)-371.7(and)-368.6(more)-367(severe)-373(post-)]TJ T* [(co)20.3(nc)14.8(u)12.2(s)0(s)16.7(i)0(o)16.8(n)12.2(,)-281.1(d)12.2(ep)14.8(re)15.8(s)11(s)11(i)0(o)16.8(n)12.2(,)-281.1(a)0(n)14.8(x)12.2(ie)18(ty)16.8(,)-275.7(a)0(n)14.8(d)-280.4(p)12.2(o)0(s)17.9(t)0(-)17.8(t)0(r)17.8(a)0(u)20.3(m)0(a)19.4(t)0(i)14.6(c)-279.2(s)11(t)0(r)17.8(e)0(s)13.6(s)]TJ 0 -1.1869 TD [(s)11(y)0(m)18.2(p)0(t)16.8(o)12.2(ms)-210.6(in)-210.8(w)13.5(o)0(m)18.2(e)0(n)-212.8(6)-215.4(m)11.4(o)0(n)19.1(t)0(h)16.8(s)-216.6(af)15.8(te)18(r)-219.8(m)11.4(il)20(d)-220.8(T)12.4(B)10.2(I)0(,)-208.3(p)0(a)14.8(r)0(t)17.8(i)0(c)18(u)12.2(la)18(rl)17.8(y)]TJ 0 -1.1923 TD [(in)-254.1(the)-257(age)-253.6(group)-257.6(younger)-253.6(than)-250.1(45)-257.3(and)-254.7(for)-253.9(some)-255.4(outcomes)]TJ T* [(in)-275.8(the)-278.6(age)-275.2(group)-273.8(65)]TJ /F5 1 Tf 7.8368 0 TD (+)Tj /F7 1 Tf .5528 0 TD (.)Tj 7.8454 0 0 6.9729 152.3905 440.3337 Tm (14)Tj 10.4607 0 0 10.4607 163.1622 435.6849 Tm [(The)-276.2(differences)-272.9(remained)-279.9(signif-)]TJ -9.6686 -1.1869 TD [(icant)-406.9(after)-413.5(controlling)-403.1(for)-405.7(pre-injury)-408.9(health)-405.5(and)-406.5(injury-)]TJ 0 -1.1923 TD [(related)-299(characteristics.)]TJ 1.046 -1.1923 TD [(Injury)-468.7(characteristics)-474.2(do)-468.7(not)-469.5(seem)-465.5(probable)-470(mecha-)]TJ -1.046 -1.1869 TD [(nisms)-372.4(of)-375.6(the)-376.2(observed)-376.8(differences,)-375.1(since)-373.4(men)-374.8(generally)]TJ 0 -1.1923 TD [(sustain)-478.2(more)-480.8(severe)-481.4(mild)-482(TBIs)-478.7(and)-482.4(more)-480.8(extracranial)]TJ T* [(injuries)-341.3(and)-341.5(show)-341.2(more)-339.9(pathology)-337.5(on)-338.6(computed)-341.7(tomog-)]TJ 0 -1.1869 TD [(raphy)-326.8(\(CT\))-324.8(than)-326(women.)-321.3(Nevertheless,)-329.1(there)-322.4(is)-331.2(a)-322.6(differ-)]TJ 0 -1.1923 TD [(ence)-332.2(in)-330(prevalence)-333.5(rates)-329(of)-332.2(psychiatric)-329.3(disorders,)]TJ 7.8454 0 0 6.9729 271.2188 340.7243 Tm (15)Tj 10.4607 0 0 10.4607 282.5007 336.0755 Tm (with)Tj -21.0769 -1.1923 TD [(women)-359.9(having)-361.2(higher)-360.1(rates)-361.5(of)-359.3(anxiety)-360.8(and)-357.7(mood)-358.3(disor-)]TJ 0 -1.1869 TD (ders,)Tj 7.8454 0 0 6.9729 82.0346 315.8362 Tm (16)Tj 10.4607 0 0 10.4607 94.7905 311.1873 Tm [(which)-469.7(are)-469.3(the)-468.3(most)-470.1(prevalent)-469.6(disorders)-465.7(world-)]TJ -3.1325 -1.1923 TD (wide.)Tj 7.8454 0 0 6.9729 84.9826 303.3637 Tm (17)Tj 10.4607 0 0 10.4607 98.3622 298.7149 Tm [(Pre-injury)-525(psychiatric)-529.8(history)-525.9(is)-526.3(the)-527.9(strongest)]TJ -3.474 -1.1923 TD [(risk)-332.8(factor)-336.3(for)-329.8(post-injury)-331.9(disorders,)]TJ 7.8454 0 0 6.9729 215.2062 290.8913 Tm (18)Tj 10.4607 0 0 10.4607 226.5448 286.2424 Tm [(and)-330.6(therefore)-335.3(can)]TJ -15.7277 -1.1869 TD [(represent)-332.1(vulnerability)-325.5(for)-329.8(appearance)-335.5(of)-326.8(symptoms)-325.6(and)]TJ 0 -1.1923 TD [(lower)-300.7(health-related)-301(quality)-299.2(of)-305.1(life)-300.1(after)-299.7(a)-300.9(TBI.)]TJ 7.8454 0 0 6.9729 261.0708 266.0031 Tm (12)Tj 10.4607 0 0 10.4607 272.0692 261.3542 Tm (Differ-)Tj -20.0797 -1.1923 TD [(ences)-267(in)-259.6(brain)-264(morphology,)-258.3(cerebral)-266(blood)-260.8(ow,)-261.6(and)-265.6(lev-)]TJ 0 -1.1869 TD [(els)-231.1(and)-233.1(role)-232.9(of)-234.7(sex)-228.8(steroids)-231.9(may)-233.9(also)-235.1(impact)-232.9(the)-229.9(processes)]TJ 0 -1.1923 TD [(after)-299.7(TBI)-300.1(in)-302.9(a)-295.5(sex-specic)-305.4(manner.)]TJ 7.8454 0 0 6.9729 210.1606 228.6424 Tm (10,19)Tj 10.4607 0 0 10.4607 72.9637 211.5212 Tm [(Apart)-203.2(from)-199.2(biological)-203.8(differences,)-201.7(sociocultural)-198.6(expec-)]TJ -1.046 -1.1869 TD [(tations)-392.5(and)-395.7(roles)-395.3(can)-394.5(produce)-393.3(gender-specic)-395.3(stressors,)]TJ 0 -1.1923 TD [(thus)-458.5(interfering)-462.8(with)-458.3(the)-457.5(recovery)-460.1(after)-462.3(TBI.)]TJ 7.8454 0 0 6.9729 259.5401 191.2818 Tm (10,20-22)Tj 10.4607 0 0 10.4607 292.422 186.633 Tm (In)Tj -22.0253 -1.1923 TD [(many)-465.5(societies,)-463.6(women)-462.9(are)-469.3(expected)-463.2(to)-465.5(take)-465.7(over)-463.7(the)]TJ 0 -1.1869 TD [(role)-379.2(of)-381(primary)-380.2(homemaker)-380.1(and)-384.8(caregiver)-378.4(for)-384(children,)]TJ 0 -1.1923 TD [(and)-487.8(men)-483.2(of)-484(primary)-488.6(wage)-484(earner.)-483.9(In)-489.4(Europe,)-481.7(women)]TJ T* [(are)-382.6(more)-383.2(likely)-381.8(to)-384.2(suffer)-384.2(from)-383.4(poverty,)]TJ 7.8454 0 0 6.9729 231.9306 141.4488 Tm (23)Tj 10.4607 0 0 10.4607 243.7794 136.8 Tm [(to)-384.2(live)-382.4(alone,)]TJ -17.3753 -1.1869 TD [(to)-400.5(take)-406.1(care)-401.7(of)-402.7(children,)-401(to)-400.5(be)-402.5(highly)-402.5(educated,)-397.4(and)-401.1(to)]TJ 0 -1.1923 TD [(be)-202(unemployed.)]TJ 7.8454 0 0 6.9729 128.4661 116.5606 Tm (24)Tj 10.4607 0 0 10.4607 138.3874 111.9118 Tm [(Sociodemographic)-201.4(factors)-200.6(are)-198.3(relevant,)]TJ -7.3002 -1.1923 TD [(because)-496(they)-488.6(have)-490.6(been)-496(shown)-486.2(to)-492.6(be)-494.6(associated)-492(with)]TJ 0 -1.1869 TD -.018 Tc [(health)-314.7(outcomes)-315.9(a).9(nd)-309.3(HRQoL)-314.5(i)2.9(n)-314.7(d)5.1(ifferent)-311.5(pop)5.1(ulations.)]TJ 7.8454 0 0 6.9729 283.5779 91.6724 Tm -.0228 Tc [(25-2)7.5(7)]TJ 10.4607 0 0 10.4607 62.022 74.5512 Tm 0 Tc [(These)-338.5(factors)-336.1(can)-334.8(have)-338.9(an)-332(age-dependent)-334.7(impact)-335.9(due)-336(to)]TJ 0 -1.1923 TD [(hormonal)-401.5(variations)-396.9(and)-401.1(changes)-405.1(in)-400.5(roles,)-400(responsibili-)]TJ 0 -1.1869 TD [(ties,)-214.9(and)-211.4(stressors)-207.9(over)-214.4(a)-208.8(life-time.)]TJ 7.8454 0 0 6.9729 203.5275 54.3118 Tm (10,28)Tj 10.4607 0 0 10.4607 223.37 49.663 Tm [(Lastly,)-211.9(differential)]TJ 8.5738 64.282 TD [(trauma)-397.7(triage)-399.1(and)-395.7(management)-396.9(of)-397.2(TBI)-397.7(can)-394.5(also)-397.7(play)-396.5(a)]TJ 0 -1.1869 TD [(role)-325(in)-319.2(functioning)-314.2(following)-322.4(TBI.)-315.7(In)-321.4(the)-322(CENTER-TBI)]TJ 0 -1.1923 TD [(study,)-282.9(we)-282(found)-273.8(that)-284.9(women)-278.6(with)-279.4(mild)-276.1(TBI)-283.9(had)-276.4(a)-284.7(higher)]TJ T* [(likelihood)-215.9(of)-213(direct)-209.4(admission)-216(to)-210.8(hospital)-212.2(\(trauma)-211(center\),)]TJ 0 -1.1869 TD [(and)-319.8(a)-317.2(lower)-322.4(likelihood)-313.4(of)-321.4(admission)-313.6(to)-319.2(intensive)-318(care)-320.4(in)]TJ 0 -1.1923 TD [(analyses)-407.1(adjusted)-403.9(for)-405.7(pre-injury)-403.5(and)-406.5(injury)-401.5(characteris-)]TJ T* (tics.)Tj 7.8454 0 0 6.9729 330.2928 652.025 Tm (14)Tj 10.4607 0 0 10.4607 341.7448 647.3762 Tm [(However,)-346.8(the)-349.1(impact)-346.7(of)-348.5(differences)-348.7(in)-346.3(care)-352.9(path-)]TJ -2.7423 -1.1869 TD [(ways)-350.9(on)-344.1(the)-349.1(long-term)-341.7(outcomes)-348.3(following)-344.1(mild)-346.5(TBI)-343.5(is)]TJ 0 -1.1923 TD (unclear.)Tj 1.0514 -1.1923 TD [(Possible)-348.9(explanations)-356(of)-353.9(differences)-354.2(in)-351.7(post-TBI)-349.7(out-)]TJ -1.0514 -1.1869 TD [(comes)-269(between)-264(men)-261(and)-265.6(women)-262.4(have)-268.4(rarely)-265.8(been)-263(tested.)]TJ 0 -1.1923 TD [(Mediation)-219.1(analysis)-220.8(is)-222.8(used)-216.6(to)-221.6(quantify)-218.7(the)-219(extent)-221.3(to)-221.6(which)]TJ 0 -1.1869 TD [(the)-332.8(relationship)-325.9(between)-323.6(two)-327.4(variables,)-329.2(such)-330.4(as)-327.8(associa-)]TJ 0 -1.1923 TD [(tion)-264.4(between)-264(sex/gender)-261.2(and)-260.2(outcomes,)-260.9(can)-264.4(be)-261.6(explained)]TJ T* [(by)-284.4(one)-287.3(or)-283.4(more)-285.7(intermediate)-285.2(variables,)-280.4(while)-287.7(controlling)]TJ 0 -1.1869 TD [(for)-335.2(other)-334.4(relevant)-335.5(factors.)-329.9(We)-334.8(hypothesized)-332.1(that)-333.7(the)-332.8(ob-)]TJ 0 -1.1923 TD -.016 Tc [(s)-5(e)-2.6(rv)-3.8(ed)-307.3(sex)-3.8(/)-.6(gend)-3.8(er)-311.7(differences)-303(in)-307.3(ou)-3.8(tcomes)-308.5(fo)-3.8(llowin)-3.8(g)-301.9(m)-4.6(ild)]TJ T* 0 Tc [(TBI)-273(could)-275.8(be)-272.4(partly)-270.2(explained)-270.1(by)-273.6(psychiatric)-269.7(history,)-270.5(so-)]TJ 0 -1.1869 TD [(ciocultural)-536.2(and)-536.6(gender-role)-533(related)-537.4(factors,)-530.5(and)-536.6(acute)]TJ 0 -1.1923 TD [(management)-440.3(of)-440.6(mild)-438.6(TBI.)-434.9(In)-440.6(addition,)-438(the)-441.2(importance)]TJ T* [(of)-299.7(these)-302.9(mechanisms)-297.6(may)-298.9(differ)-303.9(across)-299.5(age)-296.9(groups.)]TJ 1.0514 -1.1869 TD [(Therefore,)-305.1(we)-303.7(aimed)-302.6(to)-302.9(study)-305.3(whether)-302.1(the)-305.7(differences)]TJ -1.0514 -1.1923 TD [(in)-313.8(outcomes)-315.8(after)-316(mild)-308.6(TBI,)-315.7(overall)-311(and)-314.4(in)-313.8(different)-311.6(age)]TJ T* [(groups,)-240.4(were)-239.1(mediated)-239.8(by:)-236.5(1\))-240.1(psychiatric)-237.1(history;)-234.1(2\))-240.1(soci-)]TJ 0 -1.1869 TD [(odemographic)-404.4(variables)-411.2(\(living)-402.3(alone,)-409.4(living)-404.7(with)-404.1(chil-)]TJ 0 -1.1923 TD [(dren,)-463(education,)-459(and)-460.7(employment)-461.2(status/job)-456.7(category\);)]TJ T* [(and/or)-316.8(3\))-315.9(differences)-316.2(in)-313.8(care-pathways)-317.4(\(referral)-317(to)-319.2(study)]TJ 0 -1.1869 TD [(hospital)-412.8(and)-411.9(discharge)-414.4(destination)-409.6(after)-413.5(emergency)-410.6(de-)]TJ 0 -1.1923 TD [(partment)-299.6([ED]\).)]TJ /F4 1 Tf 0 -3.5173 TD (Methods)Tj /F2 1 Tf 0 -1.2411 TD [(Study)-304.1(population)]TJ /F7 1 Tf 0 -1.2032 TD [(The)-292.5(study)-289.1(population)-289.5(consisted)-289.9(of)-288.9(patients)-292.3(from)-291.3(the)-289.5(pro-)]TJ 0 -1.1869 TD [(spective)-316(multi-center)-312.5(observational)-310.2(CENTER-TBI)-313.2(study)]TJ 0 -1.1923 TD [(\(Core)-642.1(data,)-633(version)-636.3(2.1\).)-638.3(Data)-637.9(were)-634.7(collected)-639.6(from)]TJ T* [(December)-345.7(2014)-335.8(to)-340.9(December)-340.3(2017)-335.8(in)-340.9(63)-338.6(centers)-341.3(across)]TJ 0 -1.1869 TD [(Eur)10.8(op)13.6(e)-214.2(and)-206(Isr)15.9(ae)10.6(l.)-211.5(The)-205.8(st)10.2(ud)13.6(y)-215.4(w)0(a)10.6(s)-216.6(re)10.4(gis)11.6(te)12.6(re)10.4(d)-215.4(wit)11.8(h)-210(Cli)14(ni)11.4(cal)9.8(-)]TJ 0 -1.1923 TD [(Tri)14(als)12.8(.g)12.9(ov)-224.8(\(NC)9.8(T0)13.8(221)15(02)13.6(21\))16(.)-232.3(E)0(t)11.6(hic)14(al)-225.9(app)10.8(ro)14.6(val)-224.4(wa)10.6(s)-232.8(g)0(r)14.6(ant)14(ed)]TJ 0 -1.1869 TD [(for)-692.9(each)-689.9(recruiting)-687.4(site)-687.1(and)-688.3(informed)-687.7(consent)-690.3(was)]TJ 0 -1.1923 TD [(obtained)-337.7(for)-335.2(all)-335.1(patients)-330.3(by)-333.2(the)-338.3(patients)-335.7(and/or)-333(the)-332.8(legal)]TJ T* [(representative/next)-301.6(of)-299.7(kin.)]TJ 1.0514 -1.1869 TD [(Inclusion)-272.6(criteria)-277.1(for)-275.6(the)-273.2(core)-272.8(study)-278.2(were)-271.6(a)-279.2(clinical)-275.9(di-)]TJ -1.0514 -1.1923 TD [(agnosis)-264.6(of)-261.8(TBI,)-266.9(presentation)-262.8(within)-262.6(24)-165.2(h)-258.7(after)-267.2(injury,)-259.9(and)]TJ T* [(an)-467.5(indication)-458.6(for)-459.9(CT)-465.1(scanning.)]TJ 7.8454 0 0 6.9729 449.8015 178.7527 Tm (29)Tj 10.4607 0 0 10.4607 462.444 174.1039 Tm [(The)-465.9(core)-462.5(dataset)-463.7(in-)]TJ -14.2807 -1.1869 TD [(cluded)-446.7(three)-447.1(strata)-443.7(that)-447.5(are)-447.7(differentiated)-442.1(according)-445.7(to)]TJ 0 -1.1923 TD [(care)-352.9(path:)-348.5(patients)-346.5(seen)-350.9(in)-346.3(the)-349.1(ED)-348.1(and)-346.9(then)-347.7(discharged;)]TJ T* [(patients)-519.9(primarily)-511.9(admitted)-519.6(to)-514.3(the)-517.1(intensive)-513.1(care)-520.9(unit)]TJ 0 -1.1869 TD [(\(ICU\),)-461.6(and)-460.7(patients)-460.3(primarily)-457.7(admitted)-460(to)-460.1(the)-457.5(hospital)]TJ 0 -1.1923 TD (ward.)Tj 7.8454 0 0 6.9729 336.5857 116.5039 Tm (30)Tj 10.4607 0 0 10.4607 324.0566 99.3826 Tm [(For)-354.7(this)-352.3(study,)-358.8(we)-352.5(selected)-358.2(patients)-357.4(aged)-355.1(16)-354.9(years)-353.9(or)]TJ -1.0514 -1.1869 TD [(older,)-333.7(and)-325.2(classied)-334.3(as)-327.8(having)-328.6(mild)-330.3(TBI)-327.2(based)-333.2(on)-327.8(base-)]TJ 0 -1.1923 TD [(line)-496.2(Glasgow)-494(Coma)-494.6(Score)-490.4(\(GCS\))-498(13)-490.4(to)-492.6(15.)-495.1(Sex)-495.4(was)]TJ T* [(recorded)-498.1(on)-490.4(medical)-495.9(forms)-491.6(at)-491.4(admission.)-491.7(Sociodemo-)]TJ 0 -1.1869 TD [(graphic)-216.6(variables,)-215.3(medical)-219.5(history,)-216.3(and)-211.4(clinical)-221.7(and)-211.4(injury)]TJ ET 145.701 747.156 406.488 .51025 re f BT /F4 1 Tf 9.9626 0 0 9.9626 62.022 754.3557 Tm (3316)Tj 42.2865 0 TD [(MIKOLIC)-311.3(ET)-299.4(AL.)]TJ ET endstream endobj 66 0 obj <>stream /GS1 gs BT /F7 1 Tf 10.4607 0 0 10.4607 59.7543 722.0974 Tm 0 0 0 rg 0 Tc 0 Tw [(characteristics)-430.9(were)-434.2(assessed)-429(at)-426.4(admission.)-432.1(The)-428(results)]TJ 0 -1.1869 TD [(of)-462.3(rst)-459.7(CT)-459.7(scanning)-455.9(reviewed)-462.1(centrally)-461(by)-457.9(CENTER-)]TJ 0 -1.1923 TD [(TBI)-300.1(researchers)-303.1(were)-298.7(selected)-304(for)-297.3(the)-300.3(analyses.)]TJ /F2 1 Tf 0 -3.0458 TD [(Ethical)-303(approval)]TJ /F7 1 Tf 0 -1.2032 TD [(The)-428(CENTER-TBI)-421.6(study)-419.1(\(European)-421.8(Commission)-424.6([EC])]TJ 0 -1.1869 TD [(grant)-437.4(602150\))-428.2(has)-434.8(been)-436.4(conducted)-435.9(in)-433(accordance)-433.1(with)]TJ 0 -1.1923 TD [(all)-302.5(relevant)-303(laws)-298.9(of)-299.7(the)-300.3(European)-299.5(Union)-297.5(\(EU\))-299.9(if)-296.5(directly)]TJ T* [(applicable)-459.4(or)-456.9(of)-462.3(direct)-458.7(effect)-459.7(and)-455.3(all)-459.7(relevant)-460.1(laws)-456.1(of)]TJ 0 -1.1869 TD [(the)-376.2(country)-375(where)-373.2(the)-376.2(recruiting)-373(sites)-378(were)-374.6(located,)-375.1(in-)]TJ 0 -1.1923 TD [(cluding)-313.2(but)-312.4(not)-312.4(limited)-313(to,)-307.6(the)-316.6(relevant)-308.4(privacy)-314.2(and)-314.4(data)]TJ T* [(protection)-455.3(laws)-461.5(and)-455.3(regulations)-455.1(\(the)-455.1(Privacy)-457.9(Law\),)]TJ 0 -1.1869 TD [(the)-397.9(relevant)-389.7(laws)-396.4(and)-390.2(regulations)-395.5(on)-392.8(the)-392.5(use)-391.4(of)-397.2(human)]TJ 0 -1.1923 TD [(materials,)-402.6(and)-395.7(all)-400.1(relevant)-400.5(guidance)-399.3(relating)-398.5(to)-400.5(clinical)]TJ T* [(studies)-293.9(from)-285.9(time)-291.1(to)-292.1(time)-291.1(in)-292.1(force)-292.1(including)-285.5(but)-290.7(not)-290.7(lim-)]TJ 0 -1.1869 TD [(ited)-442(to)-438.4(the)-441.2(ϲ)-434.9(Conference)-441.9(on)-436.2(Harmonisation)]TJ 0 -1.1923 TD [(\(ICH\))-353.9(Harmonised)-348.7(Tripartite)-353.4(Guideline)-348.1(for)-351.5(Good)-350.9(Clini-)]TJ T* [(cal)-358.7(Practice)-352.8(\(CPMP/ICH/135/95;)-353.1(ICH)-353.9(GCP\))-354.7(and)-352.3(the)]TJ 0 -1.1869 TD [(World)-674.5(Medical)-679.1(Association)-672.9(Declaration)-677.9(of)-673.6(Helsinki)]TJ 0 -1.1923 TD [(entitled)-206.6(Ethical)-211.7(Principles)-204(for)-210.6(Medical)-207.6(Research)-208.4(Involv-)]TJ T* [(ing)-312.4(Human)-311.2(Subjects.)-313.9(Informed)-310.6(consent)-311(by)-311.5(the)-316.6(patients)]TJ 0 -1.1869 TD [(and/or)-300.5(the)-300.3(legal)-304(representative/next)-301.6(of)-299.7(kin)-301.5(was)-298.1(obtained,)]TJ 0 -1.1923 TD [(accordingly)-580.6(to)-573.9(the)-576.7(local)-580.4(legislations,)-573.5(for)-579.1(all)-578.9(patients)]TJ T* [(recruited)-268(in)-259.6(the)-262.4(core)-262(data)-265.2(set)-263.6(of)-261.8(CENTER-TBI)-264.4(and)-260.2(docu-)]TJ 0 -1.1869 TD [(mented)-306.6(in)-308.3(the)-305.7(e-CRF.)-305.2(Ethical)-308.6(approval)-302(was)-308.9(obtained)-305.2(for)]TJ 0 -1.1923 TD [(each)-283.5(recruiting)-280.9(site.)-285.4(The)-281.7(list)-278.6(of)-283.4(sites,)-279.7(ethical)-280.5(committees,)]TJ T* [(approval)-567.5(numbers,)-563.8(and)-569.1(approval)-567.5(dates)-563.1(can)-567.9(be)-570.5(found)]TJ 0 -1.1869 TD [(on)-452.5(the)-457.5(study)-451.7(website)-452.9(https://www.center-tbi.eu/project/)]TJ 0 -1.1923 TD (ethical-approval.)Tj /F2 1 Tf 0 -3.0458 TD [(Outcomes)-302.5(at)-300.5(6)-298.2(months)]TJ /F3 1 Tf 0 -1.7614 TD -.0178 Tc [(Glasgow)-221(O)2.6(ut)-4.7(come)-216.9(Scale)-222.4(E)-.3(xtended)-220(\()3.1(GOSE\).)]TJ /F7 1 Tf 17.8685 0 TD -.0175 Tc [(The)-220.9(G)1.4(OSE)]TJ 7.8454 0 0 6.9729 291.2314 320.7117 Tm -.0231 Tc (31)Tj 10.4607 0 0 10.4607 59.7543 303.5905 Tm -.0183 Tc [(assesses)-240.3(g)4.8(lobal)-235.9(f).4(unctional)-241.3(o)4.8(utcome)-243.3(follo)4.8(w)-4.9(ing)-239.1(T)-.5(BI.)-239.8(I).4(t)-235.9(p)-.6(rovi-)]TJ 0 -1.1869 TD -.0177 Tc [(des)-331.8(e)1.2(ight)-327.4(ordin)5.4(a)-4.3(l)-327.4(c)1.1(ategories)-326.4(o)0(f)-324.2(outcome:)-332.9(d)5.4(ead)-325.2(\()1(1\);)-327.4(v)0(eg)5.4(eta-)]TJ 0 -1.1923 TD -.018 Tc [(tive)-508.6(state)-508.6(\().7(2\);)-512(l)2.9(ower)-508.8(severe)-508.6(disability)-504.4(\(3\);)-512(u)5.1(pper)-508.8(s)-1.5(evere)]TJ T* -.0175 Tc [(disability)-200.4(\(4\);)-202.6(lower)-199.4(m)-.7(od)5.6(erate)-199.2(d)]TJ 12.0044 0 TD -.0165 Tc [(is)5.4(ab)6.6(il)4.4(it)4.4(y)-204.8(\()2.2(5\);)-201.6(u)6.6(pper)-203.8(m).3(o)6.6(d)1.2(erat)4.4(e)]TJ -12.0044 -1.1869 TD -.018 Tc [(disability)-439.3(\(6\);)-447(lower)-443.7(g)5.1(ood)-444.8(recovery)-444.8(\(7\);)-447(and)-439.3(upper)-443.7(good)]TJ 0 -1.1923 TD -.0184 Tc [(r)-5.2(e).5(covery)-412.6(\(8\).)-413.3(GOSE)-412.4(was)-413.8(assessed)-412.6(a).5(t)-414.9(6)-412.6(months)-413.8(by)-412.6(either)]TJ T* -.0177 Tc [(a)-513.7(q)5.4(uestionnaire)-508.3(o)0(r)-508.5(a)-508.3(telep)5.4(hone)-508.3(interview.)-510.2(When)-509.5(it)-506.3(was)]TJ 0 -1.1869 TD [(assessed)-379.3(o).1(u)5.5(t)-2.2(side)-378.1(th)5.5(e)-383.5(t)3.3(ime)-378.1(w)]TJ 11.1156 0 TD -.0179 Tc [(indow)-378.4(\(range)-378.4(58)-374.2(months\),)-374.9(it)]TJ -11.1156 -1.1923 TD -.0188 Tc [(w)-5.3(a)0(s)-230(i)-3.4(mpute)-5.4(d)-228.8(based)-228.8(o)-1.1(n)-228.8(a)-5.4(ll)-231(GO)-5.3(SE)-228.6(mea)-5.4(s)3.1(ure)-5.4(m)3.5(ents)-230(availa)-5.4(ble.)]TJ 7.8454 0 0 6.9729 291.2314 208.6299 Tm -.0231 Tc (32)Tj 10.4607 0 0 10.4607 59.7543 191.5086 Tm -.0185 Tc [(For)-363(t)-3.1(he)-368.2(analyse)-5.1(s)3.4(,)-364.7(G)-5(OSE)-363.8(w)-5.1(as)-365.1(dichotomized)-364(to)-364(inc)-5.1(o)4.6(mplete)]TJ 0 -1.1869 TD -.0196 Tc [(\()-6.4(GOSE)]TJ /F5 1 Tf 3.1867 0 TD 0 Tc (<)Tj /F7 1 Tf .5311 0 TD -.0183 Tc [(8\))-341.1(and)-336.7(c).5(omplete)-335.5(\()-5.1(GOSE)]TJ /F5 1 Tf 9.7553 0 TD 0 Tc (=)Tj /F7 1 Tf .6991 0 TD -.0193 Tc [(8\))-342.1(return)-343.1(to)-343.1(pre)-5.9(-)-.6(inj)-3.9(u)-1.6(ry)]TJ -14.1723 -1.1923 TD -.0177 Tc [(level)-300.3(o)0(f)-297.1(f)-4.5(u)5.4(n)0(ctioning)5.4(.)]TJ /F3 1 Tf 0 -2.8561 TD 0 Tc [(Short)-521.7(Form)-513.1(Health)-519.3(Surveys)-518.4(\(SF-12v2;)-513.6(SF-36v2\).)]TJ /F7 1 Tf 21.4237 0 TD (SF-)Tj -21.4237 -1.1869 TD [(12v2)-455.1(with)-452.9(12)-457.9(items)-453.5(and)-455.3(SF-36v2)-448.8(with)-452.9(36)-457.9(items)]TJ 7.8454 0 0 6.9729 273.4298 128.9763 Tm (33)Tj 10.4607 0 0 10.4607 286.0157 124.3275 Tm (are)Tj -21.6297 -1.1923 TD [(self-reported)-380.9(and)-374(generic)-378(measures)-377.6(of)-375.6(HRQoL.)-376.5(The)-373.8(re-)]TJ T* [(sults)-325(can)-318.6(be)-321.2(summarized)-322.5(as)-322.4(mental)-325.1(\()-78.9(MCS\))-322.6(and)-319.8(physical)]TJ 0 -1.1869 TD [(\(PCS\))-420.1(component)-410.8(scores)-418.7(ranging)-412.9(from)-415.9(0)-415.9(t)0(o)-416.7(100.)-417.8(MCS)]TJ 0 -1.1923 TD -.0127 Tc [(a)-12.7(n)7.6(d)-304(P)-12.7(C)13(S)-306.2(w)-12.7(e)8.8(re)-308.2(based)-309.4(o)-.5(n)-304(a)-308.2(SF)-12.7(-)10.6(12v2)-304(scor)-12.7(e)8.6(,)-304.7(a)-12.7(n)7.6(d)-304(w).8(he)-12.7(n)-295.9(t)-12.7(h)15(e)-12.7(r)8.6(e)]TJ T* -.013 Tc [(w)-13(a)8.5(s)-289.2(n)-.8(o)-293.4(S)2.5(F)-13(-)10.3(12v2)-288(scor)-13(e)8.3(,)-288.7(t)-13(h)9.3(e)-292.2(s)3.5(c)-13(o)7.3(re)-292.2(was)-294.6(d)-.8(eri)-13(v)9.3(ed)-293.4(usi)-13(n)9.3(g)-288(c)-13(o)7.2(rre-)]TJ 0 -1.1869 TD -.0124 Tc [(spondi)-12.4(n)9.9(g)-298.2(i)-12.4(t)13.1(e)-12.4(m)12.5(s)-299.4(f)-12.4(r)8.7(o)-.2(m)-299.1(a)1(va)-12.4(i)11.1(l)-12.4(a)11.1(b)-.2(l)-12.4(e)-292.4(SF)-12.4(-)10.9(36v2)-298.2(quest)-12.4(i)13.1(onna)-12.4(i)11.1(r).8(e)-12.4(s)6.7(.)]TJ /F3 1 Tf 24.0035 64.2875 TD 0 Tc [(Quality)-264.2(of)-268.2(Life)-267.9(after)-270.1(Brain)-267(Injury-Overall)-264.3(Scale)-267.7(\(QOLIBRI-)]TJ 0 -1.2357 TD (OS\).)Tj /F7 1 Tf 2.6502 0 TD [(The)-335.9(QOLIBRI-OS)]TJ 7.8454 0 0 6.9729 417.5432 713.8203 Tm (34)Tj 10.4607 0 0 10.4607 428.8251 709.1714 Tm [(is)-336.6(a)-333.4(brief)-333.4(TBI-specic)-333.3(index)]TJ -11.2782 -1.1923 TD [(of)-543.6(HRQoL)-545.2(that)-545(covers)-547.6(physical)-539.4(condition,)-544.9(cognition,)]TJ 0 -1.1869 TD [(emotions,)-313.1(daily)-310.6(life,)-315.7(personal/social)-315(aspects,)-315.7(and)-314.4(current)]TJ 0 -1.1923 TD [(situation/future)-388.7(prospects.)-388.9(The)-384.6(total)-394.1(score)-386.4(is)-390.8(on)-387.4(a)-393(scale)]TJ T* [(that)-301.1(ranges)-298.3(0100.)]TJ /F3 1 Tf 0 -2.092 TD [(Rivermead)-420.9(Post-Concussion)-427.9(Symptoms)-423.8(Questionnaire)]TJ 0 -1.2411 TD (\(RPQ\).)Tj /F7 1 Tf 3.5065 0 TD [(The)-514.7(RPQ)]TJ 7.8454 0 0 6.9729 389.4802 629.1211 Tm (35)Tj 10.4607 0 0 10.4607 402.6896 624.4723 Tm [(measures)-518.5(cognitive,)-511.2(somatic,)-513.8(and)]TJ -8.7798 -1.1869 TD [(emotional)-485.7(symptoms)-488.2(that)-485.4(are)-491(compared)-483.6(with)-490.8(the)-484.6(pre-)]TJ 0 -1.1923 TD [(injury)-385.2(level.)-390(It)-388.6(contains)-387.7(16)-387.4(items)-388.5(that)-393.3(can)-389(be)-386.2(answered)]TJ 0 -1.1869 TD [(wi)12.6(th)-292.1(0)]TJ /F5 1 Tf 2.7206 0 TD (=)Tj /F7 1 Tf .71 0 TD [(not)-285.3(exp)16.2(eri)15(enc)12(ed,)-288(1)]TJ /F5 1 Tf 7.5658 0 TD (=)Tj /F7 1 Tf .7154 0 TD [(no)-289.9(mo)12.8(re)-293.1(of)-288.9(a)-295.5(pro)16(bl)11.4(em)-294.9(\(t)12.4(han)]TJ -11.7118 -1.1923 TD [(before)-328.6(the)-332.8(injury\),)-333.3(2)]TJ /F5 1 Tf 8.4275 0 TD (=)Tj /F7 1 Tf .7154 0 TD [(mild)-330.2(problem,)-331.8(3)]TJ /F5 1 Tf 6.7637 0 TD (=)Tj /F7 1 Tf .7154 0 TD [(moderate)-334.1(prob-)]TJ -16.622 -1.1923 TD [(lem,)-414.2(or)-413.5(4)]TJ /F5 1 Tf 4.0864 0 TD (=)Tj /F7 1 Tf .7208 0 TD [(severe)-416.3(problem.)-413.1(When)-413.3(calculating)-416.8(the)-414.1(total)]TJ -4.8072 -1.1869 TD [(score,)-212.3(the)-219(category)-214()45.8(no)-211.6(more)-215.2(of)-218.4(a)-214.2(problem)-213.2(\(than)-215.2(before\))44.7()]TJ 0 -1.1923 TD [(is)-298.7(treated)-299(as)-300.7(0,)-301.4(and)-298.1(it)-299.7(has)-299.3(a)-300.9(score)-299.7(range)-298.5(of)-299.7(0-64.)]TJ /F3 1 Tf 0 -2.0974 TD [(Patient)-446.8(Health)-443.4(Questionnaire)-443.1(\(PHQ-9\).)]TJ /F7 1 Tf 17.2777 0 TD [(The)-449.7(PHQ-9)]TJ 7.8454 0 0 6.9729 542.0975 520.0439 Tm (36)Tj 10.4607 0 0 10.4607 310.8472 502.9794 Tm [(m)11.4(e)0(a)16(s)0(u)12.4(r)0(e)15.8(s)-303.3(s)11(y)0(m)12.8(p)12.2(to)16.8(ms)-297.3(of)-294.3(de)14.8(pr)14.6(es)19.1(si)15.7(on)19.1(.)-308.2(I)0(t)-291.1(c)0(o)14.8(n)0(t)16.8(a)0(i)12.6(n)12.2(s)-303.3(n)0(i)11.4(n)12.2(e)-306.3(i)0(t)14.6(e)0(m)19.4(s)]TJ 0 -1.1923 TD [(using)-598(a)-604.4(4-point)-600.6(Likert)-606.1(scale)-599.8(\(from)-603.2(0)]TJ /F5 1 Tf 16.5298 0 TD (=)Tj /F7 1 Tf .7208 0 TD [(not)-599.6(at)-605.2(all)-600.6(to)]TJ -17.2506 -1.1923 TD (3)Tj /F5 1 Tf .6666 0 TD (=)Tj /F7 1 Tf .7154 0 TD [(nearly)-299.3(every)-298.5(day\),)-300.4(and)-298.1(it)-299.7(has)-304.7(a)-295.5(score)-305.1(range)-298.5(of)-299.7(027.)]TJ /F3 1 Tf -1.382 -2.092 TD [(Generalized)-604.6(Anxiety)-606.5(Disorder)-608.1(7-item)-604.5(scale)-605.6(\(GAD-7\).)]TJ /F7 1 Tf 0 -1.1923 TD (GAD-7)Tj 7.8454 0 0 6.9729 342.0849 448.3274 Tm (37)Tj 10.4607 0 0 10.4607 354.3873 443.6786 Tm [(measures)-431.8(symptoms)-428.6(of)-424.3(anxiety.)-430.5(It)-426.6(comprises)]TJ -4.1623 -1.1869 TD [(seven)-365.7(items)-361.4(that)-366.2(can)-361.9(be)-364.5(answered)-369(from)-361.7(0)]TJ /F5 1 Tf 17.2452 0 TD (=)Tj /F7 1 Tf .7154 0 TD [(not)-366.5(at)-366.8(all)-362.2(to)]TJ -17.9606 -1.1923 TD (3)Tj /F5 1 Tf .6666 0 TD (=)Tj /F7 1 Tf .7154 0 TD [(nearly)-413.1(every)-412.3(day,)-411.2(and)-411.9(it)-413.5(can)-410.7(have)-414.7(a)-414.7(score)-408.1(range)-412.3(of)]TJ -1.382 -1.1923 TD (021.)Tj /F3 1 Tf 0 -2.092 TD [(Post-Traumatic)-450.3(Stress)-449.4(Disorder)-451(\(PTSD\).)]TJ /F7 1 Tf 17.4512 0 TD [(Checklist)-450.1(for)]TJ -17.4512 -1.1923 TD (the)Tj /F9 1 Tf 1.5663 0 TD [(Diagnostic)-338.3(and)-342.7(Statistical)-339.3(Manual)-338.3(of)-340.9(Mental)-339.3(Disor-)]TJ -1.5663 -1.1869 TD [(ders,)-461(Fifth)-460.1(Edition)]TJ /F7 1 Tf 8.2595 0 TD [(\(PCL-5\).)-456.6(PCL-5)]TJ 7.8454 0 0 6.9729 467.3763 364.1952 Tm (38)Tj 10.4607 0 0 10.4607 480.0187 359.5464 Tm [(measures)-458.9(symp-)]TJ -16.1721 -1.1923 TD [(toms)-378(of)-381(PTSD)-376.8(according)-380.6(to)-378.8(DSM-5)-383(criteria.)-379.4(It)-377.8(consists)]TJ T* [(of)-386.4(20)-387.4(items)-383(that)-387.9(can)-389(be)-386.2(answered)-390.6(with)-387.8(0)]TJ /F5 1 Tf 17.1748 0 TD (=)Tj /F7 1 Tf .7208 0 TD [(not)-388.2(at)-383(all)-389.2(to)]TJ -17.8956 -1.1869 TD (4)Tj /F5 1 Tf .6666 0 TD (=)Tj /F7 1 Tf .7154 0 TD [(extremely,)-301.7(and)-298.1(it)-299.7(has)-299.3(a)-300.9(score)-299.7(range)-298.5(of)-299.7(080.)]TJ -.336 -1.1923 TD [(For)-262.6(QOLIBRI-OS)-267.2(and)-265.6(SF-12v2)-259.1(higher)-268(values)-263.6(indicate)]TJ -1.046 -1.1923 TD [(better)-393.7(quality)-396.7(of)-397.2(life/more)-391.5(favorable)-395.9(outcomes,)-396.4(and)-395.7(for)]TJ 0 -1.1869 TD [(RPQ,)-274.5(PHQ-9,)-278.3(GAD-7,)-280.3(and)-276.4(PCL-5)-277.8(higher)-278.9(values)-279.8(indicate)]TJ 0 -1.1923 TD [(more)-296.5(severe)-302.5(symptoms/less)-297.1(favorable)-298.3(outcomes.)]TJ /F2 1 Tf 0 -2.1895 TD [(Exposure,)-299.5(baseline)-299.4(covariates)]TJ 0 -1.2357 TD [(and)-300.8(mediator)-298.7(variables)]TJ /F7 1 Tf 0 -1.2032 TD [(Figure)-449.1(1)-448.4(shows)-449.4(the)-452.1(examined)-448.9(mediation)-453.1(model)-444.7(for)-454.5(6-)]TJ 0 -1.1923 TD [(month)-261.6(outcomes.)-260.9(Sex/gender)-267.6(was)-265.6(considered)-261.2(as)-268.2(the)-262.4()45.8(ex-)]TJ 0 -1.1869 TD [(posure)49.8()-295.7(\(i.e.,)-297.2(a)-300.9(variable)-297.6(associated)-302.4(with)-295.7(outcome\))-297.3(and)-298.1(it)]TJ 0 -1.1923 TD [(was)-298.1(coded)-299.5(as)-300.7(binary)-300.5(variable)-297.6(\(men)-301.9(vs.)-295.8(women\).)]TJ 1.046 -1.1923 TD [(Psychiatric)-266.4(history)-260.4(included)-261.8(self-reported)-267(medical)-262.8(his-)]TJ -1.046 -1.1869 TD [(tory)-326.2(of)-326.8(anxiety,)-327.6(depression,)-327.9(sleep)-330(problems,)-326.1(schizophre-)]TJ 0 -1.1923 TD [(nia,)-478.5(substance)-481.6(abuse,)-478.9(or)-484(other)-480.8(disorders)-476.5(at)-480.6(admission.)]TJ T* [(Care)-242.3(pathway)-243.5(mediators)-245.2(were)-244.5(selected)-249.8(based)-241.1(on)-246.5(previous)]TJ 0 -1.1869 TD [(analyses)-618.5(of)-619.4(differences)-619.7(between)-621.7(men)-618.7(and)-617.9(women.)]TJ 7.8454 0 0 6.9729 542.0975 128.9763 Tm (14)Tj 10.4607 0 0 10.4607 310.8472 111.8551 Tm [(Referral)-425.4(was)-422.7(categorized)-426.5(to)-422.1(primary)-423.6(\(direct)-423.8(transfer)-425.8(to)]TJ 0 -1.1923 TD [(the)-300.3(study)-299.9(hospital\))-296.5(and)-303.5(secondary)-298.3(\(transfer)-304.1(from)-296.7(another)]TJ 0 -1.1869 TD [(hospital)-548.2(to)-546.8(the)-549.6(study)-543.8(hospital\).)-550.6(Discharge)-548.6(destination)]TJ 0 -1.1923 TD [(from)-329.2(the)-332.8(ED)-331.8(was)-330.6(dened)-327.4(based)-333.2(on)-327.8(discharge)-333.1(home,)-329.3(ad-)]TJ T* [(mission)-458.5(to)-460.1(intensive)-458.9(care)-461.3(unit)-454.1(or)-462.3(operating)-459.9(room,)-454.2(and)]TJ 0 -1.1869 TD [(other)-594.6(admission)-595.4(\(hospital)-594.6(ward,)-591.9(other)-594.6(hospital\))-594.6(after)]TJ ET 59.754 747.156 406.488 .51025 re f BT /F4 1 Tf 9.9626 0 0 9.9626 59.7543 753.8455 Tm [(MED)-10.3(IATORS)-307.4(OF)-302.7(SEX)-302.9(DIFFE)-10.3(RENCES)-305.4(IN)-306.7(MTBI)-302.7(OUT)-8.8(COMES)-22532.3(3317)]TJ ET endstream endobj 72 0 obj <>stream /GS1 gs BT /F7 1 Tf 10.4607 0 0 10.4607 62.022 336.0755 Tm 0 0 0 rg 0 Tc 0 Tw [(ED.)-612.9(Gender-related)-614.1(sociodemographic)-606.9(mediator)-613.9(vari-)]TJ 0 -1.1923 TD [(ables)-335.4(were)-331.2(assessed)-331.4(at)-334.2(admission:)-330.7(living)-328.8(alone)-334.3(\(yes/no\);)]TJ T* [(living)-383(with)-387.8(children)-385.5(\(yes/no\);)-380(education)-389.3(\(in)-381.8(years\);)-390.2(and)]TJ 0 -1.1869 TD [(employment)-450.3(status/job)-451.3(category)-447.1(\(unemployed;)-451.1(student;)]TJ 0 -1.1923 TD [(retired;)-749.8(professional/manager;)-748.6(associate)-753.6(professional/)]TJ T* [(technician;)-346.4(clerk/sales)-345.5(and)-346.9(service)-346.7(worker;)-345.7(skilled)-343.7(man-)]TJ 0 -1.1869 TD [(ual)-359.9(worker)-355.7(or)-359.3(machine)-358.2(operator;)-361.4(other)-356.1(manual)-360.8(worker\).)]TJ 0 -1.1923 TD [(Jobs)-424.9(indicated)-424(in)-422.2(the)-425(category)-425.4()45.8(other)49.7()-425.7(were)-423.4(classied)]TJ 0 -1.1869 TD [(into)-1099(existing)-1095.6(categories)-1096.8(using)-1096.6(European)-1096.2(Skills/)]TJ 0 -1.1923 TD [(Competences,)-283.4(qualications)-277.7(and)-281.8(Occupations,)]TJ 7.8454 0 0 6.9729 256.592 228.6424 Tm (39)Tj 10.4607 0 0 10.4607 267.3637 223.9937 Tm [(and)-281.8(ser-)]TJ -19.6298 -1.1923 TD [(vice)-319.4(workers)-317.6(were)-320.4(categorized)-318.1(with)-317.4(clerk/sales)-318.4(workers,)]TJ 0 -1.1869 TD [(and)-569.1(machine)-564.1(operators)-571.7(with)-566.7(skilled)-565.9(manual)-566.7(workers.)]TJ 0 -1.1923 TD [(Sheltered/)-429.2(special)-425.8(employments)-428.4(was)-428.1(categorized)-426.5(under)]TJ T* [(other)-491.6(manual)-485.4(worker.)-490.5(For)-490.2(age)-486.6(analyses,)-493.1(smaller)-491.8(cate-)]TJ 0 -1.1869 TD [(gories)-318(were)-320.4(merged:)-315(for)-319(age)-318.6(group)-317.2(16-45)-317.2()51.2(retired)47.1()-317.4(was)]TJ 0 -1.1923 TD [(merged)-400.9(with)-404.1()45.8(unemployed)50.7(;)-404.9(for)-400.3(45-65)-403.9()45.8(student)53.6()-404.1(was)]TJ T* [(merged)-335.9(with)-333.6()51.2(unemployed)50.7(;)-334.4(for)]TJ /F5 1 Tf 13.7604 0 TD (>)Tj /F7 1 Tf .5528 0 TD [(65,)-332.5(all)-329.6(working)-331.6(cate-)]TJ -14.3132 -1.1869 TD [(gories)-453.5(were)-455.9(merged)-455.1(together,)-455.2(and)-455.3()45.8(unemployed)50.7()-452.8(was)]TJ 0 -1.1923 TD [(merged)-297.9(with)-301.1()45.8(retired.)47.8()]TJ 1.046 -1.1923 TD [(To)-539(control)-539.8(for)-535.8(confounding)-537.4(between)-540.4(exposure)-539.4(and)]TJ -1.046 -1.1869 TD [(outcome,)-315.3(exposure)-311.8(and)-314.4(mediator,)-309.7(and)-314.4(mediator)-315.8(and)-314.4(out-)]TJ 0 -1.1923 TD [(come,)-252.3(we)-254.9(conditioned)-249(on:)-252.7(age;)-254.4(pre-injury)-251.8(physical)-252.2(health)]TJ T* [(\(no)-417.5(systemic)-416.8(disease;)-420.2(mild)-417(systemic)-422.2(disease;)-414.7(severe)-421.8(of)]TJ 0 -1.1869 TD [(life-threatening)-419.9(systemic)-422.2(disease\);)-417.8(cause)-424.2(of)-418.9(injury)-417.8(\(fall)]TJ 23.998 27.3799 TD [(or)-283.4(other)-274.8(unintentional)-277.7(injury;)-277.7(motor)-276.8(vehicle)-278.3(accident;)-281.9(vi-)]TJ 0 -1.1923 TD [(olence,)-406.8(suicide)-405.3(attempt)-407.2(or)-402.7(other\);)-403.3(baseline)-408.1(GCS)-405.3(\(range)]TJ T* [(13-15\);)-434.8(baseline)-440.7(pupillary)-430.8(reactivity)-434.7(\(both)-438.6(reactive/one)]TJ 0 -1.1869 TD -.0164 Tc [(o)-4.2(r)-203.7(bo)-4.2(th)-199.3(u)-4.2(n)1.3(reactiv)-4.2(e\);)-201.5(h)-4.2(yp)-4.2(oxia)-208.9(\()2.3(y)-4.2(e)2.5(s)-5.4(/)-1(no)-4.2(\);)-206.9(hyp)-4.2(otens)-5.4(i)-1(on\(y)-4.2(e)2.5(s)-5.4(/)-1(no\);)]TJ 0 -1.1923 TD 0 Tc [(Injury)-560.9(Severity)-555.7(Score)-555.4(\(ISS\);)-558.8(rst)-557.2(Marshall)-559.9(CT)-557.2(score)]TJ T* [(\(no)-271.2(visible)-267.8(pathology;)-262.4(cisterns)-268.6(present)-272(with)-268.6(0-5)-162.8(mm)-269.8(mid-)]TJ 0 -1.1869 TD [(line)-474.6(shift,)-473.8(cisterns)-469.1(compressed)-472.4(or)-473.1(absent)-469.5(with)-469.1(0-5)-168.2(mm)]TJ 0 -1.1923 TD [(midline)-533(shift;)-529.6(midline)-533(shift)]TJ /F5 1 Tf 12.1074 0 TD (>)Tj /F7 1 Tf .5528 0 TD [(5)-166.6(mm,)-529.3(evacuated)-531(lesion,)]TJ -12.6602 -1.1869 TD [(non-evacuated)-470.2(mass)-467.9(lesion\);)-471.4(subarachnoid)-469.8(hemorrhage)]TJ 0 -1.1923 TD [(on)-289.9(CT)-286.3(\(yes/no\);)-282.5(and)-287.3(epidural)-287.9(hematoma)-287.1(on)-284.4(CT)-286.3(\(yes/no\).)]TJ /F2 1 Tf 0 -2.3738 TD [(Statistical)-302.9(analysis)]TJ /F7 1 Tf 0 -1.2032 TD [(Descriptive)-366(statistics)-361.4(for)-356.9(TBI)-365.1(characteristics,)-359.7(mediators,)]TJ 0 -1.1923 TD [(treatment,)-401.5(and)-395.7(outcome)-397.3(variables)-400.3(were)-396.3(presented)-398.1(sepa-)]TJ 0 -1.1869 TD [(rately)-241.9(for)-243.1(men)-239.3(and)-243.9(women)-240.7(using)-240.3(percentages)-241.2(for)-237.7(categor-)]TJ 0 -1.1923 TD [(ical)-473.4(variables)-470.8(and)-471.5(median)-469.2(with)-469.1(interquartile)-469.6(range)-471.9(for)]TJ T* [(continuous)-651.6(outcomes.)-645.7(Differences)-651(were)-656.4(tested)-650.6(using)]TJ 0 -1.1869 TD -.0138 Tc [(no)3.9(n-)4.9(par)4.9(a)-.4(metric)-287.6(te)5(sts)-284.6(\()-.6(e)5.1(.)-2.3(g)3.9(.)3.2(,)-289.5(c)]TJ 10.8555 0 TD -.0147 Tc [(hi-)4(s)-3.7(qua)4.2(r)-1.5(ed)-284.3(and)-284.3(M)-2.3(ann-Whitney)]TJ -10.8555 -1.1923 TD 0 Tc [(U)-300.9(test;)-303.1(Table)-301.6(1;)-297.5(Supplementary)-299(Table)-296.1(S1\).)]TJ 1.0514 -1.1923 TD [(We)-221(performed)-215.8(mediation)-220.1(analyses)-217.4(by)-219.4(tting)-217.2(natural)-224.3(ef-)]TJ -1.0514 -1.1869 TD [(fect)-204.6(models)-195.2(for)-199.7(nested)-204(counterfactuals)-201(using)-196.9(the)]TJ /F9 1 Tf 19.0499 0 TD (medex)Tj /F7 1 Tf 7.8454 0 0 6.9729 544.3652 91.6157 Tm (40)Tj 10.4607 0 0 10.4607 313.0582 74.4944 Tm [(package)-229.3(in)-232.5(R.)-227.5(This)-225.2(method)-226.5(decomposes)-229.5(the)-224.4(total)-231.5(effect)-226.7(of)]TJ 0 -1.1923 TD [(an)-234.5(exposure)-230.5(on)-224.8(an)-234.5(outcome)-229.3(into)-226.5(1\))-229.2(the)-235.3(natural)-229.7(indirect)-230.5(ef-)]TJ 0 -1.1869 TD [(fect)-231.7(\(i.e.,)-226.8(the)-224.5(effect)-226.7(of)-229.2(the)-224.4(exposure)-225.1(on)-224.8(the)-229.9(outcome)-223.9(that)-225.3(is)]TJ ET 1 i q 1 0 0 1 62.022 723.231 cm 0 0 m .113 1.077 l .243 3.207 2.802 5.766 4.932 5.896 c 6.009 6.009 l 6.009 4.989 l 5.102 4.932 l 3.046 4.576 1.434 2.963 1.077 .907 c 1.02 0 l f* Q q 1 0 0 1 546.236 729.241 cm 0 0 m 1.02 -.113 l 3.151 -.244 5.709 -2.802 5.839 -4.932 c 5.953 -6.009 l 4.932 -6.009 l 4.876 -5.102 l 4.541 -3.097 2.883 -1.371 .85 -1.077 c 0 -1.02 l f* Q 68.031 728.22 478.205 1.0204 re f q 1 0 0 1 68.031 363.401 cm 0 0 m -1.077 .113 l -3.207 .244 -5.766 2.802 -5.896 4.932 c -6.009 5.953 l -4.989 5.953 l -4.932 5.102 l -4.576 3.046 -2.964 1.434 -.907 1.077 c 0 1.02 l f* Q q 1 0 0 1 552.189 369.354 cm 0 0 m -.113 -1.02 l -.244 -3.151 -2.802 -5.709 -4.932 -5.839 c -5.953 -5.953 l -5.953 -4.932 l -5.102 -4.876 l -3.097 -4.541 -1.371 -2.883 -1.077 -.85 c -1.02 0 l f* Q 68.031 363.401 478.205 1.0205 re f 62.022 369.354 1.0205 353.877 re f 551.168 369.354 1.0204 353.877 re f q 80.844 719.263 m 533.367 719.263 l 533.367 464.315 l 80.844 464.315 l W n q 452.763 0 0 254.948 80.844 464.315 cm /Im1 Do Q Q BT /F4 1 Tf 9.9626 0 0 9.9626 78.9732 446.3432 Tm [(FIG.)-337.6(1.)]TJ /F3 1 Tf 3.8696 0 TD [(The)-302.7(pro)-9(posed)-302.3(medi)-9.9(ation)-301.2(mo)-8.8(del)-302.3(with)-301.9(dire)-8.8(ct)-300.8(and)-301.9(indirec)-9.9(t)-304(pathways)-310.3(\(via)-301.7(psychi)-10.1(atric)-306.5(history)-10.6(,)]TJ -3.8696 -1.2974 TD [(sociod)-10.7(emographi)-10.8(c)-298.5(varia)-9.4(bles)-300(and)-307.6(care)-306.3(pathways\))-12.2(.)]TJ 7.4718 0 0 6.641 285.8456 437.8393 Tm (1)Tj 9.9626 0 0 9.9626 289.644 433.4172 Tm [(Age,)-309.4(pre-injur)-10.3(y)-300.2(physic)-10.2(al)-299.2(health,)-310.2(cause)-306.8(of)-300.4(injury)-10.6(,)-298.1(basel)-8.8(ine)]TJ -21.1461 -1.3031 TD [(Glasgo)-9.9(w)-301(Coma)-306.4(Score)-307.2(\(GCS;)-308.4(13-15\),)-304.1(basel)-8.8(ine)-301(pup)-8(illary)-303.1(reactiv)-10.3(ity;)-303.4(hypox)-8.2(ia;)-301.4(hypotens)-11.7(ion,)-307.7(Injury)-306.5(Severi)-7.6(ty)-302.6(Score)]TJ 0 -1.2974 TD [(\(ISS\),)-304.5(Mar)-7.4(shall)-301.1(CT)-304.7(score,)-306.7(su)-8.6(barachno)-9.5(id)-301.6(hemorrha)-13.2(ge,)-298.8(epi)-6.4(dural)-302.5(he)-6.4(matoma.)-310.7(CT,)-301.2(co)-7.8(mputed)-304.8(to)-7.6(mography)-10.1(;)-298.1(ER,)]TJ 0 -1.3031 TD [(emerg)-7.4(ency)-303.5(room;)-308.8(GOSE,)-309.8(Glasgow)-305.2(Out)-9.2(come)-302.3(Sca)-7.6(le)-301(Extende)-8.5(d;)-305.1(HRQoL,)-305.5(he)-6.4(alth-related)-312.1(quality)-305.5(of)-306.1(life;)-306.7(PTSD,)]TJ 0 -1.2974 TD [(post-tr)-11(aumatic)-306.2(stre)-8.8(ss)-302.6(disorder.)]TJ ET 145.701 747.156 406.488 .51025 re f BT /F4 1 Tf 9.9626 0 0 9.9626 62.022 754.3557 Tm (3318)Tj 42.2865 0 TD [(MIKOLIC)-311.3(ET)-299.4(AL.)]TJ ET endstream endobj 74 0 obj <>stream AdobedC        s!1AQa"q2B#R3b$r%C4Scs5D'6Tdt& EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz?Nlٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfom=NO0xS>_n`B3V;/?!YZA{!B FG}3?P51jooEF<9=nO#ƻ-jzѮ$݈SCTtɮ?-I#\$Ur VWF)S5_&hfGDY'&0A!:Z't"U kl*I55;_7vi^]"LlOC +Zyw\5+t" x^xd^οD%>`%ڃ'ǘ0smň$Bמ|u}9њZuVh]@,Aw6^dkFF 1#q|&Iޔ>\_DSC曦WO#rKV>5_RkZy3TmnXCq)RꆜtMoWui0ٽJFv5QM/gRHHf N'Ng}Z!>Ტ<1>8B|?,||t̄pdP;mum[>\ѵ q%嵥M +,p2HWefjt+9t hc+Hg;?u JPmu܋#Zy'~kԴGZt/Y̦9^-Bۧ~K_3~\M ZXAv*>g; S$Kh~vށ}Jm.%\Ѹv:gg:RQs7߰ ͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ áY-ޏx%zs4,jt2K-t@V$MOEOٳf͛##F_6橚kP8hJRwH3f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͍2F>ȷο޴?ο뷡޴?ο뷡޴ο뷡޴ο޴ο޴ο뷡޴ο޴ο뷡<EHnOA͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳe3*f!UEY|a 3G {1c ̒ Uڽ3yʑ!WUusv=W$]3WRhJ>WU_#Zȥ>WU_#Zȥ>WU_#Zȥ>WU_#Zȥ>WU_#Zȥ>WU_#Zȥ>WU_#Zȥ>WU_#Zȥ>WU_#Zȥ·\izUf3.-UT! 6.M^/#^FKKuf+:?2ia/)W>KZ7INlٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳ`]SUӴori n^wO^PaM:״`{gD,|vvX$xMǩ?woPYik'jZm^\ڔfA0HDw?5+jFmu}zKuL^|f8Z{L|mvMSn-Cld"XՒ2kqiP70"c4ݻo9ב1׫ygUH5+/ak5 R.QXxܶ^?ЦeKܵnCp1Cm֘U@h斩gg*YzrVuJa@TkiنezK5ۭ0m? kyIem}.{4ȒPXQƠ0W|g^xf[;X"y}0 A8Yt]+WK}q \A,"L'Tm<IyOB<ѶkK$n3Z2GLkyv=wNk{ssm4eONN%Y@9槛<3g_sEo4vg~9p@}6`Wu`t1^{e&Gik*LŽ+Ȥ *ӓ%/=;P|.y@ҭg-) Wc>&>Ş?>/qlh7/4,!tY[lC|,6~U3/ (>و"3ٰg.=W XBH<9s~ZMί1PNcyФzT ۂWsyTCVMfʬXP :o䗖yM͡jKZeգh}Ќ?3'[T]ZW>><+SHIdZ:alٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͐O?M;ӬSGV[xeYꚘ_To= PGAS`P a6{3[:alٲ]Rh*vyf͛)]A qe͛6l%?&ջkYfxDdC 2 6O~qK>ॴЏո۸sr 9g/<^kV\ji5 )ks E>t}\zY&oMwe ^[_y ^qK%;ykL-~Kj2p3J,[FD4; 6囍UfnQHdAJ20F}y/tkEcɪ[w00t#0V9Qքh{igN/5 ;IWNyouMNєjU%P_@=iC|ΝifYn"G(kȬ84\APiN)[o;?<-յwez-]С>=S 4öok-GIҴYfi bVeAo,ka$. ȓ)E4 mE3yQ򮇭닟-yRRxEA4V%Tisӵray˞e 4-/OJoI>ؔ3My3ϖ_>at8-/"omȋI*[+AJ6kshyeA54wmaee PP\0ywh7gWY3eo6/<ZZ]K:`X"}%  WTCVMf͛6ld4MȲ2=;fn.JyZHhߙ|\c-k=bQH?l]_h.{)| ~ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lj6:u󥵤 ZY!U@9O3GPD򢾝ۆ mt&A,x}fevo f͛6h׿5CǛr-&cDKPA?g +n-thO$BXJl)|EsY~UYbc4[i-X"~W#5"?~Ly-5`0fiP>"|02y[׳ٴܼ6ʰ9$7ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛9g5&E)1v4Pvn'^~/ʋO/ufOҞfKL}>[stٳf͛6lٳf͛6lٰXHޤlM7PR sf͛6lٳf͛6lٳf͛6l ifhzWvC/W˵oɍWE}_UN&ӥrbC=ջu_7~`iriwѡ1?nE-аΥzvh}wv 0u?H9f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳb76LЩyfUQܓoY2 |{- GXpPUHnѼwtH֯dՔ:/I3f͛6lٳf͛6lٳfͅ8Bz!X4G!ᰦk 2͛6lٳf͛6lٳf͛6lٳf:Ƈk6mgEylcCSOU>9=.վyװ!ihn7ݔ{aF.AX扃j1|ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6yz'tuk Ch#$kՏ7/S2hI[کǡGٮv-D]:-;LKk8E4rpnlٳf͛6lٳf͛6lٳan(VkH97?8e6lٳf͛6lٳf͛6lٳf͛6k]53gy >*Sro6V/Y2yI\*?`/xv4:I̭1 H:}ݭݺ\Z̓9G,lxlٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳd7;F򅿢5.;+IJZ'D|kSO5~aHOc"VHu?z855  cf͛6lٳf͛6lٳf͛6kwGJƢ8k6lٳf͛6lٳf͛6lٳf͛6lW+ae_\Q2_w]'N5WּѮH<#}o|4玛%7YY2zet' Xde`{68ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l<4w%SSK?e{^++yϪ}DO_L蹳fi6m{]GijV !zomtۇ/a0o+(P=/5՞LYHy`YH`YHygzC_g?o<^~WY􇚿&􇚿&􇚿&׬ߤ<Vx0,ߤ<Vx0,ߤ<Vx?3f!I75՞LK75՞LK75՞LK75՞LK]M٧te[y rXejը`LwR;lٳf͛6lٳf1yʞ[_խtv-ԫV"+50ZڦC]HW4_|Dizj:mw+[u=ՆdCU򞗪yLyזSRBW#6lh:ݎ6͖ \[y/%;CjwW1[V+#{ 6lt݂"hIĬ,m;iEbY#aZUYI_!iѵ0*R$3}TA>"͛6lٳf͛6lK_toh&yX=WIܯ2 ͤW$k%'VT}"慩O_N}WSHj!-Ҝ?فΏȋ$l6WR cf͛,,gܯ2 O"~e Fey>qO lyS˺NmWSHnj"/҂F gFGWPC+ PA^lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lW?3h\$uk6Qnf>8~o^'4o#X۸~osh:iUZD6Uǻ;uf= ٳa~&ܥCvcʋ՘8sܼkk/c~3NnzoG½sy[z4qBYNJ#~1/Mp6lٳf͛6lٳgկ{'-+o/C_2_~bSBM7Sb5@3iq1K-W.1j7GJk2?a⨔MrӼ^/u3GC\Io%ZtI (&ӑu,ma ƭXJUT#9R?s.'I?.|yiImjX?Ȧw/;y[Zu/54Ǹ> T_-.Ή4l?<5'6ٳ͛6ٰ̿ыɇ۰ǙZR;&d3O";3:4,)퇸?'5<$)̅)p>9##񸪺A#6_|8J'//3ѥ+"zҳ3$Q(Թh<B !PB0#f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lN?ߟ겏M:3;~ys>uG0V誇paMY!"HaE(,q P@1fȟ24'ojRё?7'+M ><+ y'w)mޙحmm-`BE`*/QkYf͛6lٳf͛ (hk:O$d}6B9+T ?,|g{ m5cJkrჁ|xS|~M~\j~W|},NP( + w=~,_(!t9Ԑ4b^|E+˦؞#eZj6~j_uIf,y1rywHXvMh%IfF[t0#HN:[6RHVЬkKV`L̒Ky3ŵM$}>;;y#h¡cFȪ>:ߗL_/I5" 3>L`! d}ᶿ>`m^nmؐjU PAփ7kaE]Bji;I;Ϋ+;kUۮW?&.Z5©?_MJާt&  Z $g⣑r=Z]Z(c Ffr#B,ıu'f͛6lٳf͛61ɹ06lC#y_zzŒM ~ YA9ĞFǓuhy6q*TBSTgT_CC٪36?/ B>d{ iQ`,?癧9+7EJc{W8nsf͛6s/=m[ߓ-9cP7gq1B/6M[̳T |+x/6l%/Mp6lٳf͑/5`[]xZY%E+RpJMoZ˥[K ,&+'e9dF@ E-fwX[xMw9H2*H 􄾢Fߦaq$_X T\Oj^BTr,. x =tjZwi.gE2řwEyw:h/k wW, E)Vv+[ w.g=q<([߶gaG6g{r),qTC EI36lٳf_2{F/7&f͛6l O|x==^% GtO#~f Ǔ y6qԅB@?8ʟl=ƝDD_^':B:HхU{2f͛"p򏚑C|GoD(Ϳ˯OQ݃4ZK/L|2GjcctBe]}q6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛< <1i$rUFv80}NO+_-ٿ QBFromt_rFAǮWR6l؍奕ws$ЩyfUQԒs~yO/|kkOT=QO`>&?'փ/N={@ZzHkٳa/QkYf͛6l2~ZVɵ0Mo4Y@ZͳI 'b0)Qm &w"j0SwJ ֶdCx ;]/tgtAjfTWh(UtܵH-(Zp@i+|)?_/%<&Wk/IF4yySI̞_O42/l~(#\ RPbu6~hhͨMӿUfRz-ŝYe9%qf%ccFho彟LRk0,O e]+l,y*+C}sGeieQpI|X 6]Z}V8]yfޅZΚ7<+iZh.#Q[(g[R~|Y~Jl2Z0A+t[9٭i\[-ZXF͌j${ r#YѤ(CjQ}/8r3hmXdkr!m)wc.2nx&FnM::>ce4x.\HيWg ̦ p :_~iZ[FSt:? ;Vrmo-.t_N 7c_i-Z9M#0#"sa|Fi/΃&ѭbhbB,sj yjrK?_.>O-L @}N+;hlϚn4]e',缱2Pib8+vӎ;V^]|u?1kweᰲ׬A,_DǓS˿yKFiBk(id1HUq6lٳa/ѿf͛6lA"y_{$P)| s?w~uO&n7p< *}ʿ]ԧ~:CsQ~8 "+FVSPA͛6ly>i-ͷ5I^8!~??gv-EiA"SߛPGm>J~2͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰ_iZZ>}nʋ՘9Iґz/z3qe}u.kFۭunlٰ~oм587»+,kr]3_w}ѼCNW?dga4=+DӢӴdQcAf=Yrpvlٳa/UkYf͛6l57ʬ ; Rt4GP@Q, T^fUjrWqZACZQh)c.TJWLjz6?7?O> ٵ77vX.m(NJx̤`?.yJn5J\.-ߘA\sɾ% Ŕ2EF>c౻HcZ!S$7Z0@ 5$Szl>On B((kQMz Q@:+Aʔzfӑn#M74A$ |q8ʄ* AO/(^s/)|̈ŒȍNJ9yf͛6l%/7bralٳf͛6l O<==^% GtO$~gy '_gFSɴP2S˚OmVSHnj"/҂B$Et`ªj=yf͐8PCŮ_Z[g7?.h/SQ帿Y|R%_|y;C>jEK+j9-͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6Ey:ռZP~G!?ʕ :"&ѼVzܶƸ145^jZlW\eR;9LnC*\h cu 3x#_^Eeu5S=qH(j~-+߹SP1_lZ5RNMG軋Kk{"G/øtypipOH- qY/2~ey_imsq{"Y $ =MN]i;QԬ- 53TxrVSAȇumNϞBMB;fXdp|o?1,.ŅGw׺,[ߣ`Rxt$e뿘6FIb_u6iI'2qN%~=Nv~_WwwM.꺤iq$V2GsىyK^\{[ǹ^ak=jki*7BǶI5t?\>A{1~ k45 Ԛ4JI4,(Waj]_d5i=yhVE:-~dҼigm\FhMT__>\4-i|En-`VX)dCROL| z_kq*o40sCqVZsi˫^;Iا)DRi憓{-s^uh!mF㝤ҫ=ͺ:,-_V}I%n0AWq~h+~u{ZW6 gD#R2E~pySeakF[i㵋~FӲA-fn{;suk{ %4I ]_~ty]ӭ4u%VJ@,fU^ʽ6lٳa/ѿf͛6lٳf͑5yhdJ#OtH7 FsOu&n7p ~q}ʿ\~:CuQ! gGGI]:0pF^lٳd?~S51+U%A~V|sg֠>e{ icA.Vt(~dOQnRc5u)?RrQ6lٳf͛6lٳf͛6lٳf͛6lٳf͜f="+yϦ  }&󜿥<1,rq{{3o^9ӳf͔̪U$ɼjFQq&D:1÷yõN^TiYozyfB.[slٳf͛ |(\:͛6l|clcN+/*ZjBbh808vտ/qU 5:iR)RHؽxUh̖xյtr^=7X}*[ya&_R7`%w|gSO/^ZӴQoir]r "Xik/+:+Ě`7{V|N%wy.!eSMf! MZmtH-|ۢy_m̨PײH"i{iYMO}\?>c+>W ]7"@Lq!_&~ih̷h9b2ZJsJ.|[ѣд=v=Ytr I\]s~_O2 3_,nʉz*t=7x~gwcz jwZM)X @?#DyPuj:Gíy3X4XњݢG3jo O+ +J]O6~jGkf$o2taƾ%HB|T姘è8B[ut8ͣ#Օj C,l0>ҳEٲ7*ŷ(;ȋ'e16Jʂ$+<@SjwW4,.-Ե)̒ƥۉmyI52XIf ٭rs6SL~aMaaxݥIey'$yf̈́eF_nL:͛6lٳf͛6lW|xjK$R; 5_Asq+hjL_J錃*woTXkHuQ~~NtdtuUXprf͘AT9%|H׺x:.4PFZ/5?/C[3 S" eUL!k+%C{FHf͛6lٳf͛6lٳf͛6lٳf͛$I#gv (rI=r3dkmߗ} V߲?-ޢkJAw+kk1͛653F5;UsAIqk?iɤy:7w~D>Q^M5ltCqr2P06lٳf͛ |(\:͛6lRHI#D7$TeѰtuaPPAlhFd:NA{kXTc4_/ZѴ}6Աs I =X͛65aeiUJ+kҦFH:9"݀̈́ϒ]Gw:Cs[+M=855 (헛6lٳf͉]Ywu*mn,9 lo/Y.IOȡ7!y-U Frf͛61ɹ06lٳf͛6lٳf͑5yʾhdMJ%o/ W\Tմu_1}AO- iBՔgFGGPU /6lLUeaFS 9μ#Zc;hZi=V"jcxt##3.p:ΌjI<WGI lgmٳf͛6lٳf͛6lٳf͛6lٰiZ&.\-"#{vi 4$gaG Nu,yWDΘvn!hd$O#~|ٳdg:=}BOR@~aWŎs#ɾl"cђ4;#PgcBE jT _6lٳf͛6Q&u6l5?[kBt4=.쥴8Qڄ*T5J?&aכ|FZGtK{3@0W7&Y%1Z Ռq8f2b~nL[+Ayl5b ªiJ7&޼M&H4sycFpI2#)C3`K>}|-֯hn wzL02s,^_Rm{=+Y {ui%撉[qn~S_1[nqw%iD15QTؿ8|yRnC̰\YIEky 7>K/ɳs=C$Х\2zD/N4F KK`A{wT!_1yWV4;wSj& *G~v_]WN" CTׇ&g& ^yL_+iyYT_X}hܘ}S+Pw-~P͏ho%>ڼ{pmT}$f^3SG| 4iZ΍3UGb[K78!K#) `х]ƺxP4O;I7Wd7$>kǜ}lVSך+~PR 1P#:w5.o*[Zy㹳w)?r j^Mmo [VS!0@#䑕 4"מu3FIα7PZ+U#*ZaW:'wމXŧEVҴGsл,mFZ2ٳa/ѿf͛6lٳf͛6lٳd{~@!)Y+J%n~F9y3G,f4U?ʟZզ¶)mʔŦٰճٳf͍8卣⌌޾Я?ⱹ5<{rD%ׂS0?O#Jy[Q+=bڅˆ&|.y=\PVHkTx06lٳf͛6lٳf͛6lٳfמ<?OΣ';dz_;g:|̍F/0՞BCNѐ䧦uR:gd 1;1lٳg8:U-C[I"z۾?$&ߥ<1,2B{WY>C6lٳf͛6lK?F/_lٳg;4Bywͦhw_Ȋ;,R#qئYk[̪]̏^p_ʇC5*6m'dY vĬ6^8.zU֛VG֡r) ( lWT׵[}>RL~`Ρe}--h`1 Axb q4O1藚~aUmLAM Bb_ݔWm7wz΅kz+&] b|p^;+/^yesh/m ROV&Fm@ ;??ѽ[E_8rޞM/͖>g4gxhZL^(rt[zU1O9ymsWӵ+Tm_c+wpm9Va) 8@ol4(u]qo4m^-` X`Y=uX(':՛炇"5/|mRonrS_:L^^^IӴ=J4.X[Tx9sm"Kզa6IrBy/*!U@j:IihҼ)tWt)sk<o_SJaW嵶yCG&O4m<+=wgq\o g9׷$GSMd1Wzx$l4=z^i^@~ьJ|Oħ06lٳf͛6lٳf͔܅E@IGgZyS Uo5"Zьm?k#QFAR njTxMfͅ^eF5^AnَrDbIH>a}u/wG-}@ݝݘ2͛6lٳf͛6lK?F/_lٳf͛6lٳf͛6s_4]k^LhkInn{TN󦵮+iWSXtxkfBwOsP_J6~own{:HD U~"b߼]4@]WZ>ͦŧ󳾱z+Ɏ)zz745֭oYܲϿ8xa1T}<}.7V Vϯ$L=(J~oQ\%O7yS4*/0<7.M\(bxָ/5j?cF[O˗%{F "-s Pn˓o0A$y`J+F(\a,ٳf͛6lٳf͛61ɹ06lٳf͛6lٳf͛6lٳf͑5_yS1+\Ry_&-7ͿgN\KV}ʩM9!,~I~dM5uwv ѾYf͈_[=H)$2t#/]FMQ]ŷ6[۲y ~owibi2[cm֨Z|Λ@tlO +(*yZ b9cIc` ͛6lٳf͛6յ}7H5+VId4!O`3>oٿLĚOb~7wy |#sOkvW#wCf͛!?/a>?ѴZW'DiSO4~b;9?'PAlE1$Q"`*F*l;6lٳf͛6lٳf_91f͛6lٳf͛6lٰBMkdwrļrHwZ=KR{VЭvg h]#eI#Zo}CLҴ˽&),@J4m¨^(* W}ꯪ,7Y#_Y#eIh6!oյ?6jڼzn[j[ij9zE2KFKO+O} F$?n;eTHdy/ʰi6pikL.4" B2sURxkֽpȲi'E麬:&lR8݀z6lٳf͛6lٳf͛ |mܘu6lىzHs:0\G"<sT4?no-S0nosT4?[a4sT4?no-S0EyOH?O7CihqH?O7CkEy\-S0nosT4?n#?pC\DLSڱlZI G"tXWE?\-S0nosT4?[a5"< [a4sT6OR{=Bgk;S~a3OgY<j YG ǢE%X?kɿ8kzv,/aZ鷏m;j)?m'a5"< ?hqH?O7CihqH?O7Cih?"<|>k&ĒJ$Z UAȁod{Ξz|NZZ2òaI?456YS";!v[ >OBE `*bf$Sys+y/Zܤ%Cٸ+_ߔz ߦJbdB]bvܷ) 6lٳf͛6lٳf͛ hմ@Vp@-xҾeoҾeoҾe=3~/X/OqLߥ|V?{f+__7_2Ռ\_7_2ՏJW̿cW̿coҾeoҾeoҾe=3~/X%3~/X/?./?./?./OqLߥ|V?{f+_K`k FNYk \K)I>V ?<ٳf¯(/4f͛6lٳf͛6lٳf͛6lٳf͛6lٳf̈́ڗ/cLJ9h/M'AcXFLw ϶/Pԇ'yHx4G|?d9PlA6l jz~e-pR!l㚗<}.E}3 V@U^o5:_yGNd5+{ ͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6k?W#zZD-Q^k6lٳf͛6lٳf͛6lٳf͛6lXUE"06lٳf͛6lٳgjb~yUӴSI*$Ki8W}R^<{ɓ_<Kk|Sd(Uׁ'zdοnKm.UapeIBG#o?!r~ah5o5kӼ4Yy0DRO0hdyK˶M Nzƥ[X\II+H9;|/z#DVm FmwOIdO,|wK->?5mm1.ƷrIT.:7>*9qڵ9D-&?2y{U#JT÷'TP[{^jƨlZ mCFy-]x\*8u7靏6lٳf͛6lٳa6)>10k^`iMy`W 'Zx__2D J/ޟ(C{ׄ><>mkjS]5TRؚ}w͟k9_]gZ-ovG7|V_Kol]%Q/?/~Rt _M$=y{U.֡r5v@Kεkӽwy[_Xjf Γ&v$zB3DPIbMpqpwcZEٮ_2 1O-y>hڔRdݹbތ͛6lٳa/?;Yf͛6lٳf͛6lٳf͛6lٳf͛6lٰURo-Թbdu>=yf͛6lٳf͛6lٳf͛6lٳf͍Յ^P[Jh# f͛6l*5׵+}6ӎK Aݏ:>k:lur#H4#`ٳf3yIΠI$0}Fq2  o^t-=f >2\ƕ=݊`-ʞڊYj"!=9ڴK?OҞo+<y^O|Zs_A.$  փ遵̯!hͪ붖jQ| +4Bek~!zj=w|+QVȊcmgK-EާuI"iO&qk_vft+;Ԥh!sFDC#*"/rry=Y&6ha841T+~coƿ[iL!7.èE?S/Bb䨸u9/U$tazƗ,mwQA4,J Xʽ)gѯ~z>h+n?~_LP#V"?hm]qh29-Tn͵)} ^?ھ8kMԯ 9Vid@~{JwQOYY߸`}]bc\Fx 9­A<]e>zVSǯ\EhxL(d. r@omcF߿b}]`q#z~0.oOSKwkv&4}J8sJg?v}˗{Wmqyb1Fd. rE [oJx}*U@e un?oe4}J RC'nGc? Yj\A<}J2s?E [oJxG'/|BY/\~5^E7#7Ƅw<.?oo4J}` `pRE$?v1Gv}zV~f]\A3E+ʬ~?A۵=??3ʲѵ\'澥波9ݷ=??3PMB\P'h~yU?sv ~R}B O?%Mv+\oOպn?m\F?^C*TIt1FmoG Y@P~yQ~cڞ;aw^ZHY9aשk]6b״繎kn"%_?a0<(0F͛6l|oGMNsXIG-ݺ%Q4pDg V:m=|ƷNF+i I Pߘ'rh,t++U#y6!!@E<_&-ߙ%k;;mQN.- "!MՋ|'F=I[d@ IV&'#Y =| f͛6lMO;y}D>gLVyOXeHcXG\.ӿ%- ->H~5ڰڷɞy*Y<ˈ]T{do[2_k[{{W\ԭu U$A1pfTWKQ{IoдH,Ԕxn#?`O.IWyw\揠AmfnR8A1#$g&-t348b֚G\I-yq4hƧu\~B~QwQoRPүX9tUp0ܠrMc.̶=kS+{ۮnK5IQ@_E[>^78yV7\q[O3amt.bY{Ѹ ŕv"q1RMlٳf͛6lٳf͛6lٳf͛6lٳf͛6l.K1lVp}7Jִvٳf͛6lٳf͛6lٳf͛6lٳ`[+O0vD*Jӡu *: i_ Dalٳf͑5~_OR[MYlíRm2$m=X7I>ջi^kh;{hE''I4ZeC"ʆT_+C}WY?^?ozҸMue䋯/Am2wA$$3#HE2ztmeo-yr-1F3$$V,Wj[ 6inT|U^5jc^ -*twGHtߩ=q5lyki#fw@jm$\\Mr ;#3MhL]`4Z\ e异XڨT.ԼZ^<>/&Fbf _#YtgK l<4 D1iNYNkAm&!o]G4E^ sH'Z.%ƍ+-_GLWЧ;KI}Z/t7Ѽ6YfЉp AtJ`{oO%ϬoV; /C94!yH_O}Puu!RI⁚<2E6lٳa6)>1y1ξw A}SJ-# C#$_:[L 2J}q]NX!喢~.Ymg,qW\i,P[Ȭ)_qXm"{oO 1]Z$2I$'Ȍ0o"}vKƫa\q#g!MC~[8 g9&uWT4׶p&8P~3E{Ag|j<:^msK#.R#q|q?cf1J#9cGITs+7?Vo'QCԬ:O7XYtG7 nR?ocf1J#9cuGITs+7?Vo'QCԬ:O7XYtG7 nR?ocf1J#9cuGITs+7?Vo'QCԬ:O7XYtG7 nR?ocf1J#9cuGITs+7?Vo'QCԬ:O7XYtG7 ~>וx~OoGTs?,7o? nn,NS, N۱>pW R9duGQC#԰=oGTs?,7GQa{2:K #XoG7 R9duGQC#԰=oGTs?,7GQa{2:K #XoG7 R9duGQC#԰=oGTs?,7GQa{2:K #XoG7 R9duGQC#԰=oGTr9νo_mn#wP~u^dGtuqV)9IUοE"06lٱb%,5̆Wr]흯꜏Ernmc\̐FHP0ASU $~[8m[b,Zs[\6G0c`Xv4&*99g_m GZ6[,jsH~>4ÈKUn&\"7"u #KsouVq͂)Kwh$4m0(ō5;c\"IVȼB V>KX$ѥz%CȚPM}e q5q+](|8tqc+-H4~HDWɹrZ`l{h#{u.5(؉3sƈ]jοi@;_6lٳa6)>1y1o˷,m|s&e58}hm$w0z/Fۑt9.yV-y}6?̱sPCw$ИdH œ E+AegQlSey{OO=[[WT1/yo:狟0O E{9r](IQUf^̝ /)y_˾wY\.tmlO)yRdzH-hi/uAin-> VWȾu-Bd]>{ G#Ո;ʆWZsa]bDUכ/!\ӬM;I-.1K1!tko2|˰i]-LzO r޴ql 2Wj$Ǫ,r =6[{S" 1_( =2ߑ]̗ gf. f3s 쁮Rd} k ҭTPIoj2 `ʊyr7ySFҿ,?.c|'ԂLS]2D#Ӷ(8|c-ǝ̚+]hleUb@>.,G7G_淔KU/,kkJ_Jy5h~eO70jmulZO"sGnQHS"#jwZk=[SխEޕsi2k,f{Kp6e4^c\7{^k'Kq/!$f}4]#W/ˍG7ߗwP&mSTi (*^(5-Yhu{ \G6Һܹjge|ɣ^K륅Mœųq> +g1|c%Dڄ{'[9-Qڤ?jƕ~fN$bf4WF#$s^g]2k]-_ս4xxC[)ʊ[l u]΋,>G|ɥ/C .Z+$M/.%@Hÿ_.i^/ M<"OKMJFN/s/ xI%EkMyVMk4Z=Zn˯lLfOm#3}]KD٭)/{(k,6Xl.y81x+<A[쑇KyFt4mVo!_~ӞX}0eN[cEWmHc͛SL*|돧6J4 XOBFΣP}|g+7PVMb"(YQT7W *qO)y/Mо/-VU;q<4UQQ$6A5\N߾l%y1}6ll6ʀ`+cR:fjWqO=R)`u^$U akuw$ښi!u+#+06'tVӡ'6`KsX s?6㴞t"]FJıRwKW*v_~iii2}KSYDp1P?wG8GEk蚎r`YHFpACԯڥ3hwΕ Ƨftl,IiZfut%A`A#fo=2-n4'NW5H 8c+ 3T.Tח.wiM**ʲJG"Ozy?(u)e/skK$^v/)ͣ\Z }KYk(D,[US:O1KH/+UK; O>;l3j&[Aq/Ùg n: vyzm $0I R{SAkWPY@@2Gz^IUVmki[ q<ٳa/[g8%j:T0(yzve_cHlWX4[7-?/V8u#KU}_cHlWX4[7-?/V'Ҽq-Xd^QF*PXWX4[7-?/V8u#KU}_cHlWX4[7-?/V8u#KU}_cHlWX4[7-?/V7u#KU=yX)iEx)jWû{+yƎt(&lٳf͛6lٳf͛/o? (0F͛6y[ʺ.IQ!C, vÒ똀z͘:ffAZA횂:f{AJSo PWE/yKby$vس1pƃ1mOm~i%[ n5 F9=@A&6sAJSl(wxf ߾j ׹A׮wJ/'SԒ(.⎿abXYf̈́ڗ/cnjO-\B]^)s  Jڜc@}9@}9Aj}9@}9@~9@}8Ɠ{mo- 47 sEQRh!L7̚g2 'մ-ReZ7HO'O׿6G7O׿6G7O6G7O׿6GiZify$,y3؞!GSsf2AqFOP[Kq \/4lU`H:zqQƆ:o(iz,Fpz˲jH +yn[ak \FV 韗^h]_ KC)q-FMWr<{ kT0` @䟴V%WGy4_$]"N|_}NCGme5$wm++\\+!EQgàk2kڍӭH`F5i E-Z}™sU.XݨnN-auNf \Yi:XrAg#ٽKiV ݛ9fٳa?V_nmaiH MYX"1c,>+k͛"??k)k؆y(ʹ)͛6#ob8}8n6Fn{a(Hӊf:ݿd=͛6lٳf͛6l i7-Ť aqU`"Hmභ qFUE3f͛6lmhڝƫq7B@~~C͛6Q}O0>_36"LQ򭹘鰹O*vjrh)\QV]ƖV d#҄,28}"R$fZ*rN-|?#];n ZjfcҸ{_0xм]=~1i1jbhyn95x,jz7?_ZƧ'_yn-k0䀫sOU`Jl2yW,f4noڌW^9ӥ*ۜ9 cF_"I"(&@d?BvS1iO_n^bFP7OOz]!igPAOŷsJ~n>>7+<ˉ "S%j6~B򦳠h_OiNH#3- RF zMs俑$X$ ;0/TGqcr'κ/dMPy.u-Z^ZCͻӒ:ң%ٰ?ラ,m]'9V_/Yf͛6lٳf͛6llݿ*WG|ٳf̿0ZO[jQɪ>k5+dՃ+TTփmj"mrxUtRYyD>*aL/7u˽V,t߭^zI@̲l*Uf~^*y.U[7SP%O U~Y?'-bu:*j]x ϮIX뺪qf?O3_^gM2;.yF. ݇6ɱ]wo,j^lկ/4/Ht+ codAP46€glO1^My-t1i塎S꭭U>!}g,W||jeKXΣ$3"FGq|TŮ Љc!MT3s}/nM+RŎZm)nKj-xʴ :v~_5 0806?둏}~Y/KKo7mިYe(7xYAOy/5ڧZ揗+k/xk/AT.RDD؞~>q{٬ҕd%"ٰmڰݤŴŚ"LY(ٲ԰3cǩ9#߰)ڰǦqҟiոzuǿ쑫[d״waQ}.ϴʱľITk3m]dɸІυ匰R28lزR:4-޵_4ʓ/皳 'Dn5 ޚ+Rn)5{o͏(CR\M\K}*"b*O߾B+?Ͽ3~\XTM YkξJ0_ݭJW%kM/V3\{@УӮ5`n#رe 3N̓Gik @⦽vvF?*(q5)rhy#}hѱO^:W Կ,o#XGc.$- mUe)_c|tT'9>;SB5/~֣?/&Ο{եg-Hb$݉߰/2YE]ծ%[״W屹ձ'ʳ&>ctƙ!6lٳ`=OQ>7[li4f͛6lٳ`0RYbOr_f͛6lٳf͛6lوP¿i"Sf ygV%?oi"Sf ygV%?oi"Sf gV%?oi"Sf ygV%?oi"Sf ygV%?oi"Sf gV%?oi"Sf ygV%?oi"Sf ygV%?oi"Sd7]&ϥvQA{oOQ>H B=FyRo y[#KbH%Y G*wi"Sf gV%?oi"Sf ygV%?oi"Sf ygV%?oi"Sf gV%?oi"Sf ygV%?oi"Sf gV%?oi"Sf gV%?oi"Sf gV%?oi"Sf ygV%?oi"ScsmthܬH*(h: sf͛6lٳf͜ߔNO%M'!31N[u/?lG!>N)ڿaχC':^lٳf͛6lٳf͛6lٳf͛6,m즲p$ x0-\uK WGQoq._-\uK AWGQoq._u]mկbnK%sBJћh?\7^?/:%sIr\x\7Z?/:%sIr\x\7^?/:%qJX)/E*n wØ!HaH"(1f͛6lٳf͛6lٳf͛6lٳf͛6lk:VfךVvY( >9vɭo~^i2^_R){GOȿ:ZjZư蚉 %9(lt}?F>!Anf͛6lٳf͛6lٳf͛6lٳf͛6lϗg?F1KmB =T>S9o7~\ŠDsZUGJ:ç:W3ͤ)`3f͛6lٳf͛6lٳf͛6lٳf͛6lYq/`$|_#yf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳ`]OUtGnM3_Ǿr_R/HҥD"$!@ͤKߘ:[Î:UY鶱ZDz_éYf͛6lٳf͛6lٳf͛6lٳf͛6lٳfj]Y)$2 Fq-y][]ir&QΕ>ytɩ:9(&ǃ Hf͛6lٳf͛6lٳf͛6lٳf͛6l)༹7-lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lj6uGkkJ}'9v>xG5_Hb?'50]I{-y&4UF>:FkeEgj"BOf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6b=3toZDֱNn'0W7a@yem?sbsf͛6lٳf͛6lٳf͛6lٳf͛6l-l}!Ld^M06lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfo/l쭞tVI`ܚ z't /nAEL^\I[S{ ?ʟ85-YyGZGb ΡkB,Ŧe?|L|]p6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳ`-gE>]?SKI'z?{y]O]M:Sa7ytwYZ=1c ٳf͛6lٳf͛6lٳf͛6lٰ\yl};o[H楷PYf͛6lٳf͛6lٳf͛6lٳf͛6lٳc'!yb1rT䝆s/2yiq]~Vs3coR ,<9Yלz= V4o|^h-t{(cۛ(GwsVc8k6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͘AT9_).o!M/[XfKwSl]bXOJ $?o\ٳf͛6lٳf͛6lٳf͛6lٰ]Vem^Hvy/g6lٳf͛6lٳf͛6lٳf͛6lٳf͍X8U݈Uw$kg1coh?.0*^ySk 4q6<.yj=[?y/ڕFsf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛"~|muӢۚCcyx GNMw\6w]ZLL2YOBsf͛6lٳf͛6lٳf͛6lUKJ[༹7- sf͛6lٳf͛6lٳf͛6lٳf͛6ltD.UrNs5~w{M MjxG LAP@p?!eyEFǒi1*>Գg<GGHIp}06lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf̀5 I44V.%Q{2ñ.:S3^Nvsd䗀Su(y@^/tA4L{:68{6lٳf͛6lٳf͛6lٳan'+c,m?Wrk›alٳf͛6lٳf͛6lٳf͛6lٳff 1=w, (6-~(H9O'~h`8͗Bt+I':G|o+IX$wZC(2A6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6S*` B?ߣxyt!a>iͻ-vк_| 1k((ns͛6lٳf͛6lٳf͛6l)zo Q|%ٳf͛6lٳf͛6lٳf͛6lٳf$SNs7tWB:x% T} Su=9ӢduTO?sKʞU .~J=y=$f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6CayVA=b!>0FdC4_3y'RQړ\Z)j|k~n㹵'CE,d2sf͛6lٳf͛6lٳfͅʫc-o XKo;f͛6lٳf͛6lٳf͛6lٳf?9,|'Ω?9h>jEp${vX̋üٳf͛6lٳf͛6lٲ5\hͦͷ4Ȏ:W7WZu"y;.Ӯ ͛6lٳf͛6lٳf͛6lٲ(h63w)/_O$t%D>++޲򪬖բ{>+o޳VmU3~s#m_g7?6e~s#mozXnmToY M?aS7g7?6f7ՆFLߦo޳VmU3~s#mozXnmTĮi\]h1[Ks3B{lٳf͐8lC뚈X[QsS5?nyn_YNbJYPrBF؝MܖA*JњGO0~l#ZGafJ󸚾|Zu;ct9ykY5mM[KCtT TIÒ@;++(e!ٳeBrWAB8+OVD+\OżF*H8lٳf_95{N.f͛6D|*Gyu> z</~)럛Z'cr"}e(ydCSx}~7͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6˚7t4Znm;27gF[?;~R]4E$N{syW4տ.7ȝAl9̈́WzLlٳfGwJ/7. s^M󤿔[t$/&^*{o]_K7WGIN[39(WӌFӻE#??2o=yCS5(˲j֗^DuO>y[^^ 233+X9>UԼO_Ηu#[0O 843TT<-|yuSZZmuiRzd*o<~aXs~>?[M-6ӣM-[`^w> X]g˖ڭžIkii1/ŖWsv'4o49-[SƶY۵_ͿbyLkz]Tve3z:%B$z!CsI?=5֑ZHQ Aֿ3sf͛6Qߔqp6l3^UP^UL~bAd?_k˲lnܕD>@'~MKˬRu]PM{vQu_lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͔##d`UAb9|Uhzycg|k$ʽJƧ}͍3̏/R_%%z\kq%ҿ#~vgf͛6 QJۋPjj?DO ݼ&q$ɻ$<8,~=yTO6$Sn !,wi>xE%2tzUW啥żľȰ!r|WȺ^]:INGe(~KyWAuSjwCHE}ڧ: 3f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfG^G~QPdJ;g7toz;Zhك-UO]E>"ꚆZ7;[慿x+$f͛6Au8ﴫYֽie,|rppf]#l̊TxEGC6lٲ)3J4&k,o]Б9jpA۶J!ԅ$9jxTW6lٳf͛6y-:$PUGV4;g68~h`9ʶGBmVo|D#O)~IygG_jXoquFV2Z9UT* 6 ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͐1O_X)aՙVY wߕ|q\Z$ >Ejv&yf͛j\\i7h%()mrO?"_>jVVº~n6"_i^*k\ߛ^a:֛zƅ W׺zOX[aC,|߯ R[7IK\LDlxPWm"jzuKR=J'K?R1] =l>4E5ձY#x΅5Mw5ԟ.崳泾޶ٱϦ@S|GO.F}rէ鲉}J^gƑ ד5]+\ے꺲ԛ$1ϭ۱4(٣ܲ0P=z5ZuȰ!6.<̏!_CbgӴԞ`cjkЖigJ֛A.m m'bI?|s_ۿ4B(b=kyi"?h KnD% t2;ak9y[/&gHro_ QH(tk%ugAF*:|]s^KO[ kߝ36lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳg endstream endobj 77 0 obj <>stream /GS1 gs BT /F7 1 Tf 10.4607 0 0 10.4607 59.7543 236.5228 Tm 0 0 0 rg 0 Tc 0 Tw [(due)-260.2(to)-254.1(its)-261.6(effect)-259.2(on)-251.9(the)-262.4(mediator[s]\);)-255(and)-254.7(2\))-256.3(natural)-262.2(direct)]TJ 0 -1.1869 TD [(effect)-242.9(\(i.e.,)-237.6(the)-235.3(effect)-237.5(of)-240.1(the)-235.3(exposure)-241.3(on)-235.7(the)-235.3(outcome)-240.1(that)]TJ 0 -1.1923 TD [(is)-363.7(not)-355.7(due)-357.7(to)-362.5(its)-359.1(effect)-362.2(on)-354.9(the)-359.9(mediator[s]\).)]TJ 7.8454 0 0 6.9729 245.0834 216.2834 Tm (40)Tj 10.4607 0 0 10.4607 256.7054 211.6346 Tm [(We)-356.5(chose)]TJ -18.8277 -1.1923 TD [(this)-346.9(method)-345.7(because)-344.3(the)-343.7(decomposition)-345.8(method)-345.7(is)-342(valid)]TJ 0 -1.1869 TD [(eve)12(n)-296.7(i)0(n)-297.5(t)0(h)11.4(e)-300.9(pre)11.8(se)13.6(nce)-291.5(of)-294.3(an)-294.1(int)10.6(er)10.4(ac)10.6(tio)16(n)-302.1(e)0(f)10.4(f)0(e)10.4(c)0(t)-296.3(bet)14(we)10.6(en)-294.1(th)11.4(e)]TJ 0 -1.1923 TD [(exposure)-501.4(and)-498.6(the)-495.4(mediator\(s\))-500.5(on)-495.8(the)-500.8(outcome)-494.9(\(which)]TJ T* [(can)-383.6(be)-380.8(explicitly)-374.1(modeled\),)-377.9(and)-379.4(it)-381(allows)-379.6(consideration)]TJ 0 -1.1869 TD [(of)-489.4(mul)12(ti)14.6(ple)-484.6(med)15.4(iat)11.8(ors)-483.7(si)10.2(mu)12.8(lta)11.8(neo)16.2(us)12.4(ly)11.4(.)]TJ 7.8454 0 0 6.9729 224.844 154.0346 Tm [(40,4)23(1)]TJ 10.4607 0 0 10.4607 247.4645 149.3858 Tm [(The)-482.2(mod)14.2(els)]TJ -17.9443 -1.1923 TD [(wer)13(e)-197.9(tt)13.8(ed)-191.1(us)12.4(ing)-187.7(th)11.4(e)-197.9()51.2(i)12.4(mpu)14.2(tat)17.2(ion)12.8(-ba)17.2(sed)-190.9(app)16.2(roa)17.2(ch)60.6()-198.1(i)0(m)10.6(p)0(l)11.4(e)0(-)]TJ T* [(mented)-349.9(in)-346.3(the)]TJ /F9 1 Tf 6.0104 0 TD (medex)Tj /F7 1 Tf 3.4089 0 TD [(package,)-347.8(which)-345.1(requires)-345.5(tting)-347.3(a)]TJ -9.4193 -1.1869 TD [(model)-395.9(for)-394.8(the)-397.9(outcome)-397.3(mean.)]TJ 7.8454 0 0 6.9729 189.1275 116.674 Tm (40)Tj 10.4607 0 0 10.4607 201.0897 112.0251 Tm [(Robust)-398.1(standard)-395.3(errors)]TJ -13.5111 -1.1923 TD [(with)-241.5(sandwich)-237.9(estimator)-242(were)-239.1(used)-238.3(to)-243.3(account)-238.1(for)-237.7(the)-240.7(un-)]TJ T* [(certainty)-303.8(inherent)-298.7(to)-297.5(the)-300.3(imputation)-298(model.)]TJ 1.0514 -1.1869 TD [(For)-235.4(each)-240.1(outcome,)-239.4(three)-241.1(joint)-238.1(mediation)-236.4(analyses)-239.1(were)]TJ -1.0514 -1.1923 TD [(performed:)-287.1(one)-287.3(with)-284.9(psychiatric)-285.9(history,)-286.8(one)-287.3(with)-284.9(all)-286.3(so-)]TJ T* [(ciodemographic)-445.9(variables,)-443(and)-444.4(one)-439(with)-447.4(all)-443.4(care)-445.1(path-)]TJ 24.0035 17.8576 TD [(ways)-410.5(as)-409.1(specied)-408.1(mediators)-407.7(\(Fig.)-409(1\).)-407.4(We)-410.7(analyzed)-409(the)]TJ 0 -1.1869 TD [(following)-577.1(6-month)-572.1(outcomes:)-582.2(GOSE,)-573.2(disease-specic)]TJ 0 -1.1923 TD [(HRQoL)-155(\(QOLIBRI-OS\),)-158.7(generic)-161.2(\(SF12\))-156.6(mental)-157(and)-162.6(phys-)]TJ T* [(ical)-316.2(HRQoL,)-316.9(post-concussion)-314.2(symptoms)-314.8(\(RPQ\),)-318.4(depres-)]TJ 0 -1.1869 TD [(sion)-518.1(\(PHQ-9\),)-522.8(anxiety)-523.4(\(GAD-7\),)-524.8(and)-520.3(PTSD)-523.1(\(PCL-5\).)]TJ 0 -1.1923 TD [(For)-197.5(each)-202.2(analysis,)-203.9(we)-200.7(reported)-203.4(estimates)-199.6(\(regression)-200.6(coef-)]TJ T* [(cients\))-361.7(of)-359.3(direct)-366.6(and)-357.7(indirect)-366(effect)-362.2(of)-359.3(sex/gender.)-363.5(For)]TJ 0 -1.1869 TD [(models)-525.7(with)-523.3(signicant)-524.8(indirect)-528.6(effect,)-524(we)-525.9(calculated)]TJ 0 -1.1923 TD [(the)-397.9(mediated)-396.9(proportion)-400.3(by)-398.3(dividing)-396.5(the)-397.9(indirect)-398.5(effect)]TJ T* [(by)-279(the)-278.6(total)-280.3(effect,)-280.2(and)-281.8(multiplying)-278.3(by)-279(100.)-276.9(We)-280.7(also)-283.8(per-)]TJ 0 -1.1869 TD [(formed)-292.7(separate)-300.7(analyses)-293.3(in)-297.5(different)-295.3(age)-296.9(groups:)-296.1(16-45,)]TJ 0 -1.1923 TD [(45)13.6(-65)16(,)-205.2(6)0(5)]TJ /F5 1 Tf 3.745 0 TD (+)Tj /F7 1 Tf .7587 0 TD [(ye)14.8(ars)-195.3(\(se)16(e)-208.8(t)0(h)11.4(e)-203.4(on)13.6(lin)16(e)-203.4(S)0(u)11.4(ppl)12.8(eme)16.6(nt)11.4(ary)-194.1(Ma)9.6(ter)15(ial)11.8(\).)]TJ -3.4577 -1.1923 TD [(In)-359.3(addition,)-351.2(we)-357.9(performed)-356.8(sensitivity)-354.6(analyses)-358.3(where)]TJ -1.046 -1.1869 TD [(we)-590.9(also)-587.3(modeled)-592.4(interactions)-590.2(between)-589.2(exposure)-588.2(and)]TJ 0 -1.1923 TD [(mediators)-348.1(in)-346.3(their)-347.5(effect)-351.3(on)-344.1(the)-349.1(outcomes.)-347.6(Results)-344.7(from)]TJ T* [(these)-579.3(analyses)-580.5(were)-580.5(similar)-582(and)-579.9(are)-583.1(reported)-577.3(in)-579.3(the)]TJ ET 59.754 706.507 490.167 .22675 re f 59.754 304.384 490.167 .28351 re f 59.754 688.819 490.167 .22675 re f BT /F10 1 Tf 8.9663 0 0 8.9663 59.7543 723.1179 Tm [(Table)-304.5(1.)-501.9(Men)-298.6(and)-299.2(Women)-303.7(with)-297.4(Mild)-303.8(TBI)-300(\(GCS)-303.2(13-15\):)-301.6(Baseline)-298(Characteristics,)-309.7(Psychiatric)-303(History,)-297.8(Sociodemographic)]TJ 0 -1.1065 TD [(and)-299.2(Care)-303.4(Pathway)-304.4(Variables,)-299(and)-299.2(6-Month)-304.4(Outcomes)]TJ /F11 1 Tf 7.9702 0 0 7.9702 300.359 695.0549 Tm [(Men)-8378.9(Women)]TJ /F2 1 Tf 20.5214 0 TD (p)Tj /F11 1 Tf 5.9181 0 TD [(Missing)-330.2(\(%\))]TJ /F9 1 Tf -56.6277 -2.1268 TD (N)Tj /F7 1 Tf 30.0886 0 TD [(1842)-8883.1(1022)]TJ -30.0886 -1.1239 TD [(Age)-298.2(\(median)-296([IQR]\))-20536.9(50)-330.2([32,)-330.4(65])-6299.4(58)-337.3([37,)-323.3(73])]TJ /F5 1 Tf 49.4363 0 TD (<)Tj /F7 1 Tf .8891 0 TD [(0.001)-6115.1(0)]TJ -50.3254 -1.1239 TD [(Cause)-300.7(of)-298(injury)-293.8(\(%\))]TJ /F5 1 Tf 49.4363 0 TD (<)Tj /F7 1 Tf .8891 0 TD [(0.001)-6115.1(1.7)]TJ -49.3225 -1.1239 TD [(Motor)-289.4(vehicle)-297.9(accident)-18871.5(647)-335.2(\(35.8\))-6383(331)-328.1(\(32.7\))]TJ 0 -1.131 TD [(Fall)-295.5(or)-298(other)-293.5(unintentional)-284.8(injury)-14889.9(932)-335.2(\(51.6\))-6383(617)-328.1(\(61.0\))]TJ 0 -1.1239 TD [(Suicide)-292.5(attempt,)-288.6(violence)-17950.7(226)-335.2(\(12.5\))-6880.9(63)-330.2(\(6.2\))]TJ -1.003 -1.1239 TD [(GCS)-297.5(\(%\))]TJ 50.3254 0 TD [(0.039)-6115.1(0)]TJ -49.3225 -1.1239 TD [(13)-27210.7(128)-335.2(\(6.9\))-7380.9(63)-330.2(\(6.2\))]TJ T* [(14)-27210.7(340)-335.2(\(18.5\))-6383(154)-328.1(\(15.1\))]TJ T* [(15)-26712.8(1374)-333.1(\(74.6\))-6383(805)-328.1(\(78.8\))]TJ -1.003 -1.1239 TD [(Total)-295.5(ISS)-298.6(\(median)-296([IQR]\))-18466.9(13)-330.2([8,)-332.5(19.])-6931.4(9)-332.2([4,)-325.4(16])]TJ /F5 1 Tf 49.4363 0 TD (<)Tj /F7 1 Tf .8891 0 TD [(0.001)-6115.1(0.8)]TJ -50.3254 -1.131 TD [(Psychiatric)-297.6(history)-292.9(\(%\))-19890.2(210)-335.2(\(11.6\))-6383(183)-328.1(\(18.0\))]TJ /F5 1 Tf 49.4363 0 TD (<)Tj /F7 1 Tf .8891 0 TD [(0.001)-6115.1(1.1)]TJ -50.3254 -1.5009 TD [(Sociodemogr)13.2(aphic)-300.4(variables)]TJ 0 -1.4938 TD [(Living)-297.3(alone)]TJ /F5 1 Tf 5.3064 0 TD (=)Tj /F7 1 Tf .7184 0 TD [(yes)-296.9(\(%\))-20060.9(377)-335.2(\(20.5\))-6383(279)-328.1(\(27.3\))]TJ /F5 1 Tf 43.4115 0 TD (<)Tj /F7 1 Tf .8891 0 TD [(0.001)-6115.1(0)]TJ -50.3254 -1.131 TD [(Living)-297.3(with)-297(children)-288.9(\(%\))-19086.4(383)-335.2(\(20.8\))-6383(236)-328.1(\(23.1\))-6233.6(0.166)-6115.1(0)]TJ 0 -1.1239 TD [(Education)-290.4(\(years\))-302(\(median)-288.9([IQR]\))-15066.9(13)-330.2([11,)-330.4(16])-6299.4(13)-337.3([10,)-323.3(16])-6071.8(0.015)-5617.1(19.9)]TJ 0 -1.5009 TD [(Employment)-292.1(status/jo)12(b)-303.8(category)-293.6(\(%\))]TJ /F5 1 Tf 49.4363 0 TD (<)Tj /F7 1 Tf .8891 0 TD [(0.001)-6115.1(7.7)]TJ -49.3225 -1.1239 TD [(Profession)12.1(al/manager)-19542.9(224)-335.2(\(13.3\))-6383(146)-328.1(\(15.3\))]TJ T* [(Associa)11.9(te)-303.4(professional)12.4(/technician)-14736.6(163)-335.2(\(9.6\))-6883(163)-328.1(\(9.6\))]TJ T* [(Clerk/sa)11(les/service)-20647.8(167)-335.2(\(9.9\))-6883(105)-328.1(\(11.0\))]TJ T* [(Skilled)-287.8(manual)-294.7(worker/machi)12.6(ne)-304.9(operator)-11682(223)-335.2(\(13.2\))-6880.9(41)-330.2(\(4.3\))]TJ T* [(Manua)12(l)-302.3(worker)-22029.4(203)-335.2(\(12.0\))-6880.9(70)-330.2(\(7.3\))]TJ 0 -1.131 TD [(Not)-293.5(employed)-22462.2(167)-335.2(\(9.9\))-6883(105)-328.1(\(11.0\))]TJ 0 -1.1239 TD [(Retired)-25255.7(435)-335.2(\(25.7\))-6383(355)-328.1(\(37.2\))]TJ T* [(Studen)13(t)-25162.7(161)-335.2(\(9.5\))-7380.9(86)-330.2(\(9.0\))]TJ -1.003 -1.5009 TD [(Care)-297.9(pathway)-298.7(variables)]TJ 0 -1.1239 TD (Referral)Tj /F5 1 Tf 3.4499 0 TD (=)Tj /F7 1 Tf .7184 0 TD [(secondary)-294.3(\(%\))-19193.1(287)-335.2(\(15.6\))-6383(120)-328.1(\(11.8\))-6233.6(0.006)-6115.1(0)]TJ -4.1683 -1.1239 TD [(Destination)-294.2(after)-300.1(ED)-296.9(\(%\))]TJ /F5 1 Tf 49.4363 0 TD (<)Tj /F7 1 Tf .8891 0 TD [(0.001)-6115.1(0.3)]TJ -49.3225 -1.1239 TD [(Home)-25764.7(459)-335.2(\(24.9\))-6383(344)-328.1(\(33.9\))]TJ T* [(ICU)-296(or)-298(operating)-286.8(room)-18876.9(502)-335.2(\(27.3\))-6383(180)-328.1(\(17.8\))]TJ T* [(Hospital)-291.6(ward,)-291.4(other)-300.6(hospital)-16450.2(879)-335.2(\(47.8\))-6383(490)-328.1(\(48.3\))]TJ -1.003 -1.5009 TD [(Outcomes)-294.3(at)-296.3(6)-303.8(month)]TJ /F10 1 Tf 8.7349 0 TD (s)Tj /F7 1 Tf -8.7349 -1.5009 TD [(Complete)-293.8(return)-294.8(to)-300.2(pre-injury)-288.4(functioning)-292.2(\(GOSE)]TJ /F5 1 Tf 20.2724 0 TD (=)Tj /F7 1 Tf .7184 0 TD [(8\))-298(\(%\))-5592.8(783)-335.2(\(51.5\))-6383(378)-328.1(\(44.1\))-6233.6(0.001)-5617.1(17)]TJ -20.9909 -1.1239 TD [(QoLIBRI-)-297(OS)-294.9(Total)-295.5(Score)-18078.8(75)-330.2([62,)-330.4(88])-6299.4(71)-337.3([50,)-323.3(83])]TJ /F5 1 Tf 49.4363 0 TD (<)Tj /F7 1 Tf .8891 0 TD [(0.001)-5617.1(43)]TJ -50.3254 -1.131 TD [(SF12)-300.3(MCS)-23170(51.5)-327([42.6,)-327.3(57.2])-4062.8(48.2)-327([38.4,)-327.3(56.5])]TJ /F5 1 Tf 49.4363 0 TD (<)Tj /F7 1 Tf .8891 0 TD [(0.001)-5617.1(42.7)]TJ -50.3254 -1.1239 TD [(SF12)-300.3(PCS)-23673.7(50.2[41.4,)-320.1(55.5])-4390(45.7[36.6,)-320.1(54.3])]TJ /F5 1 Tf 49.4363 0 TD (<)Tj /F7 1 Tf .8891 0 TD [(0.001)-5617.1(42.7)]TJ -50.3254 -1.1239 TD [(RPQ)-297.5(Total)-295.5(Score)-22368(4)-332.2([0,)-332.5(15])-6925.4(9)-332.2([1.5,)-329.4(20])]TJ /F5 1 Tf 49.4363 0 TD (<)Tj /F7 1 Tf .8891 0 TD [(0.001)-5617.1(43.9)]TJ -50.3254 -1.1239 TD [(PCL-5)-294.1(Total)-295.5(Score)-21642.5(6)-332.2([2,)-332.5(15])-7302.4(8)-332.2([3,)-325.4(18])-6569.7(0.004)-5617.1(45.2)]TJ T* [(PHQ-9)-294.6(Total)-295.5(Score)-21735(3)-332.2([0,)-332.5(7])-7802.3(4)-332.2([1,)-325.4(8])]TJ /F5 1 Tf 49.4363 0 TD (<)Tj /F7 1 Tf .8891 0 TD [(0.001)-5617.1(45.3)]TJ -50.3254 -1.1239 TD [(GAD-7)-299.3(Total)-295.5(Score)-21727.8(1[0,)-330.4(5])-7973.1(3)-332.2([0,)-325.4(6])]TJ /F5 1 Tf 49.4363 0 TD (<)Tj /F7 1 Tf .8891 0 TD [(0.001)-5617.1(45.5)]TJ -49.1944 -2.2477 TD [(GCS,)-232.5(Glasgow)-228.1(Coma)-237.9(Scale;)-233.8(IQR,)-238.1(interquart)12.1(ile)-242.9(range;)-230.6(ED,)-239(emergenc)11.1(y)-239.8(departmen)10.8(t;)-241.8(ICU,)-238.1(intensive)-226.2(care)-239.4(unit;)-234(GOSE,)-235.1(Glasgow)-228.1(Outcome)-238.2(Scale)-230.2(Extended;)]TJ -1.131 -1.1239 TD [(GAD-7,)-276.9(Generalize)9(d)-282.4(Anxiety)-272.7(Disorder)-280.1(7-item)-272.1(scale;)-279.9(ISS,)-276.2(Injury)-277.3(Severity)-272.5(Score;)-278.2(MCS,)-278.9(Mental)-274.6(Composite)-268.3(Score;)-278.2(PCL-5,)-278.8(Post-Trau)11.4(matic)-281.1(Stress)-277.3(Disorder)]TJ T* [(Checklist)-323.4(for)-327.8(DSM-5;)-323.2(PCS,)-320.2(Physical)-320.1(Composite)-325.2(score;)-324.2(PHQ-9,)-322(Patient)-319.5(Health)-327.8(Question)12.7(naire)-325.1(9-item;)-325.4(QOLIBRI-OS)10.3(,)-326.2(Quality)-328.1(of)-326.4(Life)-323.8(after)-328.5(Brain)-319.5(Injury-)]TJ T* [(Overall)-300.6(Scale;)-290.7(RPQ,)-296.5(Rivermead)-292.7(Post-Concu)12(ssion)-296.3(Symptoms)-286.7(Questionnaire;)-287.5(SF12v2,)-295.1(Short)-295.2(Form)-295.2(Health)-292.2(Survey)-290.7(12)-301.7(item;)-297.7(TBI,)-292.3(traumatic)-292.1(brain)-300.6(injury.)]TJ ET 59.754 747.156 406.488 .51025 re f BT /F4 1 Tf 9.9626 0 0 9.9626 59.7543 753.8455 Tm [(MED)-10.3(IATORS)-307.4(OF)-302.7(SEX)-302.9(DIFFE)-10.3(RENCES)-305.4(IN)-306.7(MTBI)-302.7(OUT)-8.8(COMES)-22532.3(3319)]TJ ET endstream endobj 82 0 obj <>stream hޔVyPTW}ucH\ 0jȈ"B 4@ ;t7 ͢,","$FA4nL418b3jLkS3իsw{QH$o !r2W.+Su uG-{@ 9/ଊ/fS"Qy2%S%ߗ*uyS}2b ʽ2ip:UPK$(U)JUt,vT!)Id2U RZ-MUEѪD2N+OVfȤɱo+UROW-G2 5UD@ͦW(jPk"ŁZAQ"jrQfϑ B]THHURTE~rvhq))W8jC糧Gd5rT4,6u#>:ش;(_͝_pQ'|VƬe_]U PXރ%]p1W& A+ҡ~bڿfk!: g58 HjihMe. 7zY:HNՂQ^QCS--'ja}:I|xOc,U=rRhU~Az>^)8\`6xޕä?㺭"V [IX_.wq'z#zACu0<0]&r_k eei`1ĐCv#9؃ L, -TBB+/ŘE4ł1q&SXGK[qqc0h ʫMY:%?ĚCCؾvcОv>ۓy4Xŕ4ۻ"S6_L~XՖj$i ל?qWT5[~V$( ļƮ64Opʊ7%}-]<]d><"gv>;7LJޢFM8k{^C vJ:W="/C oH@\oG@H'sDLzrdW շ(w]ӏvZ#W'`6zdTTVҪH'.m'zj̬w]3yqk0un]h/+zປzjUi\BfHrW2J=F˃'zJ.G\;_[1q.9#Bk6o,ב 쎮9 .Wİ,&e| nXƟvK׹옢# m;s=; gcǛk['ՑAڍEc78!Kff~!aQi95/ $4E$¤ha(!Da ;߁*3[^Zgڽ(/d ٝ/ Y'Ȅh{;;xw&x_bu䨙iwZX(He`$w<[5*q>ԳдjJEڰ$W<;0ߑhOmc&/Ξч%j}./{|% r#,-|#ac>d2@~rC 9nZ(ߘs#;]1W_^K_ w[gy]s 7&UgAJ_<{x.7("xU;ߡlkӒvDa3_[/Lmzxi%ٺZ#>>Գ4撝ɦi < F ̌ᒷ7 (xU)꿷sJtЍ+U_W<#lo8$>5YT[{B#R$PQ&^uH,1|tJu0#,0BM!, J& )h{ TrcXazu{?6tm%Z'Q۵Gulљanll5rfQ:ݔ[A7XMlXgPIk\lSipQxۺt~U!iK1}"]SycF4dmejbј5 <3/3TV KrKjL|y=P@b[MaYNxJ6`//ـ' endstream endobj 84 0 obj <>stream hޔ[PSWOZ'@arR*&H8-U[Ć4(NCDm R"`\&Kwxuj/:iOx[#cc#sMIеA0Eys^=5Kf}ݫ@`8H,?2Io0՝k-iwM \*M|y& 33mqه+W4δ\am"V܂QtӟM3ZG'{u~д%0uM'"<3;ŌF݆6HPXYL03V4a)q#)`_H_6fk6H|Qk$sls݂}$ޞKK}7&0.Cƛ&}M &?su4 EB ^c'[Lw'n[ʤfM6yT\Bz~=_e~NY"yպAul`=.vptP{{Gm~t#0pb endstream endobj 86 0 obj <>stream hTQMo +Mu 񲦉~n{wa$ 6=<1slCr8OWvqcg]gcc `gV=}v)t hkqD!=ξt#eEpDיA 4;&ŵ_ceTث51b*LSNe>f0ܦ^ZD*0Meԛ4CS1ۏ `l endstream endobj 89 0 obj <>stream /GS1 gs BT /F7 1 Tf 10.4607 0 0 10.4607 62.022 722.0974 Tm 0 0 0 rg 0 Tc 0 Tw [(Supplementary)-255.6(Figures)-253.7(S1S3.)-251.4(Because)-259.6(these)-254.2(models)-254.8(in-)]TJ 0 -1.1869 TD [(cluded)-316.6(interaction)-319.5(effect,)-323.5(we)-314.5(reported)-322.6(pure)-317.4(direct)-317.8(effect,)]TJ 0 -1.1923 TD [(pure)-393.2(indirect)-393.1(effect,)-394(and)-390.2(mediated)-391.5(interaction)-395.3(\(estimate)]TJ T* [(for)-297.3(exposure-mediator)-300(interaction\).)]TJ 1.046 -1.1869 TD [(Mediation)-441.3(analyses)-445.1(were)-439.6(performed)-443.5(in)-438.4(multiple)-441.7(im-)]TJ -1.046 -1.1923 TD [(puted)-498(datasets)-496(with)-496.2(missing)-496.4(information)-492.9(in)-498(covariates)]TJ T* [(and)-439(mediators)-440.3(imputed)-438.7(based)-441.6(on)-441.6(an)-440.4(imputation)-438.9(model)]TJ 0 -1.1869 TD [(with)-284.9(sex/gender,)-282.2(and)-281.8(all)-286.3(confounder,)-279(mediator,)-282.6(outcome,)]TJ 0 -1.1923 TD [(and)-569.1(auxiliary)-565.1(variables)-568.3(using)-570.9(the)-565.9(R)-569.7(package)]TJ /F9 1 Tf 19.9659 0 TD (mice.)Tj /F7 1 Tf 7.8454 0 0 6.9729 293.2723 627.1368 Tm (42)Tj 10.4607 0 0 10.4607 62.022 610.0156 Tm [(Exposure)-296.5(values)-296.1(did)-290.7(not)-296.1(have)-295.5(missing)-295.9(values,)-295.4(and)-298.1(unob-)]TJ 0 -1.1869 TD [(served)-309.1(outcome)-305.2(values)-306.9(were)-309.5(not)-306.9(imputed.)-302.5(The)-308.8(results)-309.1(of)]TJ 0 -1.1923 TD [(the)-495.4(mediation)-496.5(analyses)-499.2(were)-499.2(pooled)-496.6(over)-496.2(10)-495.8(imputed)]TJ 0 -1.1869 TD [(datasets)-300.9(using)-299.9(the)]TJ /F9 1 Tf 7.4682 0 TD (mitools)Tj /F7 1 Tf 7.8454 0 0 6.9729 170.9291 577.3605 Tm (43)Tj 10.4607 0 0 10.4607 181.9275 572.7117 Tm (package.)Tj -10.4165 -1.1923 TD [(Estimates)-287.3(\(regression)-287.3(coefcients\))-287.7(for)-281(direct)-290.7(and)-281.8(indi-)]TJ -1.046 -1.1923 TD [(rect)-410.5(effects)-416.2(of)-408.1(sex/gender)-413(for)-411.1(continuous)-407.7(outcomes)-407.9(are)]TJ 0 -1.1869 TD [(presented)-360.2(in)-362.5(forest)-365.7(plots.)-361(Direct)-359.9(and)-363.1(indirect)-360.6(effects)-362(for)]TJ 0 -1.1923 TD [(dichotomized)-382.7(complete)-380.7(return)-380.8(to)-378.8(pre-injury)-381.8(functioning)]TJ T* (\(GOSE)Tj /F5 1 Tf 3.1 0 TD (=)Tj /F7 1 Tf .7208 0 TD [(8\),)-239.4(obtained)-240.1(in)-243.3(logistic)-241.5(regressions,)-240(are)-241.7(reported)]TJ -3.8208 -1.1869 TD [(for)-216(women)-213.6(\(men)-215.2(as)-219.4(reference)-216.9(category\))-217.1(on)-214(a)-214.2(scale)-220.4(of)-213(odds)]TJ 0 -1.1923 TD (ratios.)Tj /F4 1 Tf 0 -2.6881 TD (Results)Tj /F7 1 Tf 0 -1.2032 TD [(About)-324.6(two-thirds)-326.6(of)-326.8(patients)-324.8(\(64%\))-330(with)-322.8(mild)-330.2(TBI)-327.2(were)]TJ 0 -1.1923 TD [(men.)-520.4(Women)-521.1(with)-523.3(mild)-519.9(TBI)-522.3(were)-526.3(older)-518.7(\(median)-521(58)]TJ 0 -1.1869 TD [(years)-418.9(vs.)-415(50)-414.5([Q1)-410.9(32,)-419.2(Q3)-413.3(65]\),)-414.4(had)-417.3(higher)-414.3(GCS)-410.7(\(79)-417.5(%)]TJ 0 -1.1923 TD [(vs.)-209.1(75%)-204.8(with)-209(GCS)-210.1(15\),)-205.5(lower)-208.6(percentage)-208.8(of)-213(abnormalities)]TJ T* [(on)-295.3(CT)-291.7(\(42.5%)-292.4(vs.)-295.8(47%\),)-288.4(and)-298.1(epidural)-293.3(hematoma)-292.6(\(5%)-290.5(vs)]TJ 0 -1.1869 TD [(10)-219.4(%\),)-215.3(and)-216.8(lower)-219.4(total)-215.2(body)-216.6(injury)-217.2(severity)-218.6(\(ISS;)-219.8(9)-215.4([4,)-217.7(16])]TJ 0 -1.1923 TD [(vs.)-599.3(13)-598.8([8,)-602.5(19.]\))-598.7(than)-597(men)-602.4(\(Table)-597.2(1;)-601(Supplementary)]TJ T* [(Table)-328.7(S1\).)-332.3(They)-329(sustained)-327.8(more)-329(TBIs)-332.4(due)-330.6(to)-330(falls)-327(\(61%)]TJ 0 -1.1869 TD [(vs.)-539.6(52%\),)-537.7(and)-542(fewer)-540.2(due)-542(to)-536(motor)-542.4(vehicle)-538.4(accidents)]TJ 0 -1.1923 TD [(\(33%)-321.6(vs.)-322.9(36%\))-321.6(and)-319.8(violence)-325.7(\(6.0%)-320.9(vs.)-322.9(12.5%\);)-320.3(and)-319.8(had)]TJ 0 -1.1869 TD [(worse)-267.2(pre-injury)-262.6(physical)-263(\(50.0%)-259.9(vs.)-268.7(58.5%)-262.3(with)-263.2(no)-262.8(sys-)]TJ 0 -1.1923 TD [(temic)-272.3(disease\))-276(and)-271(psychiatric)-269.7(health)-275.5(\(18%)-267.4(vs.)-274.1(12%)-269.8(with)]TJ T* [(history)-292.9(of)-294.3(psychiatric)-291.3(disorders;)-293.1(Table)-296.1(1;)-292.1(Supplementary)]TJ 0 -1.1869 TD [(Table)-301.6(S1\).)]TJ 1.046 -1.1923 TD [(Fewer)-212.8(women)-208.2(were)-206.6(admitted)-210.7(to)-210.8(ICU)-207(or)-207.6(operating)-210.6(room)]TJ -1.046 -1.1923 TD [(\(17%)-202.4(vs.)-203.6(27%\),)-201.6(and)-200.6(more)-204.4(were)-201.1(discharged)-201.6(home)-205.4(\(34%)-196.9(vs.)]TJ 0 -1.1869 TD [(25%\).)-526.8(Women)-526.6(had)-525.7(slightly)-524.6(lower)-528.3(years)-527.3(of)-521.9(education)]TJ 0 -1.1923 TD [(\(13)-303.7([10,)-303(16])-298.3(vs.)-306.6(13)-300.7([11,)-303(16],)]TJ /F9 1 Tf 11.6684 0 TD (p)Tj /F5 1 Tf .6612 0 TD (=)Tj /F7 1 Tf .7208 0 TD [(0.015\),)-299.5(were)-304.1(more)-301.9(often)]TJ -13.0504 -1.1923 TD [(retired)-331.7(\(37%)-332.4(vs.)-333.7(25%\),)-331.7(less)-333.8(often)-334.4(had)-330.6(job)-334(occupation)-333.7(of)]TJ 0 -1.1869 TD [(skilled)-446.7(manual)-447.5(worker)-447.8(\(4%)-447.6(vs.)-447.5(13%\))-446.2(or)-446(other)-448.3(manual)]TJ 0 -1.1923 TD [(worker)-285.2(\(7%)-285.1(vs.)-284.9(12%\),)-288.4(and)-281.8(slightly)-286.1(more)-285.7(often)-285.7(of)-283.4(profes-)]TJ T* [(sional/manager)-275.9(\(15%)-272.8(vs.)-279.5(13%\).)-272.1(Women)-277.3(more)-274.8(frequently)]TJ 0 -1.1869 TD [(lived)-348.5(alone)-345.1(\(27.0%)-346.6(vs.)-344.5(20.5%;)-344.4(Table)-350.3(1\).)-342.4(Characteristics)]TJ 0 -1.1923 TD [(of)-278(men)-277.2(and)-276.4(women)-273.2(in)-275.8(different)-279.1(age)-275.2(groups)-273.6(are)-279.6(presented)]TJ T* [(in)-297.5(Supplementary)-299(Table)-301.6(S2.)]TJ /F2 1 Tf 0 -2.6881 TD [(Mediation)-300.7(analyses)]TJ /F3 1 Tf 0 -1.7614 TD [(Mediation)-298.5(via)-303.4(psychiatric)-301(history.)]TJ /F7 1 Tf 14.7847 0 TD [(There)-298.3(was)-303.5(a)-300.9(signi-)]TJ -14.7847 -1.1869 TD [(cant)-227.3(indirect)-219.7(effect)-226.7(of)-223.8(sex/gender)-223.3(mediated)-223.5(by)-219.4(psychiatric)]TJ 0 -1.1923 TD [(history)-395.9(\()48.2(indirect)-390.7(effect)46.7(;)-399.5(Fig.)-389.7(2\))-397.2(for)-394.8(all)-394.7(outcomes)-391.7(ex-)]TJ T* [(cept)-725.9(physical)-723.7(HRQoL)-724(\(SF-12v2)-717.4(PCS)-723(-0.06)-724.3([-0.16,)]TJ 0 -1.1869 TD [(0.05]\):)-527.6(disease)-533.2(specic)-528.8(HRQoL)-528.9(\(QOLIBRI-OS;)-525.7(-0.75)]TJ 23.998 64.2875 TD [([-1.20,)-249.7(-0.30],)-244.3(proportion)-243.1(mediated)-245.2(16%\);)-246.5(generic)-248(mental)]TJ 0 -1.1869 TD [(HRQoL)-360.9(\(SF-12v2)-348.9(MCS)-357.5(-0.47)-355.8([-0.75,)-352.7(-0.19],)-352.7(proportion)]TJ 0 -1.1923 TD -.0126 Tc [(me)-12.6(d)7.6(i)2.8(a)-12.6(t)10.9(e)-12.6(d)-312.1(17%\),)-326.2(post)-12.6(-)10.7(c)-12.6(o)7.6(ncussion)-325.5(\(RP)-12.6(Q)10.9(;)-322.3(0)-.4(.36)-325.5([).6(0.12)5.1(,)-326.2(0)-.4(.60)5.1(])-12.6(,)]TJ T* [(pr)-12.6(o)7.5(porti)-12.6(o)9.7(n)-303.9(medi)-12.6(a)10.9(t)-12.6(e)10.9(d)-303.9(9%\),)-304.6(depr)-12.6(e)8.7(ssion)-303.9(\(P)-12.6(H)10.9(Q).8(-)-12.6(9)7.5(;)-300.7(0)-.4(.22)-303.9([).6(0.09,)]TJ 0 -1.1869 TD 0 Tc [(0.36],)-317.2(proportion)-313.6(mediated)-315.6(16%\),)-315.5(anxiety)-317.4(\(GAD-7;)-311.9(0.17)]TJ 0 -1.1923 TD -.0161 Tc [([0)-3.9(.06)-3.9(,)-232.2(0.)-4.6(27],)-232.2(p)-3.9(ro)-3.9(po)-3.9(rtio)-3.9(n)-231.5(m).7(edi)-16.1(a)12.8(ted)-236.9(14%\),)-232.2(and)-236.9(pos)-5(t-traum)-4.7(a)2.8(tic)]TJ T* 0 Tc [(stress)-439.6(symptoms)-434(\(PCL-5;)-433.4(0.39)-434.1([0.13,)-436.4(0.65],)-431(proportion)]TJ 0 -1.1869 TD [(mediated)-272.3(18%\).)-272.1(Differences)-271.6(in)-270.4(outcomes)-272.4(were)-271.6(partly)-270.2(ex-)]TJ 0 -1.1923 TD [(plained)-252.4(by)-251.9(psychiatric)-253.4(history,)-254.3(but)-247.3(to)-254.1(a)-252.1(small)-253(extent)-253.8(com-)]TJ T* [(pared)-249.7(with)-252.3(other)-247.7(factors)-249.3(\(proportion)-246.1(mediated)-245.2(9%)-249.5(-18%\).)]TJ 1.0514 -1.1869 TD [(The)-200.4(effect)-210.4(of)-202.1(sex/gender)-201.6(not)-204(mediated)-201.8(by)-203.2(mental)-205.8(health)]TJ -1.0514 -1.1923 TD [(problems)-484(\()42.7(direct)-483.4(effect)46.7(;)-486.2(Fig.)-481.9(2\))-489.4(was)-482.3(signicant)-486.8(for)]TJ 0 -1.1869 TD [(all)-503.1(outcomes:)-495.5(disease-specic)-501.3(HRQoL)-496.4(\(QOLIBRI-OS,)]TJ 0 -1.1923 TD [(-4.04)-502.1([-6.21,)-499(-1.88]\),)-502(mental)-503.9(HRQoL)-501.8(\(SF-12v2)-495.2(MCS;)]TJ T* [(-2.34)-458.8([-3.45,)-455.7(-1.24]\),)-453.3(physical)-458.1(HRQoL)-453(\(SF-12v2)-457.3(PCS;)]TJ 0 -1.1869 TD [(-2.54)-420.8([-3.50,)-412.3(-1.58])-418.4(\),)-419.6(and)-417.3(post-concussion)-417.2(\(RPQ;)-414.5(3.72)]TJ 0 -1.1923 TD [([2.44,)-268.4(5.01]\),)-266(depression)-269(\(PHQ-9)-265.7(1.17)-266.1([0.64,)-268.4(1.70]\);)-267.5(anx-)]TJ T* [(iety)-257.8(\(GAD-7)-256.9(1.03)-255.2([0.56,)-252.1(1.49]\);)-256.7(and)-254.7(post-traumatic)-256.6(stress)]TJ 0 -1.1869 TD [(symptoms)-298.5(\(PCL-5;)-297.9(1.83)-298.6([0.46,)-300.9(3.20]\).)]TJ 1.0514 -1.1923 TD [(Logistic)-363.8(regression)-360.1(showed)-364.3(a)-365.9(small)-361.4(indirect)-366(effect)-362.2(of)]TJ -1.0514 -1.1923 TD [(sex/gender)-364.2(mediated)-359(by)-354.9(psychiatric)-361.8(history)-357.9(\(0.96)-355.8([0.94-)]TJ 0 -1.1869 TD [(0.99],)-447.2(proportion)-443.7(mediated)-445.7(9%\),)-446.9(and)-444.4(substantial)-443.3(direct)]TJ 0 -1.1923 TD [(effect)-329.7(of)-321.4(sex/gender)-320.8(\(0.65)-323.3([0.54-0.99]\),)-321.3(indicating)-317.6(lower)]TJ T* [(likelihood)-448.9(of)-451.4(women)-446.7(for)-449(having)-447.9(better)-453.3(functional)-444.5(out-)]TJ 0 -1.1869 TD [(comes)-301.5(due)-298.1(to)-302.9(other)-296.5(factors.)]TJ 1.0514 -1.1923 TD [(Analyses)-407.1(in)-405.9(different)-403.7(age)-410.7(groups)-403.7(showed)-407.7(the)-408.7(largest)]TJ -1.0514 -1.1923 TD [(signicant)-421.8(indirect)-420.2(effect)-421.8(of)-418.9(sex/gender)-423.8(via)-419.6(psychiatric)]TJ 0 -1.1869 TD [(history)-450.1(in)-454.7(the)-452.1(age)-448.7(group)-452.7(65)-447(and)-449.9(older,)-453(indicating)-447.7(that)]TJ 0 -1.1923 TD [(worse)-484(outcomes)-483.8(in)-487.2(older)-480.8(women)-484.6(compared)-483.6(with)-480(men)]TJ T* [(were)-412.5(to)-405.9(a)-409.3(considerable)-405.8(degree)-409.7(mediated)-407.8(by)-409.1(psychiatric)]TJ 0 -1.1869 TD [(history:)-488.8(proportion)-487(mediated)-489.1(29%)-492(for)-487(post-concussion)]TJ 0 -1.1923 TD -.0126 Tc [(sympt)-12.6(o)9.7(ms,)-310(27%)-306.9(for)-308.3(post-)-12.6(t)10.7(r)-12.6(a)8.7(u)-.4(mat)-12.6(i)12.9(c)-308.1(s)-1.6(t)-12.6(r)10.7(ess)-310.5(s)-1.6(ympt)-12.6(o)9.7(m)-1.2(s,)-304.6(25%)]TJ T* 0 Tc [(fo)20.1(r)-306.5(a)0(n)20.3(x)12.2(i)15.4(e)0(t)23.5(y)12.2(,)-313.6(2)17.7(4)12.2(%)-310.5(fo)25.5(r)-311.9(d)12.2(e)13.4(p)12.2(re)21.3(s)11(s)11(i)15.4(o)12.2(n)12.2(,)-313.6(2)17.7(0)12.2(%)-310.5(f)0(o)25.5(r)-311.9(d)12.2(i)0(s)21.1(e)13.4(a)13.4(s)11(e)13.4(-)0(s)18.9(p)17.7(ec)21.4(i)25.5(c)]TJ 0 -1.1869 TD [(an)20.3(d)-594.8(m)11.4(en)20.3(t)15.4(a)0(l)-589(H)13.5(R)10.2(Q)13.5(o)12.2(L)12.4(,)-600.9(1)12.2(9)12.2(%)-597.8(f)13.2(o)12.2(r)-599.2(G)13.5(O)13.4(S)0(E)-590(\()13.2(Su)22.3(p)17.7(p)12.2(le)23.4(m)11.4(e)0(n)25.7(t)0(a)23.4(r)0(y)]TJ 0 -1.1923 TD [(Fi)20.1(g)12.2(.)-286.5(S)15.5(4)12.2(-S)23.3(6)12.2(;)-288.1(Su)22.3(p)17.7(p)12.2(le)23.5(m)11.4(e)0(n)20.3(t)15.4(a)13.4(r)0(y)-278(T)12.4(a)13.4(b)12.2(le)-280(S)15.5(3)12.2(\))13.2(.)]TJ /F3 1 Tf 0 -2.3413 TD [(Joint)-371.2(mediation)-370.5(via)-373.8(gender-related)-364.5(sociodemographic)]TJ 0 -1.2357 TD (variables.)Tj /F7 1 Tf 4.8722 0 TD [(The)-303.3(mediation)-296(analyses)-304.1(showed)-299.3(a)-300.9(negligible)]TJ -4.8722 -1.1923 TD [(indirect)-284.7(effect)-280.9(of)-278(sex/gender)-277.5(jointly)-280.9(mediated)-277.7(by)-284.4(gender-)]TJ 0 -1.1869 TD [(related)-488.6(sociodemographic)-482.3(variables)-487(\()48.2(indirect)-482.8(effect)46.7(;)]TJ 0 -1.1923 TD [(Fig.)-644.4(3\))-635.7(for)-644.1(disease)-641.6(specic)-642.6(HRQoL)-637.3(\(QOLIBRI-OS;)]TJ T* [(-0.11)-561.8([-0.74,)-564.1(0.51]\);)-560.2(generic)-562.3(HRQoL)-561.4(\(SF-12v2)-560.2(MCS)]TJ 0 -1.1869 TD [(-0.06)-447.9([-0.34,)-444.8(0.21];)-448.8(SF-12v2)-443.4(PCS)-446.6(-0.05)-447.9([-0.31,)-444.8(0.21]\),)]TJ 0 -1.1923 TD [(post-concussion)-503.9(\(RPQ;)-501.2(0.07)-499.1([-0.24,)-499(0.38]\),)-504.4(depression)]TJ T* [(\(PHQ-9;)-618.8(0.04)-618.4([-0.11,)-612.8(0.18]\),)-618.3(anxiety)-615.5(\(GAD-7;)-620.8(-0.01)]TJ 0 -1.1869 TD [([-0.14,)-791.7(0.11]\),)-791.7(and)-791.3(post-traumatic)-787.8(stress)-797.3(symptoms)]TJ 0 -1.1923 TD [(\(PCL-5;)-384.6(-0.01)-377.5([-0.36,)-379.8(0.33]\).)-374.4(Therefore,)-380.9(the)-381.6(differences)]TJ T* [(between)-215.2(men)-212.2(and)-216.8(women)-208.2(in)-216.2(6-month)-209(outcomes)-212.8(following)]TJ 0 -1.1869 TD [(mild)-297.7(TBI)-300.1(were)-298.7(not)-296.1(explained)-297.2(by)-300.7(gender-related)-295.6(sociode-)]TJ 0 -1.1923 TD [(mographic)-301.4(variables.)]TJ 1.0514 -1.1923 TD [(The)-471.3(effect)-470.6(of)-467.7(sex/gender)-472.6(that)-469.1(was)-471.5(not)-469.5(mediated)-472.8(by)]TJ -1.0514 -1.1869 TD [(so)12.4(ci)18(od)13.6(em)19.4(og)13.6(ra)15.8(p)12.2(h)0(i)16.8(c)-311.7(va)14.8(ri)17.8(ab)14.8(le)18(s)-308.7(\()0()64.4()0(d)14.6(i)0(r)17.8(e)0(c)10.6(t)-309.7(ef)15.8(fe)15.8(ct)18()56.6()0(;)-301.9(F)0(i)14.6(g)12.2(.)-313.6(3)12.2(\))-311.9(w)0(a)16(s)]TJ 0 -1.1923 TD [(si)15.7(gn)13.6(i)20.1(ca)10.6(n)12.2(t)-640.3(fo)14.6(r)-637.1(a)0(l)12.6(l)-640.3(o)12.2(u)0(t)16.8(c)0(o)14.8(m)0(e)14(s)11(:)-640.3(d)0(i)16.8(s)0(e)13.6(a)0(s)13.6(e)0(-)15.8(s)11(pe)14.8(ci)18(c)-632.3(HR)12.9(Qo)20.3(L)]TJ T* [(\(Q)15.9(OL)15(IB)12.6(R)10.2(I)0(-)15.7(O)0(S)18.1(,)-248.6(-4)14.6(.)11.5(6)0(8)-241.1([)0(-)21.1(6)0(.)12.9(8)12.2(4,)-241.8(-2)20.1(.5)12.9(2)12.2(])0(\))15.7(,)-248.6(m)11.4(e)0(n)14.8(t)0(a)12.6(l)-244.7(HR)12.9(Qo)20.3(L)-247.7(\()0(S)17.9(F)0(-)]TJ 0 -1.1869 TD [(12)13.6(v2)-734.3(M)12.4(C)0(S)14.9(;)-743.3(-2)20.1(.7)12.9(5)-741.1([)0(-)15.7(3)12.2(.8)12.9(8)12.2(,)-741.8(-1)14.6(.)11.5(6)0(1)13.6(])0(\))15.6(,)-741.8(p)12.2(h)0(y)13.6(s)11(ic)12.6(al)-735.3(HR)18.3(Qo)14.9(L)]TJ ET 145.701 747.156 406.488 .51025 re f BT /F4 1 Tf 9.9626 0 0 9.9626 62.022 754.3557 Tm (3320)Tj 42.2865 0 TD [(MIKOLIC)-311.3(ET)-299.4(AL.)]TJ ET endstream endobj 93 0 obj <>stream /GS1 gs BT /F7 1 Tf 10.4607 0 0 10.4607 59.7543 211.5779 Tm 0 0 0 rg 0 Tc 0 Tw [(\(S)12.4(F-)17.9(12)19.1(v2)-284.4(PC)14.9(S;)-283.4(-2)20.1(.5)12.9(5)-291.3([)0(-)15.7(3)0(.)18.4(5)0(1)19.1(,)-297.4(-1)20.1(.5)18.4(9])14.6(\),)-284.1(an)14.8(d)-291.3(p)0(o)19.1(s)0(t)15.7(-)0(c)15.8(o)0(n)13.6(c)0(u)14.8(s)11(si)15.7(on)]TJ 0 -1.1923 TD [(\(R)12.6(PQ)18.1(;)-298.9(4)0(.)12.9(0)12.2(1)-302.1([)0(2)20.1(.)0(7)12.9(2)12.2(,)-302.8(5)0(.)18.4(3)0(0)13.6(])0(\))15.7(,)-297.4(de)14.8(p)12.2(r)0(e)10.4(s)11(si)15.7(on)-289.9(\(P)12.4(HQ)16.1(-)13.2(9)0(;)-292.1(1)0(.)12.9(3)12.2(6)-302.1([)0(0)14.6(.)11.5(82)13.6(,)]TJ T* [(1.)12.9(9)12.2(0)0(])14.6(\))0(,)-576.8(a)0(n)20.3(x)0(i)16.8(e)0(t)12.6(y)-578.5(\(G)15.9(AD)16.1(-7)14.6(;)-580.7(1)0(.)12.9(2)12.2(1)-583.9([)0(0)14.6(.)11.5(74)13.6(,)-579.2(1)0(.)12.9(6)12.2(8])14.6(,)-579.2(a)0(n)14.8(d)-583.9(po)19.1(st)15.6(-)]TJ 0 -1.1869 TD [(tr)12.4(au)20.3(ma)14(ti)14.6(c)-290.1(s)0(t)15.6(r)0(e)15.8(s)0(s)-286.8(s)11(ym)18.2(pt)11.4(o)12.2(m)0(s)-286.4(\()0(P)17.9(C)10.2(L-)14.8(5;)-281.2(2.)12.9(2)12.2(3)-296.7([)13.2(0)0(.)12.9(8)12.2(6,)-285.1(3.)18.4(60)13.6(]\))15.6(.)]TJ 1.0514 -1.1923 TD [(Logistic)-629.3(regressions)-630.9(showed)-629.9(no)-625.9(indirect)-631.6(effect)-633.2(of)]TJ -1.0514 -1.1923 TD [(sex/gender)-217.8(on)-219.4(complete)-218.1(return)-223.6(to)-216.2(pre-injury)-219.3(level)-217.2(of)-218.4(func-)]TJ 0 -1.1869 TD [(tioning)-224.5(\(GOSE)]TJ /F5 1 Tf 6.1675 0 TD (=)Tj /F7 1 Tf .7208 0 TD (8;)Tj /F9 1 Tf 1.0026 0 TD (n)Tj /F5 1 Tf .6666 0 TD (=)Tj /F7 1 Tf .7154 0 TD [(1161/2376\))-220.2(mediated)-223.5(via)-224.4(sociode-)]TJ -9.273 -1.1923 TD [(mographic)-382.7(variables)-384.1(\(odds)-378(ratio)-385.4([OR])-383.4(1.02)-379.9([0.98,)-382.2(1.06])]TJ T* [(for)-221.4(indirect)-219.7(effect\).)-223.6(The)-222(effect)-221.3(of)-218.4(sex/gender)-217.8(not)-220.2(mediated)]TJ 0 -1.1869 TD [(by)-392.8(these)-389.6(characteristics)-392.9(was)-395.6(signicant)-389.3(\(GOSE)]TJ /F5 1 Tf 19.5865 0 TD (=)Tj /F7 1 Tf .7154 0 TD [(8;)-389.6(OR)]TJ -20.3019 -1.1923 TD [(0.61)-580.4([0.51,)-582.7(0.74])-578(for)-584.5(direct)-577.9(effect\),)-586.7(indicating)-577.8(lower)]TJ T* [(likelihood)-275.5(of)-272.6(complete)-272.3(return)-272.4(to)-275.8(pre-injury)-268(level)-276.9(of)-272.6(func-)]TJ 0 -1.1869 TD [(tioning)-284.1(for)-281(women)-284.1(due)-281.8(to)-281.2(other)-280.3(factors)-281.9(than)-282.7(the)-284.1(sociode-)]TJ 0 -1.1923 TD [(mographic)-301.4(variables)-297.3(specied.)]TJ 25.0495 15.4784 TD [(Subgroup)-331.4(age)-334.8(analyses)-331.2(showed)-337.2(the)-332.8(largest)-333.9(\(albeit)-334.9(not)]TJ -1.046 -1.1923 TD [(statistically)-332.1(signicant\))-338.1(indirect)-333.5(effect)-335.1(of)-337.6(sex/gender)-331.7(via)]TJ T* [(sociodemographic)-243.8(factors)-243.9(in)-248.7(the)-246.1(group)-246.7(65)-241.1(and)-249.3(older,)-241.6(sug-)]TJ 0 -1.1869 TD [(gesting)-363.2(that)-366.2(worse)-364.7(outcomes)-364.6(among)-361.2(older)-361.5(women)-365.4(were)]TJ 0 -1.1923 TD [(partially)-312.6(mediated)-315.6(by)-311.5(sociodemographic)-314.3(factors.)-313.7(In)-316(con-)]TJ T* [(trast,)-440.1(in)-438.4(the)-441.2(age)-437.8(groups)-436.2(16-45)-436.4(and)-439(45-65,)-441.1(there)-436.2(was)-444.4(a)]TJ 0 -1.1869 TD [(small)-296.3(\(insignicant\))-297.2(indirect)-295.5(effect)-302.6(of)-294.3(sex/gender)-299.1(via)-300.3(so-)]TJ 0 -1.1923 TD [(ciodemographic)-207.5(factors)-206(in)-210.8(the)-208.2(opposite)-210(direction)-207.4(\(Supple-)]TJ T* [(mentary)-298.8(Fig.)-297.6(S7-S9\).)]TJ /F3 1 Tf 0 -2.3846 TD [(Joint)-582.6(mediation)-576.4(via)-585.2(care)-577(pathways.)]TJ /F7 1 Tf 16.6978 0 TD [(The)-579.7(mediation)]TJ -16.6978 -1.1923 TD [(analyses)-320.4(showed)-326.4(no)-322.4(indirect)-322.6(effect)-324.2(of)-321.4(sex/gender)-320.8(jointly)]TJ T* [(mediated)-440.3(by)-441.6(care)-445.1(pathways)-438.4(\()42.8(indirect)-439.5(effect)46.7(;)-442.8(Fig.)-443.9(4\))]TJ 0 -1.1869 TD [(for)-308.1(disease-specic)-311.6(HRQoL)-306.7(\(QOLIBRI-OS,)-307.4(0.07)-309.4([-0.12,)]TJ ET 1 i q 1 0 0 1 59.754 723.231 cm 0 0 m .113 1.077 l .558 3.43 2.505 5.569 4.932 5.896 c 6.009 6.009 l 6.009 4.989 l 5.159 4.932 l 3.093 4.646 1.477 2.903 1.077 .907 c 1.02 0 l f* Q q 1 0 0 1 543.968 729.241 cm 0 0 m 1.02 -.113 l 3.474 -.397 5.449 -2.568 5.896 -4.932 c 5.953 -6.009 l 4.989 -6.009 l 4.876 -5.102 l 4.541 -3.097 2.883 -1.371 .85 -1.077 c 0 -1.02 l f* Q 65.764 728.22 478.205 1.0204 re f q 1 0 0 1 65.764 238.394 cm 0 0 m -1.02 .113 l -3.474 .397 -5.449 2.568 -5.896 4.932 c -6.009 5.953 l -4.989 5.953 l -4.932 5.102 l -4.531 3.105 -2.918 1.365 -.85 1.077 c 0 1.02 l f* Q q 1 0 0 1 549.921 244.346 cm 0 0 m -.057 -1.02 l -.504 -3.385 -2.479 -5.556 -4.932 -5.839 c -5.953 -5.953 l -5.953 -4.932 l -5.102 -4.876 l -3.084 -4.573 -1.38 -2.869 -1.077 -.85 c -.964 0 l f* Q 65.764 238.394 478.205 1.0205 re f 59.754 244.346 1.0205 478.885 re f 548.957 244.346 .96381 478.885 re f q 453.534 0 0 341.065 78.293 378.198 cm /Im2 Do Q BT /F4 1 Tf 9.9626 0 0 9.9626 76.7055 360.2267 Tm [(FIG)-7.2(.)-330.4(2)0(.)]TJ /F3 1 Tf 3.8696 0 TD -.0138 Tc [(M)-13.8(e)13.5(dia)4.3(t).9(ion)-298.3(a)4.3(na)4.3(ly)4.6(se)-13.8(s)16.2(:)-300.5(Es)5.6(t)-13.8(i)13.7(mates)-296(\()-.3(regressi)4.6(on)-298.3(coef)4.1(cients)-296(w)-1.8(i)4.6(t).9(h)-298.3(9)1.1(5)-13.8(%)-289.1(co)3.7(ndence)-299.1(i)4.7(nterv)4.3(a)-1.4(l)4.7(s)-.1(\))-301.9(o)3.7(f)-303.2(d)1.9(i)4.6(r).9(e)-13.8(c)11.3(t)-295(e)-13.8(f)14.7(f)-1.6(ect)]TJ -3.8696 -1.2974 TD -.0151 Tc [(of)-298.8(sex/gender)-302(and)-301(i)3.3(ndirect)-302(e)1.2(ffect)-302(v)-2.7(ia)-298.6(p)-15.1(s)8.7(ychiatric)-302.2(h)-3.7(isto)]TJ 21.6867 0 TD -.0139 Tc [(ry)-297.1(on)-298.4(outcomes)-296.1(followi)4.6(ng)-298.4(mi)4.6(ld)-299.8(TBI)4.6(:)-300.6(specic)-295.3(\()-.4(QO)-13.9(L)14.4(I)-1.1(BR)4.9(I-OS;)]TJ /F8 1 Tf -21.6867 -1.3031 TD 0 Tc (n)Tj /F5 1 Tf .6829 0 TD (=)Tj /F3 1 Tf .7056 0 TD -.0152 Tc [(1633\))-303.3(and)-295.4(g)-3.8(eneric)-302.3(\(SF12V2;)]TJ /F8 1 Tf 11.4039 0 TD 0 Tc (n)Tj /F5 1 Tf .6829 0 TD (=)Tj /F3 1 Tf .7056 0 TD -.0152 Tc [(1614\))-303.3(health-relate)-15.2(d)-290.5(quality)-304(o)2.3(f)-298.9(l)-2.4(ife)-300.5(\()]TJ 14.3743 0 TD -.0146 Tc [(HRQ)-14.6(o)12.7(L\),)-295.6(a)-2.2(nd)-300.5(post-concussion)-299.1(\(RPQ;)]TJ /F8 1 Tf -28.5552 -1.2974 TD 0 Tc (n)Tj /F5 1 Tf .6829 0 TD (=)Tj /F3 1 Tf .7056 0 TD -.0146 Tc [(1606\),)-301.3(d)1.1(epre)-14.6(s)15.4(s)-.9(ion)-304.8(\()4.6(PHQ-9;)]TJ /F8 1 Tf 10.7893 0 TD 0 Tc (n)Tj /F5 1 Tf .6829 0 TD (=)Tj /F3 1 Tf .7056 0 TD -.0149 Tc [(1568\),)-301.6(a)3.2(nxiety)-303.7(\(GAD-7;)]TJ /F8 1 Tf 9.3268 0 TD 0 Tc (n)Tj /F5 1 Tf .6829 0 TD (=)Tj /F3 1 Tf .7056 0 TD -.0147 Tc [(1562\),)-301.4(a)3.4(nd)-300.6(p)-14.7(o)12.8(st-traumatic)-301.8(str)-14.7(e)10.6(ss)-296.9(\(PCL-5;)]TJ /F8 1 Tf 16.3717 0 TD 0 Tc (n)Tj /F5 1 Tf .6829 0 TD (=)Tj /F3 1 Tf .6999 0 TD -.0149 Tc [(1)-14.9(5)9.3(70\))]TJ -42.0361 -1.3031 TD .2869 Tc [(s)300.6(y)299.7(m)300.5(p)302.6(t)301.6(o)304.4(m)300.5(s)300.6(.Q)302.4(O)286.9(L)315.2(I)299.7(B)304.4(R)300.1(I)299.7(-)304.4(O)302.4(S)297.9(,)5.9(S)297.9(F)305(-)298.7(1)301.8(2)301.8(v)305(2)301.8(:).2(h)298.3(i)305.4(g)298.3(h)304(e)303.2(r)0(v)305(a)299.3(l)299.7(u)304.4(e)303.2(s)-1(b)302.6(e)303.2(t)301.6(t)301.6(e)286.9(r)16.3(H)300.2(R)300.1(Q)302.4(o)298.7(L)299.7(.)5.9(R)300.1(P)300.1(Q)302.4(,P)300.1(H)305.9(Q)286.9(-)314.2(9)301.8(,G)300.3(A)304.8(D)299.9(-)304.4(7)301.8(,P)300.1(C)301.2(L)299.7(-)304.4(5)301.8(:h)304(i)299.7(g)304(h)298.3(e)303.2(rv)305(a)299.3(l)305.3(u)298.7(e)303.2(sm)300.5(o)304.4(r)301.6(e)]TJ 0 -1.2974 TD -.0141 Tc [(severe)-299.4(sympto)3.4(ms.)-300.8(QOLIB)3.4(RI)4.3(-OS,)-300.8(Qual)4.4(ity)-297.3(o)-2.3(f)-297.8(L)-1.3(i)4.3(f)-1.9(e)-299.4(a)4(fter)-301(B)3.4(r).6(ain)-298.6(I)]TJ 23.4963 0 TD -.015 Tc [(njury-Ove)-15(r)10.3(all)-298.1(S)1.7(c)-15(a)11.9(le;)-301.7(S)1.7(F12V2,)-301.7(ge)-15(n)12.7(e)1.3(ric)-296.4(s)-1.3(hort)-301.9(form)-303(he)-15(a)13.7(l)-2.2(th)]TJ -23.4963 -1.2974 TD -.0147 Tc [(survey;)-301.4(R)-1.5(P)4.2(Q)-14.7(,)-285.9(R)-1.5(iverme)-14.7(a)14(d)-300.6(Post-Concussion)-299.2(Symp)-14.7(t)10(o)2.8(ms)-302.6(Que)-14.7(s)9.7(ti)]TJ 24.0426 0 TD -.015 Tc [(onnaire;)-301.7(PHQ-9,)-301.7(Patient)-301.9(H)-1.6(ealth)-299.5(Q)-15(u)12.3(e)1.3(stionnaire;)-301.7(G)-1.7(AD-7,)]TJ -24.0426 -1.3031 TD -.014 Tc [(Genera)4.1(liz)3.3(ed)-299.9(An)3.1(xi)4.4(e)-14(t)11.3(y)-297.2(D)-1(i)4.4(s)-.3(order)-300.9(7).9(-i)4.4(tem)-302(s)-.3(cal)4.4(e)2.3(;)-300.7(P)-.8(CL-)3.5(5).9(,)-300.7(P)]TJ 20.799 0 TD -.0152 Tc [(ost-Traumatic)-302.3(S)1.5(tress)-303.1(Disorder)-302.1(Che)-15.2(c)9.9(klist)-302.1(f)-3(or)-302.1(the)]TJ /F8 1 Tf 19.0747 0 TD -.0134 Tc [(Diagn)5.4(ostic)]TJ -39.8737 -1.2974 TD -.014 Tc [(and)-296.4(S).1(tat)-14(i)15.2(stical)-296.8(Manual)-296.8(of)-296.4(Mental)-302.5(Di)4.8(sorders,)-301.1(Fif)5.2(t)2.1(h)-302.4(E)-1.2(d)5.2(i)-.9(tion.)]TJ ET 59.754 747.156 406.488 .51025 re f BT /F4 1 Tf 9.9626 0 0 9.9626 59.7543 753.8455 Tm 0 Tc [(MED)-10.3(IATORS)-307.4(OF)-302.7(SEX)-302.9(DIFFE)-10.3(RENCES)-305.4(IN)-306.7(MTBI)-302.7(OUT)-8.8(COMES)-22532.3(3321)]TJ ET endstream endobj 95 0 obj <>stream AdobedC        s!1AQa"q2B#R3b$r%C4Scs5D'6Tdt& EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz?Nlٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳg241t?_;xTE被;k}Zn/ń҈&*W`67zG8O Ky̶-gO/i$2Ggq,~buK[56=p?84H`׮},iF4ح!FR@vj+%>TV:r>-iVdّ1,u1=j4+j#_Q4;b>V̸0 :tht+A1}h;!v* U3MYtGYn$!Y˃]ݸ1TNL@2 py1ҪGsybvOҧlu jXitH_ӸiVbro?6%?04J6~nfhtFDHm;o5y@-kWWNcI%Kx+M!E^GUc?֧}(V=L:v0O0tF p?%nJxӮ3{Vo:4iOsxOWԙdo/3LӬ RV{t[XUۅЙ$h/AYR)ZmڗXijWI=X.-HJI v;q$Yf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳg8ZE{RvW9/C?ɟ:y;O"YИaEڈsgѼa< ƉgLnmakĂy$vH quz=4ia>9hNtR>(֘1i:6Fi/o$д ѕ8aFVCߕn苉.M/RY5sl,rQǗ<+6ڝYYwq).*9}sC;oUl4]+oí<I"@FÜff `Ж o)cHQAtdw2,CH~="FGu=NImB-3FͶg_YjO qf%ż#R](a>U4{&i mKv ;F8oOΚ,uBTK-7[QsβC !F(Xwy q{J[ˉQtK#n[9#cq͞Dׅ[[e5[UiuZK*2K% t TVG/uS.H,[h30$gZ u8k M2PJ]Vy$^4fnBb0~K7%,Z FY@8m׾~bT]z֕i^-6J՞hb*I UՋ({ns/+nMZOMe`\kgUբP_om+ʞ} JTi:n*1mkFE$|G|/gizdt/Xy)9RJЏihڇ Cᾷͨ?LdS׾E#uQPjŅ旨<̓&Ya4gI#e }Mw е/.7cl5 Xu Mi 7E4boSyBIΉ6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͑??yZwL/:swioP|+/SFkiOF8}W!ߒws\knH̟T4xث d{򗜴|G9+G i2!I~Nzz)9[`hCIIߗ|ɠJVЯ4BZGUaH,j~ ?We.´>d|4)F!"2ˮh^ºQY_0iXKW>$B> &=+G__PNw6\I؋y->6 dTnf1#]gbn-4EyH_æ Ym.57]7# =>?Uz9472˾vӽ[ CK3Z/Xu??&lE 2Y"HAhUO'yo&b~w۬3YcJmfH&<#ONjoZ[ߟZy hYo`F֦ ZC;w7_~VI2yIY$E!̈(Wj*k`|uCq=kKm;pq$)sT$L矓^jvi^W1~Ъ|<:c_sߑ^[֛hҭ chy7&wwJL94,vi}?bavk]n'烂Wir+?VlFtU. S[tZIQ0PsySMo(A<٦k.r'd`" Z߷x0/3Y^C(e75fžl]5^~Aj>Ը#Ғ89>4Ci$ryO,=?GkZIflg)9 wۡn~hyg_,i>W{ 6-΅iB~x>'|7Kh5CGiqmdH>ɌwPӠhƽ3>]lt;+=^Jzµc6l,"z/14Ͻg^_Ji+pB-]J|M@+MVއy`Yּz7OU晭Ȩ?m\pikI֬5;5hXL2ǐ]Hu6kGys1(n4q- c(IީOT}jd;ߝsu-Vo4Gm+}~_X9 ^1ĔZPeFjQ\1Ҽd۫ $! `zkI/柝ٮy>_-Lճ峧Z!4'ڊ$m/vo<Λ/?c,SDU9OLv~n?~G5J%W P m :-ƻK3,?ƎPдR*zl>~uqJէ7dIZvU_\|m}'>p4&"o5-Ư׵4y-H [DȯSM]ζzl=ؽ§0J9TWsm9.h|iq>(sԑY-b8'*/ձᴡ(<[[Ř[ ɬhhU:Pg:+/έs VK80VȽx۾i+/_aO6Oޡb׍>/ O%A{}JN1_IvbXʪ `ѸbyT6]q!s3iCQ^`pGa2$zA7sE=.4+֧|>ʲ^<>@ j#p*<6q#_[zmO]:dQW]UiqA6 {J0 ぽRWUSvuT^`iAӵSCmqnVXqM^rӿ34=b㲒+QmC@PO!Rk))1t\O{ȞR5Qxvÿ?0tkX[L45$^^QUm/(|cמšcA 0jƧGSױg'֗Kn}yQZDw|U}e(!/^ݑ04_x柚|ݨ]syL\`FY qF垴Dz _ǿ̋o/[/<$ŭ5YXJw`QlVy&CRHp/ Fm%F,87q׍> y_?- I|Xo~ a>uM0ߓn_?znڽ "j"ǨEͬ~U2Wg˭KnWv4 <-~Sf4][ξs#e+aavpA`A>u6ySC_lXjcMɐ jtPJMAv o/-Eu+ҵ^FUwŸ$~_gy_]B-WQ0o`K(,8=yv\,׮0/nҎI*wT9f͜y-o:.QU^$P_έO kK9,# D9~zGki:\XE!Y-$O"C24~󎿚< ڕcܰ!SOSUIɤy_-t,cGb0zS/Ⱥne}y֣-ѐ*J}6 Mzd* 'Bߔ4%]}dCn!HP*kṬ:ys~Xפ|ExY0Aܱ45vJE%5e/o`'.l)ܜ3.#>6.=Țèˈe??.$ʳLo<<6p#|\֬γ6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳcxW\#5EzW6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰ;:lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͍H⍤F$ Z$E5eWk/Hj']"/7_v-"Wk/Hj']"/ >z򷔵ƵT2@bH^1əx_5_0hVZ^%²SN.u Z$E5fk_՛OYD_Vo?eIYZ$E5fk_ՋZkZ=侍̴-*;Pu4RN ͛6lYaGyp6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf SD̋$R)Y#pYH8S XEh XEi XEi XEi XEi XEi XEib=J+ѕ X d3s"<-ZyKEЬӭo1_(ՏOX?(ՏOX?(ՏOX?(ՏOX?(ՏOX?(ՏOX?cOװ--'_V#(4 3f͛6XgQ_3͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lf=ו|Ejlqɬ_^\k30Lʒ<\Tl;Rծ/|ۤ ̩oOFo۫qy-Top̏={ z@Ku5KK!bV8㕊D@r:L@6&ck^V9X `H Zgb8Q\ZrrέU<}h{o7嵛2G!%i85&q4cyHm;ΞZӬ롧:}.X(Xh´_}K~bѼ>QKuw=I A6u6Ҽ7N7zj yxU_2 V&V_[ΓBy3IJ AZriO1~ayO3yS:4ZίL9E\vT3GBbh&͕xF ?2֛wNM_+yRʱ\_u 흣y"bxӓ#qWjY׭XkVK7RX e;2͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfͅG f͛6lٳf͛6lٳf͛6lٳf͛!Zgnk˶iњI;}R4ݩ2Sauk<>Kµ5 J9u1q_hV:<ƥwC]}RܣzwD2aWŲe䷎F+%Iդ5|S'Nb)΋^ ͛6lٳf͛6lٳe3*)f!UEX v&/4咟WB=wJnDO7ihOSzgO'LN[fy+,UPC {9]4=SEWZ8 Y'!=")K$p7>io*yNfBky`Y*4RW+t n屷my$H6EBr Vf͛9/7ʟ>Ѽqw,#Աd,t]>MSQokB=[] UƩywMԁ aRGBKS$ @UQEQvyf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰ;:lٳf͛6lٳf͛6lٳf͛6lٳb6WsY_Aե˜緙Cz+T};I[8%NnvQ>m`G~Ph5GEm{dK|=0YJBB#aqYX[igƋઠ1|ٳf͛6lٳf͛6l&O%A5 h+żb(OǕi޵Zdzڜvq=⢉4$3Ȫ`N:MZ hayWX#w!@Ija{AOJ{xx͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfkCN37M-4vI"3?7ߛiS #$k1耟\>?tmf&ZLO=7JF̝r;H9+bIAJR6׶2;:lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf?#yf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ ,?㳨/͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l,Σ<8g6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͉^M46 s4hZ;ueVC9U9Lٿo:,?o?Nc˿]ϯzœxxZOu)}{ͯLr/Bwyu|Ru&Xl7ԝwI[-|'݀Nlٳf?#yf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf́5 HԸ~b$.yJci|Vr-AƜSf͛6XgQ_3͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l<+dkZyQ즹4uyg̲I3y7. ޛsYB̪1r$9qmN#oJ%W(S=Ŕ!VWm^͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l,Σ<8g6lٳf͛6lٳf͛6lٳf͛6l<[QԵ{pevQEu䞥h +l;<[zY; <Ξib {8[,ũWΣk{>thQܫ'&&SZ5+//m\v¬rro6lٳf͛6lٳfoR7E,Vp~r?5GhjfY6kkN*-랁[,!3jIAsEߙǠ\;y+SCnĿ^V܃b?U=|C3]N]I9%&Id1U`@=(;]6ϩMi E-sgQFϋ6lٳg5u/O/X@~UYߪΨKYa>䒰',Oʯ+ P7Ӽ͞?R:\Sz޳D=2wu3X]յ杣\ƃ[% `pBЃ&e[2w>mt^M- >ğ!FL}wlBh+ARƫZwlٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳd'ߜ>X&W꺍M;(uwS^0R4 (G$C)aGyp6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l.4 j-ZuHkfBi'qX׼wK7ss8)V+a SҴ4Y徲H]Ha$qaGyp6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳaevu<ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfͅG f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͉]][+$ҰDQҬ@O-FVOԭo%EҸ?6lٳfͅG f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰc{gi cV:S"X o6{HC#AWN Ϋqqz|’"bB+sɯɿo/Ihb[vgc"7QĠ ֝S"X o6{HCio̷W^v[FP@E8cfͅG f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6D_+j  EM+xgb&GKt}ژ!2<pzѸNn]?%CZV$<%y 0A * [ENs rCCB=;w'ז4mkW$-RAT$o+ʞj7cd%Z&dG idt{T C_?>"Wߝ0~z,uZ",J(WUGQtwj t-ݻ$ mԆeI]A6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lYaGyN͛6lٳf͛6lٳf͛6lٳf͛6E<}]A4ZK~2J4 _S%tE&*6 yڴFi[32̞ZF%jv鉪$>HEܱ➉NbBZwu/[]*n-R]kJ{`ٳf͛6lٳf͛6lu/#m[Mվ.&q/HG.^,$I4Ȧwkmި~MW5..kZf_̊nTrG,k$l7ԂH f͛6rk'zg|o0G:{3Csougc0굌RAk=j=V [:eQy=Ż$Le&E^zǗu͋V o~=~yn$@k"_>OҬ3W5V {$h́yO[κEtҬR.S]\fD CjWXjaԮ5h>ʨ "r7â{yɴo-\Ӵ:Zoe[ TӏyH󥷔?2<˒N].yeHv]╅'|m[XEځa:}9/-ƭ]_Wu] Jx+Q!ҧ)%Fy(z8/`7?2[=M2q[e:qvLf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfͅG f͛6lٳf͛6lٳf͛6lٳf͑o7~eykʗzf?Z3ieuvyE?3k~Ptfڟ|x=B4ƃfW~Q^JZFrcM+L_C'[/}DngK.a".T)u8Y(yGuVAt51u8Idذva/qYҵ/ew}6 Rޛ[L陳f͛6lٳf͛6lj?~_)}E7Q?Jʙ̯,,!C\ampI}`}C+Υ{}oI{vhG`˳+"<ot?NN!Nմ0fHU#r+i^Ҭildd`RigԖ)nq##J}v˽SJ|jE.,`kK"Kz1`z6lٳd ]7`|ja?JCqmrѯYV@rZ`y$k%^]no< H9Aî)?Ϯ<ǭw~dl⾻X r8 QY&3͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l,Σ<8g6lٳf͛6lٳf͛6lٳf͛6l/'uI|yN󖥦_#E 8"6)Pu;)λmk?o.Ӧ[5?.1L0S Ȯ)i>Դ/ɲբOg797򯗭t}>mݰ5F£7g&楪ͣQ409_Ҭ-:HDgQG(w摥XiU -a^jG0^lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳd_;͗R.(cnF6/*Gp ۪v6bZK^I"C͘R6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰ_|ã\ڼYӯ-9`B>%E|k)StLG?,b;7(lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf?#yf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ ,?㳨/͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l,Σ<8g6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰ;:lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf̝_R-0$חڱ%wD~0 @=/?3< >ӳٴ/29"#Tɪ黩;< ?yWЮfQyOTU8~Cj_zT^`OXe " 4uOK+_7gKMJRōYBİ}SQ_O]KX* i,: YJ`kZ`=77hzb4)b-#CS +O~`kZޝi-&mF(4KJtnX |ͧW-iß]k~yv~αi^I$72dyIPPq8Rɭ/?F(hDT'xI[_36hɯn go,GQ<}Y`w۟ Ȟy:3ySs_i]8:0dӿ;4+Ӽ}(:Ǘަ+-ݹ5峰ɲu?$<_ teexoLWyOW_:oq䱫Y"݅Smj~WK5ߘ5T5KffJ9I"pE;wɇO_Я4}MbynDF@MkQ͛6lٳf͛6lٳf͛6lٳf͛6XgQ_3͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lCo!y/>i"q;_\d~YזolX^쭌~q=cv'A(+եy^}M]t,10@yzh;ܚHϗu˭zNfW JƊԁ~ io'iWEi>f(vEH ?:Ϙ/-m[ѯ )ܨGRxt` B=A.|u AӯIqo #Ѻ | 9Դ?TOm㻱CŴ7F꬧˯":EtkI{Wx%xB(pM<{wzu,o5iVDnwZ8]Z:j:ߗu 3Œ/@OڿimyZImg,JFтQ)E 1],}9C {TR>,/~1ʌ3f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfͅG f͛6lٳf͛6lٳf͛6lٳf̀5;& .,)a,OU"ˉޕ)<>4ꚾ+<q,Ķ̱A0@Mu"]2kdcs QeM4M/*\~gW?5-PPgUt|XUms퀼1yGyͺ]I[As!p=wj)ʹ#.cR rp 7f͛6lٳf͛6lٳ~mZ+iiLZ^_7 !';†\/0rrUhU^hV핅wsUYR |6i^xϾRV[/њ$naW".BonyznJPmIH[gSo KH܌yf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳaevu<ٳf͛6lٳf͛6lٳf͛6lٳa`n4;tK}Ԩ$'R W]_fyP򭎷R5MmI%5!&JN/J.NԵƬMjr:iFBYS[ʏ-W k&%kL[V1M3_k^frL5;X L+c 2)eWF^lٳf͛6lٳf͛ >\׵-w%Au4$ Z7xFQ$F_OmGϚކ9ҿD,-ă7K+Z$.ꨣsg(>3ڋٳа< B/+|;ơaO1&I"NM%Hxyk|pr5w+I=IJAs%԰+D"3=+ulٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ ,?㳨/E|qjE/PgmQĊT,2k_:}ho"I܂*SCB*͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6MZi8K&Jasqj[5楣jn8ѳ9d+V$Յs':'l-R5^R%1`-v6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰ;:lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf?#yf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ ,?㳨/̈́מu}̖兽'Ks:7Z2++(e!U6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfͅG ͩZjZk+k!*5_NSf#-?<̽Kͺ퍺j3yss*<(jQ5VEӈ!@ tmZeĒͭjp^ k^KEmf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٲt_hzyqNFeA"rhbwV\淐'ϚՒ]EuIy+#)b}^Zކcn,c^]O?yKzM mk{Y/ieXEi]z*O*~hy/e㦫 ziMgs+}ֹ*fTRB~qkzW3*E;GgEb߃͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳaevu<ٳf͛6lٳf͛6lٳf͛6lٳf|͡+.vk6wuh-R7.@ ?Z~gZt GQtĸTD]T([N6Oȏм`՚@Ý)RXXRE TQf͛6lٳf͛6lٰ>g@uh[J ByyBm ̒x`o*~kzi&'Xm,S[OR!:G'%f͛6p+n8?2W@cIҍyoi蕱AU=<0 gNiK= Dn%PHwrouߖ>c]cNZQ]#5xK|yZ8?;mƤL򕔚H*O/c lm=WOd:f2 ,F=1ם48kJ,u[+8o.mVOIӗqC]g4^/<|{_ySѢu-hg%62Nfc+KTG6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ ,?㳨/͛6lٳf͛6lٳf͛6lٳf͛4~O&NjW0T>EcMRAr{y佛K!fwn":]i4w9d8A0tcAi^.[m>}(CfsV噙ً3Rp^XaW FuQBxM͛6lٳf͛6lٳfm?-+ u֖TofgeD -(=473dr#Eko:yӊm%˳^8bS/-*y*?15κZUcEiPKxP|nӮO/-"(k,uq jKf鰮u|ٳf͛4?'Xhes9-qH}w5'/^O<4#$qFTi0ݣygdS.>ɰ~ yĐrȟ<ֹկll糺A-o Uh:}:]Fx+3BxE͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf?#yf͛6lٳf͛6lٳf͛6lٳf̈́PF/;]yf]iiVrLn\M_%0Å CTڿN|c_סW IuA=:w]I+@򅎍3I5טnb8=VDU뇹f͛6lٳf͛6lCO&ilOkYO-[Ӹ9bZ \7x}n&zQ1jݷ8Yyv{4_ym[귑X^&OW함~PjWռZ-uoEdfF1fHB5kzΚU[f@ lv#2u6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳg?-z!5帷[tHzt*Zd+Ovl.gm?Uy)$F_ĝ76lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lѴn]gKmOXJu忑{%$rc,Ǻf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6XgQ_3͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lYaGyp6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳaevu<(ռ]Z꺵(C<$b 69_|cym,! ~텞BuFck˘7>U };kg%^igX]N!9gv=A8}6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfͅG RFzU] 92bc b^! =yd4>7/-! ('O'ӵ3y-:K+R^kHNJ|M>zVίy󳢐Zܳz(*k?04Ωh쳾|;Ͽ>˫~͛6ٳ͛6ٳ͛6ٳ͛6ٳ͛6ٳ͛6ٰ;:ٳ͛6ٳ͛6ٳ͛6ٳ7:ϳ&&*3cm-$)FϿ%/<;gyR-f-_꺜$H" HJ;ȟG eşnrDj[]έ'"9IƔlPOm=YWћOB <$-ONΜ΋-|M3~rIqah;zֱ[iwYrInO,:nw6&~S3Ŀ[{bԴZYPHeVZ:͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf?#yf͛6lٳf͛6lٳf͛6lٳfe)Ս6\^C_9׭CN;ٴ [mhvKWс\`8T;^7ZEiڄVU_SP1?+5~fi~K:S:u!)ymvi$Fex84[?&KǮj?K. = NlVE|Uz6lٳf͛6lٳf͛9ǕgeO7:%xeN ^i5}$[[VZv-$I( j NWm~bΞ]|ˣ[yjY?F/n..`0Q "p܈maF0RZBέp=8q`.8:s[°A*K,HI )Rqf͛6lٳf͛6l~gy[\m[~^  M0'ߨzdeiJ4(VbC<5(NRG/~ktwF{E5IUL7=T`pM_=eK >d ?Ib/-bWdb:W7XfOLV1tO%z FQpÛ6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳaevu?8|N 7^h!P<,RU9#Ϙ2hV&|ԣu8g6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l#L{ VbYzaJg,h&my[V[e<W^ѓ? ~PoF^zp$ꪌY Lf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ lAƢi' f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lζ7׾QPW[Wx@HYM+I_i?1FoTUcfI_i?1FF|}jϛ-﵉!5E_ӊr7O*NqO3ʤ#.={Uӯo_q4i?NH!Cb1I_i?1FoTUcdfFO̝;E[`i_QhnmFeaJU'XƧeRyWZujQU'XƧeѵ)èj7Ou}I_Q_ ١QgdFIRyWZujQU'XƧeZXk5޳YK- U4䦕oTUcfI_i?1FoTUcd_A|6[\ijVASq%XOɪPu9(I_i?1FoTUcaw?+eRXKk9LjFLhgb^RMX{?KC®pI<-:5?(*ʿӬcSk5}%5_Q<{8TUcfI_i?1FoTUcdcȟ6oM}emk+ATUcfI_i?1FF1/mBO!7tK-aQ#F&I_i?1FoTUcfI_i?1F~wWJ ˻I=;)y XxgA͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l]6:ws.ML2A68c6iZy]su{ywͪ=Q p|+0vZ}sz/opcn/PtP [&a'mi-`7)WrhkYaw KM2ǙI'}Fܮ&yz i9\,u#.MZA$|5^Cq9amagz%-]j-U> Ms\2́/ ]KѸHƇifgrCոBڦam/u/X_Z99oe6f\BmBn_!‹ ao4 {N}1mŹΗC8}6l.@7Zsr߻IMgjlٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfZƵh|{ 4nndXZ*@߶;I4cOQo!VwY#` Iu_>#HFjc?w1G/>ٳ`x5 X.#̪ eWͅ>`w2k-ݮHy 4X%HPȄ2 # m e3*f!UEY:~cC}a:]Yܠ& ѕ_6_y:emqtg'bd&oyM : J^IUU,Y6cp6@'{I`7i^mdFy`@>)c462:T}ٰ/>"mkZ&4#qy'!CQL>͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lJgix`* &*syXX?E?E~(g\%8&X`IL%g]CpU<bL&Ӣ0[^LbF8J8YTr'E2j$vg_vet  óWjW9/giZ֑#xaR3zME9"G*P(z_2鶚iNզ+ J)摤XE dyzp"Wqzt0jYSI'Mݼ9tOՀuJL罷5IIV zmZ!LӤu4qV {r񵉡ڪMt FMW.aYy{P-z7*}_RX@x9y{ZGO~RԚ]l"᭬ىD$>ӈu$) TZ"v2K5 V-+.%BřKIpj 0&(BE}8P>@dy@Ԛʿ\n=}Qp*g`!%V+(i! L܏[J6yvO&V 4JB}9LeYoZ%?RyKvld6r/:/#kOqǛ@h"ݘ}(dF(TUNl'yjyĺn X6`(~4' L꿷6wj*˦ _8Kʄ)Fu V(UXw$p~l_~\1CZfOfG5@ Ws`[m+NH5^΢)=8˞PP`E"y?KoRMLr@0!-h{ťV#""(خS*aUaB=D4 2Pcm{i x$jO90͛zVYGc[E8"QLdr18+6Go%hεֶZ/^(±ܜ/d۷TlUu(ª8L,4>NK[TXQETv$d?PԵ Bv772gx#c^%ꪊEE/ s*GFee5 O'Ug^mtAhWpeK[Zv؅cqa{ YF ʂV³Օ͌r9Є*<>9=Ǟ5/YҼ2=W̚Mpmm'EYUUV(>eMK:!it(t3y \b\[jJfs_6yZ擢ZɬKWM-Y%H4S K?6#9~y[qO>9%?0y]GB6m2j׷fR?Z+x8C4Q]7/?05/%z:3uu5֓{rJKw/,!gN~+]hDޤG n"^R7rĝ]i K̫k-yKQLVK7p[WPi^uI5/*gz{[?Y/}KȞi9TLa˕7יm|-ޭ}-סq-hyHI$~SF.YؒIܜX~hIV,54jZ:X &0~!:QZt~ojZOLZnF9r"eQ8Q\̟.ĚZ-ZmfF^J7/vh2/ym%ռݨhifגq{ҟWx6QZa=BQzJy-~DѼ$r~J뎇\V=y}Ty4(#hH~~~dyV͖ iaw#iIIhquT[ʗ:Y5x70C)5"RʩBv['l=c'&c]ZKhQٕb6~ep^>緫e۾<QT<^qHduU ?*s?"EK 5yl.4$L8[Gns远՗/}5>/,ɑäJ~m=ūfH t'w7jOjOmwB.YQ*XYB&7&t;ƘRvK!?\[ٰ_[557$ e1,aR<4)9;]K4նrQ4#)3:%c=鉳((ۓݴڲ縿:ё&/6ٳ͛6ٳ͛6ٳ͛6ٳ͛6ٳ͛6ٳ͛6ٳ͛6ٳ͛6X~뚷4;7]3+#°R0P?4?*җn[,lơnD,u Yn+~Ѷ7hW>Cd $ȳfo Szgn=8kew!|2}z q!$yu4y~K3$>KE˪CĴ6@I\jM6a #KĚt{Zh6m{t "5$qA˯-NߑJE$BOB6"B?cRuҵ]nnQcm*dU%Y yRVLQiϦYyj"-%YrG*U]OsyV/u5}R^B_~9ן0P3CWʸ׿0u :thtƭ#!v䡔(Aצ7^qiyiI³ XǻpbZdͿr.}qM֖p D,(r>N Ɛ5kM_^dmskmco xY#fV~##!cyT# yc 0TIXkZiCDGRS!v D^aM熯95RViTja|uY%KSn'*x2gone/a MFH Xmt?_7nUt`Ѹ +O%{*pO/I&cRjcRKk pgˁuvU bASis}^j^+[ # jMFH$۲Z,^_gIt/Hi#1;q)?JI5b9`#NYZ%ғmɾ¸H֗XXwGԴo'tFVnn>-|?l|e\Zu+il"#~* ygSm5H.u ɬaajhd~K>ܔ3wVok4i%MsxWԙd_/6\W=V-mL4i zTV_i6.hE隽ROjc irqbnB]I:Flٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lo>>~ak~tֵ{dlԝ?NKScΞOjȴfX1!];r ߜQɐzT&ѮH/&Gdqze!j|P_3^i3`橢ޛHZ~Zb?wڷ.|aXmx-0B,ѕ8y^W'J+[5SY w6߷(sʾn&}smE}\2"@c4?Pjp 럥mX3i5dYhUDda3CQoXjVKf7ϗcHQArdw2,CH~="FGu=JImB3FͶgYTyȗܚՂ߭^S)FBܪO3궲^iw\A$HB#ȿƁWs"iXf%!Hμ~쁵w/]yi]R闚zZ!bxn!xѝz ^#'ǚ?iI{fC:$WK:HM{'M޷izY6Kh*IUչ Q87>ݱܴ3ֱ:ʧ+ٕ)%<5_8h^`ԮIMӵWC5cT`D_RGwۯ0y̖zfZԣmcNRzWu4$'t=U˽tKs 5q4!Y ^$dмǥChWjt!jFH;*0#~򵇜4']ӐC}@M6lk>-Zu7rXK^\IK7j£?.3jVuƊ*hI=/4矬,j}- dURhTS%yf͛ .Ku45hNх_0=*U~2[F2tت^#͛Zkz=yZ^Cq}NkH-pnl'WԾw>JRi啠(ᕢIPti`S]1OsywP{Ty] HU%ewq~7̀}sGѭEޫy :IJH抋^Ǡ76lٳd{~Om~ڍNZYR9$3t_ݫSrC-y3GǘeKq(*8Ƭ߲{bryʱxG/~miFe湝#K31dIt_W]tQe5W1@\ ]EO,IUOgya$ @$ _$y%+ܣq4q \Ե:?m򆄞`ԛL%u ԙ9т{MռݪT]yEMU "}F9zaRGž ט 7Ip'ӄ[A$Dzӥ~y+3<۫d_&m*J^[mxFLؿ$o3ˬTZŵƙo)߫xt?wk?:Ψ˦rRDbXbvV_YBGw,|k;հ4zȮ_I%1K _sߑ^[֛hҭ ڣFjc%˳`9:ٳ͛6ٳ͛6ٳ͛6ٳ͛6ٳ͛6ٳ͛6ٳ͛9I6<+IiW)hI#eNAk\w|פ5yBG:뭧,S+*2HL@~iqGqM:y" Nc{f\=G[Okٯ4ӎ3>Oçz.r+6z:G?m5Dm5e2Gva`VhiQ'Xޏi_:%-j+KYY~չcT7h~mOϒ\yiڋECt_T q^΋9y6m:Ake-q-$(ܘ=z<巔al5IYL{9tmDA"Uzw~QyO 0p5:RSy83V[_ߕm_ ME.mZHNrJ9ܼSD;V!O<9b疣qCGC+=³&DX(Џ!$tĔZvȏ=-4J+:’ӳ[ٲْ&ܴ<6kDwjWM$Q٢$c 4ys:gm}a¢ktFky DX{⶛~TW״g}%hJ'1f>`>R"_\3LqG(uG\f4 3=14-?Gb>b `ҵYyzY!hipVT>6쓟7`:ғimT\?m+%f#rW //9O9kA/=,%nMcCJA_S|sO?0)-5k# `׉=; 8`t *ß:RRaIjkK;NeDkSS[:督RQܣ5Wa䏚5;h^hvot =t9E_QvON^;?8ttyPkW,cI^/UOQ{iMc]^Y~YSz 7-?3O+mR;),mbѢ0a[4 &/͞AMjzX ܉+ŚC߮w[mkiƗpFҝ?j*C?/40&(>`- '5Jsmyvj^TgZDw偼W}e(!^ݑMˇ ~|J/5yPH64t$T1zq;12-7,} y_:?- I|H~ aayO͢entx _U!;kO [k7kZȺ$mb Kdn)6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͑̏*O#k[[Y8=K*A@=3ZB~p"ETZgkd!ğ Ѝ[o=C[j^WnMo"Y.dpȜ8?;$7GF,87S^4|0ߔn_?\蚶nڽ "`vusky7̾cY˭KnWf4EG[?yEռ?^]R,,t{a;Pl8s ֟:oG{^Ksg?b 5uބrCۥ2ʟ63~`LλhI. KS2 5P;l)5OQ-T;#m@&ivJߕ0g'5-pcZ?g~zJHzu]bU3?0g"?_iv~P>z~F@uqqo?.#G|mjഏO-1:mCsf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lɦYUh'xVhn*6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l ZU&G͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lXl]c%IH*Y$E5fyg_՛QD_VoGeIYY$E5fyg_՜^U(wR7P< i=t嗍PMU<W{/Hj(]"/7?w,"<W{/Hj-eRg"hݘCp~lٳf̀\qrmG$p~lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf̀u CdYu :T^(+h @y?Z"4fy?Z"4fy?Z"4fy?Z"4fy?Z"4fy?Z"4g/5}rTMZ/&i" gN>PH?BX7?;iћiћiћiћiъ_6 siY[Fk[Ď|,<ٳf͛k_ʹPtHٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfu_$hkrk7μRY$⫰K U$Qf'떞YV[V6~$ep~cy ֗_Kt5KƵ[!bV8㕊+F9W_><ͯI=DZǗ%V+Ìjl,m,4aZw#RW,oOvlBA'gŴ͍M8EhM7 ޜ{yxh)WLUɯu8.6Vbadwr૰O-^2|ݤ.#no,Z e{nc`ѓ#-iY~fdktdl|-CwnDڰ$+ܲԯӜU\ʇ<3jtK4YCC+EZVF ^5=DuMsWή_UŒG Nj\;F['u>}7U_FـEa\ٳf͛6lٳf͛6S2b?hE|S[GiMȉ8mI_*|TβYB$@|yϗ~["k:ލdXuBn R5$@iPxyE<Ѥ^&ԵB#"@wH]Of͛6lK4*~dDZMgGkwm$ $.h^2k_ f幼꯭,mz+w |нFp/o*jז^s5HȌ rX8q@5s }Q :NvyWGκ7n#u\\0; $qH кW|oXOO˲[;Č[XՈI[m,Dij-ϰm;<Re @;!cim{XW u?!j5/.鷚!=2JHYI4PTQTl^lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lt?4Hٳf͛6lٳf͛6lٳf͛6lٳb76wͤR{y<[ST4KJڞżRJwvRvkVߘ^uKxۜq]“*4;Olxm,q*(`ٳf͛6lٳf͛6l&O%A5h+7żB(OǕi޸aǨMGk j7Oxg (r*:E@sw}_G?O9q+JӬ/D"+o*[ؑ9Ŗ͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l)jᰕo~ImLJZ?,$ 7YYR:X/ZE?4@Gkߚ7ҵZ?FJ~S w*_Cխ{lxY!E?+S<ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳ`=d\qrmG$p~lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳ`-k9W?n6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l ZU&G͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳdv>ghmswlV;EGF CQ2fyLͿ:5?0|RXIָEYJ 4iZ_~ﴹ|,Wm%ѽ2G*֝}(IaU<Ru&Xld ,۹>ܗ6r*P*jvd6l ZU&G͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛:^-F'b@pit># 6rhbRj 3f͛6l*Co?#f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛8O})2u[?}oV<*=6v-ŰujH4oO2]yVqB^{=t"U԰;3VߔWb1u]STm:PDMh=w.o)/Yu[$ $cJX{dK{0iQWgs-r^KH⡺Ԝ #jyKizݞ\Pya (R |#ry4.N27ՓSu4[K̾agz^qiieCqs;Ja-|54C7fB&Ze[*bXJw/ dGk r4R6"_^_}Grx0[_e_N!ZCȊќl7yX /?"$"]Qtۛkioc4ۨ]ߧLyEX|/х+۸O3?1\kz?2at14KI^X!ӛ -.|GR[7y̐KxQ(R1E'b+yc:ݝZ)59 [o ^_<ͩu835̊? **αϞ[7-g*uۙtvn4䊨c %i(7ӕP s͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6ֿs?ɷf͛6lٳf͛6lٳf͛6lٳd[Ϳ]U7z,Q;DȷĐIsyZUnF1 LH/&noi v9Ӵ1kZhM囫7⽶yƜ)G*Eu;OwW?ynFhI7wseZ "ͺǟ?4[:n|噭 vFxđ: bj=7m|MkO[hwz%2[ 2,l7"J8t=5|+myIԡ8P"!n'[><}.ifkٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͐/$X~5_]f/JY9'"+)>H4g/erŖ;)ـ=Aٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳbP_YMg9q c$e]O9¿6?uB ODӚ-BkYóUFtM*?,|!.'-NrGutYߥJ[:6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰ7AMĎ͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l*Co?#f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ .K#4n"GSJJ%ee "/6lٳ`-k9W?n6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ 5]Y,s` };QT?^/)$!TrhBԜat n㶟T[=>&i`HDP 7=|.o"ו~򗛢}P[!n$xKn3*HJ ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfZr896#8?6lٳf͛6lٳf͛6lٳf͛6lOuӵj+A/$@5>/[;8DZK;Y"ªòȧ8-"6'kҰ찭{(@"*۩nwl♵Aհӝڝk7$yڵ4Qܰޔ뻻;۲氭4ٶٲϳմڴڠ#4Vº…s59o"V?45&-Vji԰ٰƐ,埑<#qEU44¹/?>g|) ~CnpQFuST>Qn 72(YFR"6i ΧU7 ;jpV=WGѵ;Nۑ Uh{8^kK˚l/msP ^L2|}'MRNt_JWG `#/ι.kW<*og߉4ȇ?|O[Emfxf*QG_ʟ]/P;KvQܗ$(YځպgT< HX{[=.㉶U/1}"+Ϋ]y[S]^\mHa`w Q:^u6lٳf͛6lٳf͛6lٳf͛6l*Co?#f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛<Ϝ3MIq1qGO1K R8ߵv!#-_;~[I Vܜ#8F[FT2j~P#)뗷51y{΃.h:oLXA%k*+V[Hr/-KM}muu ̑I [pdM4F֍ E( (FP5|PyGvFKhzLQmXH~(]L,ߓqn8|B%G?6 I0үuɭE#i ŽꢧG^|A+˿0޼FiDgƲ|-Ӎ{W= ͟#nǔm8+}:u F*}}:DzYK$K^_Sh gLX;(BydAk#1-;䟟n H+(/U XzdK~Z4{M&+cW1onESm_%_,~b5T5Kff+p$>wP |/斿i+kMd^aۓg"#FncεESZg3f͛6lٳf͛6lٳf͛6lٳf̀\qrmG$p~lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳa4G:-ЊC%J΃'?#iv7{+_Oѷ{|A; ߔjҼ>X@ս4nѲZgֻA|;A#4<=*H!6w,%NȠQr?uM@Iy`}]&a[hcLkȞM?kM.K[cg^#~M cѭmː}B8e~l;+.W\:[Ʈb>^?\5ϗMvNmb vzƦhUG;y5lM&ϰ~c0q0h»?wԲ[..8'6ٳ-1>G0)Poo|Otcw WNeA;OF]F~ʍJ G򾀗zeakon#VCԷ0~ w7s͚W զi$naW"/|9|廘&5 (պ$_ <)6ɦlٳf͛6lٳf͛6ִumJ[YXu 2$} m&Xoe Ctٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfWgBAE![֒vUlߵ3X5cB ONx$YƳB؀]zq9ܴ=HЬ틙 |O Ƿf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛k_ʹPtHٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfZr896#8?6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰ7AMĎ͛ WMkjnKBu?Rxq^\f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳ`-k9W?n5.mJ[Ũ]i?,k!Ukᄟ}CoFZ6yǯLwkڮ'7TF'~/׶zۭO&LM:-KC5"Z`ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ O]zS(.2*뺰=pd?Aʷ>jVItK) ˅I9+:#)b{^]Zކcn,c^]O?yKzM mk{Y/iגP=p'?4F-_Mңqn{y`M,ݸ;Zo=*K~('&xHn3уȀO9fqk-&̖qcX:M1{e&'-/m4mCɰ/5O. sy= . Wm{xaQf͛6lٳf͛6lٰS['Qi/9R=뜗v6~T']MtܽŹ.~z_ɿNbl;/_NI$lWmaHemhр m*NO1.9'2?WeihZC3` uy2R[uz 9VkKkyr؃\[6lٳa #̾aY.%q9_M >_ozΉK,d]ĜBUHFDҼoo2\;ss5彫ʲIo@"ZU13z4r)VSOrLX[_ t6΀LJF3B΋6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf̀\qrmG$p~lٳf͛6lٳf͛6lٳf͛6lٰ(k7,қ>-1%}!2S">AtkHon?XMNȨ̑tUeKT X~kzmKN_QhZ FW_j0"tb_N]oSO'Ks|GOT 2|F Κ( ٳf͛6lٳf͛6ll,o7]T"Klo4+-"Hđ+%"cX܅uߕ`mnR}CJ[y4}^f9go2ZnW4 QDP`Lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ ~s򏐮;(Vk(aY#wspR~Гփ!?_u{V(mֲZ/^gTS֕6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lK-J|ywe"x$Q)؃ g|.ڛK02ʮĨR)PdzdHuk[OQⷕ$`ȅ'j7͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳ`-k9W?n$55sҬ"}ם-uC4f#b̼HbU)/-&KQ4v# BJcPP͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳkx(K&(5QCGVA@/([lKf״R` /&Qa g4\CkgI{)/+O7lœIv zN%ZihOW;䪵nf͛6l:f_fy5\.RuFX3[H*pCTVV#Gޣ,Yj7if{+DVmȝ迖^w6 bϒ%œrH6J.DDŽqFRcڍw%֩iKr5̲q|=^YzVίyfLZXLZEЏ/.i7_-/ [[I k+Uۗþ~Z |o9N}FwJ'NN;1gK͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfZr896#8?6lٳf͛6lٳf͛6lٳf͛6l?:|;w揔Ż܍˷*٧|_qkʳGֿۨ<4iG`fL@ ߝ|O*^_]ԴgOecQz^_=2aAWͺOLf͛6#wggy[Ձ}/L6vpAf4H=AEw`M'Jxe]*!6qKk;;T)kp!5+* [¥acVbrM;~lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6ֿs?ɷf͛6lٳf͛6lٳf͛6lٳf!j&*AȨ5 ˭+IҬ%.*jC8ۓ7>4}"U xe_$q"+^DV*r /-W6lٳf͛6lٳf͛ /LP ؍=b8O[xfcQ;(Q̨ u b0izevwq\G,oeƲp`ŇFG?6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf9QyQt!Z,7R$ TVoO40iOSX2jI1auZl:;>lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳ`-k9W?n6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l ZU&G͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6ֿs?ɷf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf̀\qrmG$p~fil-a2C9 J?T?0?Rq,_K Y\8qȐjQRyv<~[j~hyGSRiJ4M=JeK?+rմ_'ysqm?INzOI{+IE ɨO?fu B1(Oys5\VӑJt,S+kVE|mpB <$-{wttOkҦſ80 kXҭۻ٬9$2O,:nw6&?~S3Ŀ[{bԴVYPHeVZ q2s6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf̀\qrmG$p~lٳf͛6lٳf͛6lٳf͛6l_MVCoA$Vw̞GRNw;}-;ɾtf]OPm{7J9S`Űέ]Ywihח|1ic2d>J$9iXt/$:Kg5$&1IeN7١vGY7R^=sUſmo1quI! 8dXZx硳f͛6lٳf͛6lٰ.CgesrHcmԵ? M CTo;qkSܛ:6ŽCnx;O|q~_ka6:tvGÕ3ye?ΖƷ}yK=L F@0m_/$'^y}f尺EİHSetgt>uȯHQq{kUEHVCk Bñtk&Zpe3;2J]]?W>|Tr6zjC Nq,=k5M+ϾSԴ>oyJ /7, U˥7OWo򞹣ǭa0[/mmX#X\̢ 6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛k_ʹPtHٳf͛6lٳf͛6lٳf͛6lٰ2/.bD,4`\ZӿL/W.PQfytm'R [+ -kZmX[R\`9ܲPzl"Tl.к\ f% ^5޹mX %$T Ƥ>8ٳf͛6ٳ͛6_1k<}NeRuc9Bo&Usch<o//&UY'(2kǾt0l+^Y%}57_C+AA--yLѼukwAt':Ӈ:UhVd+MDsk7 K{bBɎlٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͑̿?yo4rkj [zQ#^=6~YmeXm%ki̱DIA%n͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛^M-Ŝ,нx0)g&5"g#Kq PlR|S˚7]H5NcxGSӧ3]ԟ:Yi0°Z[HaZTvf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfZ'JnmG͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l~d\~^W.Hf:YXn=ZW3'߂?Ty[Z5_QUGWe'V=x^-jj+V$<-/(*ѫ_R2tQ{:M-|]m%t^[$;alF+9毣s'CԩKH-*Kk"ޜ(yh]hewm.E66!]p6]67z杭K\w[qj'NKMZal.cw-1gC?_u48bl]h6:%\;=F}[i(h6 saplG_k`~/+)|4\9f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛j:Xgen繝8kJ +|rhvmnbN @- =̈́ypzmb=vP zcOjFO*q 5c k8.<֕ F>;+,$ee#f\-w k):*Z7]GV WƵ4f nzeZCWpXN9Cun$l+CFRFjV\Aqv|>0/ GFEEpFl%5ش jnjzZtƳmV;l,.-滩i4TYb*~X:+Iu 0ttaPPAloX\sooqٸ(YvPd$Cf#$g״Yu\r͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lC]jއyشÏҷ"٬ JqWܣ25MXsj~}6E&4:GJT(9UQMGI]IqeN8fbA&M>l=GEض5=|\)H` sR4mRhi90SxjճV6iڌ5=VfZubiɏogZim+B;G'irUͿjGz͕LvځQefWHmeG"UePYe}B bv[y&r" {] S̷z_)XU1!Nr%֎Nd1$D7 f½>,idrCl80+q;iɈNDc\M : meAi4i԰N0Ҩ8'YKi|n - MtPO:+7[O?AEA5]aS'R'4dW#E{A/?yMQIyI-YI$,Ƥ36r6i>^y+:| -Wo V^I7bZKTPSMٲ+=S]>/9V2j\>[q_U$CCiww3iK5@ܒ>?umʷWE 1xD6)9-Z[jMݵԷZK$i2Ye-'5ge͜#NU3ZO4ȍ 0Z!Qugn[u*ڹf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6S*aUaB^* >%'s`[}+N#p/#{] H{}}5ϖfVvһrgc_N0fo3y;hl:0?~(؊(Q 43N ӴhmPGom t 9-Z]^][W:J5g=D Y;kukO1?KHf,`? Wa \ā6b@ܚ ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛<9;u|k_Y`0%$//̶&QO]̟J7<-#PX,wmz/id,*@eE/1u =@KV[+T!ub%_MZ7 ːo5j>UpԵ 53{3nP3䞛޸e7痜W'%z{K IkłͅM@\ߘmiZ<i(.n4ITWI\ EvmsZk[- n/kB}W/L94ĭ|3{k1"OEqtm.$IbIkQJ +~wkBIt ?.smlڔw7nvTr7<++//uf˚gaw`ë% VN<7<9Lڎi7:0YW,t$.9_st5k~U*]ߩm۪AssoאW%kQ׵3jnץscb O)+O|cKִ-yoLV&\$w{k{[~"I,NNUV)>ڷ=:#4::Vű˸鱫:D>^t<5}Z+11F)r4&jr9+RC#.4^>|rK~ay̺m Wm8dկoͤ>~VqRc!(F/o%4g.k*堕(d3psyZ}"]oRy#'/)9ejN4 п4|Ⱦfי5k9߭n^)C$ob8Uuym'˾hԼ ulu/"{$MPd4*o:/ 2Z[˱z'̶Z~ܬ<. +͖a_2I/̒6gbI'rr!a6g?X|ϩh I0~*&^+NËOKJhƓyf-Q9rʞ:Dp0w##mo5綒ok$y)v|嵚Vnfגq{ҟWx6QZaMBQiZR;_?Z} :7I?VY% ˈOuEܷVH7jU>^M ;?*(`~l$楷-5k+%bG6Ғ43qqݚT[ʷ:Z֭ x֝rНI)m$p]V71vexK}x?H;=bHte;WR2=YB`hʿ5SȱyE^o{[ 5*;I%8[Gnsߜބ͗,}5[J[k887eGaAbG4.%u%)-2A$ Owu7jPKQދ{Ēw2ʌW7|0F.4ڗ.`Y 7|6T J`m[ZPtĶEwS[AʲM'QJPh^hugt>89 ;c]Ihm-l0xK#)gv7Z%c="(gk(X8>" ^ :U&IP`ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳg$#jYӴpiv0\Xͩ%'gR@0Q?4?*kG^[,P՞+hF85^4OO6ll.aXR[לI!P k?C5{_[n"Eu4Nа[T]~y躞ie{ޭeytl-l'Ե+ I|iw~y}SCʺ5=B}TB6RE@⣍EB|yjs$jxDf7q I= ؈g ҈>{ѵ/7Zy2-/[uF/V6үE[UU!hɗo嗖x.(U*>r{DGԴuKysYHb^CZ(Xkh .Qݕ5K%JM4LR#!PƠoCWּʺd i"Pq,ޙ%NiT*Zcz5&zJyQPb?:w̙|{<%6^ׯ쮠xKn-뒅tj:+@FVEymRߔ|ɧiz6<+a3}]"ޥ՛/|>}O|9MiS]E,i8nmuu{5@vEQyjmFo&x.tDV Ӟg&?[oY╒W-BVLx/CN۴M"87do,Yoo4~URY`e4G=>(ڞ;˛kѸzr0ݲ➰;5ot尿ά98<> |] M-4'K65k# Ic +131gt SRm:SMլ㺎gWSxn zV{G#t}%ksqk$IiJ~J\Vg2wVuD2\Ȓ#ao?..[OY]3P-ۖS_B)TQ-qBy}gȾ9jf]\]Id㈐G!Z+;7ޝϚ}z^QNnY5Υ-aЍcx={ć|vi垙ic麜.-ӒU a3GS?'irywN}ſ.l zes'ծn j,I4=6/EO+ Oie=IwyuդLUVjdI]#j_A-H/m\Io&լ.*1Z)^mO+jN󇔵=B+x㶞FJVX1(MFGw_穼իEy=/M>+K,UI%fλ!M!K)䦊AF ͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳ endstream endobj 104 0 obj <>stream /GS1 gs BT /F7 1 Tf 10.4607 0 0 10.4607 70.7527 199.0488 Tm 0 0 0 rg -.0181 Tc 0 Tw [(In)-184.7(all)-186.9(a).8(ge)-183.5(groups,)-180(t)-2.7(he)-183.5(in)5(direct)-186.9(effect)-186.9(o)5(f)-189.1(sex)5(/)-2.7(gender)-183.7(v)-.4(ia)-188.9(care)]TJ -1.0514 -1.1869 TD -.0177 Tc [(pathways)-299.3(w)1.2(as)-299.3(n)5.4(e)-4.3(glig)5.4(ible)-302.3(\(Suppl)]TJ 12.4218 0 TD -.0175 Tc [(emen)5.6(tary)-303.3(Fig)5.6(.)-298.6(S10-S12\).)]TJ /F4 1 Tf -12.4218 -3.5661 TD 0 Tc (Discussion)Tj /F7 1 Tf 0 -1.2032 TD [(Women)-288.1(show)-287(worse)-288.8(functional,)-292(health-related)-284.8(quality)-288.3(of)]TJ 0 -1.1869 TD [(life)-386.8(and)-384.8(mental)-384.7(health)-383.9(outcomes)-380.8(following)-382(mild)-384.4(TBI.)]TJ 7.8454 0 0 6.9729 291.0046 128.9763 Tm (14)Tj 10.4607 0 0 10.4607 59.7543 111.8551 Tm [(We)-432.4(explored)-432(whether)-432.2(these)-427.6(differences)-435.4(were)-428.8(mediated)]TJ 0 -1.1923 TD [(by)-322.4(psychiatric)-323.9(history,)-319.3(gender-related)-317.3(sociodemographic)]TJ 0 -1.1869 TD [(variables,)-209.9(and)-211.4(care)-206.6(pathways.)-210.1(Our)-204.9(results)-211.6(showed)-207.2(that)-209(dif-)]TJ 0 -1.1923 TD [(ferences)-514.3(in)-514.3(6-month)-512.5(outcomes)-510.9(were)-515.5(not)-512.9(mediated)-510.7(by)]TJ T* [(gender-related)-485.3(sociodemographic)-482.3(variables)-487(\(i.e.,)-486.9(living)]TJ 0 -1.1869 TD [(alone,)-404(living)-399.3(with)-398.7(children,)-401(education)-400.1(and)-401.1(employment)]TJ 24.0035 14.2861 TD [(s)11(t)0(a)12.6(t)0(u)16.8(s)11(/j)14.6(ob)-300.7(ca)16(te)12.6(g)12.2(o)0(r)14.6(y)0(\))14.6(,)-308.2(no)19.1(r)-311.9(b)0(y)-300.7(s)0(p)17.9(e)0(c)10.6(i)0()20.1(e)0(d)-304.9(c)0(a)16(r)0(e)-303.9(p)12.2(at)12.6(h)12.2(w)0(a)16.1(y)0(s)-301.9(\()0(i)12.4(.)11.5(e.)14.1(,)]TJ 0 -1.1869 TD [(hospital)-228.5(referral)-232.7(and)-233.1(discharge)-230.1(destination)-230.7(after)-229.3(ED\).)-231.1(Dif-)]TJ 0 -1.1923 TD [(fe)10.4(re)10.4(nce)12(s)-222(i)0(n)-216.2(all)-215.8(ou)13.6(tco)14(mes)-213.4(exc)12(ept)-213.6(fo)14.6(r)-225.2(phy)15(si)10.2(ca)10.6(l)-223(HRQ)15.5(oL)-219.2(we)10.6(re)]TJ T* [(partly)-237.7(mediated)-239.8(by)-235.7(psychiatric)-237.1(history,)-238(but)-236.5(the)-240.7(proportion)]TJ 0 -1.1869 TD [(mediated)-272.3(was)-276.4(small.)-273.9(Therefore,)-272.6(other)-274.8(factors)-276.4(than)-271.8(differ-)]TJ 0 -1.1923 TD [(enc)17.4(es)-430.8(in)-433(th)11.4(e)-436.4(s)0(o)12.4(cio)14(dem)15.4(ogr)16(aph)16.2(ic)-431.8(and)-428.2(ca)10.6(re)-434(pa)14.8(thw)14(ay)-429.6(var)11.8(i-)]TJ T* [(abl)14(es)-306.1(exp)16.2(lor)13.8(ed)-310.3(in)-308.3(th)11.4(is)-309.5(st)10.2(udy)-304.7(se)13.6(em)-311.2(to)-308.3(und)15(er)10.4(lie)-302.5(dif)13.8(fe)10.4(re)10.4(nce)12(s)]TJ 0 -1.1869 TD [(bet)14(we)10.6(en)-288.7(men)-282.7(and)-287.3(wom)15.4(en)-288.7(in)-286.7(out)12.8(com)15.4(es)-289.9(af)10.4(ter)-283(mi)10.6(ld)-292.1(TB)11.8(I.)]TJ 1.046 -1.1923 TD [(History)-324.2(of)-326.8(mental)-330.5(health)-324.2(problems)-326.8(is)-325.8(a)-328(risk)-327.4(factor)-325.4(for)]TJ -1.046 -1.1923 TD -.0132 Tc [(poor)-319.7(outc)-13.2(o)7.1(me)-319.5(a)-13.2(f)8.1(t)-13.2(e)10.2(r)-319.7(m)-1.8(i)-13.2(l)12.3(d)-320.7(T)-.8(BI.)]TJ 7.8454 0 0 6.9729 434.4944 91.6157 Tm -.0158 Tc [(44-)6.5(46)]TJ 10.4607 0 0 10.4607 455.4707 86.9669 Tm -.0128 Tc [(Ge)-12.8(n)7.5(e).6(ra)-12.8(l)10.7(l)-12.8(y)9.5(,)-321(women)-320.3(a).6(nd)]TJ -13.8254 -1.1869 TD 0 Tc [(m)11.4(e)13.4(n)-253.3(h)12.2(av)20.3(e)-257.6(c)13.4(o)12.2(m)11.4(p)12.2(a)13.4(r)13.2(a)0(b)20.3(l)15.4(e)-257.6(p)12.2(r)13.2(e)0(v)20.3(a)13.4(le)23.4(n)12.2(c)13.4(e)-257.6(o)12.2(f)-257.7(p)12.2(s)11(y)12.2(c)13.4(h)12.2(ia)23.5(tr)23.3(ic)-247.5(d)17.7(i)0(s)21.1(o)12.2(r)13.2(d)12.2(e)13.4(r)0(s)24.3(;)]TJ 0 -1.1923 TD [(however,)-245(prevalence)-241.4(of)-245.5(the)-246.1(most)-242.5(frequent)-246.8(mood)-244.5(and)-243.9(anx-)]TJ T* [(iety)-236.1(disorders)-243.5(is)-239.1(higher)-235.5(in)-243.3(women.)-240(Recent)-236.1(studies)-239.7(suggest)]TJ ET 1 i q 1 0 0 1 59.754 723.231 cm 0 0 m .113 1.077 l .558 3.43 2.505 5.569 4.932 5.896 c 6.009 6.009 l 6.009 4.989 l 5.159 4.932 l 3.093 4.646 1.477 2.903 1.077 .907 c 1.02 0 l f* Q q 1 0 0 1 543.968 729.241 cm 0 0 m 1.02 -.113 l 3.474 -.397 5.449 -2.568 5.896 -4.932 c 5.953 -6.009 l 4.989 -6.009 l 4.876 -5.102 l 4.541 -3.097 2.883 -1.371 .85 -1.077 c 0 -1.02 l f* Q 65.764 728.22 478.205 1.0204 re f q 1 0 0 1 65.764 225.694 cm 0 0 m -1.02 .113 l -3.628 .575 -5.318 2.396 -5.896 4.932 c -6.009 6.009 l -4.989 6.009 l -4.932 5.102 l -4.433 2.979 -3.016 1.503 -.85 1.077 c 0 1.02 l f* Q q 1 0 0 1 549.921 231.704 cm 0 0 m -.057 -1.077 l -.635 -3.613 -2.325 -5.435 -4.932 -5.896 c -5.953 -6.009 l -5.953 -4.989 l -5.102 -4.932 l -2.986 -4.505 -1.502 -3.04 -1.077 -.907 c -.964 0 l f* Q 65.764 225.694 478.205 1.0205 re f 59.754 231.704 1.0205 491.527 re f 548.957 231.704 .96381 491.527 re f q 453.534 0 0 341.065 78.293 378.198 cm /Im4 Do Q BT /F4 1 Tf 9.9626 0 0 9.9626 76.7055 360.2267 Tm [(FIG)-7.2(.)-330.4(4)0(.)]TJ /F3 1 Tf 3.8696 0 TD .0115 Tc [(Estimates)-299.1(\()2.3(regression)-301.5(coefcients)-299.1(w).7(ith)-295.8(95%)-301.5(con)]TJ 20.9811 0 TD .0104 Tc [(dence)-297.7(i)-5.3(n)10.4(t)-9(erv)-5.7(a)0(ls\))-300.4(o)-.6(f)-301.8(d)-2.3(ir)]TJ 9.4179 0 TD .0115 Tc [(ect)-298.2(e)-.6(ffect)-298.2(of)-300.7(sex/gender)]TJ -34.2685 -1.2974 TD .011 Tc [(and)-303.3(i)1(ndirect)-298.7(e)-1.1(ffect)-304.3(via)-301(c)2.8(a)-5.1(r)2.9(e)-302.7(p)3.9(a)-5.1(t)2.9(hway)-4.7(s)-299.6(o)0(n)-302(outcomes)-299.6(f).4(ollowi)-4.7(n)11(g)-307.6(mild)-297.7(TBI)-4.7(:)-298.5(specic)-298.8(\()-3.9(QOL)-4.7(I)1(BRI-OS;)]TJ /F8 1 Tf 39.6517 0 TD 0 Tc (n)Tj /F5 1 Tf .7113 0 TD (=)Tj /F3 1 Tf .7284 0 TD .0128 Tc [(16)5(33\))-298(and)]TJ -41.0915 -1.3031 TD .0109 Tc [(generic)-304.6(\()1.7(SF12;)]TJ /F8 1 Tf 6.3165 0 TD 0 Tc (n)Tj /F5 1 Tf .7056 0 TD (=)Tj /F3 1 Tf .7341 0 TD .011 Tc [(1614\))-299.8(h)-.4(ealth-related)-297.7(q)-1.7(uality)-300.6(o)0(f)-301.2(life)-302.7(\()]TJ 15.2279 0 TD .0112 Tc [(HRQoL\),)-304(a).8(nd)-297.5(post-concussio)-5.5(n)-296.1(\()-3.7(RPQ;)]TJ /F8 1 Tf 15.4726 0 TD 0 Tc (n)Tj /F5 1 Tf .7113 0 TD (=)Tj /F3 1 Tf .7284 0 TD .0126 Tc [(16)4.8(06\),)]TJ -39.8964 -1.2974 TD .0114 Tc [(depression)-301.6(\(PHQ-)11.4(9)-7.4(;)]TJ /F8 1 Tf 8.5017 0 TD 0 Tc (n)Tj /F5 1 Tf .7113 0 TD (=)Tj /F3 1 Tf .7284 0 TD .0115 Tc [(156)3.7(8\),)-298(a)-4.6(nxiet)3.4(y)-305.8(\(GAD-7)3.7(;)]TJ /F8 1 Tf 9.8503 0 TD 0 Tc (n)Tj /F5 1 Tf .7056 0 TD (=)Tj /F3 1 Tf .7284 0 TD .0122 Tc [(156)4.4(2\),)-302.9(a)1.8(nd)-296.5(post)4.1(-tr)4.2(a)1.8(umatic)-297.6(st)4.1(ress)-298.4(\(PC)3.8(L)-3.5(-5)4.4(;)]TJ /F8 1 Tf 17.3106 0 TD 0 Tc (n)Tj /F5 1 Tf .7056 0 TD (=)Tj /F3 1 Tf .7341 0 TD .0078 Tc [(15)-5.7(70)-5.7(\))]TJ -39.9761 -1.3031 TD .0112 Tc [(symptoms.)-298.3(QOLIBRI-OS,)-303.9(SF-12v2:)-298.3(higher)-298.5(valu)-5.5(e)4.7(s)-305.1(i)1.2(ndic)]TJ 22.4265 0 TD .011 Tc [(ate)-297.1(b)-1.7(etter)-298.7(H)-4.1(RQoL.)-304.2(RPQ,)-298.5(P)-4.3(HQ)]TJ 12.1607 0 TD .0104 Tc [(-9,)-304.7(G)1(AD-7,)-299.1(P)-4.9(CL-5:)-304.7(h)-1(igher)]TJ -34.5872 -1.2974 TD .3081 Tc [(v)297.7(a)297.7(l)298.1(u)291.4(e)301.6(s)-8.2(i)298.1(n)296.7(d)301(i)292.4(c)299.9(a)297.7(t)294.4(em)293.2(o)297.1(r)294.4(es)293.4(e)301.6(v)297.7(e)296(r)294.4(es)293.4(y)298.1(m)293.2(p)301(t)294.4(o)297.1(m)293.2(s)299.1(.)-1.4(Q)295.2(O)295.2(L)298.1(I)298.1(B)297.1(R)292.8(I)298.1(-)297.1(O)295.2(S)296.3(,)]TJ 22.7281 0 TD .0108 Tc [(Quality)-300.8(o)-.2(f)-301.4(Life)-303(a).4(fter)-304.5(Bra)-5.3(i).8(n)-296.5(I).8(njury-Overall)-300.8(Scale;)]TJ -22.7281 -1.2974 TD .0119 Tc [(SF12V2,)-297.6(g).5(eneric)-297.9(short)-297.8(f)1.3(orm)-298.9(h).5(ealth)-301.1(s)2.9(urvey;)-297.6(RPQ,)-297.6(Rive)]TJ 22.2842 0 TD .0113 Tc [(rmead)-303(P)1.7(ost-Concussion)-301.7(Symptoms)-299.3(Questionna)-4.8(ire;)]TJ -22.2842 -1.3031 TD .0106 Tc [(PH)-4.5(Q-9,)-304.5(Patient)-304.7(H)1.2(ealth)-302.4(Q)3.4(ues)-4.1(t)2.6(io)-6.1(nn)10.6(a)-11.1(i).6(re;)-298.9(G)-4.5(AD-7,)-298.9(G)-4.5(ener)]TJ 22.011 0 TD .0107 Tc [(alized)-298(A)-5.6(n)10.7(x)-9.3(i).7(ety)-300.9(D)-4.8(isorder)-299(7)-2.8(-item)-300.1(s)-4(cale;)-304.4(P)1.1(CL-5,)-304.4(P)1.1(ost-)]TJ -22.011 -1.2974 TD .0111 Tc [(Trauma)-5(tic)-304.4(S)-.7(tress)-299.5(D)1.3(i)-4.6(s)2.1(order)-304.2(C)2.7(hecklist)-298.6(f).5(or)-298.6(the)]TJ /F8 1 Tf 18.5683 0 TD .0105 Tc [(Dia)-4.4(g)1.3(n)-4.8(o)1.3(stic)-301.9(an)-4.8(d)-300.3(S)1.9(tatistic)-6(al)-300.7(Ma)-4.4(nu)-4.4(al)-300.7(o)-4.4(f)-300.3(Mental)-300.7(D)-4.6(i).9(sord)-4.4(ers,)-299.3(Fifth)]TJ -18.5683 -1.3031 TD .0101 Tc [(Ed)-4.8(itio)-4.8(n.)]TJ ET 59.754 747.156 406.488 .51025 re f BT /F4 1 Tf 9.9626 0 0 9.9626 59.7543 753.8455 Tm 0 Tc [(MED)-10.3(IATORS)-307.4(OF)-302.7(SEX)-302.9(DIFFE)-10.3(RENCES)-305.4(IN)-306.7(MTBI)-302.7(OUT)-8.8(COMES)-22532.3(3323)]TJ ET endstream endobj 106 0 obj <>stream AdobedC        s!1AQa"q2B#R3b$r%C4Scs5D'6Tdt& EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz?Nlٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳg24140XXVvײGo I?0|K kYJ ^j(r9,>?7/$k2Wʟ^t(4ѡlooքLےPj^?ߙZn˥Ŧj: w& -`rRrbi_6okѯcukK(g-,(rN Ɛ5kMc~dmJ\X-*$qLޏdq$7_tѬu0ja ,vf!>:Ry愺"Vu';{-/gz2y3熯95R4 Ps0;e kڥ< yRu3k720&Y#$TD,6'/n7Pͪv]01 ,ƉG^ 5{Aɤ:ԚԒԖ >\ ӫqA,H LSis}^j^+[Y]QtIvB+E=}hDT}mJMۍqI7<:TM^k5c7Iw :,^nM:O洺K>~nfhtFVnn>-|?lm϶Zmŧ_k:OrvI*[Zi *ya_Y^u%ũX.-HJIrwdH93f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf3q [󦵬X#gvN侙ǝ<' Cg-&2?7xlQv3F߰LD7q6u5Ay<;$8BB/Vc{mZsXyOb4[pT OLG{yvNkmi 4/_㌀vlmO=y^(K*KmnDvMfd1,K?~ܢ>no*K󼚽ͶkVz\}rK ?N_\N 0i:.V%[i6[E&_ԍ8Qo~XVKf7?Ȑ 2;!$?Ñ##䦥$6yEѯlg(O ybGbFQP{;yV};QhcJM+SX٫G4m,쪯;F8mSzuBTK-7ZQsβC CP 攷I,a1#cq͞D׾mҙw[U)uVK.2K$ tШ>7%ܶmٌG'ן5ޅ.yE.<+'ۇᐨ0~Ly4dov;-{ڄH>),=Z;yX##^<ˡk.@>ncsd?ί˩||k+A$Q+D,Pc{ ~C׶;,,,2JojޏZVfueY@0nlٳfo(.ٵrIf迻V6y[f51]M<̖Q*Tq3~* O'`%8ݶ$9cd8i$`,nI'I^=CKR+u?)s <é6r:ۄjZNl@4`uo7j6^kSACHPeFԑoC/<'AJ)m"^ioT[QQӕ$l;^~Q~e~eZMik'OߔVh@6GO\=V?<SihkQdy@Bg2'9ƑBdY,j}^v4ۢpދZ͋5C8Ėiv#T~>C֔#s {UXաR:Y N>Q`|$ ί}8H<|$L{-:W眏3ͺ>?m*JO[^*|.S"v;6/8>qmqz(=[F[~#'rfQYt\VHK$?UMo?c;]ޭH k&@@姆I%WwW(tGH ڡy^SLwwq;?zwI'y2NkvV"u R<׽ v近>gu)6=?[4pjV Ja(.dӗ:Flٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛9I6E|/,k)҃hI#eW µr3lwaw\.tX$A)3oj3zUƗɒx#ȇ?6 /ӄ>nl~w#yݼotutQ1#HxG'\^p5;4jZj- )dwվZTvߖyB83_8ut׳O;#qH^9E?;Ѿp5:RSy83V[_ߕn_ ME.mZH8[^<J>9>4i%ʱO,O6iٛ*c౹p7?4<ǙOMKh73Xrޤ+Jx>'|7Kh5CGkqoex>Yw̨j#hƽ3]lt;+=ZJzµc6l,CKZ|1. ѝx!ޘOoΏ=hy=gZMX߼a=WfFSUyj?K_ɭ'_?#֬5;5hX}cqn.S:ϛ5#h ҈,oT>52_o9꺖7#yE>_X9 c$֛D~V6 /Z>vN$M楶 bKk6++TN离el=H˺l=ؽZ Q7* mW<Ͷ ͺEdlqQ^NTwU; SZnoao ɬhh T:O:ѿ+/tέs VK$l$FEr/^$~__-"Ӎ7X|Ɵ3o%Ax5u8<}%ىc*FrmBɗf҆G!2$ +B lQ?\Y|?BPsHx%MGu+_ _д7?Y^Y aMCu gn2}" 5?󏟘%u;%ϐ,dBڈe&/!$^Sa?^g4Ks9E_Qv Jӗ?+\7^mat1nRTUuT^~`iAӵWCmqnVXqMʟ^q34>kb/#+AmC@PO!Rk))1t\O{ȞRY5D^4~ammjke/#QUmGE;|,"!@jdu={~u[]by/=i{/֡Ĩ-" 8H;n|2ŨG^S.gdfip w/7jq\>.EϹi+;117l#{7d糦ڛXO1_iyηduO AϞ/jvm]0@.Fn=G])w6Y7|K_Uqz乆~6cHTqONQhuo:􍗗 >6 v? Q^Mg451Xv1ܽ<&B$1BI)5q0s qiJ/tE0@%jRU ~gy<_8QmkX!z8_׾~^SyVϨEtĊSO?064# ׍?u8OuٺЌ߼XHfFOё]cq?^uuջ<KB,@v1x:e쿜zGBMΚzeր~;ePV\N쯯bWZe2IT/LZ~AdhV[믬}o하3$3)y-|75kT.yn"R_xEw,y5Z)AQc|yu}cvYLaV7 0ǐz ;L%#yiֺ -&&2zwbxx?M{T󥇞Gn" 5uބr=SU_yCfu3E:w0oZ-5P;l)5GQ-U;#mD6ivJߕ:?NjZcZ?g~zʁBHZuؐF/o3=,a̐PNȧtA~fåyBO>ap&-`0&%rYH*~]HE5>_[xm#i@ypmΛo\f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6#wyoiw~X GC6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳa/d_'cf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛66I#6F @Pz .k_՗']"/7_v-"Wk/Hj']"/#^|tuuDY\|?bA~ѩ[aC' Qi|Wk/Hj']"/7_v-"Wk/Hj']"/[[³ʓB,lX{08lٳf̈́k|NE?V;6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳcf)xfE) P)?Z"4fCz"4Cz"4Cz"4Cz"4fCz"4doϟU^1h?lmI*'O*o+yF+䗎o6 o 0E?k-Cz"4fCz"4fCz"4Cz"4f?Z"4fCz"4a[Z–G Ju+6lٳa/dtՎ͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l>a^UF&{ypml(%I]~.*0[2K6i y-姣7l-򕍹#j:1Y1Ksw=I E_\[MKzֈ43y:p''Q~5ZM|'Yx4gd*J"a=Ǖ<Ŭ|qͬ]mlÔ1+Wa)_-^̯7i yŠ6WB򕍃FH䎵07#]Ӧ'g{hqj./B;ghHX4Uާ:m@֭oI Ԥv8e6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ |"p/Qٳf͛6lٳf͛6lٳf͛6lٳfNyuZlt$Kn)Jl.cmuLJ"IxV桩_9Hn<{\j~Ykz$$_l6׿2ZH *i="}TDRU& d6lٳf͛6lٳf͉km-ÈIn93˴]vDҵOVvnP\ YmBN)QDy{A5')a7 5wchg3Z#B))^%ܰ3%aҒHԕa]43[!VsKD^~4/AQAZ_ 'VSկ-0y\eR$2#$`(V65,]ũ*y $mg9POgUf IFGo2>h/`5TFK;H$i)%~aߞZt=u6~0| gK͛6lٰ^ϗ|jk[)]“*a}בtBQt;; 5],洈[IGSp׼0\GsV;G5ռS:34 ]},3Xɥ2DzTS0OZ]s8#~Һ mǔsͦisi5ţDҺ\-L.M֏iuL%QM0Lӭ..n-mbėƊ+ #V!E*q/WsOKuunlx[f h;`kk{[xXmEcQUF(|0Z =sLTXnI7c]C셎jj-bHRW u?˿!j5/.ך n{Xdг2iUU *; ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lMN~xOGf͛6lٳf͛6lٳf͛6lٳf͛m.=7CYZO7Y=ɧ7;xՌ LJ(ݰS7]V-[SЬ/uHi^m?ge'Ⴕ-y{b]m;E` I2.OӬxAm,qʊ͛6lٳf͛6lٳfkO&yF[]l֧o7/LyUJ-nആ+VYC~ɸELy3:%i׷MŭqI%MHfE aton/;۰urID@øn W͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳMMm2nR[7^eیKҥ*yu턿w?rɬ `K U{]O',A4f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ HJ~N?V;6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰO?'"?6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lKD_'cf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lQ{KF@ vFjHU#o7ԟwI[7'eV&wIaU?4?>Sߣ^|>8ӕ>\랇yLٿn>,?o7O :)dFCR(Z2|v8#6lKdtՎ͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6?W\ח>\kʻ f͛6lKdtՎ͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l>ձ1ڰlZOg"npK#YZ.D ] c Oc+˔[)pWm^͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l%_s"p/Qٳf͛6lٳf͛6lٳf͛6lٳfm%چe(մx(⬷g$*@$XqZg`fy=71#,2195?^oմ7i<|ib9<#?3Rկ%u.iiZrƏ6 \_>٪ϫ5˸9H44ŷ/''̚О`!Ί c(<]wLEX!ӛ -/KS̷o GF 9r,PbNEi?5k^_̾VU,e.eE[hhH(mEyR-{ Qy[H-0fk]yk}=X-˖¬G]['GkNH9,{{8 S3#iʨf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ |"p/Qٳf͛6lٳf͛6lٳf͛6lٳd_͟]U7z,(,ﮭ"A$jƧq;o=jt{mWɺ}4}6 0 W+wۻTMîi7W&%(]_|Ky˚w|K>cb֒ke5%E")@ >LjVh-`ṱP3#M(gT͛6lٳf͛6lٳfZTV-BkYu 4f2~4'N- TcCf܁I<ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfa9oNo=vi01:Pqc#*O;UP6WP?M͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l%_s"p/Qٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf̈́k|NE?V;6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰ/5^ibKn \M8 Rk 3f͛6l%_s"p/Qٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰSмu{$dڜ-#V,N} y DOL/?g| i:[ {5YyB` LWc8^-P_NaT0~kvWM-qBP X5AjL9͛69D_'cf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛"j7N5Vu2M=GKt}ژ@j㧩7U%|YUK+Qwvm--ܩT^RHTrhUEINJ_0Lj7qO\-WӰ$"(ɞQ| $Eb^BL3е_t[ȯL70$jA؃?7.I:յ($mf* &]xm;yS671ᐕh +R/z3C)͗Zpߧ~$jו|g޻%wM5WYQD#򗟼AKBݒHgC2"ױ+H3f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ |"p/Qٳf͛6lٳf͛6lٳf͛6lٳfȧ5?/&kP_: ~I%uDg-7Sͥ,\DхU_0~oZ{VHu-5+`{fYP˂0H8/GcVYI?(^FXx ={F״5]+:rE;6lٳf͛6lٳf͑H5.1zkbSoj8d#/l"潭kzrOO.^=68mk 4-̈́EϬ謑V%xGR ;6lٳg'|y̞fO#䷇^ѯ&hn`FakRRAj2_GÊA~cP̚L󇜊5'ͼ6٨:ߔv,HȰ%6%¼#4ԧѲ^3]8mw(S rV;GZvݦtfV05H#!{..bHeumtƌ@)H$nܼ{ᇝg5o&[KMOqktʙ-/J^eN7|-9m. Fna!oalٳf]q7o<1_R~[d^ +p ]0<5Ǔ5.w7b+g]4/Dj"gCQESO0sO$ jQ‘$F~@$Jzo6~T]s͖h/mMvZʐщ㓋IL72OM VѬ%ۭ~gȗwnTL5Q]wt&YR\HZͽE*pS,5M:M [Ȟ wW@Un$oOHߧ\~W\;V6uygVЭ͞p-HE"rŇ]O*~\I=k[^gAnX;G*F͹4ɖlٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳa/dtՎ͛6lٳf͛6lٳf͛6lٳf͛6s[N_8jiHCg ፦FThsJl<[Z[۹4dy# zˌsBrCԿ%DzZW-\ZcI0& 5ʋI.Cϕ5M24n,)c{cXgWGs$yON{5; =̀w@B$Yf͛6lٳf͛6l(wceKJ_&f_Eʙ7@{EeuQh4VG HLj2~MGSjcu ]>"gd­HKkZֱy,nu|ODNr5Qk@3i6w6Ze䚅K{0EfQB# af͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6p?ί0SI K_EwOݤR>QO:巙m^8.o%^"O6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳ~eXy#7FoדxdhzNH[ɛ1$p6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰO?'"?6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lMD_'cf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ |"p/Qٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf̈́kzA8qIXٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf!̍_VM0$חڱb;?V WOs^~e|k&^e寤rEFÒ;I]ALmt#6.%N-ߐZ-:,''YBCETD \u]iacq}=-5J_YO>' S O:GJ}=u-^-41h؞$`kZ`=3Wzj4)@KH]2-O~`kZޝi-G[z6ъ=(R2DM~_3iU q2yZp9Wn5~x~|αi]$72dyPPq8RI/HNnozay f-y.eQ::l_o#yIkn9M /RiȣQ׽)wvv]̖!i`@F|?4fW'9puy -GuMSOҴGQK[T2x"f>smJL{_=+2bAT Z?^}Fl;nF[X% CF++\G__~[WLǿi)~~s̟z-䶊V=272T8s^嫻?:v|59/ I P9tΫy:z]ow$^cDWWey[S]^\mHa`w Q:^w6lٳf͛6lٳf͛6lٳf͛6l%_s2ÈOGf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6y*/ɟ9gcb7ۥt ]LfG3_kf嬞`AM~5?d & ,E̋͡he~J#A/m-ts10#[Ua"ہj7[(G(T?I~# ;g?6&7[ #mFC(DC(,|1Gn ?3-I,QijEL##|ykO޶t5D]Io%ձaZEpv5m}2aa˧~u:VysXu IR~X~>*ո|AhknamX4V,"HJ=I#!UM>Yy2+%/eksmf% [ٍK;t5ʖ?{e 0 ;$%M354uQS#v/>Gg _Bߘnu]o^xU\4e3+Y>ƽAf7ʰڶf:#Oղ9"< 󒟖l/c*X;)CydAk#1*aSO*XI BnUR UxoL~VOW?:oq䱫Y"݁)ضw~WK5ߘ5T5KffJ9I"pE;wɇO_o4}Mb^a۱7Dc QTֵٳf͛6lٳf͛6lٳf͛6lٳa/dtՎ͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l"7HEHd]N@{WO-[yo7~G,/nVޟl~XN7'8Ͼvɼͮ;}?@fս4nMs[ykֻmz+A#QJmt{HtM 4DS2(bo\bO\^aAǷɳن;i^u NN4[N5i fLlwZtDmǘ45K낣],}9C {TR>Rw?+$^mt!*#6SN͛6lٳf͛6lٳf͛6lٳf͛ | 8T~vlٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳa/㞟NE?V;6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰϏ2ÈOGf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛69A8qIXٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf_5=? 8T~vlٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳa/㞟NE?V;6lٳf͑y|E<#~r'jĞw>OOĞw>OOW6:yfKy붯蕍uq_Ϳ̽WWkI t{xZq;'I7'I7'I 4=O^yq 2kQHO|6͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛69A8qIXٳf͛6lٲ9Cૣ p%&`E#zf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳ`<ߛvךxmMEݤ|Zn)tZп2˚yG]V$[߫Jf[K-7o]&+]Sd~\Jɜwjto(j:%gy,\^+k(׋3=1mkH]楡jWykXѵ[ѯ*ۼF *093f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf_5>??'"?6lٳf͛6lٳf͛6lٳf͛6'ssokm-̋ M33 Xu].i򮫣O's HgCO~e]ea. KE"v(^J7-8{y϶~jRN0r__Z?zeakon#VCԷ0~ w7szW էi$naW".Bmy͚lJPm-JE$ȿWF%QZnFwٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰO?'"?6lٳf͛6lٳf͛6lٳf͛6yVnu -Ry-\G/pCƌg7o\еxî^3.o!gYD2Z0ʪy:ic,r **H푟)sY[6Z{V HxQBoo1yFW/w~M{u6%MZ>?kzeKkXmH#X՛خlٳf͛6lٳf͛"S a0\I ыQpeiF;pstC} WM㲟ͿY02@J#V޹ͥ^M=Z7k[l$є)cS ZGo-o0yyt/YkZ֡ѻ–}"708Ʉ[?8 .1e?SW"kN6͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳDeMBs]*9h|3#ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf6~a7ko0m C!tI CLuzv:"* W6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰϏ2ÈOGf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛69A8qIXٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf_5>??QÈOGfHh䞔k?:yB;K=nS("ݍ+EUbOL9͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf_5>??'"?ޏ>Iyر{&Y)FcS儳#Qh$UVTiBH?:o4O04ѯH ޟd~j5_2ɰN{;(WܚE}Qsf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lkw_N +LʂD"\毐gϚՒ]ERNpα䄯EخhzΩ7Xg?ש⠱yϾRޓm:ZKi%XaEi]=p/3t2U=Y4&߂}ֹ)fURB~qKiZW3*G;G )~ rc6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf̈́j|N?V;6lٳf͛6lٳf͛6lٳf͛6lYt9qnMf.mFAc57x[m] ^-]cO9l֥je8ZWe?ADEK=̎/9*v{alٳf͛6lٳf͛6ls/?ÉDu_\/nGX_@@z`'7?.o&s?1p#,spm D{KTO^kM@'zg6lٳgu7i_+y]ēOK{?D r鄟>X=OuH4GZ\J'Kt*VCowߖ>d]cNZY]kuxtƯo 3q^~v[EC+)4$pyJK?UT,77R~3ZYZKC F=1Wל8XkK uK+8o.ROIӗqC]g3V/4u}OFKI8Tʎs1?dO3f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰϏ2p/Qٳf͛6lٳf͛6lٳf͛6lٳceԉJCF>9|=:ƛF'ݤ3#ؾ7)/f=zP׺KL ȏCgccsxti4̾SIYgnѤ[,J,ܢ+ EX6lٳa #̾aWIwC'@빩;p痯 [X *Lnъ6~gdS>  yG-[/XG2^!Y *~$e#"z_i~jun|ٹYT$ X?yx:坵wH%3ђE*i@t?ɋ>K{TtA.^tbbcfM#216lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ | 8T~vlٳf͛6lٳf͛6lٳf͛6lٰ([6қ>-1%!2S"Zʍ%1ܳ#^!(檞մʰ<{樋 8,^ Ֆ˓zu/4h^bYR@[ o'* BB06lٳf͛6lٳf͛7\~FhluI <QYĞxz\K}cQ&N-E< -H"Lh?~rk-쑵)UQd¬V?Qyv>c]%n/TrԱD~Azoyf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6yUd~_lW^#IE")EεgK3yFo+=I!~ŏ6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٲ {nH][HP`̜zkȅXt'%M[QN$8;6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰO?'"?6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lKdtՎ͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l&Ws"p/QCw$YKiusIWG]'b3rS_N7$~/Zm֛/nU,VN%Kc"cqdIt^zU7֡u9/U*+3f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lKD_'c6bYBrJsy+ɞnYeHJ[H:1XҴFԵa ^ R8x_^lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛98j>o,줻b]sYO=- 4yedp_|[~q-lv}J@%9 :a_7.ő/Eg_-ũnuC"ؠBc:0>pvy[B:{y{Lׯ[pϟ=#J军?_Z~wKGWB,t-@ߋ M~",#/HT ˭sj>y͡h7zoous4Z9Os'4EXmSՈ3f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰO?'"?6lٳf͛6lٳf͛6lٳf͛66Yc'C8Գ9|m桢vtW7q bI/V8߉Xҽ2Q]~@ާik:|#Ӡr 7Rܝr+L;i<Ɨ/4y'a 8:j?7v+OM2gHk<6m#ӏa6lٳf͛6lٳf͛$m#1'9x,>F˩,䘰Τzl͝y橦hgHoY8[܉a~q"Z >ϲ%ŋs>LxGe>Nn?(| ,KMz[Mo0H/~aRה/c^Zu{2dǓIV!k\_u=&}-mm') 3Wn_Qqhtw4=n?ُgK͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf_5>??'"?6lٳf͛6lٳf͛6lٳf͛6lڿ_>G>Y泭^%h kkvV]8[_ېnv?宿1y1h/9DhKnK45vUEpΔ4:6lٳf͛6lٳf͛6Bt ^95M'3qFk8*[1 EO 3E{O%/.]:ATӾuD'iQy<ؙb%:#-so[/GyjZTzlfŧv)/K+RsyKpe(iқM~[Qu[KPH12KշUڧ;N..b#91P#ۏ͛6l؍ݝ oww0?ۆTWCVc-2[Y8" A@Q*(T 0,F* HUB9m=+kegh;X#BjR$T(2 YacVbԱs͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfo5=? G ?6lٳf͛6lٳf͛6lٳf͛6l`1FfPZEA^]i\FM3M$Im!tIURܘ84mUH+pKA ʒj_NBe(OQ^ٳf͛6lٳf͛6liz`:_niԧ*}8۬:Ăw^PQ@`{!踎4Y$] N"YVf$c$ԓPƱDh8 ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͞X04@kxh@Ow?ɛ=FڔR{CpeS1|].Ɠ$0չG%D9沵4|̴<Y\ΖHcjZS;('R J/T?0?Rq,nHu/%tTP=5Iۮ͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf_5>??QÈOGf͛6S*`OPwԂcPP͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lM.4'L)bq9j/ ڶ'Ti'I{+IE ɨO?fo 8ĢK5=-rZONDsӍ)QO譮=YI N/,dޛgLgEL*i_KO@Kֵ}*MCKvye(I[tUEG;q0Y?.%-څC/Pqٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l%_s2ÈOGf͛6lٳf͛6lٳf͛6lٳfͅ`o4;M&iEg|eu!dQ^'|RӼO&iU 8_^F`I'[-Qsy=6|[ uuowzV6yw,qsS7A]߲Msi: CUm.󝔷S%y=;ЂVS9P^{Tu~7]szTllٳf͛6lٳf͛6/ⴲ$1)]ϦgIjN-j{u7YԵ-p ޹|I/s6:{`ۏQb-G*W9uϕga_kkYnn;2#.yG4Ⱦhgfn4FDM ͌QNV9!G,N\]Dj%,5EPBjg6lٲ $]~`\-m&Lv#|߆^INdatͻHSetմwt?yRFd"$J"7Wc..ŢM%fvd0u8~<|1mk%mRԆ@ X({P_|i}:V_S+YKn%W ,XO\0S]-j^ uQ@@Urjnrm6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf̈́kzA8qIXٳf͛6lٳf͛6lٳf͛6lٰ2/.bD,4n\ZӿL7W.PQfytj~qTo|yBZkmk-ԗ(wL@G_*CmzCC|f}>]oo5oܣH}˜A{*6ԿşZ>>޹m[b$T ƬxTS6lٳf͛6lٳf͑6>a_$_ryT9qXtBЛɰ~U\,E"[t ɥ0b|y(3:F=wזIo_ikoi'F b7- k}<3v?o/.s6U8Ve3fg$HŝݠBw$$f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6ywA4km"ß-,^rz354 sauccj|V)c tkM&)n׋Q)trd] ]Mg n-d7ۜBc6ywAiXszpԟ+ savƱ,sj8aHÄc]qϯ6Fzw-Ii L1ͅci'qnv{!_l1͍57˂O)Dlt{.S):܍>i9ճ军ɱ5̽WҦƗ$",-م<>?K0_gk+htC` o^XE;lsj˭ߙEv%Դm^׸!yNBP7 9K 6ӈ!,H&JA}3UN[`BgoՔOQ*}g2%mo,'O(k[^J G ,0@椱#LS뷚Ǖd7m:M{ZRv$*J ,l\:=VSld W+2Cm,8(|,}|ݥzԓ+0KooU՞E;@ιWזiM:T}n?8ϔ7PC'XM/`8 Rd"NN +S\>M42|ZG49""}=-Qc@)^8 >.y r)\jcq,VDhUӛ8o6wu: ޛ JZM-Fx؁#;k<&.8%\(~(^aA64֬4-.=ZImbX?Y&kp,1JcCԵAo.j2Zb]Z-R\@q(E*~> ͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lJӴp,m]%Ϧ)O)77sdXNZky[q3N]yVA ++o0i0eb(J8-FƇ|0t7KӴxmGmk vUZs`[/N{Hcuv(dP,U}+6Gto˿#hΓZYjsuaXzòs?k,Կ(,=BQϨӗH`}COl.4R6ATxqeaqh((,h@; /h~`d5($!u XwV/sBncb x3ǻƠf$lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛<^t/IklR^f[U.O_%y̞k򖑨$~[Y _P0D&i~%t٫c-֕izy[/2.D?.<ժ[O4iS=7S7<~,UC;`55HO;Y2$&/OZͅM@\hmrҴ?2~.p\hAu%x*1ڧ =hvl_wyPk8iIi%WՔl=[O֚ҴZZwY7Z[F:B3G$9q ;Eϕaǚ[GqEEWo /z~l$楷ߛ-u[;%-bG6Ғ43uUέ7.5x70C)5B%*'l~~fo3i2* smF5դou^<~6~ep^>i簒=X4x5 )`CVGPX(0w>T$^caWMA_HNIw$ÅvHkQN:KYyG_ZiWb#OM*= v!&o3񪙰ZPtĶEɳ[ʲ'Qʜ>u呭٭>8Vy}+/&^\̪~հʴꐱ-r;3<)<,ʡeeaPbs7zG>kS:ݎEkikg!H&42wj o?&Ky-b{#t(fgk(X8>" ^ :U;U'Af͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͜TgygNuyqc60Rߛi2<^!\/7Ϛ~o~W6ZnmnstiI`bd_+\~[FcK]h{L֢?J xxCq#q,gb3ykE/<~d\ڵh#KMxj>%wCKVߗz桧=DYm+yĝ]-۠y̚t4Yk&ѯ~uVe)avo yO5 F^ס[]M Ŵ,+` ï=R<{tլ.D]=%rTԚmFy48|X,GѵKkˤ.caqu$T*8T weϖo%i"OY\h׆!i'q !zQz6O%ǥkz.6%UȫwJ82 02ӟMՃXE\ZJGڎT]Ob3hU1]GMyTn754*u>%L0,54yjz͆anך$Xx&e+ vcP7^Iht[MVIe]Ad}Bqo2(8oL *\Fu-1?jyrY^C>Ο=3"M~+Km_]@0۵5 ]H#+Jb򮋩yrve4F{MoRX'̾K{Wt476;" |6u[7,Mk~v:\" L+Qڹ?OfbW;EWRik0xY $VNŷ|co^tC_\y]oRu0FNbCat ];4nLNWG.*aT{;K.QiO͕Ld_I&r#s)uc -/罂 ..=ڳVxFתS2]w5/Ԗ$֮$aqPE> -mCZo"Zip򖧨\^Env^P8%)h.+7{H0"2Yץce#y$t1鶑1e<@#9f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6 endstream endobj 109 0 obj <>stream /GS1 gs BT /F7 1 Tf 10.4607 0 0 10.4607 62.022 722.0974 Tm 0 0 0 rg 0 Tc 0 Tw [(that)-198.2(rates)-199(of)-196.7(common)-192.6(mental)-200.4(health)-194.2(disorders)-194.7(have)-198(increa-)]TJ 0 -1.1869 TD [(sed)-283(in)-275.8(women)-284.1(and)-276.4(remained)-279.9(stable)-282.1(in)-281.2(men)-277.2(in)-281.2(the)-278.6(last)-280.7(de-)]TJ 0 -1.1923 TD [(cades,)-423.5(with)-425.8(younger)-421.6(women)-425(at)-426.4(particular)-420.6(risk.)]TJ 7.8454 0 0 6.9729 264.4724 701.8581 Tm (47,48)Tj 10.4607 0 0 10.4607 286.5259 697.2093 Tm (We)Tj -21.4617 -1.1923 TD [(found)-534(that)-534.2(psychiatric)-535.2(history)-531.4(partly)-535.8(explained)-535.6(worse)]TJ 0 -1.1869 TD [(outcomes)-592.2(in)-590.2(women)-593(in)-590.2(all)-595.2(domains)-589.4(except)-591.8(physical)]TJ 0 -1.1923 TD [(health-related)-219.7(quality)-217.9(of)-218.4(life;)-219.7(nevertheless,)-222(the)-219(sex/gender)]TJ T* [(differences)-207.8(still)-209(largely)-213.4(remained)-204(unexplained)-207.6(by)-208.6(this)-211.4(fac-)]TJ 0 -1.1869 TD [(tor.)-294.4(In)-294.3(the)-294.9(age)-291.5(group)-290.1(65)-295.3(years)-294.3(and)-292.7(older,)-295.8(psychiatric)-291.3(his-)]TJ 0 -1.1923 TD [(tory)-250.3(explained)-248.4(a)-252.1(higher)-246.3(proportion)-248.6(of)-250.9(the)-251.5(womens)-248.9(worse)]TJ T* [(outcomes)-229.1(compared)-228.9(with)-230.7(other)-226.1(age)-231.9(groups.)-229.5(These)-230.1(results,)]TJ 0 -1.1869 TD [(together)-483(with)-485.4(the)-484.6(recent)-482.4(nding)-483.8(of)-484(sex)-483.6(differences)-484.2(in)]TJ 0 -1.1923 TD [(symptoms)-358.1(after)-359.3(mild)-357.3(TBI)-354.3(but)-361.1(not)-355.7(after)-359.3(orthopedic)-355.6(inju-)]TJ 0 -1.1869 TD (ry,)Tj 7.8454 0 0 6.9729 73.3606 577.3605 Tm (12)Tj 10.4607 0 0 10.4607 83.9055 572.7117 Tm [(suggest)-264.6(that)-263.2(symptoms)-255.2(after)-267.2(TBI)-262.2(are)-263.4(not)-258.2(\(complete-)]TJ -2.092 -1.1923 TD [(ly\))-300.5(the)-300.3(result)-298.5(of)-299.7(differences)-300(in)-297.5(mental)-303.4(health)-297.1(history.)]TJ 1.046 -1.1923 TD [(We)-307.7(selected)-309.4(sociodemographic)-303.4(variables)-302.8(that)-306.6(differed)]TJ -1.046 -1.1869 TD [(between)-464.5(men)-466.9(and)-466.1(women,)-467.6(and)-466.1(that)-463.7(can)-464.9(be)-467.5(associated)]TJ 0 -1.1923 TD [(with)-333.6(gender)-329.6(roles)-335.6(and)-330.6(with)-328.2(health)-335.1(outcomes.)-331.4(In)-332.2(Europe,)]TJ T* [(women)-349.1(are)-355.5(less)-350.1(likely)-354.8(to)-351.7(be)-348.3(employed,)-351.8(and)-352.3(more)-350.7(likely)]TJ 0 -1.1869 TD [(to)-210.8(take)-205.6(care)-212(of)-207.6(children,)-205.9(to)-210.8(live)-209(alone,)-208.9(and)-206(to)-205.4(nish)-210(tertiary)]TJ 0 -1.1923 TD (education.)Tj 7.8454 0 0 6.9729 105.4488 490.1668 Tm (24)Tj 10.4607 0 0 10.4607 118.148 485.518 Tm [(Overall,)-466.2(these)-465.5(mediators)-467.4(did)-464.1(not)-464.1(substan-)]TJ -5.3654 -1.1923 TD [(tially)-319(explain)-322.8(differences)-321.6(in)-319.2(outcomes)-315.8(between)-323.6(men)-320.6(and)]TJ 0 -1.1869 TD [(women.)-196.6(Only)-201.3(worse)-202.1(outcomes)-196.6(of)-202.1(older)-199(women,)-196.6(compared)]TJ 0 -1.1923 TD [(with)-241.5(men)-233.9(of)-240.1(the)-240.7(same)-237.9(age,)-236.6(were)-239.1(to)-243.3(some)-233.7(extent)-242.9(explained)]TJ T* [(by)-246.5(these)-248.7(sociodemographic)-243.8(variables.)-247.9(In)-245.5(contrast)-251.2(to)-243.3(other)]TJ 0 -1.1869 TD [(groups,)-332.5(in)-335.4(the)-332.8(age)-334.8(group)-333.4(65)]TJ /F5 1 Tf 11.3703 0 TD (+)Tj /F7 1 Tf .5528 0 TD [(,)-335.3(women)-332.8(had)-336(lower)-333.2(educa-)]TJ -11.9231 -1.1923 TD [(tion)-296.9(and)-303.5(more)-296.5(frequently)-300.4(lived)-299.7(alone.)]TJ 1.046 -1.1923 TD [(We)-318.6(had)-314.4(information)-314(on)-317(employment)-314.8(status)-317(and)-314.4(broad)]TJ -1.046 -1.1869 TD [(job)-474.9(category.)-478.9(In)-478.5(our)-477.1(data,)-475.9(slightly)-481.2(more)-475.4(women)-479.2(were)]TJ 0 -1.1923 TD [(professionals/managers,)-459.5(while)-455.7(more)-459.1(men)-456.1(were)-461.3(manual)]TJ T* [(workers.)-343.9(Because)-346.3(all)-351.3(manager)-344.1(and)-346.9(professional)-343.3(occupa-)]TJ 0 -1.1869 TD [(tions)-302.1(were)-298.7(in)-302.9(the)-300.3(same)-302.9(category,)-300.1(differentiation)-297.8(between)]TJ 0 -1.1923 TD [(higher-status)-327.8(jobs)-328.4(was)-330.6(not)-328.6(possible.)-329.7(That)-331.2(is)-325.8(relevant)-330.1(be-)]TJ T* [(cause)-397.1(women)-392.5(have)-393.1(less)-398.9(access)-395.7(to)-395.1(the)-392.5(highest)-395.7(decision-)]TJ 0 -1.1869 TD [(making)-356.6(positions)-354.1(and)-357.7(higher)-354.7(tertiary)-359.6(education,)-356.1(and)-357.7(are)]TJ 0 -1.1923 TD [(underrepresented)-519.4(on)-517.5(corporate)-520.6(boards)-516.3(in)-519.7(management)]TJ T* (positions.)Tj 7.8454 0 0 6.9729 102.3874 290.8913 Tm (4952)Tj 10.4607 0 0 10.4607 125.2913 286.2424 Tm [(In)-310.5(addition,)-313.3(women)-311.2(are)-312.2(more)-312.8(likely)-311.4(to)-313.8(be)]TJ -6.0483 -1.1869 TD [(paid)-315.2(less)-312.1(for)-308.1(the)-316.6(same)-313.8(job,)-306.2(and)-314.4(to)-313.8(perform)-312(domestic)-307.2(and)]TJ 0 -1.1923 TD [(care)-222.9(giver)-215.2(duties.)]TJ 7.8454 0 0 6.9729 133.3417 266.0031 Tm (53,54)Tj 10.4607 0 0 10.4607 153.2976 261.3542 Tm [(However,)-216.7(we)-217(did)-220.2(not)-220.2(have)-219.6(informa-)]TJ -8.7256 -1.1923 TD [(tion)-302.3(on)-300.7(salary,)-299.8(hours)-296.7(worked)-302.5(in)-302.9(household,)-297.8(role)-297.9(of)-299.7(a)-306.3(pri-)]TJ 0 -1.1869 TD [(mary)-404.9(wage-earner,)-401.8(and)-406.5(role)-400.9(of)-402.7(a)-403.9(primary)-407.3(caregiver)-400.1(for)]TJ 0 -1.1923 TD [(children/)-364.6(elderly)-359.8(family)-363.2(members,)-362.9(which)-366.8(can)-361.9(be)-364.5(partic-)]TJ T* [(ularly)-487(relevant)-487.2(for)-492.4(younger)-481.2(and)-487.8(middle-age)-490.7(women.)]TJ 7.8454 0 0 6.9729 293.2723 216.17 Tm (54)Tj 10.4607 0 0 10.4607 62.022 199.1054 Tm [(Therefore,)-446(we)-450(could)-443.8(capture)-448.5(gender)-443.4(roles)-449.4(and)-444.4(gender-)]TJ T* [(sp)12.4(eci)9.8(c)-312.5(str)12.6(ess)13.9(ors)-310.3(onl)12.8(y)-318.4(t)0(o)-319.2(a)-322.6(lim)15.2(it)14.6(ed)-321.2(ext)19.4(ent)14(,)]TJ 7.8454 0 0 6.9729 238.1102 191.2818 Tm (53)Tj 10.4607 0 0 10.4607 249.2787 186.633 Tm [(whi)14(ch)-315.8(cou)16.2(ld)]TJ -17.901 -1.1923 TD [(explain)-436.6(why)-439(worse)-440.6(outcomes)-435(in)-438.4(women)-441.2(were)-439.6(less)-436.8(ex-)]TJ 0 -1.1869 TD [(plained)-263.2(by)-262.8(specied)-261.8(mediators)-261.4(in)-265(age)-264.4(groups)-262.8(16-65)-257.6(com-)]TJ 0 -1.1923 TD [(pared)-520.7(with)-517.9(the)-522.5(65)-517.5(years)-516.5(and)-520.3(older.)-518(Fullling)-520.9(family,)]TJ T* [(household,)-373.7(and)-379.4(work-related)-375.4(duties)-375.4(and)-374(being)-378.8(paid)-374.8(less)]TJ 0 -1.1869 TD [(can)-324(represent)-321.2(a)-322.6(burden)-320(in)-319.2(recovery)-324.6(from)-318.4(a)-322.6(TBI,)-326.5(particu-)]TJ 0 -1.1923 TD [(larly)-298.7(in)-302.9(young)-296.5(and)-298.1(middle)-299.2(adulthood.)]TJ 7.8454 0 0 6.9729 220.0818 116.5606 Tm (22,55)Tj 10.4607 0 0 10.4607 72.9637 99.4393 Tm [(The)-227.5(role)-222(of)-229.2(primary)-223.1(wage)-223.8(earner,)-223.8(and)-227.6(masculine)-223.3(norms)]TJ -1.046 -1.1869 TD [(such)-265.4(as)-262.8(stoicism,)-262.3(self-reliance,)-261.7(and)-260.2(restrictive)-265.5(emotional-)]TJ 0 -1.1923 TD [(ity)-238.7(can)-237.3(inuence)-238.9(return)-234.5(to)-237.9(work)-236.1(and)-238.5(participation)-237.6(in)-232.5(reha-)]TJ T* [(bilitation)-534.6(after)-532.8(a)-534(TBI.)]TJ 7.8454 0 0 6.9729 160.2141 66.7276 Tm (56,57)Tj 10.4607 0 0 10.4607 183.4582 62.0787 Tm [(As)-533.7(a)-534(consequence,)-531.9(gender)]TJ -11.6088 -1.1869 TD [(identity)-511.3(can)-519.1(impact)-509.3(recovery.)]TJ 7.8454 0 0 6.9729 192.7558 54.3118 Tm (53,58)Tj 10.4607 0 0 10.4607 215.7732 49.663 Tm [(A)-517.7(qualitative)-512.4(study)]TJ 9.3001 64.282 TD [(with)-257.8(men)-250.1(who)-254.7(experienced)-256.2(a)-252.1(TBI)-256.8(demonstrated)-250.6(that)-257.8(gen-)]TJ 0 -1.1869 TD [(der)-459.7(identity,)-451(and)-455.3(in)-454.7(particular)-458.5(masculine)-456.3(norms,)-454(moti-)]TJ 0 -1.1923 TD [(vated)-318(men)-315.2(to)-313.8(return)-315.8(to)-319.2(work)-311.9(more)-312.8(quickly)-318.6(and)-314.4(speed)-317(up)]TJ T* [(discharge)-381.8(and)-374(recovery,)-378.1(which)-372.2(was)-379.4(benecial)-379.5(for)-373.2(some)]TJ 0 -1.1869 TD [(and)-634.1(detrimental)-629.2(for)-627.9(others.)]TJ 7.8454 0 0 6.9729 436.2519 676.9698 Tm (59)Tj 10.4607 0 0 10.4607 450.7086 672.321 Tm [(In)-630.3(addition,)-627.6(masculine)]TJ -13.1588 -1.1923 TD [(traits)-338.7(can)-334.8(reduce)-339.3(the)-332.8(likelihood)-335.1(of)-337.6(recognizing)-331.3(and)-336(self-)]TJ T* [(reporting)-752.8(health)-747(complaints,)]TJ 7.8454 0 0 6.9729 441.5243 652.025 Tm (60,61)Tj 10.4607 0 0 10.4607 467.0361 647.3762 Tm [(particularly)-750.6(in)-747.3(the)]TJ -14.7197 -1.1869 TD [(domain)-470.4(of)-467.7(psychological)-468.4(functioning.)]TJ 7.8454 0 0 6.9729 477.1274 639.6093 Tm (56)Tj 10.4607 0 0 10.4607 489.8833 634.9604 Tm [(In)-473.1(the)-468.3(general)]TJ -16.9038 -1.1923 TD [(European)-527.2(population,)-527.3(men)-526.5(perceive)-532.6(\(or)-524.9(report\))-530.2(better)]TJ T* [(health)-535.6(than)-532(women.)]TJ 7.8454 0 0 6.9729 401.4424 614.6644 Tm (24)Tj 10.4607 0 0 10.4607 414.8219 610.0156 Tm [(More)-533.9(detailed)-533.8(measurement)-531.2(of)]TJ -9.7282 -1.1869 TD [(gender)-291.7(identity)-294.5(would)-292.1(contribute)-287.3(to)-292.1(better)-296.1(understanding)]TJ 0 -1.1923 TD [(the)-240.7(underlying)-232.1(mechanisms)-237.9(that)-236.1(cause)-234.5(gender)-237.5(differences)]TJ 0 -1.1869 TD [(in)-302.9(health-related)-301(outcomes.)]TJ 1.0514 -1.1923 TD [(Studies)-208.2(on)-208.6(sex)-207.2(and)-211.4(gender)-205(differences)-213.2(in)-205.4(care)-212(pathways)]TJ -1.0514 -1.1923 TD [(and)-547.4(their)-542.6(impact)-541.8(on)-544.6(long-term)-536.8(functioning)-541.8(after)-543.6(TBI)]TJ 0 -1.1869 TD [(are)-274.2(scarce.)-279(Large)-271.2(retrospective)-275.5(studies)-272.2(of)-272.6(cardiovascular,)]TJ 0 -1.1923 TD [(trauma)-609.1(and)-607(critical)-605.5(care)-607.6(patients)-606.7(found)-599(that)-610.1(women)]TJ T* [(were)-472.1(less)-474.7(likely)-468.6(to)-470.9(receive)-469(ICU)-472.5(treatment.)]TJ 7.8454 0 0 6.9729 501.392 515.055 Tm (62-64)Tj 10.4607 0 0 10.4607 524.6361 510.4062 Tm [(In)-467.7(our)]TJ -20.226 -1.1869 TD [(data,)-362.1(more)-356.1(women)-359.9(had)-357.7(direct)-355.8(referral)-357.4(to)-362.5(study)-354.1(hospital,)]TJ 0 -1.1923 TD [(and)-466.1(were)-466.7(less)-469.3(triaged)-462.7(to)-465.5(ICU.)-466.4(In)-462.3(studies)-467.3(of)-462.3(treatment)]TJ T* [(and)-216.8(care)-217.4(pathway,)-215.7(it)-213(is)-217.4(difcult)-217.6(to)-210.8(completely)-217.5(avoid)-216.2(resid-)]TJ 0 -1.1869 TD [(ual)-278.6(confounding)-266.4(related)-277.3(to)-275.8(medical)-273.7(needs,)]TJ 7.8454 0 0 6.9729 489.7133 465.2786 Tm (64)Tj 10.4607 0 0 10.4607 500.4282 460.6298 Tm [(which)-274.6(could)]TJ -17.9118 -1.1923 TD [(explain)-328.3(observed)-322.6(difference)-327.3(in)-330(care)-325.8(pathways.)-323.9(Triage)-326.2(of)]TJ T* [(mild)-216.4(TBI)-208(patients)-211(to)-216.2(different)-208.6(care)-217.4(pathways)-210.8(is)-212(not)-209.4(clearly)]TJ 0 -1.1869 TD [(associated)-432.4(with)-425.8(outcome.)]TJ 7.8454 0 0 6.9729 422.4755 427.918 Tm (65,66)Tj 10.4607 0 0 10.4607 444.5857 423.2692 Tm [(Because)-427.6(there)-430.8(is)-428.8(no)-425.4(evi-)]TJ -12.5735 -1.1923 TD [(dence)-379.6(of)-381(worse)-375.6(functional)-379.5(outcomes)-375.4(of)-375.6(patients)-379(triaged)]TJ T* [(to)-286.7(o)17.7(t)0(h)22.3(e)13.4(r)-295.7(d)12.2(e)13.4(s)11(ti)20(n)17.7(a)0(t)23.5(i)0(o)22.3(n)12.2(s)11(,)]TJ 7.8454 0 0 6.9729 399.4015 402.9731 Tm -.0158 Tc (67)Tj 10.4607 0 0 10.4607 410.1731 398.3243 Tm 0 Tc [(a)13.4(d)12.2(m)11.4(i)0(s)21.1(s)16.5(io)22.3(n)12.2(s)-292.5(to)-281.2(I)13.2(C)10.2(U)-295.5(f)13.2(o)12.2(l)0(l)25.5(o)12.2(wi)23.5(n)12.2(g)-296.7(m)16.8(i)0(l)20(d)]TJ -9.2838 -1.1869 TD [(TBI)-451.9(could)-443.9(often)-448.3(be)-451.3(unnecessary.)]TJ 7.8454 0 0 6.9729 457.2282 390.5574 Tm (66)Tj 10.4607 0 0 10.4607 469.7574 385.9086 Tm [(Additionally,)-446.4(some)]TJ -14.9798 -1.1923 TD [(studies)-353.5(associate)-347.1(ICU)-353.3(admission)-346.1(with)-349.9(increased)-353.5(risk)-349.1(for)]TJ T* [(PTSD)-295.5(1)-291.3(year)-294.5(after)-294.3(injury.)]TJ 7.8454 0 0 6.9729 421.0582 365.6125 Tm (68)Tj 10.4607 0 0 10.4607 431.9432 360.9637 Tm [(For)-289.6(some)-293.3(mild)-292.3(TBI)-294.7(patients,)]TJ -11.3649 -1.1869 TD [(however,)-212.5(monitoring)-203.8(in)-205.4(hospital)-212.2(and)-206(intensive)-209.6(care)-206.6(can)-210.2(be)]TJ 0 -1.1923 TD [(benecial)-368.6(to)-368(promptly)-367(identify)-367.2(any)-368.6(deterioration)-364.4(and)-368.6(to)]TJ T* [(initiate)-203.4(surgery)-199.5(or)-196.7(critical)-204.4(care)-201.2(intervention)-194.6(if)-204.4(necessary.)]TJ 7.8454 0 0 6.9729 544.3652 328.2519 Tm (66)Tj 10.4607 0 0 10.4607 313.0582 311.1873 Tm [(For)-322.2(the)-316.6(functional,)-319.1(HRQoL)-317.6(and)-319.8(mental)-314.2(health)-318.8(outcomes)]TJ T* [(we)-352.5(analyzed,)-348.6(care)-352.9(pathways)-351.7(did)-350.3(not)-344.9(explain)-349.9(differences)]TJ T* [(between)-301.9(men)-298.9(and)-298.1(women.)]TJ 1.0514 -1.1869 TD [(Biological)-531(differences)-527.6(and)-531.1(particularly)-528.4(sex)-532.3(steroids)]TJ -1.0514 -1.1923 TD [(represent)-402.5(another)-400.9(pathway)-400.7(that)-398.7(can)-399.9(mediate)-403.8(sex)-402.3(differ-)]TJ T* [(ences)-212.8(in)-210.8(outcomes.)]TJ 7.8454 0 0 6.9729 391.6912 253.5307 Tm (69)Tj 10.4607 0 0 10.4607 401.7259 248.8818 Tm [(For)-208.4(instance,)-206.9(animal)-211.2(models)-206(suggest)]TJ -8.4763 -1.1869 TD [(that)-301.1(the)-300.3(hypothalamic-pituitary-adrenal)-300.1(axis)-300.1(\(HPA\))-299.7(axis,)]TJ 0 -1.1923 TD [(which)-345.1(modulates)-338.3(the)-343.7(stress)-342(response,)]TJ 7.8454 0 0 6.9729 471.3447 228.6424 Tm (70)Tj 10.4607 0 0 10.4607 482.74 223.9937 Tm [(and)-341.5(microglia,)]TJ 7.8454 0 0 6.9729 544.3652 228.6424 Tm (71)Tj 10.4607 0 0 10.4607 313.0582 211.5212 Tm [(which)-258.4(inuence)-255.2(cerebral)-260.6(inammation,)-252.1(have)-257.6(sex-specic)]TJ 0 -1.1869 TD [(responses.)-322.9(After)-321.4(TBI,)-321.1(female)-320.6(rodents)-316.6(have)-322.6(shown)-318.1(stron-)]TJ 0 -1.1923 TD [(ger)-324.2(inammatory)-320(response,)]TJ 7.8454 0 0 6.9729 428.8818 191.2818 Tm (19)Tj 10.4607 0 0 10.4607 440.107 186.633 Tm [(greater)-322.8(anxiety)-317.4(and)-319.8(reduc-)]TJ -12.1454 -1.1923 TD [(tion)-486.6(of)-484(sociability,)]TJ 7.8454 0 0 6.9729 394.6393 178.8094 Tm (72)Tj 10.4607 0 0 10.4607 407.5652 174.1606 Tm [(and)-482.4(differential)-484.1(stress)-488.4(response)]TJ 7.8454 0 0 6.9729 544.3652 178.8094 Tm (70)Tj 10.4607 0 0 10.4607 313.0582 161.7448 Tm [(than)-201.4(males.)-205.5(Hormonal)-194.4(differences)-202.4(can)-204.8(be)-202(of)-196.7(particular)-203.8(im-)]TJ T* [(portance)-306.2(in)-302.9(explanation)-302(of)-299.7(symptoms)-298.5(in)-302.9(pre-menopausal)]TJ T* (women.)Tj 7.8454 0 0 6.9729 346.507 141.4488 Tm (10)Tj 10.4607 0 0 10.4607 359.3763 136.8 Tm [(Moreover,)-482.1(genetic)-484.2(factors)-482.4(can)-486.6(interact)-484(with)]TJ -4.4278 -1.1869 TD [(sex)-310.1(and)16.2(/o)11.4(r)-317.4(gen)16.2(der)-307.9(on)-311.5(th)11.4(ei)12.6(r)-317.4(i)0(m)10.6(pac)12(t)-315.2(o)0(f)-310.5(out)12.8(co)14.8(me)-311.2(aft)9.6(er)-309.3(TB)11.8(I.)]TJ 0 -1.1923 TD [(For)-300.5(example,)-297.9(being)-297.5(carrier)-294.7(of)-299.7(an)-299.5(APOE4)-296.1(allele)-298.2(had)-298.1(neg-)]TJ T* [(ative)-266(impact)-260(on)-257.3(the)-262.4(GOSE)-259.5(measured)-262.6(1-5)-254.9(years)-261.8(after)-261.8(TBI,)]TJ 0 -1.1869 TD [(and)-455.3(the)-446.7(effect)-454.3(was)-449.8(stronger)-449.7(in)-449.2(women)-452.1(compared)-451.1(with)]TJ 0 -1.1923 TD (men.)Tj 7.8454 0 0 6.9729 333.7511 79.2 Tm (73)Tj 10.4607 0 0 10.4607 324.0566 62.0787 Tm [(To)-305.9(our)-303.7(knowledge,)-310.5(this)-303.5(is)-309.5(the)-305.7(rst)-307.9(study)-305.3(that)-306.6(explores)]TJ -1.0514 -1.1869 TD [(underlying)-302.6(mechanisms)-303(of)-299.7(differences)-305.4(in)-302.9(outcomes)-299.5(after)]TJ ET 145.701 747.156 406.488 .51025 re f BT /F4 1 Tf 9.9626 0 0 9.9626 62.022 754.3557 Tm (3324)Tj 42.2865 0 TD [(MIKOLIC)-311.3(ET)-299.4(AL.)]TJ ET endstream endobj 113 0 obj <>stream /GS1 gs BT /F7 1 Tf 10.4607 0 0 10.4607 59.7543 722.0974 Tm 0 0 0 rg 0 Tc 0 Tw [(TBI)-310.9(between)-312.8(men)-309.8(and)-308.9(women)-305.7(using)-310.7(a)-311.7(mediation)-306.8(frame-)]TJ 0 -1.1869 TD [(work.)-262.5(We)-264.4(explored)-264(three)-262.8(possible)-260(explanatory)-260.8(pathways:)]TJ 0 -1.1923 TD [(one)-265.6(via)-262.4(psychiatric)-258.8(history,)-259.7(one)-265.6(via)-262.4(gender-related)-263.1(socio-)]TJ T* [(demographic)-340.7(variables,)-334.6(and)-336(one)-341.5(via)-338.3(care)-336.7(pathways.)-340.2(The)]TJ 0 -1.1869 TD [(method)-340.3(allowed)-337.9(studying)-335.9(joint)-335.7(mediation)-333.9(for)-340.6(both)-338.1(path-)]TJ 0 -1.1923 TD [(ways,)-317.6(and)-314.4(including)-318(interaction)-314(between)-318.2(sex/gender)-315.4(and)]TJ T* [(mediators)-310.2(in)-308.3(their)-304.1(impact)-308.8(on)-306.1(outcomes.)-309.7(We)-307.7(used)-308.7(a)-306.3(large)]TJ 0 -1.1869 TD [(multi-center)-491.3(European)-483.8(cohort)-490.2(of)-484(TBI)-489.8(patients)-487.4(and)-487.8(in-)]TJ 0 -1.1923 TD [(cluded)-300.3(different)-300.8(domains)-296.7(of)-299.7(functioning)-298(after)-299.7(6)-302.1(months.)]TJ 1.0514 -1.1923 TD [(Implications)-245.4(of)-245.5(this)-249.3(study)-245.7(involve)-248.2(informing)-245.4(clinicians)]TJ -1.0514 -1.1869 TD [(and)-249.3(patients)-249(about)-248.7(different)-252(risks)-245.9(of)-250.9(poorer)-248.5(outcomes)-245.3(fol-)]TJ 0 -1.1923 TD [(lowing)-368.8(mild)-368.2(TBI)-365.1(in)-368(context)-366.2(of)-370.1(sex,)-369(gender,)-366.9(and)-368.6(mental)]TJ 0 -1.1869 TD [(health.)-459(If)-455.9(supported)-454.7(by)-457.9(future)-456.7(evidence,)-457(the)-457.5(results)-455.5(of)]TJ 0 -1.1923 TD [(our)-466.3(and)-471.5(other)-464.5(recent)-466.1(studies)]TJ 7.8454 0 0 6.9729 184.7054 564.8881 Tm (11,12)Tj 10.4607 0 0 10.4607 207.2125 560.2393 Tm [(could)-470.9(be)-467.5(utilized)-466.8(for)]TJ -14.0964 -1.1923 TD [(organizing)-236.3(follow)-237.7(up)-241.1(care,)-238.4(for)-237.7(instance)-240.1(scheduling)-238.5(earlier)]TJ 0 -1.1869 TD [(or)-375.6(more)-372.4(frequent)-371.4(appointments)-374.2(for)-373.2(women)-370.8(and)-374(persons)]TJ 0 -1.1923 TD [(with)-420.3(\(history)-420.6(of)-82.9(\))-420.3(psychiatric)-421.4(difculties.)-420.9(Further,)-418.8(other)]TJ T* [(potential)-216.1(sociocultural)-214.9(and)-216.8(biological)-214.7(mechanisms)-216.3(of)-213(sex/)]TJ 0 -1.1869 TD [(gender)-356.7(differences)-359.6(should)-352.7(be)-353.7(measured)-354.7(and)-357.7(explored)-356.2(in)]TJ 0 -1.1923 TD [(upcoming)-299.6(TBI)-300.1(research.)]TJ 1.0514 -1.1923 TD [(This)-230.7(study)-229.4(also)-235.1(has)-234.3(some)-233.7(limitations.)-231(Mediation)-229.9(analy-)]TJ -1.0514 -1.1869 TD [(ses)-436(assume)-436.8(complete)-434.9(control)-431.4(for)-432.8(confounding)-429(between)]TJ 0 -1.1923 TD [(exposure)-506.9(and)-509.5(mediators,)-504.6(mediators)-505.3(and)-509.5(outcome,)-505(and)]TJ T* [(exposure)-393.1(and)-390.2(outcome.)-385.8(We)-389(controlled)-390.3(for)-389.4(a)-393(substantial)]TJ 0 -1.1869 TD [(number)-320.8(of)-316(pre-injury,)-316.1(clinical)-319.3(and)-314.4(injury)-320.2(characteristics.)]TJ 0 -1.1923 TD [(In)-500.2(addition,)-497.6(for)-497.8(each)-500.3(set)-496.6(of)-500.2(mediators,)-499.2(we)-498.8(performed)]TJ T* [(joint)-297.7(mediation)-301.4(with)-295.7(mediators)-299.4(included)-294.3(simultaneously,)]TJ 0 -1.1869 TD [(thus)-285(providing)-278.1(additional)-285.1(control)-279.7(for)-286.4(confounding.)-276.6(How-)]TJ 0 -1.1923 TD [(ever,)-369.7(unmeasured)-368.2(confounding)-358.6(remains)-370.4(possible,)-367.7(which)]TJ T* [(might)-323.4(have)-322.6(biased)-323.2(the)-322(observed)-322.6(associations.)-325.1(Moreover,)]TJ 0 -1.1869 TD [(some)-233.7(relationships)-228.1(may)-233.9(be)-229(non-linear,)-229.2(which)-231.3(can)-231.9(compli-)]TJ 0 -1.1923 TD [(cate)-529.6(adjustment.)]TJ 7.8454 0 0 6.9729 130.9606 340.7243 Tm (44)Tj 10.4607 0 0 10.4607 144.2834 336.0755 Tm [(We)-530(only)-527.7(had)-525.7(information)-530.8(on)-522.9(self-)]TJ -8.0806 -1.1923 TD [(reported)-523.2(medical)-523(history)-515.1(of)-521.9(psychiatric)-519(disorders,)-524.6(but)]TJ 0 -1.1869 TD [(not)-317.8(a)-317.2(measure)-318.2(of)-316(mental)-319.6(health)-313.4(symptoms)-314.8(before/)-318.6(at)-318(the)]TJ 0 -1.1923 TD [(time)-204.4(of)-196.7(injury.)-200.3(We)-204.8(did)-198.5(not)-198.5(adjust)-202(for)-199.7(or)-202.1(analyze)-199(the)-202.8(impact)]TJ T* [(of)-440.6(interventions)-443.7(and)-439(therapies)-443.7(after)-440.6(hospital)-439.8(admission)]TJ 0 -1.1869 TD [(and)-260.2(discharge.)-261.9(Further,)-261.7(as)-262.8(frequently)-257(occurs)-260.4(in)-259.6(longitudi-)]TJ 0 -1.1923 TD [(nal)-267.8(TBI)-262.2(studies,)-266.1(6-month)-263.2(outcomes)-261.6(were)-266.2(not)-263.6(available)-265.7(in)]TJ T* [(a)-409.3(considerable)-405.8(number)-407.5(of)-402.7(patients,)-405.4(which)-404.7(can)-410.7(compro-)]TJ 0 -1.1869 TD [(mise)-300.9(validity)]TJ 7.8454 0 0 6.9729 114.8598 241.1149 Tm (.74)Tj 10.4607 0 0 10.4607 70.7527 223.9937 Tm [(The)-417.1(subgroup)-417.1(age)-421.6(analyses)-423.4(had)-417.3(lower)-419.9(power.)-422.4(Addi-)]TJ -1.0514 -1.1923 TD [(tionally,)-537.7(age)-535.4(groups)-539.2(\(16-45,)-536.3(45-65,)-533.2(65)]TJ /F5 1 Tf 16.6111 0 TD (+)Tj /F7 1 Tf .5528 0 TD [(\))-539.6(were)-537.2(rather)]TJ -17.1639 -1.1869 TD [(broad)-532.8(and)-531.1(possibly)-526.7(included)-532.8(persons)-526.9(in)-536(different)-528.4(life)]TJ 0 -1.1923 TD [(stages,)-237(characterized)-241.4(by)-235.7(different)-235.7(roles,)-237.4(stressors)-240.5(and)-233.1(bio-)]TJ T* [(logical)-466(processes.)-462.6(For)-463.1(instance,)-467.1(some)-461.3(previous)-461.5(studies)]TJ 0 -1.1869 TD [(fo)14.6(un)19.1(d)-470.1(i)0(n)16.8(c)0(r)15.8(e)0(a)16(s)11(ed)-462.1(ri)17.8(sk)-459.1(of)-456.9(PT)17(SD)-458.9(fo)14.6(ll)14.6(o)12.2(w)0(i)12.6(n)12.2(g)-464.7(m)0(i)16(l)0(d)-460.1(T)0(B)17.2(I)-469.1(fo)20.1(r)]TJ 0 -1.1923 TD [(wo)14.9(me)14(n)-199.1(a)0(g)14.8(e)0(d)-191.1(3)0(0)19.1(-)0(3)14.6(9)-199.1(ve)14.8(rs)13.5(u)12.2(s)-205.7(1)12.2(8)0(-)14.6(2)0(9)19.1(,)]TJ 7.8454 0 0 6.9729 195.0236 153.9212 Tm (11)Tj 10.4607 0 0 10.4607 204.8881 149.2724 Tm [(an)14.8(d)-199.1(o)0(f)-191.3(p)0(o)19.1(s)0(t)15.7(-)0(c)15.8(o)0(n)13.6(c)0(u)14.8(s)11(si)15.7(on)]TJ -13.8742 -1.1923 TD [(sy)12.4(m)11.4(p)0(t)16.8(o)0(m)18.2(s)-265.4(fo)14.6(r)-263.2(w)0(o)20.3(m)0(e)14(n)-258.7(ag)14.8(ed)-256.1(35)19.1(-4)14.6(9)-264.2(v)12.2(er)15.8(su)12.4(s)-259.9(1)0(7)13.6(-)0(3)20.1(4)0(.)]TJ 7.8454 0 0 6.9729 257.5558 141.4488 Tm -.018 Tc [(7,)-18(12)]TJ 10.4607 0 0 10.4607 273.7133 136.8 Tm 0 Tc [(In)-256.3(ou)19.1(r)]TJ -20.4536 -1.1869 TD [(st)15.7(ud)13.6(y)12.2(,)-292(th)16.8(e)-290.1(g)0(r)14.6(o)0(u)19.1(p)-291.3(ag)14.8(ed)-283.2(45)19.1(-6)14.6(5)-291.3(l)0(i)20(k)0(e)14.8(l)0(y)-281.2(i)0(n)16.8(c)0(l)12.6(u)0(d)19.1(e)0(d)-283.2(b)0(o)13.6(t)0(h)-281.2(f)0(e)15.8(m)11.4(al)12.6(es)]TJ 0 -1.1923 TD [(in)-297.5(p)12.2(r)0(e)15.8(-)0(m)13.8(e)0(n)14.8(o)12.2(pa)14.8(us)17.9(e)-300.9(a)0(n)14.8(d)-302.1(me)14(n)12.2(o)0(p)13.6(a)0(u)14.8(s)11(e,)-294.8(an)14.8(d)-296.7(g)0(r)14.6(o)0(u)13.6(p)12.2(s)-303.3(4)0(5)19.1(-)0(6)14.6(5)-302.1(an)14.8(d)]TJ T* (65)Tj /F5 1 Tf .9864 0 TD (+)Tj /F7 1 Tf 1.1164 0 TD [(in)16.8(cl)18(ud)13.6(ed)-554.2(bo)19.1(th)-557.6(re)15.8(ti)14.6(re)15.8(d)-567.7(a)0(n)20.3(d)-567.7(\(u)20.1(n\))14.6(em)14(p)12.2(l)0(o)16.8(y)0(e)14.8(d)-567.7(p)12.2(e)0(r)15.8(s)0(o)12.4(n)12.2(s.)]TJ -2.1028 -1.1869 TD [(Th)13.8(e)-311.7(r)0(e)15.8(s)11(ul)16.8(ts)-304.1(ar)15.8(e)-311.7(o)0(b)19.1(t)0(a)12.6(i)0(n)16.8(e)0(d)-299.5(i)0(n)-302.9(a)-311.7(Eu)13.8(ro)20.1(pe)14.8(an)-304.9(s)11(t)0(u)16.8(d)0(y)-300.7(w)0(i)12.6(t)0(h)-302.9(a)-306.3(su)12.4(b)12.2(-)]TJ 0 -1.1923 TD [(st)15.7(an)14.8(ti)14.6(al)-301.7(p)12.2(r)0(o)14.6(p)0(o)19.1(r)0(t)12.4(i)0(o)16.8(n)-307.5(o)12.2(f)-311.9(la)18(rg)14.6(e)-306.3(t)0(r)12.4(a)0(u)20.3(m)0(a)-300.3(c)0(e)10.6(n)12.2(te)12.6(rs)-300.9(in)-297.5(ur)14.6(b)12.2(a)0(n)-304.9(a)0(r)15.8(e)0(a)16(s)]TJ T* [(in)-422.2(No)14.9(rt)17.8(h-)14.6(We)17.4(st)15.7(er)15.8(n)-432.2(E)12.4(ur)14.6(op)19.1(e.)]TJ 7.8454 0 0 6.9729 170.9291 66.7276 Tm [(30)24.5(,7)20.2(5)]TJ 10.4607 0 0 10.4607 192.6992 62.0787 Tm [(Th)13.8(er)15.8(ef)15.8(or)14.6(e,)-419.4(th)16.8(e)-431(g)0(e)14.8(n)12.2(er)15.8(al)12.6(iz)18(-)]TJ -12.709 -1.1869 TD [(ab)14.8(il)14.6(it)14.6(y)-291.3(o)12.2(f)-295.7()0(n)16.9(d)12.2(in)16.8(gs)-285.6(to)-281.2(ot)16.8(he)14.8(r)-290.3(a)0(r)10.4(e)0(a)16(s)-292.5(is)-282.4(li)14.6(m)11.4(i)0(t)14.6(e)0(d)14.8(.)]TJ 25.0495 64.282 TD [(Important)-276.7(indicators)-272.3(of)-278(gender)-275.4(roles)-276(and)-276.4(identity)-272.9(were)]TJ -1.046 -1.1869 TD [(not)-393.6(measured)-398.1(in)-400.5(this)-395.7(study.)-396.8(Sex)-397.9(was)-401(based)-398.3(on)-398.2(medical)]TJ 0 -1.1923 TD [(forms)-215.2(and)-211.4(will)-216.6(not)-214.8(always)-213.6(correspond)-215.8(to)-216.2(gender)-210.4(\(identify-)]TJ T* [(ing)-317.8(as)-317(a)-322.6(woman)-316.6(or)-321.4(a)-317.2(man\).)-322.9(We)-318.6(recognize)-319.8(that)-317.4(there)-322.4(is)-320.4(a)]TJ 0 -1.1869 TD [(notable)-236.1(minority)-239.1(of)-234.7(intersex,)-239.6(transgender,)-236.4(and)-238.5(non-binary)]TJ 0 -1.1923 TD [(persons,)-211.9(who)-216.8(are)-214.6(not)-214.8(captured)-214(by)-219.4(this)-211.4(dichotomy.)-212.9(We)-215.6(rec-)]TJ T* [(ommend)-311.8(inclusion)-319.2(of)-316(self-reports)-314.2(and)-319.8(more)-318.2(measures)-318(of)]TJ 0 -1.1869 TD [(gender)-297.1(where)-302.7(practical)-297.2(in)-302.9(future)-299.5(TBI)-300.1(studies.)]TJ 1.046 -1.1923 TD [(In)-245.5(conclusion,)-248.7(men)-244.7(and)-243.9(women)-246.1(differ)-249.7(in)-243.3(outcomes)-245.3(fol-)]TJ -1.046 -1.1923 TD [(lowing)-374.2(mild)-373.6(TBI,)-375.3(and)-379.4(those)-374.6(differences)-375.8(are)-377.2(only)-376(partly)]TJ 0 -1.1869 TD [(explained)-411(by)-414.5(psychiatric)-410.6(history,)-416.8(and)-411.9(not)-409.9(explained)-416.4(by)]TJ 0 -1.1923 TD [(gender-related)-349.8(sociodemographic)-346.8(and)-352.3(care)-352.9(pathway)-346.5(dif-)]TJ 0 -1.1869 TD [(ferences.)-432.3(Future)-427.4(studies)-429.4(should)-428.6(explore)-433.4(further)-427.2(aspects)]TJ 0 -1.1923 TD [(of)-446(gender)-443.4(roles)-444(and)-444.4(identity,)-445.6(and)-444.4(biological)-442.3(factors)-449.9(as)]TJ T* [(underpinnings)-559.7(of)-565.3(sex)-559.4(and)-563.7(gender)-568.1(differences)-560.1(in)-568.5(TBI)]TJ 0 -1.1869 TD (outcomes.)Tj /F4 1 Tf 0 -2.2762 TD -.0002 Tc (Acknowledgments)Tj /F7 1 Tf 0 -1.2032 TD 0 Tc [(We)-486.6(are)-491(grateful)-492.9(to)-487.2(all)-492.2(patients)-487.4(and)-487.8(investigators)-488.3(who)]TJ 0 -1.1923 TD [(participated)-300.6(in)-297.5(the)-300.3(CENTER-TBI)-296.9(study.)]TJ /F4 1 Tf 0 -2.4605 TD [(The)-296.2(CENTER-TBI)-302.4(Participants)-298.8(and)-303.8(Investigators)]TJ /F7 1 Tf 0 -1.2032 TD [(Cecilia)-797.4(A)]TJ 3.8425 .2385 TD ()Tj .5203 -.2385 TD [(kerlund,)-791.6(Karolinska)-794.5(Institutet,)-792(Stockholm,)]TJ -4.3628 -1.1923 TD [(Sweden;)-533(Krisztina)-538(Amrein,)-532.5(University)-532.4(of)-532.7(Pe)]TJ 18.7735 .0434 TD ()Tj .3848 -.0434 TD [(cs,)-533(Pe)]TJ 2.2275 .0434 TD ()Tj .3848 -.0434 TD (cs,)Tj -21.7706 -1.1869 TD [(Hungary,)-435.9(Nada)-435.2(Andelic,)-440.1(Oslo)-435.6(University)-434.8(Hospital)-438.6(and)]TJ 0 -1.1923 TD [(University)-472.8(of)-473.1(Oslo,)-472.8(Oslo,)-472.8(Norway;)-475.5(Lasse)-475.1(Andreassen,)]TJ T* [(University)-261.4(Hospital)-259.8(Northern)-257.6(Norway,)-262.7(Tromso,)-257.3(Norway;)]TJ 0 -1.1869 TD [(Audny)-604.2(Anke,)-603.7(University)-608.2(Hospital)-606.6(Northern)-604.4(Norway,)]TJ 0 -1.1923 TD [(Tromso,)-652.9(Norway;)-659.8(Anna)-658.6(Antoni,)-655.3(Medical)-662.9(University)]TJ T* [(Vienna,)-504.4(Vienna,)-509.8(Austria;)-502.7(Ge)]TJ 11.8093 .0434 TD ()Tj .3848 -.0434 TD [(rard)-506.1(Audibert,)-509.4(University)]TJ -12.1941 -1.1869 TD [(Hospital)-628.3(Nancy,)-628.2(Nancy,)-628.2(France,)-628(University)-629.9(Hospital)]TJ 0 -1.1923 TD [(Nancy,)-254.2(Nancy,)-254.2(France;)-255.6(Philippe)-256.6(Azouvi,)-256.3(Raymond)-252(Poin-)]TJ T* [(care)-455.9(Hospital,)-459.6(Assistance)-455.3(PubliqueHopitaux)-449.7(de)-456.7(Paris,)]TJ 0 -1.1869 TD [(Paris,)-277.5(France;)-282.7(Maria)-278.8(Luisa)-282.3(Azzolini,)-278.4(S.)-281.9(Raffaele)-278.9(Univer-)]TJ 0 -1.1923 TD [(sity)-563.7(Hospital,)-568(Milan,)-569.8(Italy;)-565.1(Ronald)-569.1(Bartels,)-568.2(Radboud)]TJ T* [(University)-369.8(Medical)-375.6(Center,)-371.1(Nijmegen,)-374.5(the)-376.2(Netherlands;)]TJ 0 -1.1869 TD (Pa)Tj .6124 .0379 TD ()Tj .3848 -.0379 TD [(l)-634.9(Barzo)]TJ 2.8941 .0379 TD ()Tj .4173 -.0379 TD [(,)-633.4(University)-635.4(of)-635.7(Szeged,)-634.4(Szeged,)-634.4(Hungary;)]TJ -4.3086 -1.1923 TD [(Romuald)-839.5(Beauvais,)-840.8(ARTTIC,)-843.2(Munchen,)-837.8(Germany;)]TJ T* [(Ronny)-201(Beer,)-198.2(Medical)-202.2(University)-201.8(of)-202.1(Innsbruck,)-201.5(Innsbruck,)]TJ 0 -1.1869 TD [(Austria;)-518.9(Bo-Michael)-518.7(Bellander,)-519.7(Karolinska)-518.1(University)]TJ 0 -1.1923 TD [(Hospital,)-649.3(Stockholm,)-648.7(Sweden;)-652.2(Antonio)-649.2(Belli,)-655.5(NIHR)]TJ T* [(Surgical)-702(Reconstruction)-706.5(and)-704.6(Microbiology)-702.8(Research)]TJ 0 -1.1869 TD [(Centre,)-658.3(Birmingham,)-657.8(UK;)-662.2(Habib)-659.4(Benali,)-661.6(Assistance)]TJ 0 -1.1923 TD [(Publique0Hopitaux)-486.3(de)-489.2(Paris,)-488.9(Paris,)-488.9(France;)-488.6(Maurizio)]TJ T* [(Berardino,)-463.4(AOU)-463.7(Citta)]TJ 8.9098 .0434 TD (`)Tj .8509 -.0434 TD [(della)-466.6(Salute)-461.9(e)-468.9(della)-461.1(Scienza)-466.8(di)]TJ -9.7607 -1.1869 TD [(TorinoOrthopedic)-502.7(and)-504(Trauma)-509.1(Center,)-506.6(Torino,)-506.8(Italy;)]TJ 0 -1.1923 TD [(Luigi)-468.7(Beretta,)-468.3(S.)-466.2(Raffaele)-474(University)-467.3(Hospital,)-465(Milan,)]TJ T* [(Italy;)-554.3(Morten)-555(Blaabjerg,)-552.2(Odense)-552.8(University)-554.1(Hospital,)]TJ 0 -1.1869 TD [(Odense,)-541.3(Denmark;)-540(Peter)-541.4(Bragge,)-542.3(Monash)-538.8(University,)]TJ 0 -1.1923 TD [(Victoria,)-429.1(Australia;)-430.4(Alexandra)-428.2(Brazinova,)-430.7(Trnava)-427(Uni-)]TJ T* [(versity,)-307.3(Trnava,)-312.5(Slovakia;)-308.2(Vibeke)-315.4(Brinck,)-307.2(Quesgen)-313(Sys-)]TJ 0 -1.1869 TD [(tems)-967.5(Inc.,)-962.3(Burlingame,)-964.7(California,)-970.5(USA;)-961.1(Joanne)]TJ 0 -1.1923 TD [(Brooker,)-757.9(Monash)-761(University,)-759.3(Melbourne,)-760.3(Australia;)]TJ T* [(Camilla)-571.8(Brorsson,)-570.4(Umea)]TJ 10.1889 .0325 TD ()Tj .9593 -.0325 TD [(University,)-569.6(Umea)]TJ 7.0563 .0325 TD ()Tj .3848 -.0325 TD [(,)-573.8(Sweden;)]TJ -18.5893 -1.1869 TD [(Andras)-623.5(Buki,)-626.6(University)-619.1(of)-624.9(Pe)]TJ 13.251 .0379 TD ()Tj .3848 -.0379 TD [(cs,)-625.2(Hungary;)-621.7(Monika)]TJ ET 59.754 747.156 406.488 .51025 re f BT /F4 1 Tf 9.9626 0 0 9.9626 59.7543 753.8455 Tm [(MED)-10.3(IATORS)-307.4(OF)-302.7(SEX)-302.9(DIFFE)-10.3(RENCES)-305.4(IN)-306.7(MTBI)-302.7(OUT)-8.8(COMES)-22532.3(3325)]TJ ET endstream endobj 118 0 obj <>stream /GS1 gs BT /F7 1 Tf 10.4607 0 0 10.4607 62.022 722.0974 Tm 0 0 0 rg 0 Tc 0 Tw [(Bullinger,)-887.4(Universita)]TJ 8.7147 .0217 TD ()Tj .3848 -.0217 TD [(tsklinikum)-885.7(Hamburg-Eppen)7(dorf,)]TJ -9.0995 -1.1869 TD [(Hamburg,)-518(Germany;)-523.8(Manuel)-516.9(Cabeleira,)-523.9(University)-521.5(of)]TJ 0 -1.1923 TD [(Cambridge,)-481.5(Addenbrookes)-481.4(Hospital,)-481.3(Cambridge,)-481.5(UK;)]TJ T* [(Alessio)-596.2(Caccioppola,)-598(Fondazione)-593.8(IRCCS)-596.4(Ca)]TJ 18.9307 .0434 TD (`)Tj .9809 -.0434 TD (Granda)Tj -19.9117 -1.1869 TD [(Ospedale)-448.1(Maggiore)-448.1(Policlinico,)-444.6(Milan,)-450.6(Italy;)-445.9(Emiliana)]TJ 0 -1.1923 TD [(Calappi,)-828.2(Fondazione)-826.9(IRCCS)-829.4(Ca)]TJ 14.1452 .0434 TD (`)Tj 1.214 -.0434 TD [(Granda)-827(Ospedale)]TJ -15.3592 -1.1923 TD [(Maggiore)-464.3(Policlinico,)-460.9(Milan,)-461.4(Italy;)-467.6(Maria)-463.1(Rosa)-462.5(Calvi,)]TJ 0 -1.1869 TD [(S.)-661.3(Raffaele)-658.3(University)-662.4(Hospital,)-654.7(Milan,)-661.9(Italy;)-657.2(Peter)]TJ 0 -1.1923 TD [(Cameron,)-763.9(Monash)-766.4(University,)-764.7(Melbourne,)-765.7(Victoria,)]TJ T* [(Australia;)-782.7(Guillermo)-777.3(Carbayo)-785.5(Lozano,)-779.6(Hospital)-780.1(of)]TJ 0 -1.1869 TD [(Cruces,)-527.2(Bilbao,)-527.3(Spain;)-528.2(Marco)-525.9(Carbonara,)-525.1(Fondazione)]TJ 0 -1.1923 TD [(IRCCS)-737.3(Ca)]TJ 4.3519 .0434 TD (`)Tj 1.1219 -.0434 TD [(Granda)-740.3(Ospedale)-740.7(Maggiore)-740.7(Policlinico,)]TJ -5.4738 -1.1869 TD [(Milan,)-374.7(Italy;)-375.4(Ana)-378.2(M.)-371.6(Castan)]TJ 11.3758 .0054 TD ()Tj .4173 -.0054 TD (o-Leo)Tj 1.9782 .0379 TD ()Tj .4173 -.0379 TD [(n,)-371.9(Hospital)-379(Universi-)]TJ -14.1885 -1.1923 TD [(tario)-488.4(12)-485(de)-489.2(Octubre,)-485.7(Madrid,)-483.9(Spain;)-484.8(Simona)-483.4(Cavallo,)]TJ T* [(AOU)-593.7(Citta)]TJ 4.3194 .0434 TD (`)Tj .981 -.0434 TD [(della)-591.2(Salute)-592(e)-599(della)-591.2(Scienza)-596.8(di)-590.2(Torino)]TJ -5.3004 -1.1869 TD [(Orthopedic)-441.1(and)-439(Trauma)-444.1(Center,)-441.5(Torino,)-436.3(Italy;)-440.5(Giorgio)]TJ 0 -1.1923 TD [(Chevallard,)-680.8(Niguarda)-680.1(Hospital,)-681.8(Milan,)-683.6(Italy;)-678.9(Arturo)]TJ T* [(Chieregato,)-458.6(Niguarda)-457.9(Hospital,)-459.6(Milan,)-456(Italy;)-456.7(Giuseppe)]TJ 0 -1.1869 TD [(Citerio,)-472.9(Universita)]TJ 7.3002 .0379 TD (`)Tj .8563 -.0379 TD [(Milano)-471.6(Bicocca,)-471.3(Milano,)-470.8(Italy)-472.2(and)]TJ -8.1565 -1.1923 TD [(ASST)-344.2(di)-346.3(Monza,)-347.4(Monza,)-347.4(Italy;)-348.3(Iris)-348.1(Ceyisakar,)-345.2(Erasmus)]TJ T* [(Medical)-408.1(Center-University)-408.6(Medical)-413.6(Center,)-409(Rotterdam,)]TJ 0 -1.1869 TD [(the)-522.5(Netherlands;)-527.2(Hans)-518.9(Clusmann,)-524.2(Aachen)-523.3(University,)]TJ 0 -1.1923 TD [(Aachen,)-500.9(Germany;)-502.1(Mark)-501.4(Coburn,)-501.3(University)-499.9(Hospital)]TJ T* [(of)-516.5(Aachen,)-511.8(Aachen,)-517.2(Germany;)-512.9(Jonathan)-510.1(Coles,)-516.8(Cam-)]TJ 0 -1.1869 TD [(bridge)-257.2(University)-256(Hospital)-259.8(NHS)-255.7(Foundation)-251.6(Trust,)-260.1(Cam-)]TJ 0 -1.1923 TD [(bridge,)-419.1(UK;)-418.3(Jamie)-423(D.)-419.4(Cooper,)-418.8(Monash)-419.5(University)-418.6(and)]TJ T* [(The)-579.7(Alfred)-585.5(Hospital,)-578.8(Melbourne,)-581.5(Victoria,)-580.9(Australia;)]TJ 0 -1.1869 TD [(Marta)-636.5(Correia,)-634.2(MRC)-633.7(Cognition)-630.1(and)-634.1(Brain)-634.5(Sciences)]TJ 0 -1.1923 TD [(Unit,)-284.2(Cambridge,)-275.6(UK;)-282.8(Amra)-284.5(C)]TJ 12.0261 .2493 TD ()Tj .4986 -.2493 TD (ovic)Tj 1.3386 .0434 TD ()Tj .3902 -.0434 TD [(,)-281.1(Universita)]TJ 4.3194 .0217 TD ()Tj .3848 -.0217 TD (tsmedizin)Tj -18.9578 -1.1923 TD (Go)Tj .8021 .0217 TD ()Tj .4173 -.0217 TD [(ttingen,)-439.4(Go)]TJ 4.2761 .0217 TD ()Tj .4173 -.0217 TD [(ttingen,)-439.4(Germany;)-442.5(Nicola)-436.8(Curry,)-442.1(Oxford)]TJ -5.9128 -1.1869 TD [(University)-543.2(Hospitals)-541.4(NHS)-542.9(Trust,)-547.3(Oxford,)-540.5(UK;)-543(Endre)]TJ 0 -1.1923 TD [(Czeiter,)-332.8(University)-326.4(of)-332.2(Pe)]TJ 9.8149 .0434 TD ()Tj .3848 -.0434 TD [(cs,)-332.5(Hungary;)-329(Marek)-330.8(Czosnyka,)]TJ -10.1997 -1.1923 TD [(University)-825(of)-820(Cambridge,)-823(Addenbrookes)-817.4(Hospital,)]TJ 0 -1.1869 TD [(Cambridge,)-394.8(UK;)-391.2(Claire)-395.7(Dahyot-Fizelier,)-393.2(CHU)-396.4(Poitiers,)]TJ 0 -1.1923 TD [(Potiers,)-678(France;)-678.3(Paul)-675.1(Dark,)-678.6(Salford)-674.3(Royal)-678.9(Hospital)]TJ T* [(NHS)-613.4(Foundation)-609.3(Trust,)-612.3(Salford,)-614(UK;)-613.4(Helen)-609.4(Dawes,)]TJ 0 -1.1869 TD [(Oxford)-319(Brookes)-321.8(University,)-320.3(Oxford,)-318.3(UK;)-326.2(Ve)]TJ 17.9281 .0379 TD ()Tj .3848 -.0379 TD [(ronique)-320.8(De)]TJ -18.3129 -1.1923 TD [(Keyser,)-361.4(Antwerp)-356.3(University)-358.9(Hospital)-362.8(and)-357.7(University)-358.9(of)]TJ T* [(Antwerp,)-317.7(Edegem,)-314.3(Belgium;)-316.8(Vincent)-316.2(Degos,)-316.2(Assistance)]TJ 0 -1.1869 TD [(PubliqueHopitaux)-509.3(de)-510.9(Paris,)-516(Paris,)-510.6(France;)-515.7(Francesco)]TJ 0 -1.1923 TD [(Della)-476.2(Corte,)-471.2(Maggiore)-475.2(Della)-476.2(Carita)]TJ 14.6872 .0434 TD (`)Tj .8563 -.0434 TD [(Hospital,)-475.9(Novara,)]TJ -15.5435 -1.1923 TD [(Italy;)-413.4(Hugo)-410.5(den)-411.9(Boogert,)-408.8(Radboud)-408.3(University)-413.1(Medical)]TJ 0 -1.1869 TD [(Center,)-224.8(Nijmegen,)-222.8(the)-219(Netherlands;)-223.7(Bart)-224(Depreitere,)-225.6(Uni-)]TJ 0 -1.1923 TD [(versity)-839.1(Hospitals)-839.5(Leuven,)-839.2(Leuven,)-839.2(Belgium;)]TJ /F12 1 Tf 20.9522 0 TD ($)Tj /F7 1 Tf .6775 0 TD (ula)Tj /F12 1 Tf -21.6297 -1.1923 TD ($)Tj /F7 1 Tf .6775 0 TD [(ilvesi,)-620.8(University)-624.5(of)-624.9(Novi)-618.7(Sad,)-624.8(Novi)-624.1(Sad,)-619.4(Serbia;)]TJ -.6775 -1.1869 TD [(Abhishek)-791.9(Dixit,)-789(University)-792.5(of)-792.9(Cambridge,)-790.4(Adden-)]TJ 0 -1.1923 TD [(brookes)-452.9(Hospital,)-448.8(Cambridge,)-454.4(UK;)-450.8(Emma)-449.9(Donoghue,)]TJ T* [(Monash)-408.7(University,)-407(Melbourne,)-408(Australia;)-408.7(Jens)-407.5(Dreier,)]TJ 0 -1.1869 TD (Charite)Tj 2.5689 .0379 TD ()Tj .7479 -.0379 TD [()-361.7(Universita)]TJ 4.65 .0217 TD ()Tj .3848 -.0217 TD [(tsmedizin)-356.8(Berlin,)-363.7(Berlin,)-358.2(Germany;)]TJ -8.3516 -1.1923 TD [(Guy-Loup)-317(Dulie)]TJ 6.3193 .0434 TD (`)Tj .3848 -.0434 TD [(re,)-319.5(CHR)-318.4(Citadelle,)-313.7(Lie)]TJ 8.8719 .0434 TD (`)Tj .3848 -.0434 TD [(ge,)-315.1(Belgium;)-316.8(Ari)]TJ -15.9608 -1.1923 TD [(Ercole,)-271.3(University)-266.8(of)-267.2(Cambridge,)-270.2(Addenbrookes)-264.6(Hospi-)]TJ 0 -1.1869 TD [(tal,)-269.3(Cambridge,)-264.7(UK;)-272(Patrick)-264.4(Esser,)-268.7(Oxford)-270.2(Brookes)-267.6(Uni-)]TJ 0 -1.1923 TD [(versity,)-334.4(Oxford,)-334.5(UK;)-337(Erzse)]TJ 10.6712 .0434 TD ()Tj .3848 -.0434 TD [(bet)-338.3(Ezer,)-337(University)-331.9(of)-332.2(Pe)]TJ 10.3352 .0434 TD ()Tj .3848 -.0434 TD (cs,)Tj -21.776 -1.1923 TD (Pe)Tj .6124 .0434 TD ()Tj .3848 -.0434 TD [(cs,)-440.9(Hungary;)-432(Martin)-432.6(Fabricius,)-435.5(Region)-439(Hovedstaden)]TJ -.9972 -1.1869 TD [(Rigshospitalet,)-242.1(Copenhagen,)-238.4(Denmark;)-241.9(Valery)-243.9(L.)-241.6(Feigin,)]TJ 23.998 64.282 TD [(Auckland)-572.7(University)-564.9(of)-570.7(Technology,)-564.8(Auckland,)-566.6(New)]TJ 0 -1.1869 TD [(Zealand;)-244.2(Kelly)-244.3(Foks,)-235.5(Erasmus)-240.3(MC,)-242.2(Rotterdam,)-239.9(the)-246.1(Neth-)]TJ 0 -1.1923 TD [(erlands;)-489.6(Shirin)-485(Frisvold,)-482.7(University)-483.6(Hospital)-487.4(Northern)]TJ T* [(Norway,)-414.4(Tromso,)-414.4(Norway;)-410.5(Alex)-411.5(Furmanov,)-411.6(Hadassah-)]TJ 0 -1.1869 TD [(Hebrew)-500.6(University)-499.9(Medical)-494.9(Center,)-501.2(Jerusalem,)-497(Israel;)]TJ 0 -1.1923 TD [(Pablo)-652(Gagliardo,)-647.7(Fundacio)]TJ 11.1427 .0434 TD ()Tj .4173 -.0434 TD [(n)-649(Instituto)-646.8(Valenciano)-645.6(de)]TJ 10.4607 0 0 10.4607 313.0582 647.3762 Tm (Neurorrehabilitacio)Tj 7.4411 .0434 TD ()Tj .4173 -.0434 TD [(n)-247.9(\(FIVAN\),)-250.6(Valencia,)-246.7(Spain;)-246.3(Damien)]TJ -7.8584 -1.1869 TD [(Galanaud,)-587.1(Assistance)-585.3(Publique)-585()-583.9(Hopitaux)-581.6(de)-586.8(Paris,)]TJ 0 -1.1923 TD [(Paris,)-618.9(France;)-624.1(Dashiell)-616.3(Gantner,)-621.2(Monash)-614.6(University,)]TJ T* [(Melbourne,)-516.4(Victoria,)-521.2(Australia;)-517.1(Guoyi)-514.3(Gao,)-518.4(Shanghai)]TJ 0 -1.1869 TD [(Renji)-361.4(Hospital,)-362.1(Shanghai)-359.4(Jiaotong)-361.8(University/Sch)6.6(ool)-361.1(of)]TJ 0 -1.1923 TD [(Medicine,)-276(Shanghai,)-266.5(China;)-273.2(Pradeep)-269.6(George,)-273.5(Karolinska)]TJ 0 -1.1869 TD [(Institutet,)-759.5(Stockholm,)-757.1(Sweden;)-755.2(Alexandre)-758.8(Ghuysen,)]TJ 0 -1.1923 TD [(CHU,)-281.9(Lie)]TJ 3.5932 .0434 TD (`)Tj .3848 -.0434 TD [(ge,)-277.1(Belgium;)-278.9(Lelde)-285.3(Giga,)-275.3(Pauls)-279.2(Stradins)-281.7(Clini-)]TJ -3.978 -1.1923 TD [(cal)-624.3(University)-619.1(Hospital,)-622.2(Riga,)-620(Latvia;)-622.9(Ben)-625.3(Glocker,)]TJ 0 -1.1869 TD [(Imperial)-201(College)-200.2(London,)-196.7(London,)-202.1(UK;)-196.1(Jagos)]TJ 17.8305 .0379 TD ()Tj .5528 -.0379 TD (Golubovic,)Tj -18.3833 -1.1923 TD [(University)-521.5(of)-521.9(Novi)-521.1(Sad,)-516.4(Novi)-521.1(Sad,)-521.8(Serbia;)-519.1(Pedro)-518.7(A.)]TJ T* [(Gomez,)-406.8(Hospital)-400.7(Universitario)-403.5(12)-403.7(de)-402.5(Octubre,)-404.4(Madrid,)]TJ 0 -1.1869 TD [(Spain;)-446.9(Johannes)-444(Gratz,)-445.1(Medical)-446.1(University)-440.2(of)-446(Vienna,)]TJ 0 -1.1923 TD [(Austria;)-226.3(Benjamin)-221.3(Gravesteijn,)-224.4(Erasmus)-224(Medical)-223.9(Center-)]TJ T* [(University)-321(Medical)-316(Center,)-316.9(Rotterdam,)-315.7(the)-316.6(Netherlands;)]TJ 0 -1.1869 TD [(Francesca)-769.6(Grossi,)-768.3(Maggiore)-762.4(Della)-768.8(Carita)]TJ 18.0636 .0379 TD (`)Tj 1.1544 -.0379 TD (Hospital,)Tj -19.218 -1.1923 TD [(Novara,)-376.5(Italy;)-380.8(Russell)-377.2(L.)-377.1(Gruen,)-373.7(Medical)-375.6(University)-375.2(of)]TJ T* [(Vienna,)-471.8(Austria;)-464.7(Deepak)-469.1(Gupta,)-463.6(All)-470.5(India)-464.5(Institute)-466.8(of)]TJ 0 -1.1869 TD [(Medical)-885.1(Sciences,)-883.1(New)-886.4(Delhi,)-883.1(India;)-882.6(Juanita)-882.2(A.)]TJ 0 -1.1923 TD [(Haagsma,)-409.4(Erasmus)-408.3(Medical)-408.1(Center-University)-403.2(Medical)]TJ T* [(Center,)-306.1(Rotterdam,)-304.9(the)-311.2(Netherlands;)-305(Iain)-303.3(Haitsma,)-306.7(Eras-)]TJ 0 -1.1869 TD [(mus)-285(MC,)-280.1(Rotterdam,)-277.8(the)-284.1(Netherlands;)-283.3(Raimund)-281.3(Helbok,)]TJ 0 -1.1923 TD [(Medical)-559.9(University)-559.5(of)-559.8(Innsbruck,)-553.7(Innsbruck,)-559.1(Austria;)]TJ T* [(Eirik)-359.4(Helseth,)-360(Oslo)-359.7(University)-358.9(Hospital,)-362.1(Oslo,)-359(Norway;)]TJ 0 -1.1869 TD [(Lindsay)-545(Horton,)-543.7(University)-543.2(of)-538.2(ϲ,)-545.5(ϲ,)-540.1(UK;)]TJ 0 -1.1923 TD [(Jilske)-788.5(Huijben,)-782.8(Erasmus)-782.3(Medical)-782.1(Center-University)]TJ T* [(Medical)-522(Center,)-517.4(Rotterdam,)-521.7(the)-517.1(Netherlands;)-521.8(Peter)-519.7(J.)]TJ 0 -1.1869 TD [(Hutchinson,)-389.5(Addenbrookes)-383.8(Hospital)-389.9(and)-384.8(University)-386(of)]TJ 0 -1.1923 TD [(Cambridge,)-476.1(Cambridge,)-470.7(UK;)-472.5(Bram)-472(Jacobs,)-473.2(University)]TJ T* [(of)-559.8(Groningen,)-554.6(University)-554.1(Medical)-554.5(Center)-561.5(Groningen,)]TJ 0 -1.1869 TD [(Groningen,)-267.3(the)-273.2(Netherlands;)-267(Stefan)-269(Jankowski,)-270.7(Shefeld)]TJ 0 -1.1923 TD [(Teaching)-518.4(Hospitals)-514.3(NHS)-515.8(Foundation)-511.7(Trust,)-509.4(Shefeld,)]TJ T* [(UK;)-450.8(Mike)-445(Jarrett,)-446(Quesgen)-448.4(Systems)-446.4(Inc.,)-442(Burlingame,)]TJ 0 -1.1869 TD [(California,)-477.3(USA;)-473.3(Ji-yao)-475.1(Jiang,)-471.4(Shanghai)-473.2(Renji)-475.2(Hospi-)]TJ 0 -1.1923 TD [(tal,)-469.8(Shanghai)-462.3(Jiaotong)-464.7(University/Sch)6.6(ool)-464.1(of)-467.7(Medicine,)]TJ T* [(Shanghai,)-337(China;)-332.9(Faye)-335.6(Johnson,)-333.3(Salford)-332.8(Royal)-337.5(Hospital)]TJ 0 -1.1869 TD [(NHS)-266.5(Foundation)-262.4(Trust,)-260.1(Salford,)-261.7(UK;)-266.6(Kelly)-260.6(Jones,)-264.5(Auck-)]TJ 0 -1.1923 TD [(land)-250.1(University)-250.6(of)-245.5(Technology,)-245.1(Auckland,)-252.3(New)-246.9(Zealand;)]TJ T* [(Mladen)-213.4(Karan,)-215.3(University)-212.6(of)-213(Novi)-217.6(Sad,)-212.9(Novi)-212.2(Sad,)-212.9(Serbia;)]TJ 0 -1.1869 TD [(Angelos)-267.6(G.)-262.2(Kolias,)-265.1(Addenbrookes)-259.2(Hospital)-265.2(and)-265.6(Univer-)]TJ 0 -1.1923 TD [(sity)-433.6(of)-429.8(Cambridge,)-427.3(Cambridge,)-432.7(UK;)-429.2(Erwin)-431.8(Kompanje,)]TJ T* [(Erasmus)-473.3(Medical)-478.6(Center,)-468.6(Rotterdam,)-472.9(the)-473.7(Netherlands;)]TJ 0 -1.1869 TD [(Daniel)-361(Kondziella,)-355.7(Region)-357.7(Hovedstaden)-357.1(Rigshospitalet,)]TJ 0 -1.1923 TD [(Copenhagen,)-254.7(Denmark;)-252.8(Evgenios)-251(Koraropoulos,)-252.4(Univer-)]TJ T* [(sity)-276.4(of)-272.6(Cambridge,)-270.1(Addenbrookes)-275.4(Hospital,)-269.9(Cambridge,)]TJ 0 -1.1869 TD [(UK;)-255.7(Lars-Owe)-248.5(Koskinen,)-249.2(Umea)]TJ 12.5572 .0325 TD ()Tj .6341 -.0325 TD [(University,)-249.9(Umea)]TJ 6.7312 .0325 TD ()Tj .3848 -.0325 TD [(,)-254(Swe-)]TJ -20.3073 -1.1923 TD [(den;)-309.8(Noe)]TJ 3.3168 .0434 TD ()Tj .3848 -.0434 TD [(mi)-309.2(Kova)]TJ 3.1488 .0434 TD ()Tj .3848 -.0434 TD [(cs,)-310.8(University)-310.2(of)-305.1(Pe)]TJ 7.6796 .0434 TD ()Tj .3848 -.0434 TD [(cs,)-310.8(Pe)]TJ 2.0053 .0434 TD ()Tj .3848 -.0434 TD [(cs,)-310.8(Hungary;)]TJ -17.6896 -1.1923 TD [(Ana)-443.2(Kowark,)-446.9(University)-440.2(Hospital)-444(of)-440.6(Aachen,)-441.3(Aachen,)]TJ 0 -1.1869 TD [(Germany;)-507.5(Alfonso)-506.2(Lagares,)-506.2(Hospital)-509.1(Universitario)-506.5(12)]TJ ET 145.701 747.156 406.488 .51025 re f BT /F4 1 Tf 9.9626 0 0 9.9626 62.022 754.3557 Tm (3326)Tj 42.2865 0 TD [(MIKOLIC)-311.3(ET)-299.4(AL.)]TJ ET endstream endobj 122 0 obj <>stream BAHAEG+AdvP41CBCA wy3E AdvP41CBCAb9؅AV8_bE{?xXt3&wp`M:7K[& endstream endobj 125 0 obj <>stream /GS1 gs BT /F7 1 Tf 10.4607 0 0 10.4607 59.7543 722.0974 Tm 0 0 0 rg 0 Tc 0 Tw [(de)-440.4(Octubre,)-442.3(Madrid,)-435.1(Spain;)-441.4(Linda)-438.2(Lanyon,)-439.3(Karolinska)]TJ 0 -1.1869 TD [(Institutet,)-336.8(Stockholm,)-339.8(Sweden;)-332.4(Steven)-340.5(Laureys,)-339.4(Univer-)]TJ 0 -1.1923 TD [(sity)-357.7(of)-359.3(Lie)]TJ 3.9509 .0434 TD (`)Tj .3902 -.0434 TD [(ge,)-353(Lie)]TJ 2.5093 .0434 TD (`)Tj .3848 -.0434 TD [(ge,)-358.4(Belgium;)-354.8(Fiona)-353.9(Lecky,)-358.2(University)]TJ -7.2352 -1.1923 TD [(of)-316(Shefeld,)-311.1(Shefeld,)-311.1(UK,)-313.8(and)-308.9(Salford)-311.2(Royal)-315.8(Hospital,)]TJ 0 -1.1869 TD [(Salford)-311.2(UK;)-315.3(Didier)-312.4(Ledoux,)-309.3(University)-315.6(of)-310.5(Lie)]TJ 18.4267 .0379 TD (`)Tj .3848 -.0379 TD [(ge,)-309.6(Lie)]TJ 2.4659 .0379 TD (`)Tj .3848 -.0379 TD (ge,)Tj -21.6622 -1.1923 TD [(Belgium;)-577(Rolf)-577.5(Lefering,)-576.5(Witten/Herdecke)-573.2(University,)]TJ T* [(Cologne,)-745.8(Germany;)-746(Valerie)-747.6(Legrand,)-744.7(ICON,)-745.6(Paris,)]TJ 0 -1.1869 TD [(France;)-721.7(Aurelie)-716.2(Lejeune,)-714.2(Lille)-719.1(University)-716.6(Hospital,)]TJ 0 -1.1923 TD [(Lille,)-620.8(France;)-618.7(Leon)-616.3(Levi,)-617.8(Rambam)-616.1(Medical)-619.5(Center,)]TJ T* [(Haifa,)-678.2(Israel;)-679.7(Roger)-675.7(Lightfoot,)-675(University)-678.7(Hospitals)]TJ 0 -1.1869 TD [(Southhampton)-450.1(NHS)-450.8(Trust,)-449.8(Southhampton,)-444(UK;)-450.8(Hester)]TJ 0 -1.1923 TD [(Lingsma,)-463.8(Erasmus)-462.5(Medical)-456.9(Center-University)-462.8(Medical)]TJ 0 -1.1869 TD [(Center,)-333.2(Rotterdam,)-326.6(the)-327.4(Netherlands;)-326.7(Andrew)-328.4(I.R.)-327.4(Maas,)]TJ 0 -1.1923 TD [(Antwerp)-247.9(University)-250.6(Hospital)-248.9(and)-249.3(University)-245.1(of)-250.9(Antwerp,)]TJ T* [(Edegem,)-590.7(Belgium;)-593.2(Marc)-592.4(Maegele,)-593.7(Cologne-Merheim)]TJ 0 -1.1869 TD [(Medical)-386.5(Center)-388.1(\(CMMC\),)-388.1(Witten/Herdecke)-383.5(University,)]TJ 0 -1.1923 TD [(Cologne,)-393.6(Germany;)-393.7(Marek)-395.9(Majdan,)-391.6(Trnava)-394.5(University,)]TJ T* [(Trnava,)-518.4(Slovakia;)-514.1(Alex)-514.5(Manara,)-511.8(Southmead)-515.9(Hospital,)]TJ 0 -1.1869 TD [(Bristol,)-534.9(Bristol,)-534.9(UK;)-537.5(Geoffrey)-535(Manley,)-532.5(University)-532.4(of)]TJ 0 -1.1923 TD [(California,)-531.5(San)-522.5(Francisco,)-529.7(California,)-526.1(USA;)-527.5(Costanza)]TJ T* [(Martino,)-501(M.)-501.7(Bufalini)-499.3(Hospital,)-497.5(Cesena,)-499.9(Italy;)-500.1(Hugues)]TJ 0 -1.1869 TD (Mare)Tj 1.7289 .0379 TD ()Tj .3848 -.0379 TD [(chal,)-215.7(CHR)-215.4(Citadelle,)-216.2(Lie)]TJ 9.4626 .0379 TD (`)Tj .3848 -.0379 TD [(ge,)-217.5(Belgium;)-213.9(Julia)-214.2(Mattern,)]TJ -11.9611 -1.1923 TD [(University)-456.5(Hospital)-454.9(Heidelberg,)-460.8(Heidelberg,)-455.4(Germany;)]TJ T* [(Catherine)-341.5(McMahon,)-339(The)-335.9(Walton)-339.1(Centre)-339.3(NHS)-337(Founda-)]TJ 0 -1.1869 TD [(tion)-399.9(Trust,)-401(Liverpool,)-400.6(UK;)-396.6(Be)]TJ 12.1779 .0379 TD ()Tj .3848 -.0379 TD [(la)-399.3(Melegh,)-402.4(University)-396.9(of)]TJ -12.5627 -1.1923 TD (Pe)Tj .6178 .0434 TD ()Tj .3848 -.0434 TD [(cs,)-722.7(Pe)]TJ 2.4171 .0434 TD ()Tj .3848 -.0434 TD [(cs,)-722.7(Hungary;)-719.2(David)-724.5(Menon,)-717.1(University)-722.1(of)]TJ -3.8046 -1.1923 TD [(Cambridge,)-481.5(Addenbrookes)-481.4(Hospital,)-481.3(Cambridge,)-481.5(UK;)]TJ 0 -1.1869 TD [(Tomas)-622.3(Menovsky,)-616.5(Antwerp)-621.9(University)-619.1(Hospital)-622.9(and)]TJ 0 -1.1923 TD [(University)-283.1(of)-283.4(Antwerp,)-279.7(Edegem,)-281.8(Belgium;)-278.9(Ana)-280.6(Mikolic,)]TJ T* [(Erasmus)-673.9(Medical)-668.3(Center-University)-668.7(Medical)-668.3(Center,)]TJ 0 -1.1869 TD [(Rotterdam,)-445.8(the)-441.2(Netherlands;)-440.5(Benoit)-441.3(Misset,)-440.7(University)]TJ 0 -1.1923 TD [(of)-288.9(Lie)]TJ 2.0811 .0434 TD (`)Tj .3848 -.0434 TD [(ge,)-288(Lie)]TJ 2.4442 .0434 TD (`)Tj .3848 -.0434 TD [(ge,)-288(Belgium;)-289.7(Visakh)-285.2(Muraleedharan,)-289.4(Karo-)]TJ -5.295 -1.1923 TD [(linska)-359.1(Institutet,)-358.5(Stockholm,)-356.1(Sweden;)-359.5(Lynnette)-359.2(Murray,)]TJ 0 -1.1869 TD [(Monash)-761(University,)-753.9(Melbourne,)-754.9(Victoria,)-759.7(Australia;)]TJ 0 -1.1923 TD [(Ancuta)-402.1(Negru,)-395.3(Emergency)-400.7(County)-396.9(Hospital)-395.3(Timisoara,)]TJ T* [(Timisoara,)-368.9(Romania;)-362.2(David)-366.8(Nelson,)-360.4(Karolinska)-366.4(Institu-)]TJ 0 -1.1869 TD [(tet,)-242.2(Stockholm,)-231.4(Sweden;)-240.3(Virginia)-235.9(Newcombe,)-237.6(University)]TJ 0 -1.1923 TD [(of)-223.8(Cambridge,)-216(Addenbrookes)-215.8(Hospital,)-221.1(Cambridge,)-216(UK;)]TJ T* [(Daan)-229.3(Nieboer,)-231(Erasmus)-224(Medical)-229.3(Center-University)-229.7(Med-)]TJ 0 -1.1869 TD [(ical)-310.8(Center,)-306.1(Rotterdam,)-304.9(the)-305.7(Netherlands;)-305(Jo)]TJ 17.2127 .0379 TD ()Tj .4173 -.0379 TD [(zsef)-306.5(Nyira)]TJ 3.8154 .0379 TD ()Tj .3848 -.0379 TD (di,)Tj -21.8302 -1.1923 TD [(University)-424(of)-424.3(Pe)]TJ 6.5198 .0434 TD ()Tj .3848 -.0434 TD [(cs,)-424.6(Pe)]TJ 2.1245 .0434 TD ()Tj .3848 -.0434 TD [(cs,)-424.6(Hungary;)-421.2(Otesile)-422.6(Olubukola,)]TJ -9.4139 -1.1923 TD [(University)-527(of)-527.3(Shefeld,)-522.4(Shefeld,)-527.8(UK;)-526.7(Matej)-526(Oresic,)]TJ 0 -1.1869 TD (O)Tj .2005 .2276 TD ()Tj .5203 -.2276 TD [(rebro)-374.6(University,)-374.5(O)]TJ 7.5333 .2276 TD ()Tj .5203 -.2276 TD [(rebro,)-379.3(Sweden;)-370.4(Fabrizio)-376.8(Ortolano,)]TJ -8.7744 -1.1923 TD [(Fondazione)-723.9(IRCCS)-726.4(Ca)]TJ 9.7336 .0434 TD (`)Tj 1.111 -.0434 TD [(Granda)-729.5(Ospedale)-724.5(Maggiore)]TJ -10.8446 -1.1923 TD [(Policlinico,)-482.5(Milan,)-483.1(Italy;)-483.8(Aarno)-482.8(Palotie,)-483.7(University)-478.2(of)]TJ 0 -1.1869 TD [(Helsinki,)-275.3(Helsinki,)-275.3(Finland,)-276.7(Massachusetts)-273.2(General)-279.3(Hos-)]TJ 0 -1.1923 TD [(pital,)-252.5(Boston,)-245.6(MA,)-249.8(USA,)-249.6(and)-243.9(The)-249.1(Broad)-252.9(Institute)-244.6(of)-250.9(MIT)]TJ T* [(and)-444.4(Harvard,)-444.5(Cambridge,)-443.6(MA,)-439.5(USA;)-446.2(Paul)-442(M.)-442.1(Parizel,)]TJ 0 -1.1869 TD [(University)-689.5(Hospital)-687.9(of)-689.9(Grenoble,)-690.2(Grenoble,)-690.2(France;)]TJ 0 -1.1923 TD (Jean-Franc)Tj 4.0105 0 TD [()-51.8(ois)-432.8(Payen,)-436.5(University)-434.8(Hospital)-433.2(of)-435.2(Grenoble,)]TJ -4.0105 -1.1923 TD [(Grenoble,)-300(France;)-304.3(Natascha)-300.5(Perera,)-301.8(ARTTIC,)-301.2(Munchen,)]TJ 0 -1.1869 TD [(Germany;)-231.1(Vincent)-224.1(Perlbarg,)-232(Assistance)-227.7(Publique)-227.3()-226.2(Hopi-)]TJ 0 -1.1923 TD [(taux)-521.1(de)-521.7(Paris,)-521.4(Paris,)-521.4(France;)-521.1(Paolo)-521.9(Persona,)-515.2(Azienda)]TJ T* [(Ospedaliera)-362.6(Universita)]TJ 8.9369 .0434 TD (`)Tj .7425 -.0434 TD [(di)-357.1(Padova,)-353.8(Padova,)-359.2(Italy;)-359.2(Wilco)]TJ -9.6794 -1.1869 TD [(Peul,)-555.1(Leiden)-554.9(University)-559.5(Medical)-554.5(Center,)-555.4(Leiden,)-554.2(the)]TJ 24.0035 64.282 TD [(Netherlands)-867.8(and)-867.2(Medical)-868.8(Center)-870.4(Haaglanden,)-870.3(the)]TJ 0 -1.1869 TD [(Hague,)-910(the)-907.3(Netherlands.)-910.5(Anna)-907.9(Piippo-Karjalainen,)]TJ 0 -1.1923 TD [(Helsinki)-243.5(University)-239.7(Central)-242.5(Hospital;)-244.3(Matti)-247.5(Pirinen,)-237.8(Uni-)]TJ T* [(versity)-280.9(of)-278(Helsinki,)-280.8(Helsinki,)-280.8(Finland;)-283.7(Horia)-279(Ples,)-285.3(Emer-)]TJ 0 -1.1869 TD [(gency)-315.8(County)-315.6(Hospital)-314(Timisoara,)-320.1(Timisoara,)-314.7(Romania;)]TJ 0 -1.1923 TD [(Suzanne)-460.3(Polinder,)-464(Erasmus)-462.5(Medical)-467.8(Center-University)]TJ T* [(Medical)-256.4(Center,)-251.9(Rotterdam,)-256.1(the)-257(Netherlands;)-256.2(Inigo)-254.4(Pom-)]TJ 0 -1.1869 TD [(poso,)-374.3(Hospital)-373.6(of)-375.6(Cruces,)-375.5(Bilbao,)-370.1(Spain;)-376.4(Jussi)-372.7(P.)-374(Posti,)]TJ 0 -1.1923 TD [(Turku)-598.8(University)-597.4(Hospital)-595.8(and)-601.6(University)-597.4(of)-597.8(Turku,)]TJ T* [(Turku,)-749.8(Finland;)-755.2(Louis)-749.5(Puybasset,)-755.3(Pitie)]TJ 17.0338 .0434 TD ()Tj 1.1381 -.0434 TD (-Salpe)Tj 2.1733 .0434 TD ()Tj .3848 -.0434 TD (trie)Tj .9593 .0434 TD (`)Tj .3848 -.0434 TD (re)Tj -22.0741 -1.1869 TD [(Teaching)-545.5(Hospital,)-540.9(Assistance)-547.4(Publique,)-540.9(Ho)]TJ 18.4429 .0434 TD ()Tj .4119 -.0434 TD [(pitaux)-547.6(de)]TJ -18.8548 -1.1923 TD [(Paris)-240.3(and)-243.9(University)-239.7(Pierre)-246.3(et)-242.1(Marie)-240.9(Curie,)-243.6(Paris,)-239.6(France;)]TJ 0 -1.1869 TD [(Andreea)-228.3(Radoi,)-228.4(Vall)-229.5(dHebron)-228.3(Research)-235.5(Institute,)-227.6(Barce-)]TJ 10.4607 0 0 10.4607 310.8472 560.2393 Tm [(lona,)-379.5(Spain;)-381.8(Arminas)-381.2(Ragauskas,)-383.1(Kaunas)-379.4(University)-380.6(of)]TJ 0 -1.1923 TD [(Technology)-370.4(and)-379.4(Vilnius)-370.8(University,)-374.5(Vilnius,)-375.5(Lithuania;)]TJ 0 -1.1869 TD [(Rahul)-202(Raj,)-209.5(Helsinki)-205.6(University)-201.8(Central)-204.6(Hospital;)-206.4(Malinka)]TJ 0 -1.1923 TD [(Rambadagalla,)-840.1(Rezekne)-838.3(Hospital,)-839(Latvia;)-834.3(Jonathan)]TJ T* [(Rhodes,)-253(NHS)-255.7(Lothian)-258.8(and)-254.7(University)-256(of)-256.3(Edinburg,)-249.3(Edin-)]TJ 0 -1.1869 TD [(burgh,)-430.3(UK;)-440(Sylvia)-436(Richardson,)-431.7(Cambridge)-433.4(Institute)-439.7(of)]TJ 0 -1.1923 TD [(Public)-306(Health,)-311.5(Cambridge,)-308.1(UK;)-309.9(Sophie)-309.2(Richter,)-306.9(Univer-)]TJ T* [(sity)-271(of)-272.6(Cambridge,)-275.6(Addenbrookes)-270(Hospital,)-269.9(Cambridge,)]TJ 0 -1.1869 TD [(UK;)-494.2(Samuli)-491(Ripatti,)-497.8(University)-494.4(of)-494.8(Helsinki,)-492.1(Helsinki,)]TJ 0 -1.1923 TD [(Finland;)-343.3(Saulius)-349.1(Rocka,)-344.2(Kaunas)-352.3(University)-342.7(of)-348.5(Technol-)]TJ T* [(ogy)-380.6(and)-390.2(Vilnius)-381.6(University,)-385.3(Vilnius,)-386.3(Lithuania;)-382.5(Cecilie)]TJ 0 -1.1869 TD [(Roe,)-315.7(Oslo)-310.9(University)-315.6(Hospital/University)-310.6(of)-316(Oslo,)-315.6(Oslo,)]TJ 0 -1.1923 TD [(Norway;)-497.2(Olav)-503.6(Roise,)-500.5(Oslo)-495.2(University)-499.9(Hospital,)-503(Oslo,)]TJ T* [(Norway;)-459.3(Jonathan)-466.7(Rosand,)-459(The)-465.9(Broad)-464.3(Institute,)-460.6(Cam-)]TJ 0 -1.1869 TD [(bridge)-354.7(MA)-353.5(Harvard)-353.1(Medical)-353.9(School)-352.5(and)-357.7(Massachusetts)]TJ 0 -1.1923 TD [(General)-431(Hospital,)-427.1(Boston)-430.6(MA,)-428.6(USA;)-429.9(Jeffrey)-430.4(V.)-430.3(Rose-)]TJ T* [(nfeld,)-512.6(The)-514.7(Alfred)-520.5(Hospital,)-513.8(Monash)-511.7(University,)-515.4(Mel-)]TJ 0 -1.1869 TD [(bourne,)-1029.3(Victoria,)-1036.1(Australia;)-1032(Christina)-1035.6(Rosenlund,)]TJ 0 -1.1923 TD [(Odense)-601.6(University)-602.8(Hospital,)-605.9(Odense,)-606.3(Denmark;)-599.6(Guy)]TJ T* [(Rosenthal,)-208.7(Hadassah-Hebrew)-208.2(University)-207.2(Medical)-213(Center,)]TJ 0 -1.1869 TD [(Jerusalem,)-361.5(Israel;)-359.9(Rolf)-360.7(Rossaint,)-364.2(University)-358.9(Hospital)-357.3(of)]TJ 0 -1.1923 TD [(Aachen,)-208.3(Aachen,)-213.7(Germany;)-209.4(Sandra)-207.2(Rossi,)-210.3(Azienda)-215.2(Ospe-)]TJ T* [(daliera)-662.1(Universita)]TJ 7.1864 .0434 TD (`)Tj 1.0514 -.0434 TD [(di)-660.6(Padova,)-662.7(Padova,)-662.7(Italy;)-662.7(Daniel)]TJ -8.2378 -1.1869 TD [(Rueckert,)-215.3(Imperial)-217.3(College)-211(London,)-218.3(London,)-212.9(UK;)-212.4(Martin)]TJ 0 -1.1923 TD (Rusna)Tj 2.1136 .0434 TD ()Tj .3848 -.0434 TD [(k,)-393.5(ϲ)-391.5(Neurotrauma)-392.7(Research)-392.7(Organisa-)]TJ -2.4984 -1.1923 TD [(tion,)-448(Vienna,)-450.2(Austria;)-448.5(Juan)-449.6(Sahuquillo,)-448.2(Vall)-446.2(dHebron)]TJ 0 -1.1869 TD [(Research)-446.9(Institute,)-444.4(Barcelona,)-445.8(Spain;)-446.9(Oliver)-447.9(Sakowitz,)]TJ 0 -1.1923 TD [(University)-527(Hospital)-525.3(Heidelberg,)-525.9(Heidelberg,)-525.9(Germany)]TJ T* [(and)-379.4(Klinik)-376.4(fu)]TJ 5.1811 .0108 TD ()Tj .4173 -.0108 TD [(r)-377(Neurochirurgie,)-377.3(Klinikum)-379.8(Ludwigsburg,)]TJ -5.5985 -1.1869 TD [(Ludwigsburg,)-413(Germany;)-420.8(Renan)-420.8(Sanchez-Porras,)-420.7(Klinik)]TJ 0 -1.1923 TD (fu)Tj .4173 .0108 TD ()Tj .4119 -.0108 TD [(r)-523.3(Neurochirurgie,)-512.8(Klinikum)-520.8(Ludwigsburg,)-516(Ludwigs-)]TJ -.8292 -1.1923 TD [(burg,)-382.9(Germany;)-388.3(Janos)-389.8(Sandor,)-381.1(University)-386.1(of)-391.8(Debrecen,)]TJ 0 -1.1869 TD [(Debrecen,)-479.7(Hungary;)-480.8(Nadine)-483.4(Scha)]TJ 13.7658 .0217 TD ()Tj .3848 -.0217 TD [(fer,)-485.1(Witten/Herdecke)]TJ -14.1506 -1.1923 TD [(University,)-390.8(Cologne,)-393.6(Germany;)-393.7(Silke)-394.1(Schmidt,)-391.4(Univer-)]TJ T* [(sity)-206(Greifswald,)-206.3(Greifswald,)-206.3(Germany;)-209.4(Herbert)-203.6(Schoechl,)]TJ 0 -1.1869 TD [(AUVA)-813.3(Trauma)-818(Hospital,)-817.3(Salzburg,)-812.9(Austria;)-817(Guus)]TJ 0 -1.1923 TD [(Schoonman,)-220.3(Elisabeth-Twee)-224.7(Steden)-226.7(Ziekenhuis,)-221.4(Tilburg,)]TJ T* [(the)-208.2(Netherlands;)-207.4(Rico)-208.8(Frederik)-211(Schou,)-204.7(Odense)-211.4(University)]TJ 0 -1.1869 TD [(Hospital,)-351.2(Odense,)-357(Denmark;)-355.7(Elisabeth)-350.4(Schwendenwein,)]TJ 0 -1.1923 TD [(Medical)-576.1(University)-570.3(Vienna,)-574.8(Vienna,)-574.8(Austria;)-578.5(Charlie)]TJ T* [(Sewalt,)-655.1(Erasmus)-657.6(Medical)-657.4(Center-University)-652.5(Medical)]TJ 0 -1.1869 TD [(Center,)-598.7(Rotterdam,)-603(the)-603.8(Netherlands;)-603.1(Toril)-603.2(Skandsen,)]TJ ET 59.754 747.156 406.488 .51025 re f BT /F4 1 Tf 9.9626 0 0 9.9626 59.7543 753.8455 Tm [(MED)-10.3(IATORS)-307.4(OF)-302.7(SEX)-302.9(DIFFE)-10.3(RENCES)-305.4(IN)-306.7(MTBI)-302.7(OUT)-8.8(COMES)-22532.3(3327)]TJ ET endstream endobj 129 0 obj <>stream /GS1 gs BT /F7 1 Tf 10.4607 0 0 10.4607 62.022 722.0974 Tm 0 0 0 rg 0 Tc 0 Tw [(Norwegian)-747.9(University)-749.2(of)-749.5(Science)-754(and)-747.9(Technology,)]TJ 0 -1.1869 TD [(NTNU)-483.7(and)-487.8(St.)-483.3(Olavs)-481.8(Hospital,)-486.7(Trondheim)-481.2(University)]TJ 0 -1.1923 TD [(Hospital,)-437.9(Trondheim,)-437.2(Norway;)-443(Peter)-438.4(Smielewski,)-442.4(Uni-)]TJ T* [(versity)-513.9(of)-511.1(Cambridge,)-514(Addenbrookes)-508.5(Hospital,)-513.8(Cam-)]TJ 0 -1.1869 TD [(bridge,)-635.8(UK;)-640.5(Abayomi)-635.7(Sorinola,)-632(University)-635.3(of)-641.1(Pe)]TJ 21.3912 .0379 TD ()Tj .3848 -.0379 TD (cs,)Tj -21.776 -1.1923 TD (Pe)Tj .6124 .0434 TD ()Tj .3848 -.0434 TD [(cs,)-592.7(Hungary;)-583.7(Emmanuel)-586.2(Stamatakis,)-588.7(University)-586.6(of)]TJ -.9972 -1.1923 TD [(Cambridge,)-481.5(Addenbrookes)-481.4(Hospital,)-481.3(Cambridge,)-481.5(UK;)]TJ 0 -1.1869 TD [(Simon)-599.8(Stanworth,)-602.3(Oxford)-600.8(University)-602.8(Hospitals)-601(NHS)]TJ 0 -1.1923 TD [(Trust,)-298(Oxford,)-291.2(UK;)-299.1(Robert)-297.1(Stevens,)-296.2(Johns)-293.5(Hopkins)-295.9(Uni-)]TJ T* [(versity)-302.5(School)-298.3(of)-299.7(Medicine,)-297.6(Baltimore,)-301.7(Maryland,)-301(USA;)]TJ 0 -1.1869 TD [(William)-445.9(Stewart,)-441.3(Queen)-444.6(Elizabeth)-445.5(University)-445.7(Hospital)]TJ 0 -1.1923 TD [(and)-460.7(University)-461.9(of)-462.3(Glasgow,)-460.8(Glasgow,)-460.8(UK;)-461.7(Ewout)-459.9(W.)]TJ 0 -1.1869 TD [(Steyerberg,)-255.1(Erasmus)-251.1(Medical)-256.4(Center-University)-251.4(Medical)]TJ 0 -1.1923 TD [(Center,)-338.6(Rotterdam,)-337.4(the)-338.3(Netherlands)-342.1(and)-336(Leiden)-338.1(Univer-)]TJ T* [(sity)-243.9(Medical)-240.1(Center,)-246.4(Leiden,)-239.8(the)-246.1(Netherlands;)-239.9(Nino)-244.7(Stoc-)]TJ 0 -1.1869 TD [(chetti,)-564.2(Milan)-565.1(University,)-564.2(and)-563.7(Fondazione)-561.3(IRCCS)-563.8(Ca)]TJ 22.4751 .0379 TD (`)Tj -22.4751 -1.2303 TD [(Granda)-485.6(Ospedale)-486(Maggiore)-486(Policlinico,)-482.5(Milano,)-487.1(Italy;)]TJ 0 -1.1923 TD [(Nina)-677.1(Sundstro)]TJ 5.7556 .0217 TD ()Tj .4173 -.0217 TD [(m,)-670.7(Umea)]TJ 3.7124 .0325 TD ()Tj 1.0568 -.0325 TD [(University,)-678(Umea)]TJ 7.1593 .0325 TD ()Tj .3848 -.0325 TD [(,)-676.8(Sweden;)]TJ -18.4863 -1.1869 TD [(Anneliese)-302.6(Synnot,)-298.8(Monash)-294.9(University,)-298.6(Melbourne,)-299.6(Aus-)]TJ 0 -1.1923 TD [(tralia)-471.8(and)-466.1(La)-472.7(Trobe)-467.5(University,)-466.6(Melbourne,)-467.6(Australia;)]TJ T* [(Riikka)-246.1(Takala,)-244.1(Turku)-241.1(University)-239.7(Hospital)-243.5(and)-243.9(University)]TJ 0 -1.1869 TD [(of)-283.4(Turku,)-278.3(Turku,)-278.3(Finland;)-283.7(Vikto)]TJ 12.5518 .0379 TD ()Tj .4173 -.0379 TD [(ria)-283.1(Tama)]TJ 3.2463 .0379 TD ()Tj .3848 -.0379 TD [(s,)-286.3(University)-277.7(of)]TJ -16.6003 -1.1923 TD (Pe)Tj .6124 .0434 TD ()Tj .3848 -.0434 TD [(cs,)-235(Pe)]TJ 1.9294 .0434 TD ()Tj .3848 -.0434 TD [(cs,)-229.5(Hungary;)-226.1(Tomas)-232.1(Tamosuitis,)-226.8(Kaunas)-233.1(Univer-)]TJ -3.3114 -1.1923 TD [(sity)-271(of)-267.2(Health)-268.8(Sciences,)-265.3(Kaunas,)-270.3(Lithuania;)-268.7(Mark)-268.4(Steven)]TJ 0 -1.1869 TD [(Taylor,)-299.6(Trnava)-296.9(University,)-293.2(Trnava,)-296.2(Slovakia;)-297.3(Braden)-299.1(Te)]TJ 0 -1.1923 TD [(Ao,)-228.3(Auckland)-231.3(University)-228.9(of)-229.2(Technology,)-223.4(Auckland,)-230.6(New)]TJ T* [(Zealand;)-412.2(Olli)-406.3(Tenovuo,)-410.8(Turku)-409.1(University)-407.7(Hospital)-411.5(and)]TJ 0 -1.1869 TD [(University)-472.8(of)-478.5(Turku,)-473.4(Turku,)-473.4(Finland;)-473.4(Alice)-476.2(Theadom,)]TJ 0 -1.1923 TD [(Auckland)-567.3(University)-570.3(of)-565.3(Technology,)-570.2(Auckland,)-566.6(New)]TJ T* [(Zealand;)-569.3(Matt)-571.9(Thomas,)-566(Southmead)-564.7(Hospital,)-568(Bristol,)]TJ 0 -1.1869 TD [(Bristol,)-529.5(UK;)-532.1(Dick)-530.7(Tibboel,)-534.5(Erasmus)-527.5(Medical)-532.8(Center,)]TJ 0 -1.1923 TD [(Sophia)-276.6(Childrens)-272.2(Hospital,)-275.3(Rotterdam,)-272.4(the)-278.6(Netherlands;)]TJ T* [(Marjolein)-505.3(Timmers,)-507(Erasmus)-505.9(Medical)-505.7(Center,)-506.6(Rotter-)]TJ 0 -1.1869 TD [(dam,)-487.9(the)-490(Netherlands;)-489.2(Christos)-489.8(Tolias,)-488.3(Kings)-488.4(College)]TJ 0 -1.1923 TD [(London,)-207.5(London,)-202.1(UK;)-206.9(Tony)-205.6(Trapani,)-204.9(Monash)-208.2(University,)]TJ T* [(Melbourne,)-402.6(Victoria,)-402(Australia;)-403.3(Cristina)-402.9(Maria)-403.5(Tudora,)]TJ 0 -1.1869 TD [(Emergency)-828.9(County)-825(Hospital)-828.8(Timisoara,)-829.6(Timisoara,)]TJ 0 -1.1923 TD [(Romania;)-253.8(Peter)-254.2(Vajkoczy,)-256.5(Charite)]TJ 13.3864 .0434 TD ()Tj .6395 -.0434 TD [()-258.7(Universita)]TJ 4.5471 .0217 TD ()Tj .3848 -.0217 TD (tsmedizin)Tj -18.9578 -1.1923 TD [(Berlin,)-260.7(Berlin,)-266.1(Germany;)-258.2(Shirley)-265.6(Vallance,)-262.9(Monash)-262.4(Uni-)]TJ 0 -1.1869 TD [(versity,)-421.1(Melbourne,)-413.4(Victoria,)-423.7(Australia;)-419.6(Egils)-415.7(Valeinis,)]TJ 0 -1.1923 TD [(Pauls)-230.4(Stradins)-222(Clinical)-230.3(University)-228.9(Hospital,)-226.6(Riga,)-229.8(Latvia;)]TJ T* (Zolta)Tj 1.7397 .0434 TD ()Tj .3848 -.0434 TD .6923 Tc [(nV)692.3(a)]TJ 1.9727 .0434 TD 0 Tc ()Tj .3848 -.0434 TD [(mos,)-690.8(University)-689.5(of)-695.3(Pe)]TJ 9.6632 .0434 TD ()Tj .3848 -.0434 TD [(cs,)-695.6(Pe)]TJ 2.39 .0434 TD ()Tj .3848 -.0434 TD [(cs,)-690.2(Hungary;)]TJ -17.3048 -1.1869 TD [(Mathieu)-241.3(van)-238.5(der)-237.5(Jagt,)-239.8(Erasmus)-240.3(MC)-242.9()-237.1(University)-239.7(Medical)]TJ 0 -1.1923 TD [(Center)-306.8(Rotterdam,)-304.9(Rotterdam,)-310.3(the)-305.7(Netherlands;)-305(Gregory)]TJ T* [(Van)-253.5(der)-253.7(Steen,)-249(Antwerp)-253.3(University)-250.6(Hospital)-248.9(and)-254.7(Univer-)]TJ 0 -1.1869 TD [(sity)-222.2(of)-223.8(Antwerp,)-225.5(Edegem,)-222.2(Belgium;)-224.7(Joukje)-221.4(van)-227.6(der)-221.2(Naalt,)]TJ 0 -1.1923 TD [(University)-613.7(of)-619.4(Groningen,)-614.2(University)-613.7(Medical)-619.5(Center)]TJ T* [(Groningen,)-440.7(Groningen,)-440.7(the)-441.2(Netherlands;)-440.5(Jeroen)-444.6(T.J.M.)]TJ 0 -1.1869 TD [(van)-444.4(Dijck,)-444.1(Leiden)-446.5(University)-440.2(Medical)-446.1(Center,)-447(Leiden,)]TJ 0 -1.1923 TD [(the)-522.5(Netherlands)-515.5(and)-520.3(Medical)-516.5(Center)-523.5(Haaglanden,)-518(the)]TJ T* [(Hague,)-378.9(the)-376.2(Netherlands;)-375.4(Thomas)-377(A.)-376.1(van)-374(Essen,)-378.1(Leiden)]TJ 0 -1.1869 TD [(University)-310.2(Medical)-310.6(Center,)-311.5(Leiden,)-310.3(the)-311.2(Netherlands)-315(and)]TJ 0 -1.1923 TD [(Medical)-240.1(Center)-236.3(Haaglanden,)-236.2(the)-235.3(Hague,)-238(the)-235.3(Netherlands;)]TJ T* [(Wim)-278.1(Van)-280.6(Hecke,)-280.1(icoMetrix)-283.1(NV,)-281.3(Leuven,)-275.6(Belgium;)-278.9(Car-)]TJ 0 -1.1869 TD [(oline)-321.4(van)-325.2(Heugten,)-324.1(Oxford)-319(Brookes)-321.8(University,)-320.3(Oxford,)]TJ 23.998 64.282 TD [(UK;)-337(Dominique)-331.7(Van)-334.8(Praag,)-332.5(Antwerp)-334.6(University)-331.9(Hospi-)]TJ 0 -1.1869 TD [(tal,)-421.1(Edegem,)-417.3(Belgium;)-414.4(Thijs)-415.7(Vande)-417.5(Vyvere,)-414.4(icoMetrix)]TJ 0 -1.1923 TD [(NV,)-319.2(Leuven,)-313.5(Belgium;)-311.4(Roel)-317.2(P.J.)-313.5(van)-314.4(Wijk,)-315.3(Leiden)-316.4(Uni-)]TJ T* [(versity)-562.7(Medical)-559.9(Center,)-560.8(Leiden,)-565(the)-560.5(Netherlands)-558.9(and)]TJ 0 -1.1869 TD [(Medical)-240.1(Center)-236.3(Haaglanden,)-236.2(the)-235.3(Hague,)-238(the)-235.3(Netherlands;)]TJ 0 -1.1923 TD [(Alessia)-253.5(Vargiolu,)-249.2(ASST)-252.1(di)-248.7(Monza,)-249.8(Monza,)-249.8(Italy;)-250.8(Emma-)]TJ T* [(nuel)-250.1(Vega,)-244.8(Lille)-247.6(University)-245.1(Hospital,)-242.8(Lille,)-246.9(France;)-244.7(Kim-)]TJ 0 -1.1869 TD [(berley)-228.9(Velt,)-223.3(Erasmus)-224(Medical)-223.9(Center-University)-218.9(Medical)]TJ 0 -1.1923 TD [(Center,)-262.7(Rotterdam,)-261.5(the)-262.4(Netherlands;)-261.6(Jan)-255.9(Verheyden,)-262.7(ico-)]TJ T* [(Metrix)-226.7(NV,)-221.7(Leuven,)-221.4(Belgium;)-224.7(Paul)-225.2(M.)-219.9(Vespa,)-222.9(University)]TJ 0 -1.1869 TD [(of)-559.8(California,)-553.2(Los)-555(Angeles,)-558.3(Los)-555(Angeles,)-552.9(California,)]TJ 0 -1.1923 TD [(USA;)-375.7(Anne)-371.4(Vik,)-370(Norwegian)-374(University)-369.8(of)-370.1(Science)-374.6(and)]TJ 0 -1.1869 TD [(Technology,)-337.2(NTNU,)-336.7(Trondheim,)-334.2(Norway)-339.2(and)-336(St.)-336.9(Olavs)]TJ 0 -1.1923 TD [(Hospital,)-551.7(Trondheim)-540.8(University)-548.6(Hospital,)-546.3(Trondheim,)]TJ T* [(Norway;)-237.1(Rimantas)-238.7(Vilcinis,)-234.2(Kaunas)-238.5(University)-234.3(of)-240.1(Health)]TJ 0 -1.1869 TD [(Sciences,)-395.4(Kaunas,)-389.5(Lithuania;)-393.3(Victor)-393.7(Volovici,)-388(Erasmus)]TJ 0 -1.1923 TD [(MC,)-204.2(Ro)11.6(tte)11.8(rda)17.2(m,)-210.1(th)11.4(e)-214.2(N)0(e)10.6(t)0(h)11.4(e)0(r)10.4(lan)14(ds)12.4(;)-212.2(Nic)9.8(ol)11.4(e)-214.2(v)0(o)13.6(n)-210(Ste)11.8(in)11.4(bu)]TJ 20.5458 .0108 TD ()Tj .4065 -.0108 TD [(che)12(l,)]TJ -20.9522 -1.1923 TD [(Uni)14(ver)11.8(si)10.2(ta)]TJ 3.745 .0217 TD ()Tj .3794 -.0217 TD [(ts)10.2(med)15.4(izi)11.8(n)-822.4(G)0(o)]TJ 5.4847 .0217 TD ()Tj .4119 -.0217 TD [(tti)13.8(ng)13.6(en,)-819.1(Go)]TJ 4.6284 .0217 TD ()Tj .4119 -.0217 TD [(tt)14.6(ing)12.8(en,)-813.7(Ge)10.6(rma)11(ny)13.6(;)]TJ -15.0611 -1.1869 TD [(Daphne)-248.1(Voormolen,)-235.6(Erasmus)-245.7(Medical)-245.6(Center-University)]TJ 0 -1.1923 TD [(Medical)-251(Center,)-241(Rotterdam,)-245.3(the)-246.1(Netherlands;)-245.4(Petar)-248.7(Vule-)]TJ T* [(kovic,)-318.5(University)-315.6(of)-321.4(Novi)-315.2(Sad,)-315.9(Novi)-320.6(Sad,)-315.9(Serbia;)-318.6(Kevin)]TJ 0 -1.1869 TD [(K.W.)-317.2(Wang,)-315.1(University)-310.2(of)-315.9(Florida,)-313.7(Gainesville,)-314.3(Florida,)]TJ 0 -1.1923 TD [(USA;)-841.8(Eveline)-837.5(Wiegers,)-837.8(Erasmus)-836.5(Medical)-836.3(Center-)]TJ T* [(University)-321(Medical)-316(Center,)-316.9(Rotterdam,)-315.7(the)-316.6(Netherlands;)]TJ 0 -1.1869 TD [(Guy)-260.1(Williams,)-255.3(University)-256(of)-256.3(Cambridge,)-253.9(Addenbrookes)]TJ 0 -1.1923 TD [(Hospital,)-232(Cambridge,)-226.8(UK;)-223.2(Lindsay)-230.7(Wilson,)-227(University)-223.5(of)]TJ 10.4607 0 0 10.4607 313.0582 398.3243 Tm [(ϲ,)-534.7(ϲ,)-529.3(UK;)-526.7(Stefan)-534.6(Winzeck,)-532.9(University)-527(of)]TJ 0 -1.1869 TD [(Cambridge,)-481.5(Addenbrookes)-481.4(Hospital,)-481.3(Cambridge,)-481.5(UK;)]TJ 0 -1.1923 TD [(Stefan)-323.2(Wolf,)-317.5(Charite)]TJ 8.0806 .0434 TD ()Tj .7046 -.0434 TD [()-323.8(Universita)]TJ 4.6121 .0217 TD ()Tj .3848 -.0217 TD [(tsmedizin)-318.8(Berlin,)-314.9(Ber-)]TJ -13.7821 -1.1923 TD [(lin,)-281.4(Germany;)-285.3(Zhihui)-277.7(Yang,)-283.9(University)-277.6(of)-283.4(Florida,)-281.2(Gain-)]TJ 0 -1.1869 TD [(esville,)-737.4(Florida,)-731(USA;)-733.4(Peter)-736.5(Yle)]TJ 14.3457 .0379 TD ()Tj .3848 -.0379 TD [(n,)-735(VTT)-731.3(Technical)]TJ -14.7305 -1.1923 TD [(Research)-365.6(Centre,)-354.8(Tampere,)-359.5(Finland;)-359.6(Alexander)-357.8(Younsi,)]TJ T* [(University)-456.5(Hospital)-460.3(Heidelberg,)-455.4(Heidelberg,)-455.4(Germany;)]TJ 0 -1.1869 TD [(Frederick)-441.5(A.)-441.1(Zeiler,)-441.6(University)-434.8(of)-440.6(Cambridge,)-438.2(Adden-)]TJ 0 -1.1923 TD [(brookes)-512.5(Hospital,)-513.8(Cambridge,)-508.6(UK)-515(and)-509.5(University)-510.7(of)]TJ T* [(Manitoba,)-288(Winnipeg,)-281.4(MB,)-285.5(Canada;)-288.9(Veronika)-284.5(Zelinkova,)]TJ 0 -1.1869 TD [(Trnava)-627.5(University,)-618.4(Trnava,)-626.8(Slovakia;)-622.5(Agate)-620.3(Ziverte,)]TJ 0 -1.1923 TD [(Pauls)-230.4(Stradins)-227.5(Clinical)-230.3(University)-223.5(Hospital,)-226.6(Riga,)-229.8(Latvia;)]TJ T* [(and)-487.8(Tommaso)-484.8(Zoerle,)-488.1(Fondazione)-485.4(IRCCS)-482.6(Ca)]TJ 19.0445 .0434 TD (`)Tj .8671 -.0434 TD (Granda)Tj -19.9117 -1.1869 TD [(Ospedale)-301.7(Maggiore)-301.7(Policlinico,)-298.3(Milan,)-298.8(Italy.)]TJ /F4 1 Tf 0 -2.9916 TD [(Funding)-301.1(Information)]TJ /F7 1 Tf 0 -1.2032 TD [(This)-290.3(study)-283.6(was)-292.7(supported)-281.3(by)-289.9(The)-287.1(Netherlands)-287.9(Organiza-)]TJ 0 -1.1869 TD [(tion)-470.3(for)-465.3(Health)-469.3(Research)-468.5(and)-466.1(Development)-467.4(\(ZonMw\).)]TJ 0 -1.1923 TD [(The)-541.8(authors)-538.8(A.)-538.6(Mikolic,)-536.7(S.)-536.6(Polinder,)-539.9(L.)-539.7(Wilson)-536.6(and)]TJ T* [(M.)-458.4(Zeldovich)-455.3(were)-461.3(supported)-454.7(by)-452.5(the)-457.5(European)-456.7(Union)]TJ 0 -1.1869 TD [(7th)-453.3(Framework)-450.9(Programme)-447.5(\(EC)-451.9(grant)-453.7(602150\).)-449.2(Addi-)]TJ 0 -1.1923 TD [(tional)-463.1(support)-458.7(was)-460.7(obtained)-456.9(from)-459.3(the)-457.5(Hannelore)-460.7(Kohl)]TJ 0 -1.1869 TD [(Stiftung)-235.1(\(Germany\),)-235.6(OneMind)-233.7(\(USA\),)-239.3(Integra)-237.3(LifeScien-)]TJ 0 -1.1923 TD [(ces)-720.8(Corporation)-719.5(\(USA\),)-716.3(and)-720.8(Neurotrauma)-717.9(Sciences)]TJ T* (\(USA\).)Tj /F4 1 Tf 0 -2.9374 TD [(Author)-303.3(Disclosure)-299.8(Statement)]TJ /F7 1 Tf 0 -1.2032 TD [(No)-299.5(competing)-299.2(nancial)-300.8(interests)-301.9(exist.)]TJ ET 145.701 747.156 406.488 .51025 re f BT /F4 1 Tf 9.9626 0 0 9.9626 62.022 754.3557 Tm (3328)Tj 42.2865 0 TD [(MIKOLIC)-311.3(ET)-299.4(AL.)]TJ ET endstream endobj 133 0 obj <>stream /GS1 gs BT /F4 1 Tf 10.4607 0 0 10.4607 59.7543 722.0974 Tm 0 0 0 rg 0 Tc 0 Tw [(Supplementary)-300.9(Material)]TJ /F3 1 Tf 7.4718 0 0 7.4718 59.7543 712.1761 Tm [(Supplemen)-12.3(tary)-305.9(Table)-298.1(S1)]TJ 0 -1.1988 TD [(Supplemen)-12.3(tary)-305.9(Table)-298.1(S2)]TJ 0 -1.2064 TD [(Supplemen)-12.3(tary)-305.9(Table)-298.1(S3)]TJ 0 -1.1988 TD [(Supplemen)-12.3(tary)-305.9(Figure)-298.3(S1)]TJ T* [(Supplemen)-12.3(tary)-305.9(Figure)-298.3(S2)]TJ T* [(Supplemen)-12.3(tary)-305.9(Figure)-298.3(S3)]TJ T* [(Supplemen)-12.3(tary)-305.9(Figure)-298.3(S4)]TJ T* [(Supplemen)-12.3(tary)-305.9(Figure)-298.3(S5)]TJ 0 -1.2064 TD [(Supplemen)-12.3(tary)-305.9(Figure)-298.3(S6)]TJ 0 -1.1988 TD [(Supplemen)-12.3(tary)-305.9(Figure)-298.3(S7)]TJ T* [(Supplemen)-12.3(tary)-305.9(Figure)-298.3(S8)]TJ T* [(Supplemen)-12.3(tary)-305.9(Figure)-298.3(S9)]TJ T* [(Supplemen)-12.3(tary)-305.9(Figure)-298.3(S10)]TJ T* [(Supplemen)-12.3(tary)-305.9(Figure)-298.3(S11)]TJ T* [(Supplemen)-12.3(tary)-305.9(Figure)-298.3(S12)]TJ /F4 1 Tf 10.4607 0 0 10.4607 59.7543 563.7542 Tm (References)Tj /F3 1 Tf 7.4718 0 0 7.4718 63.496 553.7762 Tm [(1.)-507(Maas,)-303.7(A.I.R.,)-306.4(Menon,)-300.8(D.K)-9.7(.,)-296.5(Adelson,)-312.5(P.D.,)-301(Andelic,)-306.9(N.,)-300.6(Bell,)-307.2(M.J.,)-306.9(Belli,)-305.8(A.,)]TJ 1.214 -1.1988 TD [(Bragge,)-294.2(P.,)-289(Brazinova,)-291.5(A.,)-291.9(Buki,)-292.7(A.,)-284.3(Chesnut,)-299.4(R.M.,)-291.6(Citerio,)-290(G.,)-288.8(Cobur)-11.5(n,)-282.9(M.,)]TJ T* [(Cooper,)-308.5(D.J.,)-301.1(Crowder,)-306.9(A.T.,)-311.6(Czeiter,)-307.5(E.,)-300.7(Czosnyka,)-309.5(M.,)-306.4(Diaz-Arrastia,)-309.5(R.,)]TJ T* [(Dreier,)-233.2(J.P.,)-236.4(Duhaime,)-239.4(A.C.,)-236.2(Ercole,)-234.2(A.,)-238.8(van)-227.6(Essen,)-233.9(T.A.,)-235.7(Feigin)-8.5(,)-227.9(V.L.,)-240.4(Gao,)-232.2(G.,)]TJ T* [(Giacino,)-285.2(J.,)-289.1(Gonzalez-La)-12(ra,)-284.3(L.E.,)-288.2(Gruen,)-285.7(R.L.,)-291.7(Gupta,)-289.1(D.,)-285.4(Hartings,)-290.6(J.A.,)-284.8(Hill,)]TJ T* [(S.,)-217.2(Jiang,)-222(J.Y.,)-221.2(Ketharanathan,)-227.8(N.,)-217.1(Kompanje,)-222.5(E.J.O.,)-229.1(Lanyon,)-218.2(L.,)-223(Laureys,)-226.6(S.,)]TJ 0 -1.2064 TD [(Lecky,)-305(F.,)-303.1(Levin,)-306.6(H.,)-304(Lingsma,)-301.3(H.F.,)-310.9(Maegele,)-300.4(M.,)-306.4(Majdan,)-301.8(M.,)-306.4(Manley,)-308.9(G.,)]TJ 0 -1.1988 TD [(Marsteller,)-308.8(J.,)-304.3(Mascia,)-303(L.,)-306.5(McFadyen,)-309.5(C.,)-301.1(Mondello,)-308.6(S.,)-300.7(Newcomb)-11.5(e,)-297(V.,)]TJ T* [(Palotie,)-303(A.,)-307.1(Parizel,)-303.2(P.M.,)-306.8(Peul,)-301.1(W.,)-303.3(Piercy,)-310.7(J.,)-304.3(Polinder,)-305.4(S.,)-300.7(Puybasset,)-314.4(L.,)]TJ T* [(Rasmussen,)-311.3(T.E.,)-305.2(Rossaint,)-304.6(R.,)-304.2(Smielewski,)-308.6(P.,)-304.2(Soderberg,)-309.2(J.,)-304.3(Stanworth,)]TJ T* [(S.J.,)-301.2(Stein)-9.8(,)-296.2(M.B.,)-304.4(von)-302.2(Ste)-9.3(inbuchel,)-303.6(N.,)-300.6(Ste)-9.3(wart,)-303.2(W.,)-303.3(Steyerberg,)-311.8(E.W.,)]TJ T* [(Stocchetti,)-306(N.,)-300.6(Synnot,)-301.1(A.,)-291.9(Te)-300.9(Ao,)-296.9(B.,)-301.8(Tenovuo,)-302.9(O.,)-292.4(Theado)-10.7(m,)-297.8(A.,)-291.9(Tib)-9.9(boel,)]TJ 0 -1.2064 TD [(D.,)-300.6(Videtta,)-304.6(W.,)-303.3(Wang)-9.7(,)-296.2(K.K.W.,)-314.5(Williams,)-305.4(W.H.,)-303.5(Wilson,)-307.1(L.,)-306.5(and)-303.9(Yaffe,)-298.4(K.;)]TJ 0 -1.1988 TD [(InTBIR)-304.7(Participants)-305.8(and)-303.9(Investi)-10.4(gators.)-303(\(2017\).)-304.4(Lancet)-305(Neurol)-10.9(.)-296.2(16,)-308.1(987)]TJ T* (1048.)Tj -1.214 -1.1988 TD [(2.)-507(Peeters,)-306.8(W.,)-303.3(van)-303.4(den)-298.1(Brand)-10(e,)-297(R.,)-304.2(Polinder,)-305.4(S.,)-308.3(Brazinova,)-306.6(A.,)]TJ 1.214 -1.1988 TD [(Steyerberg,)-311.9(E.W.,)-300.2(Lingsma,)-308.9(H.F.,)-303.3(and)-303.9(Maas,)-303.7(A.I.)-305.7(\(2015\).)-304.4(Epidemi)-10.5(ology)-301.9(of)]TJ T* [(traumatic)-305.5(brain)-306.8(injury)-304.7(in)-304(Europe.)-308(Acta)-302.9(Neurochir.)-306.3(\(Wien.\))-303.8(157,)-306.5(1683)]TJ T* (1696.)Tj -1.214 -1.2064 TD [(3.)-507(Frost,)-285.9(R.B.,)-287(Farrer)-11.7(,)-281(T.J.,)-286(Primosch)-12.2(,)-281(M.,)-283.6(and)-288.7(Hedges,)-283.5(D.W.)-292.3(\(2013\).)-289.2(Prevalence)]TJ 1.214 -1.1988 TD [(of)-298.6(traumatic)-313.1(brain)-299.2(inju)-9.6(ry)-295(in)-304(the)-302.9(general)-303.2(adult)-302.7(populat)-11.6(ion:)-302.1(a)-302.5(meta-)]TJ T* [(analysis.)-302.6(Neuroep)-12.5(idemiology)-308.7(40,)-300.5(154159.)]TJ -1.214 -1.1988 TD [(4.)-507(Chang,)-229.7(V.C.,)-235(Ruseckaite,)-232(R.,)-228.3(Collie,)-234.6(A.,)-231.2(and)-228(Colantonio,)-237.7(A.)-223.3(\(2014\).)-236.1(Examining)]TJ 1.214 -1.1988 TD [(the)-302.9(epidemiology)-309(of)-298.6(work-relate)-13.2(d)-303(traumatic)-305.5(brain)-306.8(injury)-304.7(through)-305.6(a)]TJ T* [(sex/gender)-303.6(lens:)-304.7(analysis)-309.9(of)-298.6(workers)-312.3(compensation)-306.9(claims)-309.3(in)-296.4(Vi)-8.1(ctoria,)]TJ 0 -1.2064 TD [(Australia.)-308(Occup.)-305.8(Environ.)-311.5(Med.)-298.8(71,)-300.5(695)-10.3(703.)]TJ -1.214 -1.1988 TD [(5.)-507(Farace,)-291.4(E.,)-285.5(and)-288.7(Alv)-8.3(es,)-289(W.M.)-290.4(\(2000\).)-289.2(Do)-290.2(women)-289.8(fare)-289.7(worse:)-290.4(a)-287.3(metaanalysi)-12.6(s)]TJ 1.214 -1.1988 TD [(of)-298.6(gender)-305.1(differences)-312.7(in)-296.4(traumatic)-313.1(brain)-299.2(in)-8.1(jury)-304.2(outcome.)-304.4(J.)-304(Neurosurg.)]TJ T* [(93,)-300.5(539545.)]TJ -1.214 -1.1988 TD [(6.)-507(Fausto-Sterling,)-309.7(A.)-306.8(\(2012\).)]TJ /F8 1 Tf 12.1856 0 TD [(Sex/Gender:)-310.4(Biology)-312.1(in)-298.1(a)-299.5(Social)-305.7(World)-13.3(.)]TJ /F3 1 Tf 15.7441 0 TD [(Taylor)-302.2(&)]TJ -26.7157 -1.1988 TD [(Francis)-306.6(Group:)-303(Milton)-307(Park,)-302.1(Abi)-8.7(ngdon-on-Thames)-12.7(,)-296.2(Oxfordshire,)-316.1(UK.)]TJ -1.214 -1.1988 TD [(7.)-507(Gupte,)-306(R.,)-304.2(Brooks,)-303.3(W.,)-303.3(Vuk)-9.7(as,)-302.4(R.,)-304.2(Pierce,)-301.5(J.,)-304.3(and)-303.9(Harris,)-301.9(J.)-304(\(2019\).)-304.4(Sex)-305.8(dif-)]TJ 1.214 -1.2064 TD [(ferences)-294.4(in)-288.9(traumatic)-297.9(brain)-291.6(injury:)-289.8(what)-293(we)-288.5(know)-289.8(and)-288.7(what)-293(we)-288.5(should)]TJ 0 -1.1988 TD [(know.)-305.3(J.)-296.4(Neuro)-12.2(trauma)-301.9(36,)-300.5(3063)-9.5(3091.)]TJ -1.214 -1.1988 TD [(8.)-507(Slewa-Younan,)-305.8(S.,)-308.3(Baguley,)-302(I.J.,)-310.8(Heriseanu,)-306.5(R.,)-304.2(Cameron,)-306.3(I.D.,)-307.1(Pitsiavas,)-309.3(V.,)]TJ 1.214 -1.1988 TD [(Mudaliar,)-302.9(Y.,)-304.2(and)-303.9(Nayyar,)-307.5(V.)-298.1(\(200)-10(8\).)-301.9(Do)-297.8(men)-307.8(and)-296.3(women)-305(differ)-308.9(in)-296.4(their)]TJ T* [(course)-304.3(following)-310.6(traumatic)-305.5(brain)-306.8(injury?)-304.3(A)-298.9(preli)-9.4(minary)-303.8(prospective)-308.2(in-)]TJ T* [(vestigation)-309.3(of)-298.6(early)-308.7(outcome.)-304.4(Brain)-305.1(Inj.)-300.5(22,)-308.1(183191.)]TJ -1.214 -1.2064 TD [(9.)-507(Cancelliere,)-267.1(C.,)-263.2(Donovan,)-267.3(J.,)-266.3(and)-266(Cassidy,)-269.2(J.D.)-262.9(\(2016\).)-266.4(Is)-263.7(sex)-263.2(an)-258.9(indicator)-270.2(of)]TJ 1.214 -1.1988 TD [(prognosis)-266.4(after)-263.7(mild)-264(trauma)-13.6(tic)-261.5(brain)-261.3(injury:)-267(a)-264.6(systematic)-268.9(analysis)-271.9(of)-260.6(the)]TJ T* [(ndings)-302.9(of)-306.1(the)-302.9(World)-302.9(Health)-308.1(Organization)-304.6(Collabo)-11.1(rating)-298.3(Centre)-312.6(Task)]TJ T* [(Force)-306(on)-295.5(Mi)-8.5(ld)-294(Trauma)-13.5(tic)-299.5(Brain)-305.1(Injury)-304.7(and)-303.9(the)-302.9(ϲ)-306.9(Collabo)-11.1(ra-)]TJ T* [(tion)-245.3(on)-234.8(Mi)-8.5(ld)-240.9(Traumatic)-244.7(Brain)-244.4(Injury)-244(Pro)-9.7(gnosis.)-242.4(Arch.)-245.4(Phys.)-247.1(Med.)-245.7(Rehabil.)]TJ T* [(97,)-300.5(S5S18.)]TJ -1.7148 -1.1988 TD [(10.)-505.4(Bazarian,)-278.6(J.J.,)-282(Blyth,)-278.4(B.,)-279(Mookerjee,)-284.1(S.,)-277.9(He,)-274.2(H.,)-281.3(and)-273.6(McDermo)-11.6(tt,)-274.4(M.P.)-276.2(\(2010\).)]TJ 1.7224 -1.2064 TD [(Sex)-305.8(differences)-305.1(in)-304(outcome)-304.1(after)-309.2(mild)-301.9(traumatic)-305.5(brain)-306.8(injury.)-305(J.)-304(Neuro-)]TJ 0 -1.1988 TD [(trauma)-309.5(27,)-300.5(527539.)]TJ -1.7224 -1.1988 TD [(11.)-505.4(Yue,)-256.9(J.K.,)-256.8(Levin,)-253.5(H.S.,)-255.4(Suen,)-255.3(C.G.,)-263.4(Morrissey,)-260.2(M.R.,)-253.7(Runyon,)-260.1(S.J.,)-255.6(Winkler,)-256.6(E.A.,)]TJ 1.7224 -1.1988 TD [(Puffer,)-240.7(R.C.,)-240.9(Deng,)-236.6(H.,)-235.7(Robinson,)-240.2(C.K.,)-238.5(Rick,)-237.4(J.W.,)-235.5(Phelps,)-236(R.R.L)-10.9(.,)-235.8(Sharma,)-238(S.,)]TJ T* [(Taylor,)-310.1(S.R.,)-301.1(Vassar)-10.9(,)-296.2(M.J.,)-306.9(Cnossen,)-309.9(M.C.,)-303.7(Lingsma,)-308.9(H.F.,)-303.3(Gardner,)-305.9(R.C.,)]TJ T* [(Temkin)-9.6(,)-227.9(N.R.,)-240.3(Barber,)-233.5(J.,)-236(Dikmen)-9.5(,)-227.9(S.S.,)-236.9(Yuh,)-235.3(E.L.,)-242.7(Mukherjee,)-235.2(P.,)-235.9(Stein,)-237.7(M.B.,)]TJ 0 -1.2064 TD [(Cage,)-302.6(T.A.,)-311.6(Valadka,)-303.3(A.B.,)-305.1(Okonkwo,)-308.9(D.O.,)-304.4(and)-303.9(Manley,)-301.3(G.T.)-308.2(\(2019\).)-304.4(Age)]TJ 0 -1.1988 TD [(and)-303.9(sex-mediate)-11.4(d)-295.4(differences)-312.7(in)-304(six-month)-300.3(outco)-13.3(mes)-297.9(after)-309.2(mild)-301.9(trau-)]TJ T* [(matic)-239.5(brain)-230.9(injury)-236.4(in)-235.7(young)-229.3(adul)-10.1(ts:)-231.7(a)-226.6(TRACK-)-11.3(TBI)-228.2(study.)-239(Neurol)-10.9(ogical)-231.8(Res.)]TJ T* [(41,)-300.5(6096)-9.5(23.)]TJ -1.7224 -1.1988 TD [(12.)-505.4(Levin,)-245.9(H.S.,)-247.8(Temkin)-9.6(,)-243.1(N.R.,)-247.9(Barber,)-248.7(J.,)-243.6(Nelson)-10.3(,)-243.1(L.D.,)-242.6(Rober)-10(tson,)-246.6(C.,)-248(Brennan,)-250.6(J.,)]TJ 1.7224 -1.1988 TD [(Stein,)-306(M.B.,)-304.4(Yue,)-302.4(J.K.,)-309.9(Giacino,)-307.9(J.T.,)-301.2(McCrea,)-307.9(M.A.,)-309.7(Diaz-Arrastia,)-309.5(R.,)]TJ 33.6052 89.9958 TD [(Mukherjee,)-303.4(P.,)-304.2(Okonkwo,)-308.9(D.O.,)-304.4(Boase)-10(,)-296.2(K.,)-301.8(Markow)-12.8(itz,)-297(A.J.,)-307.6(Bodien,)-307.7(Y.,)]TJ 0 -1.1988 TD [(Taylor,)-226.6(S.,)-224.8(Vassar)-10.9(,)-220.3(M.J.,)-231(Manley,)-233(G.T.,)-225(TRACK-)-11.3(TBI)-220.6(Investi)-10.4(gators,)-227.1(Adeoye,)-232.2(O.,)]TJ T* [(Badjatia,)-304.8(N.,)-300.6(Bullock,)-312.5(M.R.,)-299.2(Chesnut,)-314.6(R.,)-296.6(Co)-10(rrigan,)-298.6(J.D.,)-308.7(Crawford,)-310(K.,)]TJ T* [(Dikmen,)-305.8(S.,)-300.7(Duhaime,)-307.7(A.C.,)-304.5(Ellenbogen,)-309.8(R.,)-304.2(Feeser,)-301.4(V.R.,)-306.4(Ferguson,)-306.7(A.R.,)]TJ T* [(Foreman,)-300.6(B.,)-309.4(Gardner,)-305.9(R.,)-304.2(Gaudette,)-310.1(E.,)-300.7(Gonzalez,)-305.3(L.,)-306.5(Gopinath,)-306.7(S.,)]TJ T* [(Gullapalli,)-307.4(R.,)-296.6(Hem)-10(phill,)-301.1(J.C.,)-309.2(Hotz,)-303.7(G.,)-304(Jain,)-303.6(S.,)-300.7(Keene,)-305.8(C.D.,)-305.6(Korley,)-305.4(F.K.,)]TJ 0 -1.2064 TD [(Kramer,)-258.4(J.,)-266.3(Kreitzer,)-266.9(N.,)-255.1(Li)-8.7(ndsell,)-257.3(C.,)-263.2(Machamer,)-267.9(J.,)-258.8(Mad)-8.4(den,)-260.4(C.,)-255.6(Ma)-8.9(rtin,)-259.8(A.,)]TJ 0 -1.1988 TD [(McAllister,)-223.5(T.,)-217.2(Merchant,)-220.3(R.,)-220.7(Nolan,)-221.8(A.,)-216(Ngweny)-10.6(a,)-211.8(L.B.,)-221.1(Noel,)-221.6(F.,)-219.6(Palacios,)-221.4(E.,)]TJ T* [(Puccio,)-307(A.,)-299.5(Rabinowi)-10.2(tz,)-298.4(M.,)-306.4(Rosand,)-301.7(J.,)-304.3(Sander,)-305.9(A.,)-307.1(Satris,)-306.2(G.,)-304(Schnyer,)-304.8(D.,)]TJ T* [(Seabury,)-273.8(S.,)-277.9(Sun,)-277.3(X.,)-273.2(Toga,)-276.3(A.,)-269.1(Va)-8.5(ladka,)-272.1(A.,Wang,)-279.1(K.,)-279(Yuh,)-273.2(E.,)-270.3(and)-273.6(Zafonte)-10.5(,)]TJ T* [(R.)-296.3(\(2021\).)-304.4(Ass)-9.7(ociation)-302.1(of)-306.1(sex)-301.1(and)-303.9(age)-297.6(with)-307.7(mild)-301.9(traumatic)-305.5(brain)-306.8(injury-)]TJ T* [(related)-303.2(symptoms:)-310.2(a)-302.5(TRACK-TBI)-307.8(Study.)-304.3(JAMA)-304.5(Netw.)-304.8(Open)-301.6(4,)-302.2(e2130)-9.5(46)]TJ 0 -1.2064 TD (e213046.)Tj -1.7224 -1.1988 TD [(13.)-505.4(Mushkudiani,)-310.7(N.A.,)-303.9(Engel,)-303.6(D.C.,)-305.6(Steyerberg,)-311.9(E.W.,)-300.2(Butcher,)-311.2(I.,)-302.7(Lu,)-303.9(J.,)]TJ 1.7224 -1.1988 TD [(Marmarou,)-302.2(A.,)-307.1(Slieker,)-306(F.,)-303.1(McHugh,)-308.3(G.S.,)-308.5(Murray,)-306.2(G.D.,)-300.8(and)-303.9(Maas,)-303.7(A.I.R.)]TJ T* [(\(2007\).)-304.4(Prognostic)-310.3(value)-298.7(of)-306.1(demographic)-309.1(characteristic)-16.7(s)-295.5(i)0(n)-304(traumatic)]TJ T* [(brain)-299.2(injury:)-305(results)-308.3(from)-304.5(The)-302.8(IMPACT)-308.9(Study.)-304.3(J.)-304(Neurotrauma)-306.6(24,)-308.1(259)]TJ T* (269.)Tj -1.7224 -1.2064 TD [(14.)-505.4(Mikolic)]TJ 4.3021 .0379 TD ()Tj .3642 -.0379 TD [(,)-288.6(A.,)-284.3(van)-280.7(Klav)-9.6(eren,)-281.2(D.,)-285.4(Ou)-8.8(de)-281(Groeniger,)-291.3(J.,)-289.1(Wiegers,)-286.2(E.J.A.,)-289.3(Lingsma,)]TJ -2.944 -1.1988 TD [(H.F.,)-303.3(Zeldovich,)-310.2(M.,)-298.8(von)-302.2(Steinbuechel,)-313.6(N.,)-300.6(Maas,)-303.7(A.I.R.,)-306.4(Roeters)-311.1(van)]TJ T* [(Lennep,)-303.5(J.E.,)-301.2(and)-303.9(Polinder,)-305.4(S.)-308(\(2020\).)-304.4(Differences)-309.7(between)-303.4(men)-300.3(and)]TJ T* [(women)-297.4(in)-304(treatment)-309.6(and)-303.9(outcome)-304.1(after)-309.2(traumatic)-305.5(brain)-306.8(injury.)]TJ T* [(J.)-296.4(Neurotr)-13.2(auma)-300.9(38,)-300.5(2352)-9.5(51.)]TJ -1.7224 -1.1988 TD [(15.)-505.4(Hartung,)-214.2(C.M.,)-220.3(and)-212.9(Leer,)-217(E.K.)-215(\(2019\).)-213.3(Sex)-214.7(and)-212.9(gender)-214(in)-213(psychopatholo)-15.8(gy:)]TJ 1.7224 -1.1988 TD [(DSM5)-298.1(and)-303.9(beyond.)-305.6(Psyc)-10.4(hol.)-302.1(Bull.)-304.1(145,)-298.9(390.)]TJ -1.7224 -1.2064 TD [(16.)-505.4(Riecher-Ro)]TJ 5.7665 .0152 TD ()Tj .4173 -.0152 TD [(ssler,)-306.6(A.)-299.2(\(2017\).)-304.4(Sex)-305.8(and)-303.9(gender)-297.5(differences)-312.7(in)-304(mental)-302.2(disor-)]TJ -4.4615 -1.1988 TD [(ders.)-300.3(Lancet)-305(Psychi)-10.9(atry)-298.3(4,)-302.2(89.)]TJ -1.7224 -1.1988 TD [(17.)-505.4(Steel,)-304.9(Z.,)-298.4(Marnane)-9.2(,)-296.2(C.,)-308.7(Iranpour,)-306.9(C.,)-301.1(Chey,)-306(T.,)-300.7(Jackson,)-312.9(J.W.,)-303.8(Patel,)-306.7(V.,)-298.4(and)]TJ 1.7224 -1.1988 TD [(Silove,)-242.1(D.)-247.2(\(2014\).)-243.7(The)-242.1(global)-245.8(prevale)-9.6(nce)-238.6(of)-245.4(common)-244.1(mental)-249.1(disorders:)-254.5(a)]TJ T* [(systematic)-306.8(review)-306.4(and)-303.9(meta-analysis)-309.5(1980-2013.)-307.5(Int.)-301(J.)-304(Epidemiol.)-310.6(43,)]TJ T* (476493.)Tj -1.7224 -1.2064 TD [(18.)-505.4(Ponsford,)-309.5(J.,)-296.7(Alw)-8.7(ay,)-297.7(Y.,)-304.2(and)-303.9(Gould,)-304.9(K.R.)-301.9(\(201)-10.1(8\).)-301.9(Epidemiology)-304.8(and)-303.9(natural)]TJ 1.7224 -1.1988 TD [(history)-304.7(of)-298.6(psych)-11.7(iatric)-301.4(disorders)-307.3(after)-309.2(TBI.)-304.3(J.)-296.4(Neurop)-11.7(sychiatry)-309.1(Clin.)]TJ T* [(Neurosci.)-307.3(30,)-300.5(262270)]TJ -1.7224 -1.1988 TD [(19.)-505.4(Spani,)-299.5(C.B.,)-306.7(Braun,)-304.5(D.J.,)-308.7(and)-303.9(Van)-298.7(Eldik,)-307.2(L.J.)-306.7(\(2018\).)-304.4(Sex-related)-307(responses)]TJ 1.7224 -1.1988 TD [(after)-301.6(traumatic)-305.5(brain)-306.8(injury:)-305(Considera)-13.7(tions)-298(for)-310.4(preclinical)-304.9(modeling.)]TJ T* [(Front.)-303.4(Neuroendoc)-12.8(rinol.)-305(50,)-300.5(5266.)]TJ -1.7224 -1.1988 TD [(20.)-505.4(Poritz,)-306.8(J.M.P.,)-299.7(Vos,)-310.6(L.,)-298.9(Ngan,)-303.2(E.,)-308.3(Leon-Novelo,)-306.2(L.,)-306.5(and)-303.9(Sherer,)-304.9(M.)-298.5(\(2019\).)]TJ 1.7224 -1.2064 TD [(Gender)-303.1(differences)-305.1(in)-304(employme)-10.8(nt)-302.1(and)-296.3(economic)-310.9(quality)-303.7(of)-306.1(life)-298.9(fol-)]TJ 0 -1.1988 TD [(lowing)-301.7(traumatic)-305.5(brain)-306.8(injury.)-305(Rehab)-8.9(il.)-301(Psychol.)-304.9(64,)-300.5(6571)-9.5(.)]TJ -1.7224 -1.1988 TD [(21.)-505.4(Corrigan,)-308.6(J.D.,)-301.1(Lineberry,)-311.2(L.A.,)-302.2(Komaroff,)-311.8(E.,)-300.7(Langlois,)-311.2(J.A.,)-307.6(Selassie,)-305(A.W.,)]TJ 1.7224 -1.1988 TD [(and)-296.3(Woo)-9.9(d,)-295.7(K.D)-9.7(.)-296.2(\(2007\).)-304.4(Employ)-11.7(ment)-304.5(after)-301.6(traumatic)-305.5(brain)-306.8(injury:)]TJ T* [(differences)-305.1(between)-303.4(men)-307.8(and)-296.3(women)-9.1(.)-303.8(Arch.)-298.5(Phys.)-307.8(Med.)-306.4(Rehabil.)-302.4(88,)]TJ T* (14001409.)Tj -1.7224 -1.2064 TD [(22.)-505.4(Haag,)-303.7(H.L.,)-306.7(Caringal,)-304.3(M.,)-306.4(Sokoloff,)-304.5(S.,)-308.3(Kontos,)-302.7(P.,)-304.2(Yoshida,)-307.9(K.,)-301.8(and)-303.9(Colanto-)]TJ 1.7224 -1.1988 TD [(nio,)-302.1(A.)-299.2(\(2016\).)-304.4(Being)-304.5(a)-302.5(woman)-303.2(with)-300.1(acqui)-10.7(red)-300.5(brain)-306.8(injury:)-305(challenges)]TJ T* [(and)-296.3(implicatio)-12.6(ns)-297.4(for)-302.8(prac)-11.1(tice.)-300.6(Arch.)-306.1(Phys.)-307.8(Med.)-298.8(Rehab)-8.9(il.)-301(97,)-300.5(S64)]TJ T* (S70.)Tj -1.7224 -1.1988 TD [(23.)-505.4(Malmusi,)-301.3(D.,)-308.2(Vives,)-303.7(A.,)-299.5(Benach)-9.6(,)-296.2(J.,)-304.3(and)-303.9(Borrell,)-305.8(C.)-300.9(\(2014\).)-312(Gender)-303.1(inequal-)]TJ 1.7224 -1.1988 TD [(ities)-297.8(in)-304(health:)-302.7(exploring)-311.7(the)-302.9(contribution)-310.8(of)-298.6(living)-302.2(conditions)-311.6(in)-304(the)]TJ T* [(intersection)-309.4(of)-298.6(social)-305.3(class.)-308.8(Glob.)-307.2(Health)-300.5(Action)-309.7(7,)-302.2(23189.)]TJ -1.7224 -1.2064 TD [(24.)-505.4(Eurostat.)-307.3(\(2018\).)-304.4(The)-302.8(life)-306.5(of)-298.6(women)-305(and)-303.9(men)-300.3(in)-304(Europe:)-308(a)-294.9(statistica)-15.5(l)]TJ 1.7224 -1.1988 TD [(portrait-2018)-312.1(edition.)-305.2(https://ec.eur)-16.1(opa.eu/eurostat/cac)-20(he/)]TJ T* [(infographs/womenme)-14.2(n_2018)-299.7(\(La)-8.8(st)-299.7(accessed)-304.1(Octob)-13.2(er)-301(8,)-302.2(2021\).)]TJ -1.7224 -1.1988 TD [(25.)-505.4(Prause,)-267.4(W.,)-273(Saletu,)-270.5(B.,)-263.9(Tribl,)-271.1(G.G.,)-273.9(Rieder,)-270(A.,)-269.1(Rosenber)-12.3(ger,)-265.2(A.,)-269.1(Bolitschek,)-275.8(J.,)]TJ 1.7224 -1.1988 TD [(Holzinger,)-305.5(B.,)-301.8(Kapfhammer,)-314.3(G.,)-304(Katschnig,)-309.4(H.,)-304(Kunze,)-299.9(M.,)-306.4(Popovic,)-304.8(R.,)]TJ T* [(Graetzhofer,)-304.5(E.,)-308.3(and)-303.9(Zeitlhofer,)-302.5(J.)-304(\(2005\).)-304.4(Effect)-12.2(s)-295.5(o)0(f)-306.1(socio-demograp)-15.4(hic)]TJ 0 -1.2064 TD [(variables)-302(on)-303.1(health-rela)-10.8(ted)-300.5(quality)-303.7(of)-306.1(life)-298.9(determined)-308(by)-305.4(the)-302.9(quality)]TJ 0 -1.1988 TD [(of)-298.6(life)-298.9(in)-8.1(dexGerman)-302.7(versi)-9.9(on.)-303.4(Hum.)-303.1(Psychopharmacol.)-316.3(20,)-300.5(359)]TJ T* (365.)Tj -1.7224 -1.1988 TD [(26.)-505.4(Kivits,)-294.1(J.,)-304.3(Erpelding,)-297.9(M.L.,)-301.5(and)-296.3(Guil)-10.1(lemin,)-297.8(F.)-295.2(\(2013\).)-304.4(Social)-294.8(determ)-11.3(inants)-293.6(of)]TJ 1.7224 -1.1988 TD [(health-related)-227.8(qual)-10.1(ity)-225.4(of)-222.7(life.)-230.9(Rev.)-227.9(Epidemiol.)-234.8(Sante)-222.6(Publi)-9.8(que)-225.6(61)-224.4(Suppl)-227.2(3,)]TJ T* (S189S194.)Tj -1.7224 -1.1988 TD [(27.)-505.4(Lahana,)-254(E.,)-255.1(Pappa,)-255.4(E.,)-255.2(and)-250.8(Niakas)-10.4(,)-250.7(D)0(.)-247.2(\(201)-10(0\).)-248.8(The)-257.3(impact)-254.2(of)-253(ethnicit)-11.1(y,)-253.1(place)]TJ 1.7224 -1.2064 TD [(of)-298.6(residence)-310.4(and)-296.3(socioecono)-15.9(mic)-304.5(status)-300.3(on)-303.1(health-rel)-11.7(ated)-299.5(quality)-303.7(of)]TJ 0 -1.1988 TD [(life:)-299.2(results)-308.3(from)-304.5(a)-302.5(Greek)-304.2(health)-302.4(survey.)-307.6(Int.)-301(J.)-304(Public)-306.4(Health)-300.5(55,)-308.1(391)]TJ T* (400.)Tj -1.7224 -1.1988 TD [(28.)-505.4(Bale,)-246.8(T.L.,)-242.7(an)-8.5(d)-242.3(Epperson,)-250.5(C.N.)-252.2(\(2015\).)-243.7(Sex)-252.6(differences)-252(and)-243.2(stress)-250.8(across)-251.2(the)]TJ 1.7224 -1.1988 TD [(lifespan.)-306.8(Nat.)-303.6(Neurosci.)-307.3(18,)-300.5(1413)-9.5(1420.)]TJ -1.7224 -1.1988 TD [(29.)-505.4(Maas,)-227.8(A.I.)-9.8(,)-227.9(Menon,)-232.5(D.K.,)-237.9(Steyerberg,)-236(E.W.,)-239.5(Citerio,)-236.9(G.,)-228.1(Lecky,)-236.7(F.,)-234.8(Manley,)-233(G.T.,)]TJ 1.7224 -1.2064 TD [(Hill,)-299.6(S.,)-300.7(Legr)-9.4(and,)-304.2(V.,)-298.4(Sorgner,)-311.3(A.,)-299.5(Participants,)-313.7(C.-T.,)-307.1(and)-303.9(Investigators)]TJ 0 -1.1988 TD [(\(2015\).)-258.9(Collabo)-11.1(rative)-264(European)-263.1(NeuroTr)-13.1(auma)-263(Effectiveness)-270.5(Research)-265.1(in)]TJ T* [(Traumatic)-305.4(Brain)-305.1(Injury)-304.7(\(CENTER-T)-11.8(BI\):)-299.9(a)-302.5(prospective)-308.3(longitudinal)-309.6(obser-)]TJ T* [(vational)-301.8(study.)-307.3(Neurosurgery)-311.6(76,)-300.5(6780)-9.5(.)]TJ -1.7224 -1.1988 TD [(30.)-505.4(Steyerberg,)-281.5(E.W.,)-277.4(Wiegers,)-278.6(E.,)-277.9(Sewalt,)-279.8(C.,)-278.4(Buki,)-277.6(A.,)-269.1(Citeri)-11.3(o,)-271.2(G.,)-281.3(De)-270.5(Keyser,)-279(V.,)]TJ 1.7224 -1.1988 TD [(Ercole,)-241.8(A.,)-246.4(Kunzmann,)-242.9(K.,)-248.7(Lanyon,)-248.5(L.,)-238.2(and)-243.2(Lecky,)-244.3(F.)-242.1(\(201)-10(9\).)-241.2(Case-mix,)-246.2(care)]TJ ET 59.754 747.156 406.488 .51025 re f BT /F4 1 Tf 9.9626 0 0 9.9626 59.7543 753.8455 Tm [(MED)-10.3(IATORS)-307.4(OF)-302.7(SEX)-302.9(DIFFE)-10.3(RENCES)-305.4(IN)-306.7(MTBI)-302.7(OUT)-8.8(COMES)-22532.3(3329)]TJ ET endstream endobj 139 0 obj <>stream /GS1 gs BT /F3 1 Tf 7.4718 0 0 7.4718 74.8913 724.1384 Tm 0 0 0 rg 0 Tc 0 Tw [(pathways,)-308.9(and)-303.9(outcomes)-303.6(in)-304(patients)-303.9(with)-307.7(traumatic)-305.5(brain)-306.8(injury)-304.7(in)]TJ 0 -1.1988 TD [(CENTER-TBI:)-312.2(a)-294.9(Euro)-11.5(pean)-297.1(prospect)-13.9(ive,)-302.2(multicentre,)-309.8(longitudinal,)-309.9(cohort)]TJ T* [(study.)-307.3(Lancet)-305(Neurol.)-307.1(18,)-300.5(9239)-9.5(34.)]TJ -1.7224 -1.1988 TD [(31.)-505.4(Wilson,)-307.1(J.T.,)-301.2(Pettig)-10(rew,)-300.7(L.E.,)-303.4(and)-303.9(Teasdale,)-305.3(G.M)-10.1(.)-296.2(\(1998\).)-304.4(Structured)]TJ 1.7224 -1.1988 TD [(interviews)-295.6(for)-287.7(the)-287.7(Glasgow)-292.1(Outcome)-287.1(Scal)-10.1(e)-281.5(and)-288.7(the)-287.7(extended)-293.1(Glasgow)]TJ T* [(Outcome)-309.8(Scale:)-299.5(guideli)-11(nes)-298.2(for)-302.8(their)-305.8(use.)-301.9(J.)-304(Neurotrauma)-314.1(15,)-300.5(573)]TJ 0 -1.2064 TD (585.)Tj -1.7224 -1.1988 TD [(32.)-505.4(Kunzmann,)-220.1(K.,)-218.3(Wernis)-12(ch,)-215.3(L.,)-215.4(Richar)-12.2(dson,)-219(S.,)-217.2(Steyerberg,)-228.4(E.W.,)-216.7(Lingsma,)-225.5(H.F.,)]TJ 1.7224 -1.1988 TD [(Ercole,)-294.9(A.,)-299.5(Maas,)-296.1(A.,)-291.9(Menon,)-300.8(D.,)-293(and)-296.3(Wilson,)-299.5(L.)-291(\(2020\).)-304.4(Imputation)-299.3(of)-291(or-)]TJ T* [(dinal)-286(outcomes:)-296.3(a)-279.8(compariso)-14(n)-282.6(o)0(f)-291(approaches)-290.3(in)-288.8(traumatic)-290.3(brain)-291.6(injury.)]TJ T* [(J.)-304(Neurotrauma)-306.6(38,)-308.1(455463.)]TJ -1.7224 -1.1988 TD [(33.)-505.4(Ware,)-307.1(J.,)-296.7(Jr.,)-308.5(Kosinski,)-307.6(M.,)-306.4(and)-296.3(Keller,)-312.2(S.D.)-297.2(\(199)-10(6\).)-301.9(A)-298.9(12-item)-307.1(short-corm)]TJ 1.7224 -1.2064 TD [(health)-279.7(survey)-11.4(:)-281(construction)-290.1(of)-283.4(scales)-286.6(and)-281.2(preliminary)-282.9(tests)-289.2(of)-283.4(reliability)]TJ 0 -1.1988 TD [(and)-303.9(validity.)-303.9(Med.)-306.4(Care)-304.7(34,)-300.5(220233.)]TJ -1.7224 -1.1988 TD [(34.)-505.4(von)-302.2(Steinbu)]TJ 6.3811 0 TD [()-126.3(chel,)-305.8(N.,)-300.6(Wilson,)-307.1(L.,)-298.9(Gibbo)-10.5(ns,)-297.7(H.,)-304(Mue)-8.4(hlan,)-297.7(H.,)-304(Schmidt,)-314.6(H.,)]TJ -4.6588 -1.1988 TD [(Schmidt,)-307(S.,)-300.7(Sasse)-10.7(,)-296.2(N.,)-308.2(Koskinen,)-304.5(S.,)-300.7(Saraj)-10.3(uuri,)-302.1(J.,)-304.3(Ho)]TJ 20.6912 .0076 TD ()Tj .4173 -.0076 TD [(fer,)-298.6(S.,)-308.3(Bullinger,)-304(M.,)]TJ -21.1085 -1.1988 TD [(Maas,)-205.1(A.,)-208.4(Neugeba)-11.5(uer,)-207.9(E.A.M.,)-215.5(Powell,)-208.1(J.,)-205.6(Von)-206.4(Wild,)-216.3(K.,)-203.2(Zitnay,)-213.3(G.,)-213(Bakx,)-209.2(W.,)]TJ T* [(Christensen,)-306.9(A.L.,)-309.8(Formisano,)-310.9(R.,)-296.6(an)-8.5(d)-295.4(Truelle,)-308.8(J.)-304(\(2012\).)-304.4(QOLIBRI)-308.1(Overall)]TJ 0 -1.2064 TD [(Scale:)-254(a)-257(brief)-258.5(index)-256.1(of)-253(health-related)-258.1(quality)-258.2(of)-260.6(life)-253.4(after)-256.1(traumatic)-260(brain)]TJ 0 -1.1988 TD [(injury.)-305(J.)-304(Neurol.)-307.1(Neurosurg.)-311.9(Psychiatry)-309.3(83,)-300.5(10411047.)]TJ -1.7224 -1.1988 TD [(35.)-505.4(King,)-304(N.S.,)-305.1(Crawford,)-310(S.,)-300.7(Wend)-9(en,)-298.9(F.J.,)-303.6(Moss,)-310.5(N.E.,)-305.1(and)-296.3(Wade,)-309.9(D.T.)-304.8(\(1995\).)]TJ 1.7224 -1.1988 TD [(The)-302.8(Rivermead)-307.3(Post)-305.2(Concussion)-311.2(Symptoms)-306.9(Questionnaire:)-312.5(a)-302.5(measure)]TJ T* [(of)-298.6(symptoms)-309.9(commonly)-305.9(exper)-10.2(ienced)-298.2(after)-309.2(head)-297.1(injury)-304.7(and)-303.9(its)-298.4(reliabil-)]TJ T* [(ity.)-301.5(J.)-304(Neurol.)-307.1(242,)-306.5(587592.)]TJ -1.7224 -1.1988 TD [(36.)-505.4(Kroenke,)-309.4(K.,)-301.8(and)-303.9(Spitzer,)-305.8(R.L.)-306.6(\(2002\).)-304.4(The)-302.8(PHQ-9:)-299.7(A)-306.5(new)-298(depress)-11.5(ion)-301.8(diag-)]TJ 1.7224 -1.2064 TD [(nostic)-306.3(and)-303.9(severity)-305.7(measure.)-307.6(Psychiatric)-306.2(Ann.)-303(32,)-308.1(509515.)]TJ -1.7224 -1.1988 TD [(37.)-505.4(Spitzer,)-305.8(R.L.,)-306.9(Kroenke,)-309.4(K.,)-301.8(Williams,)-305.4(J.B.,)-309.9(and)-296.3(Lowe,)-304.2(B.)-309.1(\(2006\).)-304.4(A)-298.9(brief)-304(mea-)]TJ 1.7224 -1.1988 TD [(sure)-230(for)-234.5(assessing)-228.1(gener)-9.7(alized)-229.7(anxiety)-232(disorder:)-239.7(the)-227(GAD-7.)-234.9(Arch.)-230.2(Intern.)]TJ T* [(Med.)-298.8(166)-10.3(,)-296.2(1092109)-12.2(7.)]TJ -1.7224 -1.1988 TD [(38.)-505.4(Bovin,)-306.4(M.J.,)-299.3(Ma)-8.9(rx,)-297.7(B.P.,)-309.8(Weathers,)-306.1(F.W.,)-302.6(Galla)-10.4(gher,)-297.5(M.W)-9.4(.,)-296.5(Rodriguez)-13.8(,)-296.2(P.,)]TJ 1.7224 -1.1988 TD [(Schnurr,)-311.2(P.P.,)-304.6(and)-296.3(Keane,)-304(T.M.)-310.6(\(2016\).)-304.4(Psychometric)-308.7(properties)-312.8(of)-298.6(the)]TJ 0 -1.2064 TD [(PTSD)-301(Check)-10.5(list)-297(for)-302.8(Diagno)-10.9(stic)-299.1(and)-303.9(Statistical)-307.1(Ma)-8.9(nual)-300.8(of)-298.6(Mental)]TJ 0 -1.1988 TD [(Disorders-Fifth)-314.6(Edition)-300.8(\(PCL-5\))-310.1(in)-296.4(veteran)-10.1(s.)-303.3(Psychol.)-304.9(Assess.)-305.8(28,)-308.1(1379)]TJ T* (1391.)Tj -1.7224 -1.1988 TD [(39.)-505.4(De)-300.8(Smedt,)-306.6(J.,)-304.3(le)-295.3(Vrang)-9(,)-296.2(M.,)-306.4(and)-303.9(Papantoniou,)-309(A.)-299.2(\(201)-10(5\).)-301.9(ESCO:)-305.2(Towards)-307.2(a)]TJ 1.7224 -1.1988 TD [(Semantic)-254(Web)-249.9(for)-257.3(the)-249.8(European)-255.5(Labor)-253.3(Market.)-256.2(http://)-11.9(events.linkeddata)]TJ T* [(.org/ldow2015/pa)-16(pers/ldow2015_pa)-15.9(per_10.pdf)-233.9(\(Last)-232.7(accessed)-235.8(October)]TJ T* [(9,)-302.2(2021\).)]TJ -1.7224 -1.2064 TD [(40.)-505.4(Steen,)-239.9(J.,)-243.6(Loeys,)-238.5(T.,)-240(Moe)-8.4(rkerke,)-242.9(B.,)-241.1(and)-235.6(Vansteelandt,)-247.1(S.)-239.7(\(2017\).)-243.7(Medex:)-247.3(an)]TJ 1.7224 -1.1988 TD [(R)-296(package)-306.9(for)-302.8(ex)-9.2(ible)-301(mediation)-305.6(analysis)-309.9(using)-303.2(natural)-300.8(effect)-312.3(models.)]TJ T* [(J.)-304(Statistical)-307.1(Software)-310.6(76.)]TJ -1.7224 -1.1988 TD [(41.)-505.4(Steen,)-300.6(J.,)-304.3(Loeys,)-306.7(T.,)-308.3(Moerkerke,)-304.4(B.,)-309.4(and)-296.3(Vansteelandt,)-315.4(S.)-300.4(\(2017\).)-304.4(Flexible)]TJ 1.7224 -1.1988 TD [(mediation)-222.2(analysis)-226.4(with)-224.3(multiple)-227.5(mediators.)-225.8(Am.)-225(J.)-220.5(Epidemiol.)-227.2(186,)-223(184)]TJ T* (193.)Tj -1.7224 -1.2064 TD [(42.)-505.4(Buuren,)-303.9(S.,)-308.3(and)-296.3(Grooth)-13.4(uis-Oudshoorn,)-312.6(C.)-300.9(\(2011\).)-304.4(MICE:)-306(Multivariat)-13.4(e)]TJ 1.7224 -1.1988 TD [(Imputation)-306.8(by)-305.4(Chained)-302.3(Equations)-313.7(in)-296.4(R.)-303.9(J.)-304(Stat.)-300.4(Softw.)-306.7(45.)]TJ -1.7224 -1.1988 TD [(43.)-505.4(Lumley,)-307.5(T.,)-300.7(and)-303.9(Lumley,)-307.5(M.T.)-303(\(2006\).)]TJ /F8 1 Tf 16.9809 0 TD [(The)-306.8(mitools)-308.7(Package.)]TJ /F3 1 Tf 8.9002 0 TD [(University)-305.4(of)]TJ -24.1587 -1.1988 TD [(Washington:)-309.9(Seattle,)-308.2(WA.)]TJ -1.7224 -1.1988 TD [(44.)-505.4(van)-303.5(der)-300.5(Naalt,)-301.3(J.,)-304.3(Timmer)-11.2(man,)-298.8(M.E.,)-303.3(de)-303.8(Koning,)-311.2(M.E.,)-303.3(van)-303.4(der)-300.5(Horn,)-307.6(H.J.,)]TJ 1.7224 -1.1988 TD [(Scheenen,)-309.2(M.E.,)-303.3(Jacobs,)-308.1(B.,)-301.8(Hageman,)-308.1(G.,)-304(Yilmaz,)-307.4(T.,)-300.7(Roks,)-303.7(G.,)-304(and)]TJ T* [(Spikman,)-303.6(J.M.)-306.6(\(2017\).)-304.4(Early)-304.5(predic)-10.9(tors)-301.7(of)-298.6(outco)-13.3(me)-298.3(after)-301.6(mild)-309.5(traumatic)]TJ 0 -1.2064 TD [(brain)-299.2(in)-8.1(jury)-304.2(\(UPFRONT\):)-306.8(an)-304.4(observational)-311.2(cohort)-302.5(study.)-307.3(Lancet)-305(Neurol.)]TJ 0 -1.1988 TD [(16,)-300.5(5325)-9.5(40.)]TJ -1.7224 -1.1988 TD [(45.)-505.4(Cnossen,)-309.9(M.C.,)-303.7(van)-303.4(der)-300.5(Naalt,)-301.3(J.,)-304.3(Spikman,)-311.1(J.M.,)-306.9(Nieboer,)-302(D.,)-308.2(Yue,)-302.4(J.K.,)]TJ 1.7224 -1.1988 TD [(Winkler,)-218.7(E.A.,)-220.5(Manley,)-217.8(G.T.,)-217.5(von)-218.7(Steinbuechel,)-222.6(N.,)-217.1(Polinder,)-221.9(S.,)-217.2(Steyerberg,)]TJ T* [(E.W.,)-247.1(and)-250.8(Lingsma,)-248.2(H.F.)-249.9(\(2018\).)-251.3(Prediction)-249.3(of)-245.4(persi)-10.3(stent)-246(post-concussion)]TJ T* [(symptoms)-309.9(after)-301.6(mild)-301.9(traumatic)-313.1(brain)-299.2(in)-8.1(jury.)-304.4(J.)-296.4(Neuro)-12.2(trauma)-301.9(35,)-300.5(2691)]TJ 0 -1.2064 TD (2698.)Tj -1.7224 -1.1988 TD [(46.)-505.4(Scholten,)-291.1(A.C.,)-289.3(Haagsma,)-296.4(J.A.,)-284.8(Cnoss)-11(en,)-283.7(M.C.,)-288.6(Olff,)-293(M.,)-283.6(van)-288.3(Beeck,)-291(E.F.,)-284.8(and)]TJ 1.7224 -1.1988 TD [(Polinder,)-305.4(S.)-300.4(\(2016\).)-312(Prevalence)-302(of)-306.1(and)-303.9(risk)-300.8(factors)-306.4(for)-302.8(anxiet)-9.5(y)-298.3(and)-303.9(de-)]TJ T* [(pressive)-305.6(disorders)-307.3(after)-309.2(traumatic)-305.5(brain)-306.8(injury:)-305(a)-302.5(systematic)-306.8(review.)]TJ T* [(J.)-304(Neurotrauma)-306.6(33,)-308.1(19691994.)]TJ -1.7224 -1.1988 TD [(47.)-505.4(Gulland,)-306.8(A.)-299.2(\(2016\).)-304.4(Women)-312.4(have)-296.7(higher)-305.3(rates)-303.8(of)-306.1(mental)-302.2(disorders)-307.3(than)]TJ 1.7224 -1.1988 TD [(men,)-300.5(NHS)-304.2(survey)-307.3(nds.)-308.3(BMJ)-303.7(354,)-298.9(i5320.)]TJ -1.7224 -1.2064 TD [(48.)-505.4(McManus,)-307.3(S.,)-300.7(Bebbingt)-11.8(on,)-303.4(P.E.,)-301.1(Jenkins,)-309.2(R.,)-304.2(and)-296.3(Br)-9.6(ugha,)-304.4(T.)-300.4(\(2016\).)-304.4(Mental)]TJ 1.7224 -1.1988 TD [(health)-203.8(and)-212.9(wellbeing)-205.1(in)-205.4(England:)-212.2(the)-204.2(Adult)-208(Psy)-9.7(chiatric)-205.4(Morbi)-10(dity)-209.7(Survey)]TJ T* [(2014.)-304.9(https://assets.pu)-19.4(blishing.service.gov.uk)-19.3(/government/up)-13.2(loads/)]TJ T* [(system/uploads)-16(/attachment_data/l)-16.8(e/556596/apms-2014-f)-16.8(ull-rpt.pdf)]TJ T* [(\(Last)-301(accessed)-311.7(October)-306.6(14,)-300.5(2021\).)]TJ -1.7224 -1.1988 TD [(49.)-505.4(Krivkovich,)-303.9(A.,)-291.9(Robinson,)-300.9(K.,)-294.2(Starikova,)-304.8(I.,)-295.1(Valentino,)-293.4(R.,)-296.6(and)-296.3(Yee,)-297.9(L.)-291(\(2017\).)]TJ 1.7224 -1.2064 TD [(Women)-304.8(in)-304(the)-295.3(work)-11.4(place)-302.1(2017.)-304.9(https://womeninthewo)-17.7(rkplace.com/)]TJ 0 -1.1988 TD [(2017#!)-307.4(\(Last)-301(accessed)-311.7(October)-306.6(9)-301.9(2021\).)]TJ -1.7224 -1.1988 TD [(50.)-505.4(Devillard,)-268.5(S.,)-262.7(Hunt,)-269.7(V.,)-268(and)-266(Yee,)-260(L.)-268.3(\(2018\).)-266.4(Still)-262.3(loo)-9.3(king)-262.8(for)-264.9(room)-266.9(at)-261.3(the)-264.9(top:)]TJ 1.7224 -1.1988 TD [(Ten)-302.8(years)-302(of)-306.1(research)-307.2(on)-295.5(women)-305(in)-304(the)-302.9(workplace.)-306.3(https://www)]TJ T* [(.mckinsey.com)-16.3(/~/media/McKinsey/Feat)-16.6(ured%20Insig)-13(hts/Gender%)]TJ 33.5976 88.797 TD [(20Equal)-11(ity/Still%20looking%)-17.7(20for%20room%20)-17.6(at%20the%20top%)]TJ 0 -1.1988 TD [(20Ten%20year)-12.7(s%20of%20resear)-15.9(ch%20on%20)-14.7(women%20in%20the)-14(%)]TJ T* [(20workpla)-13(ce/Still-looking-for-)-17.1(room-at-the-top.pd)-17(f)-300.8(\(Last)-301(accessed)]TJ T* [(October)-306.6(14,)-308.1(2021\).)]TJ -1.7224 -1.1988 TD [(51.)-505.4(Salina)-9(s,)-288.2(P.C.,)-301.6(and)-296.3(Bagni,)-295.4(C.)-293.3(\(2017\).)-296.8(Gender)-295.5(equali)-9.5(ty)-295(from)-296.9(a)-287.4(european)-297.6(per-)]TJ 1.7224 -1.1988 TD [(specti)-11(ve:)-296(myth)-306.2(and)-303.9(reality.)-304.3(Neuron)-310.1(96,)-300.5(721729.)]TJ -1.7224 -1.2064 TD [(52.)-505.4(Europ)-11(ean)-297.6(Comission.)-311.5(\(2019\).)-304.4(Report)-310.2(on)-295.5(equal)-10.8(ity)-301.3(between)-303.4(women)-305(and)]TJ 1.7224 -1.1988 TD [(men)-307.8(in)-296.4(the)-302.9(EU.)-300.4(htt)-10.4(ps://ec.europa.eu/info)-19.9(/sites/default/les/ai)-18.9(d_)]TJ T* [(develop)-11.1(ment_cooperation_fun)-17(damental_rights/annu)-17.6(al_report_ge_)]TJ T* [(2019_)-9.5(en.pdf)-302.8(\(Last)-301(accessed)-311.7(October)-306.6(9,)-302.2(2021\).)]TJ -1.7224 -1.1988 TD [(53.)-505.4(Stergio)-11.8(u-Kita,)-302.7(M.,)-306.4(Manseld,)-301.5(E.,)-308.3(Sokoloff,)-304.5(S.,)-308.3(and)-303.9(Colantonio,)-306(A.)-299.2(\(201)-10.1(6\).)]TJ 1.7224 -1.1988 TD [(Gender)-310.7(inuences)-301.5(on)-303.1(return)-309.1(to)-297.9(work)-307.4(after)-301.6(mild)-309.5(traumatic)-305.5(brain)-306.8(injury.)]TJ 0 -1.2064 TD [(Arch.)-306.1(Phys.)-307.8(Med.)-298.8(Reha)-9.4(bil.)-300.5(97,)-300.5(S40S45.)]TJ -1.7224 -1.1988 TD [(54.)-505.4(Mackenzi)-11.3(e,)-289.4(C.R.)-301.3(\(2014\).)-296.8(It)-299.1(is)-294.1(hard)-293(for)-295.2(mums)-296.5(to)-297.9(put)-297.4(themselves)-302.9(rst:)-300.6(how)]TJ 1.7224 -1.1988 TD [(mother)-10.6(s)-295.5(diagnosed)-309.6(with)-307.7(breast)-303.3(cancer)-303.3(manage)-307.8(the)-302.9(sociological)]TJ T* [(bounda)-10.5(ries)-284(between)-288.2(paid)-285(work,)-292.5(family)-286(and)-281.2(caring)-287.2(for)-287.7(the)-287.7(self.)-284.9(Soc.)-291.2(Sci.)]TJ T* [(Med.)-306.4(117,)-306.5(96106.)]TJ -1.7224 -1.1988 TD [(55.)-505.4(Mollayeva,)-309(T.,)-300.7(Bordigno)-14.6(n,)-298.1(C.,)-301.1(Ishtiaq,)-312.9(M.,)-298.8(Colquhoun)-12.7(,)-296.2(H.,)-304(DSouza,)-312.4(A.,)]TJ 1.7224 -1.2064 TD [(Archam)-10.5(bault,)-302.9(P.,)-304.2(Lewko,)-306.6(J.,)-304.3(Quilico,)-306.9(E.,)-300.7(and)-303.9(Colantonio,)-306(A.)-306.8(\(2019\).)]TJ 0 -1.1988 TD [(Knowled)-10.9(ge)-298.6(of)-298.6(sex)-308.7(and)-296.3(gender)-305.1(and)-303.9(related)-303.2(in)-8.1(formation)-306.1(needs)-306(in)-296.4(pa-)]TJ T* [(tients)-305.3(with)-307.7(traumatic)-305.5(brain)-306.8(injury:)-305(in-depth)-303.9(inter)-9.9(view)-301.4(study.)-307.3(Disability)]TJ T* [(Rehab)-8.9(il.)-301(111.)]TJ -1.7224 -1.1988 TD [(56.)-505.4(Seidler,)-212(Z.E.,)-211.8(Dawes,)-208.1(A.J.,)-208.9(Rice,)-205.4(S.M.,)-212.2(Oliffe,)-208.9(J.L.,)-208.4(and)-205.3(Dhill)-9.5(on,)-204.8(H.M.)-207.7(\(2016\).)-213.3(The)]TJ 1.7224 -1.1988 TD [(role)-304.9(of)-306.1(masculinity)-306.7(in)-304(mens)-300.1(help-seeking)-311.9(for)-302.8(depression:)-306(a)-302.5(systematic)]TJ T* [(review.)-306.7(Clin.)-307.6(Psychol.)-304.9(Rev.)-303.7(49,)-300.5(1061)-9.5(18.)]TJ -1.7224 -1.2064 TD [(57.)-505.4(Addis,)-304(M.,)-306.4(and)-303.9(Mahalik,)-305.8(J.)-304(\(2003\).)-304.4(Men,)-301.2(masculi)-11.1(nity,)-303.5(and)-296.3(the)-302.9(contexts)-310(of)]TJ 1.7224 -1.1988 TD [(help)-304.3(seeking.)-309.8(Am.)-300.9(Psychol.)-304.9(58,)-308.1(514.)]TJ -1.7224 -1.1988 TD [(58.)-505.4(Schopp)-11.1(,)-296.2(L.H.,)-306.7(Good,)-306.3(G.E.,)-308.5(Barker,)-304.7(K.B.,)-307.4(Mazurek,)-308.3(M.O.,)-302.6(and)-303.9(Hathawa)-10.2(y,)-298.6(S.L.)]TJ 1.7224 -1.1988 TD [(\(2006\).)-304.4(Mascul)-13.1(ine)-297.2(role)-304.9(adherence)-305.6(and)-303.9(outcomes)-311.2(among)-298.1(men)-307.8(with)]TJ T* [(traumatic)-313.1(brain)-299.2(inju)-9.7(ry.)-302.9(Brain)-297.5(In)-8.1(j.)-300(20,)-300.5(11551162.)]TJ -1.7224 -1.1988 TD [(59.)-505.4(DSouza,)-312.4(A.,)-299.5(Fabricius)-12.2(,)-296.2(A.,)-307.1(Amodio,)-302(V.,)-306(Colquhoun,)-308.9(H.,)-304(Lewko,)-306.6(J.,)-304.3(Haag,)-303.7(H.,)]TJ 1.7224 -1.2064 TD [(Quilico,)-306.9(E.,)-308.3(Archambault,)-305.9(P.,)-304.2(Colanto)-11.6(nio,)-302.1(A.,)-299.5(and)-303.9(Mollayeva,)-309(T.)-300.4(\(2020\).)]TJ 0 -1.1988 TD [(Mens)-308.3(gendered)-305.4(experiences)-308.5(of)-298.6(rehabil)-10.3(itation)-300.4(and)-303.9(recovery)-305.9(follow)-12.2(ing)]TJ T* [(traumatic)-313.1(brain)-299.2(inju)-9.7(ry:)-302.9(a)-294.9(ree)-9.4(xive)-299.2(thematic)-307.1(analysis.)-310.2(Neuropsychol.)]TJ T* [(Rehab)-8.9(il.)-301(122.)]TJ -1.7224 -1.1988 TD [(60.)-505.4(Dolan)-9(,)-288.6(A)0(.)-284(\(2011\).)-296.8(You)-291.8(cant)-286.9(ask)-296.9(for)-287.7(a)-287.3(Dubonnet)-296.3(and)-288.7(lemonade!:)-295.1(working)]TJ 1.7224 -1.1988 TD [(class)-308.5(masculinity)-306.7(and)-303.9(mens)-307.7(health)-302.4(practices.)-311.2(Soc.)-298.8(Healt)-10.3(h)-297.8(Illness)-308.8(33,)]TJ T* [(5866)-9.5(01.)]TJ -1.7224 -1.2064 TD [(61.)-505.4(del)-302.4(Pilar)-304.2(Sa)]TJ 5.9942 .0304 TD ()Tj .387 -.0304 TD (nchezLo)Tj 3.5737 .0304 TD ()Tj .4173 -.0304 TD [(pez,)-302(M.,)-306.4(CuellarFlores,)-315.9(I.,)-302.7(and)-296.3(Dre)-9.2(sch,)-298.3(V.)-305.7(\(2012\).)]TJ -8.6498 -1.1988 TD [(The)-302.8(impact)-307.3(of)-298.6(gender)-305.1(roles)-304.5(on)-303.1(health.)-310.3(Women)-304.8(Health)-300.5(52,)-308.1(182)]TJ T* (196.)Tj -1.7224 -1.1988 TD [(62.)-505.4(Todor)-11(ov,)-300.5(A.,)-299.5(Kaufmann)-11.5(,)-296.2(F.,)-303.1(Arslani,)-308.8(K.,)-301.8(Haider,)-306(A.,)-307.1(Bengs,)-305.7(S.,)-300.7(Goliasch,)-307.5(G.,)]TJ 1.7224 -1.1988 TD [(Zellweg)-9.7(er,)-278.5(N.,)-277.8(Tontsch,)-291.3(J.,)-273.9(Sutte)-11.3(r,)-277.7(R.,)-281.4(Buddeberg,)-282.7(B.,)-286.6(Hollinger,)-283.5(A.,)-284.3(Zemp,)]TJ T* [(E.,)-308.3(Kaufmann,)-307.7(M.,)-298.8(Siegemund,)-310.9(M.,)-306.4(Gebhard,)-301.1(C.,)-308.7(Gebhard,)-308.7(C.E.,)-305.6(and)-296.3(on)]TJ 0 -1.2064 TD [(behalf)-308.3(of)-298.6(the)-302.9(Swiss)-304.9(Society)-304.7(of)-306.2(Intensive)-309(Care,)-305(M.)-298.5(\(2021\).)-304.4(Gender)-310.7(differ-)]TJ 0 -1.1988 TD [(ences)-254.1(in)-250.9(the)-249.8(provision)-255(of)-245.4(intensive)-255.9(care:)-255.4(a)-241.8(Bayesian)-257.1(approach.)-252.3(In)-8.1(tensive)]TJ T* [(Care)-304.7(Med.)-306.4(47,)-300.5(577587.)]TJ -1.7224 -1.1988 TD [(63.)-505.4(Larsson)-12.1(,)-250.7(E.,)-255.1(Lindstro)]TJ 9.4541 .0076 TD ()Tj .4173 -.0076 TD [(m,)-252.3(A.-C.,)-260.4(Eriksson,)-259(M.,)-253.3(and)-250.8(Oldner,)-259.3(A.)-253.7(\(2019\).)-258.9(Impact)-254.2(of)]TJ -8.149 -1.1988 TD [(gender)-305.1(on)-303.1(post-traumatic)-315.6(intensive)-301.4(care)-308.3(and)-303.9(outcomes.)-311.5(Scand.)-301.5(J.)]TJ T* [(Trauma)-309.4(Resusc.)-302.3(Emer)-10.9(g.)-298.1(Med.)-306.4(27,)-300.5(115.)]TJ -1.7224 -1.1988 TD [(64.)-505.4(Fowler,)-311.3(R.A.,)-299.9(Sabur,)-308.5(N.,)-300.6(Li,)-304.9(P.,)-304.2(Juurlink,)-305.3(D.N.,)-305(Pinto)-10.3(,)-296.2(R.,)-304.2(Hladunewi)-10.8(ch,)-298.8(M.A.,)]TJ 1.7224 -1.2064 TD [(Adhikari,)-250.5(N.K.,)-245.5(Sibbald,)-242.1(W.J.,)-243.1(and)-243.2(Martin,)-245.9(C.M.)-242.7(\(2007\).)-243.7(Sex-and)-247(age-based)]TJ 0 -1.1988 TD [(differences)-312.7(in)-296.4(the)-302.9(delivery)-307.6(and)-303.9(outcomes)-311.2(of)-298.6(critical)-308.3(care.)-308.5(CMAJ)-298.5(177,)]TJ T* [(1513)-9.5(1519.)]TJ -1.7224 -1.1988 TD [(65.)-505.4(Volovici,)-258.8(V.,)-252.9(Ercole,)-264.6(A.,)-254(Citerio,)-252.1(G.,)-258.5(Stocchetti,)-260.5(N.,)-255.1(Haitsma,)-260.4(I.K.,)-255.2(Huijben,)-260.6(J.A.,)]TJ 7.4718 0 0 7.4718 325.9275 231.0236 Tm [(Dirven,)-305(C.M.F.,)-310.6(van)-303.4(der)-300.5(Jagt,)-301.6(M.,)-306.4(Steyerberg,)-311.9(E.W.,)-307.8(Nelson,)-306.5(D.,)-300.6(Cnossen,)]TJ T* [(M.C.,)-311.3(Maas,)-303.7(A.I.R.,)-306.4(Polinder,)-305.4(S.,)-300.7(Menon,)-308.4(D.K.,)-306.2(and)-303.9(Lingsma,)-301.3(H.F.)-303(\(201)-10(9\).)]TJ 0 -1.2064 TD [(Intensive)-309(care)-300.7(admissi)-11.7(on)-295.5(criteria)-306.5(for)-310.4(traumatic)-305.5(brain)-306.8(injury)-304.7(patients)]TJ 0 -1.1988 TD [(across)-311.9(Europe.)-308(J.)-296.4(Crit.)-308(Care)-304.7(49,)-300.5(158161.)]TJ -1.7224 -1.1988 TD [(66.)-505.4(Bonow,)-260.4(R.H.,)-258.9(Qu)-8.8(istberg,)-259.6(A.,)-254(Rivara,)-266(F.P.,)-258(and)-258.4(Vavilala,)-259.8(M.S.)-257.5(\(2019\).)-258.9(Intensive)]TJ 1.7224 -1.1988 TD [(care)-262.7(unit)-252.9(admissi)-11.7(on)-250(patter)-12.1(ns)-251.8(for)-257.3(mild)-256.4(traumatic)-267.5(brain)-253.7(inju)-9.7(ry)-249.5(in)-258.5(the)-257.3(USA.)]TJ T* [(Neurocrit.)-308.7(Care)-304.7(30,)-308.1(157170.)]TJ -1.7224 -1.1988 TD [(67.)-505.4(Ratcliff,)-307.4(J.J.,)-304.8(Adeoy)-11.1(e,)-297(O.,)-307.5(Lindsell,)-303.9(C.J.,)-309.2(Hart,)-303.7(K.W.,)-308.9(Pancioli,)-306.8(A.,)]TJ 1.7224 -1.1988 TD [(McMullan,)-312.6(J.T.,)-301.2(Yue,)-302.4(J.K.,)-309.9(Nishijima,)-302.2(D.K)-9.7(.,)-296.5(Gordon,)-312.5(W.A.,)-306.6(Valadka,)-303.4(A.B.,)]TJ 0 -1.2064 TD [(Okonkwo)-12.7(,)-227.9(D.O.,)-228.5(Lingsma,)-233(H.F.,)-235(Maas,)-235.4(A.I.,)-230.1(Manley,)-233(G.T.,)-232.6(and)-228(investi)-10.4(gators,)]TJ 0 -1.1988 TD [(T.-T.)-306.4(\(2014\).)-304.4(ED)-304.2(disposition)-306.7(of)-306.1(the)-302.9(Glasgow)-307.3(Coma)-299(Scal)-10.1(e)-296.7(1)0(3)-300.2(t)0(o)-305.5(1)0(5)]TJ T* [(traumatic)-313.1(brain)-299.2(inju)-9.7(ry)-295(pat)-10.4(ient:)-301.8(analysis)-302.3(of)-306.1(the)-302.9(Transforming)-308.3(Research)]TJ T* [(and)-303.9(Clinical)-304.3(Knowled)-10.9(ge)-298.6(in)-304(TBI)-296.5(study.)-307.3(Am.)-308.5(J.)-296.4(Emerg.)-309(Med.)-306.4(32,)-300.5(844)]TJ T* (850.)Tj -1.7224 -1.1988 TD [(68.)-505.4(ODonne)-10.2(ll,)-301(M.L.,)-301.5(Cre)-9.7(amer,)-301.9(M.,)-298.8(Holmes,)-309.7(A.C.N.,)-308.9(Ellen,)-300.4(S.,)-308.3(McFarlane,)-309.5(A.C.,)]TJ 1.7224 -1.2064 TD [(Judson)-11.8(,)-296.2(R.,)-304.2(Silove,)-302.8(D.,)-308.2(and)-296.3(Br)-9.6(yant,)-303.8(R.A.)-299.6(\(2010\).)-304.4(Posttrau)-14.6(matic)-300.2(stress)-311.5(dis-)]TJ 0 -1.1988 TD [(order)-310.1(after)-301.6(injury:)-305(does)-308.7(admission)-307.3(to)-297.9(intensive)-309(care)-300.7(unit)-306(increase)-309.2(risk?)]TJ T* [(J.)-304(Trauma)-309.4(Acute)-302.4(Care)-304.7(Surg.)-304.3(69,)-300.5(627-632.)]TJ -1.7224 -1.1988 TD [(69.)-505.4(Vagner)-9.8(ova,)-238.9(K.,)-233.5(Koerner,)-243(I.P.,)-242.4(and)-235.6(Hurn,)-239.4(P.D.)-240.1(\(2008\).)-243.7(Gender)-234.8(an)-8.5(d)-234.7(the)-234.6(injured)]TJ 1.7224 -1.1988 TD [(brain.)-307.1(Anesthesia)-305.4(Analgesi)-11.1(a)-294.9(107,)-306.5(201214.)]TJ ET 145.701 747.156 406.488 .51025 re f BT /F4 1 Tf 9.9626 0 0 9.9626 62.022 754.3557 Tm (3330)Tj 42.2865 0 TD [(MIKOLIC)-311.3(ET)-299.4(AL.)]TJ ET endstream endobj 157 0 obj <>stream /GS1 gs BT /F3 1 Tf 7.4718 0 0 7.4718 59.7543 724.1384 Tm 0 0 0 rg 0 Tc 0 Tw [(70.)-505.4(Russell,)-298.8(A.L.,)-302.2(Richardson,)-299.6(M.R.)-10.6(,)-288.6(Bauma)-10.3(n,)-290.5(B.M.,)-296.8(Hernandez)-13.6(,)-288.6(I.M)-8.8(.,)-288.9(Saperst)-11.6(ein,)]TJ 1.7224 -1.1988 TD [(S.,)-224.8(Handa,)-219.7(R.J.,)-221.2(and)-220.5(Wu,)-224.9(T.J.)-217.4(\(2018\).)-228.5(Differential)-225.8(responses)-223.7(of)-222.7(the)-219.4(HPA)-215.6(axis)]TJ T* [(to)-305.5(mild)-301.9(blast)-304.5(traumatic)-305.5(brain)-306.8(injury)-304.7(in)-304(male)-303.6(and)-296.3(remale)-308.7(mice.)-305.5(Endocri-)]TJ T* [(nology)-303.8(159,)-306.5(23632375.)]TJ -1.7224 -1.1988 TD [(71.)-505.4(Caplan,)-207.9(H.W.,)-212.5(Cox,)-212.4(C.S.,)-207(and)-205.3(Bedi,)-209.4(S.S.)-206.2(\(201)-10(7\).)-203.3(Do)-206.7(microglia)-213.6(play)-204.5(a)-203.9(role)-206.3(in)-205.4(sex)]TJ 1.7224 -1.1988 TD [(differences)-312.7(in)-296.4(TBI?)-303.6(J.)-304(Neurosci.)-307.3(Res.)-304.3(95,)-308.1(509517.)]TJ -1.7224 -1.2064 TD [(72.)-505.4(Mychasiuk)-12.3(,)-265.8(R.,)-266.3(Heha)-9.3(r,)-270.1(H.,)-266.1(Farran,)-273.4(A.,)-269.1(and)-273.6(Esser,)-266.7(M.J.)-276.2(\(2014\).)-274(Mean)-269.6(girls:)-268.9(Sex)]TJ 1.7224 -1.1988 TD [(differences)-312.7(in)-296.4(the)-302.9(effects)-311.8(of)-298.6(mild)-301.9(traumatic)-313.1(brain)-299.2(injury)-304.7(on)-303.1(the)-302.9(social)]TJ T* [(dynamic)-11.4(s)-212(o)0(f)-215.1(juvenile)-213.8(rat)-212.4(play)-219.6(behaviour.)-218.9(Behav.)-218.8(Brain)-214(Res.)-213.2(259,)-215.5(2842)-9.5(91.)]TJ -1.7224 -1.1988 TD [(73.)-505.4(Ponsford,)-309.5(J.,)-304.3(McLaren,)-307.6(A.,)-299.5(Scho)]TJ 14.0218 .0076 TD ()Tj .4097 -.0076 TD [(nberger,)-309.6(M.,)-306.4(Burke,)-306.7(R.,)-296.6(Rudz)-10.4(ki)-297(D.,)-308.2(Olver,)-302.4(J.,)]TJ -12.7091 -1.1988 TD [(and)-228(Ponsford)-13.3(,)-220.3(M)0(.)-230.2(\(2011\).)-236.1(The)-226.9(association)-239.6(between)-227.5(apolipoprotein)-240.6(E)-224.2(and)]TJ 33.6052 11.9959 TD [(traumatic)-305.5(brain)-306.8(injury)-304.7(severity)-305.7(and)-303.9(runctional)-308.3(outcome)-304.1(in)-304(a)-302.5(rehabilita-)]TJ 0 -1.1988 TD [(tion)-298.4(sample.)-310.5(J.)-296.4(Neurotr)-13.2(auma)-300.9(28,)-300.5(1683)-9.5(1692.)]TJ -1.7224 -1.1988 TD [(74.)-505.4(Corrigan,)-308.6(J.D.,)-301.1(Harrison-F)-13.5(elix,)-299.1(C.,)-301.1(Bogner)-11.9(,)-296.2(J.,)-304.3(Dijkers,)-309.8(M.,)-298.8(Terril)-10.8(l,)-294.8(M.S.,)-310.9(and)]TJ 1.7224 -1.1988 TD [(Whiteneck,)-231(G.)-235.5(\(2003\).)-228.5(Systema)-11.9(tic)-223.6(bias)-231.9(in)-228.2(traumatic)-237.2(brain)-230.9(injury)-236.4(outcome)]TJ T* [(studies)-258(because)-256(of)-260.6(loss)-253.5(to)-260(follow-up.)-261.7(Arch.)-253(Phys.)-262.3(Med.)-253.3(Reha)-9.5(bil.)-255(84,)-255(153)]TJ T* (160.)Tj -1.7224 -1.2064 TD [(75.)-505.4(Cnossen,)-302.3(M.C.,)-311.3(Polinder,)-305.4(S.,)-300.7(Lingsma,)-308.9(H.F.,)-303.3(Maas,)-303.7(A.I.)-9.8(R.,)-296.6(Menon,)-308.4(D.,)]TJ 1.7224 -1.1988 TD [(Steyerberg,)-236(E.W.,)-239.5(Investigators,)-245.1(C.T.,)-237.3(and)-228(Particip)-12.7(ants)-232.4(\(2016\).)-236.1(Variatio)-11.1(n)-229.5(i)0(n)]TJ T* [(structure)-241.2(and)-235.6(process)-244.9(of)-230.3(care)-240(in)-235.7(traumatic)-244.8(brain)-238.5(injury:)-236.7(provider)-238.9(prol)-11.3(es)]TJ T* [(of)-298.6(European)-308.6(neurotrauma)-311.9(centers)-308.2(participating)-306.2(in)-304(the)-302.9(CENTER-TBI)]TJ T* [(study.)-307.3(PloS)-296.6(One)-302.1(11,)-308.1(e0161367e01613)-13.3(67.)]TJ ET 59.754 747.156 406.488 .51025 re f BT /F4 1 Tf 9.9626 0 0 9.9626 59.7543 753.8455 Tm [(MED)-10.3(IATORS)-307.4(OF)-302.7(SEX)-302.9(DIFFE)-10.3(RENCES)-305.4(IN)-306.7(MTBI)-302.7(OUT)-8.8(COMES)-22532.3(3331)]TJ ET endstream endobj 161 0 obj <>stream 8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0 b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup` E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn 6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O( l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~> endstream endobj 163 0 obj <>stream hdVyTSW{Ī9g꾕*"hjKE @! CBNWqAqiTĎNqi9熹y8g3s e,޾=c%xqbN<g Ot!܋挿 *ȅ<1{EJvd53k5ffy]eB;(X((rulv,NA"PBB"6OBN6#,`yEbˎ})^_,dD"^6#qE#~BKCB ƻ(c_,F2Q`t)a h Yb ;+fl֋a;H?D7#ÿeaj_1+b8b.v닉I|DsL2}"9#+#Y"0<,F,ryaP(,) ,~ d0poђp~0AOeIE(+Q`He `XYe S8*r5ԞѠ'YKQZ}`҃x7 %gg@Ihv WZf7MY^|FY'zmw%*=lEfH#fHMJݚ fKR2Qpcƫ5&!aEϒ.1-jt]#6AS!UՎ ,W[to4܊jĂ DV\k%Af>dJ 0Kr%/7ůXVnj~"p_`Aߤ*c .W4uǢ H\K`#ѭ_>N@`'ambJT,%U `^`I\GG GMU&16d`"-fCA΁^:Gc@C 班&<5Q>ݠ" 6'KS>gꋲql,+K jx[ǫJ#u|j\I#$;* OW). Z/>z)f[ ,Zyȧj!@ER 3xjjucŞmجZi*+Sq-W>9Ev X/_$*z3p20?&)*[iR`uܤ=c+A/v柽yKt~M;OH}aqgnܖ v >HZo k b?=R~FXo--8Kt7Ý>JxkmXQ>Hą̋=w&jz%j̵IW=H3f4 UmNF3C*6 p-rBYNE#0 N|r*+ZDxܕc{}\Ft\yt`-X '!2H -Im0 Ʌ+@ X`s"ad ȩϝ'nUPSiidi0z%\[ עoj' 6n'o$QV{Hlp})ue{nY=mzv_X/gSz~XiˎcvT=.ZgP[( 6aR6ҀV޺aIڏm L{-$(DMrE1Xʧ9|e-f"x1zaXkn֙My)i `YL6SyR‹O9,B yRBkx6{noiW'#ծڳn?5Ģc$^ BbiuP,dM.?QЕԃOW2E:Pq4Z칣c&aXfai̔5)0lRm'|Mm5Ԅ$J{y,WJ8N@9U%:j4YSRB+E ޞF̕ '܅Gj˺n@L%2ȥ BQ(\h-2 0ET<=]C oJ/"r`?pU;l5FlX ` PRv¡&Y@ 'Yyp3L(Qjqz)YdRF"-||{Nwݥ74oF4~M endstream endobj 164 0 obj <>stream 8;Z\7?(-Bg%*TaI,P94goP%+fIHETVMEm9m',trGDoZ#rEL9=LV8,^klUPJEF%n]-_R:$_':;Mqb2B5G2)XH 4kDi9]Z;*iM!s@;V)(\UMZq-(gCM/ZIVK^;OERTaA:L-*JQOWoU:X[pC>jE (O7,`X1:-pRAQq<8%9+n.:9^,WZh0+@m=,C#rFc5+OAKYUmQ)P"0#HrufMm=L80["OY 7h.Kl.VngAM+=$SB8WHU3@d[0iV^=2)VNl)XUkLe?O5mc0eno5_Ts8]PoM@e@u(te GK5KkYe\Qbp@@rA~> endstream endobj 57 0 obj <>stream 8;Z]"#nk)t$q7`,"hBXt[4M>*+\eXkAk#9p')i8IbP?&t9.>.6mTu&hEnCt]M72_= $j'ar-j@[iXHW7PoIFu0*io%`\mb_R0KO:Z=JW+NB,eCo219j(@?`3oP'JQ"bh')1 f;F)W6[[/T3j8#=Rr]*]5uOMtMDQe-O6[FJ3Z+X5\+#(;,.Rpr)posYY@U[jCl#?# &3kXt2NG?FJQlfmPhigCT?(]L04V`=p=fC8N%OS@H=)Acdfh"MXO28r[7q-O(`CFr +R3!3s8%&feqk&[A4DC8N+GS:?h(W2f9BB/c7kG7UGcg#V-52B:u#a#8lt(WpKG_L 09?"=I\,58_=qrSY0&^B.i3?VT4E&?EK#(obECa(Xj*QdfgN@bg?">>OqE2Xo[Ob4 >sF,6 endstream endobj 67 0 obj <>stream 8;Z]";/QIj#XnFd(Z[VWeT><=0OPZ\TC@d=au79a'9=DtP$VgPK&6"G4JanhnVJ);r1d3T*>0Se<7gQ]NaHr.u=,q,5] Q>K6,%UkSlN*15`CYFO7m:8MYX-9g;E3]V$g.'d5_stbr5ea&XX4%'8b8BcAp_mR[ $4)Ym-!A<"^077$ZCL+$M6?NCMX16DN2\M%](T+UVb!_RZq#2hViY@M+Z:BJR$(X$ B$Q]-U!C=N4EZNj2'_9I<-[TaSa9j.FFtgtSkGP*aFP#6Q%q)g`i\.Q-=`f!9-CGL EW%=nZLkGG#B!7=T$lYX0#J!*].VOEHmHP endstream endobj 73 0 obj <>stream 8;Z]!l`l*c%#*r$IcuQ9dSJT-\iL2Z5n(Wd+.LrOjd`#JeVMX^kP2n:]\H'M^_\jKE^C8DGB$mDL#:[DSL;YfM&32Xs-O91b&5]RPr8>h:dUk pFCE)>OM6\'KWk+X@6#='O%JSXpIJCY0s=t)N)JV`F8VMpdJRsgI8WuTnopb8%:*)=6oI[kk_f:_UX9N\Z@Us)mAB!S6h;((Y*U[)]=A[XYu4b>lL+i 2&%8X$\M_L81p3Tm(?GLNg._h[Ep/Sb'N_N[HIm4rWV>?4DG.!WOD=1bU1$=ZomUS[?(["T;4`[K)fC,2![HL%3`D!DQ YGKnnp%jge'\-sq'`,m//?i7DJ9!I95!S7!(DpoaPB3[0X7PXM7]ZN2/m[^7p'K\7 qA6AC/<@OH!1SZm`r~> endstream endobj 78 0 obj <>stream 8;Z\6$')nG%.sQakjPTV@PH`(5U*>qe[?`s_i1jU+T>gn!9"UQEt7f>j'r81N0Dsj `/7#YlHZcli0@RXKMfG>;%jj$RjOUG:^#lUT#fK#_ffh8&uA+.So'!%;-??9BOQ<_ iqk=o6PbSfCgIsob*Oc]qe5FfN`QoFR!Tc%J]7TE_J0aUWE&4Q]cfn'3\OTLaThn2 ImKicV'\m;#osCUqF(MH"^Wcb3aRJ=F(lSs)NA' Ykl0;ehhKR(.6YM?ZnK"ATtEA5AtfT6#-M/3$;^%h$WNNYYgmoC-tmAe2kWr>t*-d Rb)'>XeZZ8[gRN5BD$4RD[rt$Ug#Bmn++=Rm+DTpfZ4F*#0O$[`ZWjXn9K0$di?6S 3"F!RHX*[nO*~> endstream endobj 90 0 obj <>stream 8;Z\76%[#t#j_LTk]_1\CI]P$Jee#6>hZ/J&k\:#m;!TOXt-jAG8K"Z-#?"=SN.TT )C)N@?cFVE`H?F4?&aCLC_b'2Dk57YS5p;)[&/+/ab:>PB`r8115p?o&g'[nf"]Q; qC:C`J=Y6Ce.[HOE,hQingkO/H_pAGjd`#eolYD35[K0YNFddCcoCM\jjc#XI.?<> mh%]jYp*THk:,H[+WQEc/dciU#a",2p%@/mk<]>1%hq9k#D$U_27$HbMFK5/'6n#C FFa&Og_s*fn-#*'".h-R9cE!]RnuB11guDg;.+0?R-mfrX?C><-n=gV%RQSo"M)R' akS[fkZ,P$P*S\6'?o#uQfCX1PU;rnT?@aq@1bX`CD.UNHf\&X)156e@-`<'8uH@Q 0s!>f41SfQT6[9;5^rp#Y/bQm[^18NM%RbJqt2o-=\Wefh35@^ThpH*CF0q?p=_niXl[f~> endstream endobj 94 0 obj <>stream 8;Z]"#nhk5$q560gkYcG+7>?Y'Ps[Y$P9bhN8H6?q"fK!>)=;C#RHsWT;d^[`g[i8 ;(Ju4pu38'3K@7d0L^Mj1h]9D1WGmJlNSp;6FU!J.d`%0QlDq/D$;eeP]8%n\7X`( -lDi`V_+7^(Wq1!CH8Gak)tSun#20_[DYgC\p,.iqDFt/p/b8WY`RZhBDFD*BD(Ou 4fkh$b[]aY^+h.K-.IVgX'Z+:g?u>^%*RX1q3VpAW0n-]=+nLjLp2->E<:cZ+*/NAI$KG eZ>rK)9&\&^.)K:CIA7g2C^VUKFh[qe`1$0$A23_:qLBH1,dWiD+ZH](i3MJM!Gpp >FMh9QRjA&#o;*-?cKn53YOAXM+]S(Gk:Fe-tm5hBC1'BX.9us^)Jl:eUXrX+.]Oc !)^"/%f~> endstream endobj 100 0 obj <>stream 8;Z]"$a,.*$q7cMp;;@3:\W?*4IF5-`4#T[B5B=@'m_mL#V+4@/HGi'3Bg*ZKSJ]1 ;8Cp)WDj\Sq,HX7^'Pd@7Bf[f;QZ'dGL1q\)$uk"B[Qjofa&)0^cmgh=3J5=dkL%` 41Flff$nbtZ*dnu`;<0XZIN3gQ:m'3oeNXQ6IP\8MfmU=f,_9W>N\dLP5H/X YLZ(JAA,;bVB,]!a,sPG"tF8n>`X0].WQd&YO6_)CG]gla%@qjiAE>`M$ktgr_X]m Yk\TrbOt\fCALJjcIM^_W,#[lQ'%AY9KAp"U3[Q?O#G3,$-24(XO^?'"Z+2!@#1(T Z*m;V:)4Ys^/o(i='tT]XGck6\8F"s7QJrX1$!o%C_JO4r6K,Sk_cK"(4YtHK>Veb Q9J*69QE86*0joC3`g#)p8AFeiEZl3f.4JA1W@n6Vsb9*9!W*NFHREKSC7FK(?=Mn 0[fU`hmcJ[%0-^)?&A~> endstream endobj 105 0 obj <>stream 8;Z]"kn/Rk%#*/+qOsPR6U,9t@Jk\^$/lHCdC7.U*1u[#b9HPU%KSrHpAM1(f=Y9q 'K%]$LbI$3OQ2k-1ij(]NdqZYr>=io?T2AH2o\_s=6bUH=`!7<_[$l;.AJ$NAU,@5 PI?,SD:E?eqe>I@\FLi#Tag24t1p5SPi8 \X\&]f,mG@LU?<[KUXIC]7LZr2CNJddFY1Qr,4hVB9--;KJ&Z_gQ]c_j6J\3otM[? (9-e()7,,8loA^`qN\CA1h,NQgWl`KU`8ZSU6"'s?_8\/2ZUqSO$W~> endstream endobj 110 0 obj <>stream 8;Z]"5oKeJ#_ftl"h@C9ku390!-N)iRjfB9rFfjgJ#c[eXlAsG6Ct;e.hp;I@7VR0 N.hBN)#NCBk:A<9*FsE[1^f6P#%?#57V!C6Pk9#d$BhDj,Z_A]UW3k1%-+ijX;*ID 72Z!>1)]bDla#A)@lZ55Im]\B\M+e7I,Q2IJrpGU,cp<=h+7R56;8IrHX9"FO.i^F LbWN,!gUXHEYafPfDOjSZ5pP#Jb/URc09;SDD4,,hfW3:=kMiFC*,)pVI8Jl>mFes k&o2/?Tgsd&RI9e5S@Fo?2\,t>'>SHF5D\n/>5_6WNA3T?-XUU]B*G5KDUQ^_n:Z1 ''hLiAQ4/$oaA@'e/@pY)'I.:US&[5PAq)?7*B_8leTqa.ggm3j*INdje>0>`"F'` FqUgQ*X@Y,#6PE$QAj endstream endobj 114 0 obj <>stream 8;Z]"!HQ+$#Xrh7$Z_e5Vj"3ts$0gDD.f9^2F[fK&YgcFYmEMQppQf%DrIJ"S+m8k PHD`#RN&V"hN+AVO-/;CAW0cAi%&NRmQ\P?U^Lnp]"jioit>^G(eK+Hq]oPDM2)qS ^o?`W,PF"-k#Oh-)K%?;&!.O0l3lg'Mp[2MFK&'Gc'%]Eqb"_]I.a0I)4dX)^21NP B]aI-)&N(J`d3SAV?Blh`UP4!(ruY:CP]`\,3LM_jVgpXW#Zg [UZZC*K5P%>#Q;Gl+)Eg$_Ll2CLOG`=+":Tc8-3FOAX:f'fV92Ai_Fpb>,#X`#(33 MR'9hXm!%s5`7H?);kBUN#jW_N-p36mS/\2%o0RDZPACPWT/cb:e$TGp%9*X3ptKs WDuW6djWcd'-]8kYIQD%QEE6k)6*H2W:5P:/?OZ^bD7YRqF[NoOBAehQ3GSjqN.$^ ]c!+$$.uE3-7b'2@\#+`Rrm%9ffj=.T(T1QaKN0m(S_XUKU@81(NVT1fO;IAYb$[I a8P43s2htZ!8N`Wd/~> endstream endobj 119 0 obj <>stream 8;Z]"9,bZ$#_[:!$Z[7nfTsPd8Y_pdZgd92A:@.J..SHA@uRZKk;b&^3B"l='Rf"P 5@k@KiqWXb2FYt%4enInXY938TR7S,";EWGO]F9L-$(o.rE"a@[7c:EkM N]KR)g7$3$$aALgUP'LK?Pp57&Z5G%"h0k"%q>op(8>q:!jHfQ0pXBk'7eY%Mbe#m MQW=c(@)#DU*Ca&"-t`(mGm^7gNt>?&%Or?U53fB .[r>S=faDQX;0*deGBC0*59.;mFUTSf(JSc,l:X1c(g.jG:eT((,DV[q_DAfoU\g< ;8?@)S'_t1\=Hal6?oX/@iL^hbA[92lVm0INLr82BB0Il=.=^8A6fFHQacTM7WQ8. &N#i94E*&FZSUDl1S6]r^3L$-VMdS/qK6K/?qaciIBN9+AOQR@BU/3E_K#$-IU3gp J!)JId7`r5S'_S2Lt*Ff`58+V^tA1ZL!G1Oc^?Hie*Z$['3i+EWSt03+]a)"R-=@6 4bO`UAR1LTl#g]L`!WsMe\jnuSH_R#OP_V=ocO.m0`VU75XY~> endstream endobj 126 0 obj <>stream 8;Z]";3Jg>$q#CA$i2nGSSko=QGb*`4$VgOPD!E;'JOFC\".2nGWaaH>+6Oih'.Sj SST>6:H*=Df28/c/EP*&OI3;DYpeTuX=b>CCfAYiN+Hg[A:/)fkKU8X _XBI)(?dVq.AKDDIsp__g?Mj=GeNFWBe(Dg:H.V*ds]"b(FphJVG6S]IdJ"omP/e- k5/`8FL0+ncb.CK?!>7rANe8)^"5J`eg2^$s'JC'lDYMCml]fG'V"l>0(cDXJ`jH0 *2=:N)7:V;i4D2=Ae_P&9"QM/6dTGb>/J@L4E%AG?2/AN%gd#9Z0(@Pii(d00:;K% [p^=j'LMRTjj2Z endstream endobj 130 0 obj <>stream 8;Z\6$')qX#g<64aEQca"#f4R_X'mIW:9-/SWQ5:8<0jd++jg#"kGl""QFMOIfn@a^N_N>"6"B,p@UI)qfjV/)% n)Lp=@On\[K-_:s&c29.NoHlSong#=Y]^R\*_5&QUetj^HKhot_N_]h 3qsSscH83&]//bhP](M'7]0&5__Ng[gH2/r.`^3`rH<29mAu,KG&u/i"QR!"Wu;'Q LmH"7lHu]sP4CqJ`pPkJq_ZkVNoN,0lQu&&)L;]0n\Dq?&!eH+0Fr]RVQl2VItgd> 1`)'1j$&>ET>V>?Nnp+hkJ`I=UO=s@WSE9?op?p*HoFRICrtUhf"iPQgZUZP3I49L pNE04HMs7\:G*+=,jY'W_3*"In'aI@OB8Tn]m9.!AB.Ri endstream endobj 134 0 obj <>stream 8;Z\5>B8aX%-.:>aQr29D*04FZCFLl5NR!U2O5cl!hmiqHD)PCViKZd>/!$]T(H.9 -b4*G?ht$(K@A-oA@X7nC;"'1SG+0Jm?iIVT(XY4s/dL((O?Z2]#E?Cdd-a_$]_nq J69G#[HM2BF8!iW*,j"(MGU'[pFTY7\9K"BF'RtKFrC;"o3MrBLSHA;K"[gYJ5:u? ^\XNH>KIgUa^45>SUY)AGJt`f_mGc 8Vq/`Ci/pSgaooe2`k'::O'W1GhBR]HK6Qp-g_CGV>t&WL6K$WB/Y^'Mq0MI(c:0, hip$?g"bW\?6f44p7V3/%>Q5Eh5T9\-%HB"YDa^XJBt&.PXu0-UY*(od$#L`T8-%L oUes'8WhG*)'"$5B?6m:S3cZ[m-R:q'4gLbH"+"kRdm$+.\jm'k%WI[7&A)/fA9'> p7eG)3AGs=L0Zg`09uamh3YEBM+Z64b0_gm?1rme;Mh-X^@Wo8@O"/*pChAV^d=NN -Mi1r9bCqkMM<'\HBe(\d!/Yf-m^`;4Uq?pQXPp>2*e#`8*<=uX/B/&;>1OW_FZZ( -Q4@hV8]cHZS95b%GuXjM@e=dd%C/o-Ukq7%uV<1!@g?9ObMh$!#qh-O#'I+:[)Yq [3/8jhsI6?_JP,XU2X\Z\i\.`Z+L2G;OT*&Y+=EQg"g.">Y?8_%0qEC Q*"WVV3_?u2]"6eq*H#57%j-D!D@H4H=cKu2A6mcY^_s4RRJ6"E-pgl9-C\,$-V.% 0O@sXR[!E/:OB,X[sM'STj*5e]'u^c-diEAV$B]4cPA4T+>@*uUfW.4S])PlAfdhD 1V.FtZpH]HS]M@/S'N],DmF=dk2e3%5@/l7%?tXO$cJ3_!Vmo?f%nq7$*;\5`ur9*2=%1NN4(a O1+CH1]4GmqQ3QET)epk/>(/~> endstream endobj 140 0 obj <>stream 8;Z]!D0dB\%"j!.$i2p=?"3'ki!]]\q*j"m!m14)QBZ!1f./?q??t\rWO!u4L%RZ9 4Kc2#1B.8@IF<;;WS?P?MGfo9iAQW6YcCe@UHc:>Cd#5_Y0@@qrYK_oBn:@VBg!=p E#kJQrIS8dd:)EshJ>PZ0ra`L4V/ZRSsO\.rIS2fef/aR+0(;m*HoL>"iXIV;O)tNi%L%m/mmP-fQgm6$IJp!L1EM\WpYX.1`2N]sV_^17!!088' Z`E42+\u_oBecFjUIT'^KH/6-7*m_/E>r])5] ,5;NQ&")..=7(Ws,T+U:T_;ZHclH@VCA:=/6WcU-7^n,oHm$e'.l^0;$!fU?!d:k;2A[q#$?^USGOAm\1eL5^#l3_ !I:nK&O#]86:'\;dmo%f7o9)t/-3hASAA-q6XtZR;ES!7`=p^kB!?u7)jDV8XF:ZP W.XCVU@9Kkl;;@Tdl'NGEtH%820r4YJMG_*i(kp#[3"'Ckt,9AE4F(_?DR+p>Qpc3fPjSmuLqG<^Z`ChlsTdI/i31L9U[WE$$f?Pl.s irjklYtp"ciF>KO,@%l*j>upad-i@WM7S4T\3\?r4G?js(PRj9T''f-#R\/fpZ!," `mYaN`kS89-eg];bU#K)Qb3ePideY\m#H:Dfo7:'T+fg+_+oqMD1_>E>WpNn,L`(L lT.P2OWV`66S7p$.je)4behiIDd4DCY/'ZtXAO"R>G5uUn/"cr6c4I6!G5dpe5*HlPE5o/T67d*pfek!>')/da8OY(q?@dVIGS\ 1LE%Y>fG8X1`'cu.#6Fe8C)0=GX?ti,QqrWV^0;Mdi@sMDV:dgCfE-kLE>i2,6L@j PH(qDpDD;`g?Ru1UcV"@4mF9\"Z--#LmSJqLgXV`Y2*b]L%"l@hctX8!'A5,F8~> endstream endobj 158 0 obj <>stream 8;Z\t;%CGs$q#+9$i2nt9qA(q=4"n\_%16n.jVP:%1kHPfR[CB[XUF^?e!a!Uphh< h7TT[V`e_&TFu$!rjB!*F_*1cnr-kVM[;[o)jc*c#:E@^@6T;4c<+&*Kt*58k>o4= V>*uR*CECX7=ha&b@+s3gt_/h,;Su\@+^UcMaO1lKuMPA>f:-@bJ9%`FnFlZ(upKU C=-J&^%l`faAI*58_5)7:d('oLQ!(TN""m9D[@S?&4-XGKFgHU+bUEd:O*BL@aJ3W~> endstream endobj 169 0 obj <> endobj 197 0 obj <>stream hTU PSg >y^"ZD@G9bAR ! W0 J EE.CPD%4$1M>).Y,KD>RHkNyH&I2fY\݋gœB8Nd\\y8i6>İx#9a30O 6Xa!|l>G+^\xy^ b6AK2ݲ**7|-N$?k*~:'S$z@3: Qj3e^5)`rݳ?)U`k !r{l p}"RH`7:}MS+5!}Łrn <{GG,Eٓ-gFC~5sp87s<:b)/_< Jo0՚ONR(Dxc 0(Ȁ0d lvא- Y{k 7c}w|. >_類Ȧ]_wN3{UǘxNq/,Dw6UTښ04 G"t ĿM͇PWp[.oEchL3 0f]T!+kDhxޕ~Eb1vJ񲽩em[UvqYAAŒKnN|P)Lt-( 5D|[8f:"WČ/i76jduļM+7oFʤ8Პʫʾv{ ̣%YE9L2.1^;sm^7>¨55,j.>8^&S*coZ=\iIޤ_\KmONhH>Ξ,ImOD+u~9yٓWl &Xz}bOoid;W[&*uFxiRVqxRWf8-B%Ivz=\?E2Rh\:Ⴧbek|"zyP?6zK| ~'Xq(ݖ@!EQ\Kstc~гmQTןd(1TIE:3d % |N͡;8\BMuQ{+/@ݾ-rzQyqasݑS]Z8^i -?&#鵊„4yXC) ֍SkFdFv#4}V^)I##,$|TbRP!eII4 #j8=??z\eBӥr 8L#`Is WJ7&Kݩ< HV盅U7pذU0A'f+ӈ0$U{^u>F H Wx9!U@zڇOU Uuʔˎhp$$–f˔2e gIyLYlB@ʿ2 h <&kwJRZ,SQ8_\:P}@ߣQodTKOx7v] endstream endobj 189 0 obj <>stream hTMo ;@BFP.*4BI3u!6?43w?3xk+v\倓|fێ %t8xΞyl. ŹoΐA]Ërj@]A}& NNivRdƪ丶>stream hlVyT6Xc1.e5mB{pʈDLߢhY,E J7zyKI1//x=zB(7& x:&z%$;Uw3"w{lIjC_4y@5Ceghݠ}Hjf3Q'eb t ulGb( 4f.z Km<ꔃ p97CdAGGޘ-8Y% +X @~@{r/.=vxLIL@Ρ7`OpBe/&IpAk9!5m1&v\< h;.:,!#eަse<6*'2!5U'IXC{I=,/?螮 hrQq .0Bo0]䥊Rvrf)9+ /~.+-Qh4]:') s~=|ϫ *">0kֵ2$*X#vk͠jsh4n `Hi֘H9)ېMgɲܰ5h StFHJ9E<_8@+ʋ5`;,E ŏ\ l,ʦFd{3mwNp龒扻jP+!MOg0n^=[]t {S0ޙaaɱ]]qoaPk_>YAHVg1Ò+Z9Eig]mD{̣ǕEjnG!)K;ņDKװ_]hsrETĤ;rRa/YIlbV񴣚RTQ z =OÁڻAYtHM|x_ȞaF?IC>u,+%;G>Uϼ{ߍ<#4l8/ M^=cqOυTѥ2쥲A [7{ oLVVS}(+S~>stream hTMo ;@BۤPk5}hv'tHz迟 ]_^~ -3tw-BCvj@|L3{ߍt8}q5:?X~|q8 hp }6 ?x *kh A+׀@e&~(tQPzIH0i j\7l.(LjGԲ 4 MKҫ:(hIl>stream hlWwXٲǀӾnDEE%# A$`Z(HP * v1Vs~q{:WuxJ<rVګc //hn*Zr16OܧB}NK?}tקa;Ќ)*V**gTTzUL%! D\|.&cȇj(;QW]$ *e6c0Lƣyb!HF +d12z݄' 'B#"KB8-X"UJ_WGl:R:o&bc=ѝ+]LedqܱxL}Ȥ[HqԵ2OߍށVlx}tCrFzl:bnõlH D:fCY#* k/yۘ%|tX+@`4=3&7+1VdHY3hZp|̒ڀfzPM%h1ŠZ%Dvށلok2x-L'h"uB L( Cnc_ -p/tD}CD_A"Spz,XKS_ 7GEh2 gQlM<!D,vQ>\{/ i,&v\E@4ů!U6aۼ뉊S-Xi#]v5z7bkDӰg6gi@jn|fY'1DӞ+oe=ֵ//ޱ@}ޥ">:7G8BZGCՅ'KΨ9b{­c(t܊34PFt m0&j0[Py$[q؍JNf+<%cZTRLH$cvM[/M4SGAf,B[Clx>{b_8GOR:Oa X^s~zIGGډ]>( D+4D)̂i9޵?i8yCv@|5sN93P3e՝j83"7[y1R<ZI/3BwTiIiU ܺ4`fRCj @prEK=K u9mx*u!3s'@|݇&ۯ$],$џJ%õ"Z+/ZY1'.ՅH"ʮȺTrYb癶^c>̔*ӷsj^M}MHQj3M615-{=;FEnJsR E`ɰD|ǵn2v4q-q+@ڷt8_u%g7D6үF`!"LEH +\E`sHUY (xMDsf_DRw5pj2aI$L},V{%γu5e]Wl 0Wt_i dj} i {vFzzR֌Qz@_x(in+,*G t-u@څxq4ڥؘF8$ $Cr|]Xx]lu>޾޺U (A!h`CsAMٹkM"s}p47pfB _ iB>)x:]p:pr$k`$3wԝ V_qokZbE4E,<5u9vw"Ge /#pѽ1C=TǃoKc#v-ӵWgwA0V,LJ: ITȉ GbDHIJT˂}RhHSGMܯzcZ/ɭhèU VjdExi sl< g`VCPNQ8/dJeRw̛݊ʯ]_;iPC;ow3v 7VUM;->_fk|j)SGZ;}sŽAя ߶^lEX?.Qރ`+7~gѶ渙i17>li- n._ LD$zao?(y>/DHB3TÅw`h,­ %uXxUBF_“'&V\^Gǚ[cyZwPܐ)-!a!*`+<%4ɥHW淪E&JZtAWIz | ZKiԿt[0Z FC*4!X@.D"ݢGc/6I.- $l,ZKKr2d')QXƾ~/#lǰBɝjCt΋:ם"<}/H A;.(cJ y# >αEkzr @ ņ]9Yo-PeC0<"qϮZ}xVG4)%͆N}rxܒʗ=-|~nMpбumf9rD,T?%i@0Rȋs+R@ [-Tt {Ps6LG&j.@R̲Z0qj%l1@fn;'Q)9iYiM^}2zs.MN ]8_dy}Azh&Y t(tH Ou-`r6+M>[/`CrL_p6f|ӀiJbRlZ"7 bCjU_B Y +iojJ:`ѹp_[/i.FtɗMjXy9BK dGG[ߢCstnN&Fw8^RGXFն\w)֮"Q\rk]b1QAϵ5شe$UU#۳0߱_s}2 Gxا<.=Dמ8pCMMɎ=ko3z pj#2$__,+JP=_||qFF7Äu&Xhn<"'QyW_d46&.r˷jOH,\~ \$bZ71m6ޖr)2EH3Ckk\== 䈄څr(YxW8VUXYXF DHd`6i=712IK'DryEBv֎;e3řYdb‚#cRbv\pʹxP"R5elJ;VgEBRͺdc' jEJk ,(6xE=]} WHl 霓HoV\Xmnr &Yq.Ֆ:\Cjq(l, cF|o*D"*?-U|92_mzG[cTCe˩}: 9-0k\U]R~*xDXLtxDiI6~e%QUsj.Q`6S endstream endobj 192 0 obj <>stream hTMo0 ;@R@BHkJ=Ck{HL4B~v6!?fRN£JN B& 4]TSESg3\{]qG ԩHy`y(Y|HR$թބ9+ N* 2֔C6HB6M8GUɢ'(1~'2yڽO-#_] endstream endobj 170 0 obj <>stream HVMs6We,ANOJm'Lh RCRV_߷e[xݷ1Qf22BF :jKTޞtiTt_g" oGd<`S–~M푘(X6@;Cʡ L@p džQ "/tpJũG!f\A`v;kODO͐+q{" $v8@M!RKh3);Ao#c-½ gM7\ʚ;FmZ@:IHbS$zY λ1EqlC^yXj:|Я4 (}" ڇѰodz9^Mf}[* EvxY}Oz{68HnU".2q. :SxpLQxO6G2*^&.жYS0%sXdgQk0Zs ^Ɖ eO_So0sϰfE ݴ9]WaR&+sfl(E BA{}6$/e( ikJx/R暒xA$5y#]@7#|%x nHv:Tͦ&;b1fl|1$&ITH ̮r/I~K4((j*LMS)M]eCI*CgN0GtV]xlII*0yai]vw5 ^ʾ}~6>+Wjy^' )ʁX `%& endstream endobj 207 0 obj <>stream hbd`ab`ddprtuvL) {XHxdl(}Wcߍ!|KWh]z@ bD~!%gQȏElY ՗?@ bD~:8CCmiꌕ;z,\[s`{C֙_]X\h?9uyWm>stream hTn {bˋR`cCH"ȏKz k)q` vg>.5[p:֠6*U,=qsBߓİᾺ4c'8]WqF!@Hh,hz#R`qRavBlVۉaT_2YUQ,HGqިdj8pZ7p˭җʚJXm;#C~x endstream endobj 171 0 obj <>stream HVˎ6+fSnGEvG6dBh, "pWGEw8>~}Iҵޖݏ>XR G׬lYWS=zp.ΨemE_ Z'9 u>֝\h$Fi?(\OTEZd!X{9+Ff#S3p$ EHr v| hcjqಁM4HOQ ͬ($ 9ح"&OwE?$#Ն 4MD9]CTuAu@A[冴nyvHJ hE?#t=J<#aҺ̳KqD-l.#VWFHcybWؠh**:WO2G>stream hdV TTGh=l%H0nAPG! DQ١d aueQE\ (lFI?N⨉sS3S8s;yU{_ :ZP~g--MX7"=;?A朒 ˜FÕVVfcC+VWF'D6thbhTF)BBc b'ݢ"c躡;# ,V[X_!}z:yZV DW`-0X v"$pȅd+ 8`KpDpWH*<&2֊z-.MRdP)W/qPwZA=3g4x"?4S{WgYI1y%&ds-nXrPkP*WIuFK7Ɯm8zVopXNLv0)rE(X2Ć Ldť0 A:-ͥofZE8J"^d@ N?/Hm\L#"޺9Z[vEK>."vd1lAF&7vAi4CW{_=zkBzn/܂N6|[~ը[,ʅ'Ԃk7{m7(귂zK9_V`Jc掠+" !)G?S\wg(C2CRBFBS^LIy~!(z@xj 7FOAuo*/byQh-!3YM9{'.ts-m=GNJYсIi{ZYsMά ?6j|S0uD`4&:07azd+{s@wN{JjR W7}ufdt }Ґ h/'7 %2|*L|yր/A\,vjo@t|| tq;C"pp مҢ2hN/4k׿kx_JKhPi{K˂qwԱ¶]޾샻's7`>y cna72F_`>-%$gp)KI:Mj "#\c*ۑٟ/{~ oߢ+th䟒 xݶsnӅT%;5 %"+^94`POh&;$,tjܛԽw܀se?ESjPm]d)%Fgd^fHaH,m#Kly0yDmg5h|f q_U{4?Ɲp չ.kdmA.NgVz07)lafq1x=pvđ bx EɢI^=s聎{%NY'k VgcQak6}R1Q##y"0~DOv_p^#yM|ZxxW9d5ѳ9 Knm. =` 4Q8 ̨X>|)&]Av}/z,D8b)}hq R +iUhIb^fqq rq~WɼDbfye/L/\,)_"Y[ vL% ad#Yozart.gɳwEHk!LMsn`߂>̭T½7"::7!7݅RȟM*+N <*+l>wisn^e*vs9>=_%fUxQ3Vu@}ABڢjkm_پI7\3hd^I=s;z=ZY;2?ծs'Ȗ]qύ= ~ķ7sPNjMdİ l4K@68S2! Xf |X{zgF G+PMp.Л Ow#J(?3=?u!wTr*\|UD;9m #I]y7o9S}FM[SG[S ٩TXi댬 M00+&jnh\/R*o’!JKKbÓ+jjJe!DDDYGYopeǵv Oqd (+\/FJ8?pQVSWPg)PrXtQta:FH OO};.lf4Ht'TJ _񯠧n8Q}ǔ+B [Ґ1^Ib"Q]N?]@h ҿ0ؿ340,*lhJl^RWwgxDoLw٤:3Y8mYmiwB6e,%FeP +' 0"4 endstream endobj 211 0 obj <>stream hTN0EYX8oRBꂇha88.إE9w{;, d@?\ǽ'k!p^V=Wߡ 's8] {!ڽA2/! xpvڠPg-@?y$|i/\Se䏍K4DIoF/m$Tf[򌍈u.V MFGH㦌eHHFHՒV6d(FT ň*"9-Ksb irt86ďܘ endstream endobj 172 0 obj <>stream HVrF+pDdV,[ǥcӕHXd?W[򺇠%KR)Vz==ݯ3*\euuYb-FH*" H@< "J~]\8? bZ"AKʾ*eTϿHE닅VxJ$Z?_~CTBPIvTF2ȖD@_؏+o;3g`0  =kߕ! c_B&ʷ}Pm]һ Nj!ALCkaGi'ɰ.((8TyFAϋʹ% "C= dI Y;ĆF.n n<THy>"cel8Ou>C$82(>$5qP8]0޴} c695fXeDRDl+O4I1z z T4g۾ؔOxl܍NhH9qBWjJvXQO)uz z6$|Jz\XJ"'& (LDI.wS9qxzEφ*'JCQۣVWu GKKz>gn3_緡ұ<ov Iįf(f ~$'6mR0/3W*`2JcLQ4 4N0,Qs3_ FV#H; >5q( UѲb`ewРKҿX'6 @tkiԓ'1V)(y ͷI@K D3Ѐ'8Cp8S: pЋyH3d)1In6o}ewɛl@>(e(2PY=m0WM$uΗ=`3iAo|_ȄՑ3z^SѝN͡-=G3}aeP"VCJk0xFNrި)]Uzh!Yһ n$%k|tѷp3G"CU endstream endobj 173 0 obj <>stream HtVn6Sx8"){؋MQ'F3E{!kXH~LI|矻3ͥ*d^Uiu7T( E]j_Vqg XI^ [ZIܰۯ~VE.ǰ*6:Ru׻˷un i>x:+o~S=㴈vv?.VgP,8|ZcC_ۤղgE*~?BI@c0~z) 1jo|Q*u :j gv`.yʡQ֧ۏ <$+*ZA }Sz1=Sw ٞE GS;#% F|HDPjƜԢBH*-5<>rl_w4:Ղʣ'!ʖBê`DxOa ?ߘ6W`A% _ģa(oCJz B.dQ14ŵ6g u#RߥyH]p-4FLjޥ_>f e_.Q6bJ:Og4N3Zx! )~2fnzQ-c$Al)} ~2áќbg|(aiV3HS{J[ /- ) ط<! ӄXE"dHaT#+6!aK Bܱ5"Y䟳/H,6D4]yh%IT_Mt$,qQJ&ݥMx(_$!U2XG,I#5s&J 4hT٫9Ǹs/ )5HWsz _A,-.}xj' 9  d! s"֔/(,,Q[RV5?U0-%-ÂrJ?dx FtD:k2g ~D$LuO0!M#aO>ՃP[O9Sڅ@((. ! endstream endobj 174 0 obj <>stream Hl9zd;FZ݀ S O4UKlqI6S/}I`MItYkAOQ^ {QJ *@#uҳۊYv|*†{FU\/;U+'asAʸN *EzRJզLxlr;kv*vV'}fg!qɲv'oaKE9x~c_thV,@'䙪Ͻ,vcf>+Tzcrl[\z\ , ]PX"SW;0NkzC}-T;!a4Ẕ2miʱBm`+FJlN źں;ygZpp8n+ٽ3F2 zH芺`8kA`ɸy,PDW^Q_ J <$kpvjD$O2b>6Kt7񠱲G(_*u %Li^B~ƧvAQm1|I݋u ]Nn}&{/ u)h1!>stream HlV;$) \ >w=CElQϘ;)Tlѕ>)}H>1+צ( Jjw_XB~]%JȨ MҠB|MKqcg^VW/5ok!s~-T\X0ޏx(<ٖJB4Gk@Hnc(.xc4R&Hx} JHih b-z,>r`ڽOw3$W4O)6#( }K{e_e oӆ4(CZfD}U}iRI2w$l V_2 .WT$yXC7ؘ S}~^*#:ȍ8iPN A0׶3okn[Iɟ`QB f@_:{#[jԈ`q@$,n~$M@9Bp;' @F{w}*+tqZ O=!\E|;:Ks ͨU@0YP3z^ cӫp2*WQ`^@J5igw?F>`aﯮ({A髋dCVxxENFb )ڏn\mq}B:T}_Ķ*OL6҇rusP|P[ {~. TΓ'(9/'Nh!keEMna}mykS%0Pv2k1f|Ϥk/Ϭ J>x^VC5?$q_Mc7 PΉ185k<׊J{'5 _C+u mf_AG):/jq£P8 (_ hm/&<"/ %Dщ&2صLڑ"4kv7v2'f*4.F9/".VS"2k8^52`ر;A!̷M ES|_ <)bO V oeuLN *j[E;4(1AbUTyŭ]vڀi'Mg{oW0!MK5ĉ75<՛bЖCq=@mbBq}H0xn\8 ⱑz s;yWEHKwܗO y endstream endobj 176 0 obj <>stream HdK,)絊@zrru?Fv~E'LR|酦>?Jc1n擓.$ԙpzVHC\AkkQ赞WA0Jv,\>0jXچ }kx'4k~ldf"kiZeƇj^jQUBߟ֊OEzl7qdžqKi5vx Rwc5]RD֢x2sg.Z~\ǝ75߂™)gv,&2GIX;Q3|fWA0q0V"buFA2ˋ~SB\$.J{}YWrY\.d21{~u{ŊwΫ#50-w~D/], wE4 pYnƉ=heOEڸ6Ud)#;Yv{}:347tK3;`m&q\y6ret_ۥY\vȪUQ5 ߄PoR7^rPGnY\8D6EpY#ؼ^~<8hP|)}`+jmK}؟C?^ p=s~G:-!ڞG'#ѼJDŽ Cw^!i,HB)hL['{` x'aw;- WݕNwvS(4hoEPTTr(8vȫaZ5.2 1&HҚ ǂUיӛ ~9\}͔KG@d{ 3?jū{5+sdg `q jBzD2\(=~Vl{7_4K\ђ%A%ʳ~,] D~b?P%{VZ ѹY .#,Au$MB9]m ;0?yFp&(J)zȋCCA/ȟf _ussv:^ry/%W^y endstream endobj 177 0 obj <>stream HdWn&7 )L(KluW70pfHQ?aHKRIT PNsRf@JM^R"\`I]K%=X0'V7N_X]J,ݐ]R6[p8AwHͶ璸nTĝ- -v %J8jʕs>>.U`$<f5U :Ab4˕T3fXj* X#}j;0HO]sPEiuJ%X3fe qH=W|]^xĬAr-nlӾ2l',6ޒvw5TDRy r谝 :93==b dG Ÿ^`}|/DxME\8_W8.?oyjU.mW._fc]h?  `!}څ=f:y, ޱ!`<ΨRawkJZbc!b7\q8N<CNj56bxx\cI"igǥ^B0bMsn?@ot~,XtigLEFMbc&i; e(&Fd=8x_ųV^x q)k{+ lC_2ZӃazcX0!^\q'>&"˰֋1&k?<| |+<粓bDž;^MXA_O1, B9*mA]K J[#kB.^ ǔPpqu@L =ŨZs,GzD_va=/-~Mk[gKTCbd!ȂHLJbߕg'HӠh"r$TQ{xk*g@%z5<.ZgڳL׳gj=Ժ~T~=vk#'Eg(u۵Ρ¾p|ݛ0I!Ku~^~?ޮ?כ_5|>?Z܍G>Eu'{T] endstream endobj 208 0 obj <>stream htXiTW6 *"qK\H"n(FPT\A}m֦m١hVd\PMq51'پd2o1UkfdNS?}svt3eMk7oKFEJc#KxrXL@DhT*]=aciڤۛy,}wX=#M)NsM OJMNJ DFwsJHpfGHs* D"bB$x(7$IFrzĈInwiaii#G@:88r0 geV:8xQy4B5q@pG#_G-U2jha G0f1=xBI\'_%-;%8u0:qANg=I҃ &,7A1' FDi/9Ó&'uL^2lW_1rw唫G59:g9O37,\1[&6q W_|*F"x S׍JTzuF!O |nEx\wrW9K$)<5_3wzv.X0 f[Vb#ta a'!!B|Ge2en Nap$q13Pwh,ھݙ|i#Ỏ<w+~ݶ4O6<oh-mW{}TG`V'gMDHj;r;P#$طzMq$yJ|BBb Ǡ؋^'oY'> eԊ+eX O_^ٶGO{`ݙ;g.;>,?:q;w=*2nt-(fVs.x"v8vԙޣQ[C:.OehTY9\Ǽc}v ]oVscDvPgOӟWJ5;U| +߇w٨}̊r#*پ5T \9 Ȇ{&KQw`%řUq :*Nʠd {nRTBʋG*Aj}zx3cm4,k-ﰸ %!uNwZq2΃451V-ꙛxO'v\H'd\^^ӝr<Kl4p8a7xA1ӏ^/ԝb`-7v^.>@p ~q>e癭S)VLmC0|MM˖(7JX *oObla:kfk#(%wvN@{>]zFT[fRӈV`}܍$OVd` «bP)W iCަwiHB0C{WהSծw fu4^ߓ P >Nm$ H' y!3SlVބщ?20 \?pn45 6rEQ apՅK:l{ݬWp ) w? ^V l1QsmzJ: V )ꎥApX>UWfz#(@F6IeŊ .9kiM.~ Z6MLRPO^n_GW323oа + t\˾W.6mL߆[8L. oި7}XjVaaHB'rF'` J69 a%ׄrÿ? &qʈ+x#d<Ujʆ֘ ?4#BB 0$=^d!gYRv^܇Ms8>J&5#?ѢWtջM6mDQo a!%v8=6!x1K8fbg3dO=˰ 'pǣ Vv~۾k%/4ʭi؀M6]ځ#\Mс4_>Yאٛ0< ô>Jz`=Ov+v[vέqJ $X!e sLU`7P9g}y.Iaυ,fLMoaP~987M|Q6y#ߚUm!Os* y#x 濠J T v]c]衤dV-IJٵYp;&߼.f[3<$c%d;&HkyM=~2Ӯ}B:C_zԯy԰ͤmvK"՚GsMd$F>" JdžbΎhH/d]`ǐ+, n4nDr=W0xܶ;C=%[pO=ÖG,XЯ5n4TFi5aT-`x.|MH҇lvАV5t#\$߳XN\E,# K]AKyROO |K(U 5tqcT'CgtւΥ.nO_"U5`]1ԖCKf{ˎ`pTtW+yv<_m9YdOfB&d9amMH%rltkSZ5w5hF2n9mh!-x* u{̮ջ Ԛt<$FXG8H^H!G|G~#GI肅[IT3D7+᷑E~L.LB:Wq2 (^jl9]4P2EecW9Wp&Rb*AɪsҙĎ!8sOBʑ26Їl;\QqPϖV}({-%߉E>{Lg/]4e; '9.r!}(ջ[~M9.¢ jVIs, rU Cq9 7`!-{B+5iG q)W^^rn5ҵYz:u5N'}O?@gTt^DZ(p!{C'חp0P>ᰨ_/Τ_'첵ᩳ?i:-Y_uGkrw I&XQP> @9 RR 1HJhNs{fu4*4erW%2VU-LMa%Z!/ؤa/S2K|O{CC[kz8F/^q߶0I@ 8>M2£rOJ!J0Ŵʶ٥,72%$dٱer!203϶كٹʳ.<Gt¿ 2^(P+r#R3O-Q VrI^z#~OA;2__(6\'2Պb qƓ4tgemh%'0C EKP- FvwdE)Fb_Ah_ѝ_-߼%Mf' n`v|c|rOK_ҏ=WfOcENPo_G];s6z3#Ѫu="BYe!DȘ {+Z~?i?3_ G<L$ws?~2ȉ Pf堮Ek wf Q>s_$F6*0˂J{eLI}Ϸ0 *‹%x"Y܎=Gm# !BRI(w}эo"wgJVk<|A| ?tzE)?CU2= go;Ip{S9B(kNC::tTT4Yl͝c#cx_ t`wFsUSµ\ 5",Ԩs u9}{]#eԥ(bg˞Q ,-6*C둌cO|aDTCA[}c ]X*LKEl.ezdSzzz5F{%g |Б&6Hg;8i-Zmc cw95KiBq9ylz8S^]LԮ=B"@ s_?{၌ڡ>YդحSͺ\ eg@)-V &#kŁJT+{ʦMN2)pbIu~ JԤ+LU٩" qBTPQK5:}J4BSnhGYu\,E9%LqQEg1c~)Sj.怅E%kӹ۔Y]R"!yO@RiU{+QQ' r7>뛍p%4T6`{ćdj5J!IZR_\>OQ 92:7+>']S1bBS_]Et pX&TWu. "f%&3!ȂSw^}Nh Zh?Ce̒&'Zl6,m#&m_~1u 'eˑlE>&mazUqjSv$kmOዘ@ Vl0b MDA(/"uWCNm]Cw al5u7mnk7{u 0u|\,.|aĢs4<m+]m5~ЩB2S41x 8ouWZ-8ݸSf2LH2Լ³M1UW0 D&2O({*⺪FڬkK$eik~xH=.& sÓpyfN2JR^,e|qmdMqE[SY.̶A2jEҘLDiWyvܱ=cW6qttbb^@sS1fS%j\nW0V$6%;>/De&֦_z7u\2C^LŒX4O%%Rk0 '' endstream endobj 196 0 obj <>stream hctYwfNm۶ݦm6S35ӎvk+haSX*r+ mB*B:#J *=2L*2Ȣ2!l* *+sl̥3<*'|*,B* "*?LPu*:QWEt UTT *KD],r(ˣR"JJ2*(kTE9Q!kJF-T6jQUF}0IF#$QlfS1%ꛭlf42ۢNGfgȮhiuC+;Z[=Fz^hgF{:X}NV9b BW{0C*==eDo{أǢ=`O@{Av2;LPg 9S4 wc3#hg1\ua3,0]I$K1])rSݕtw5gk83Zrqs nOy&|Ƴs _|W5/ox)Ïy%)L>s^KވfN~[׼};ѷ+Ey?ć|"7>>_e~_7٦ endstream endobj 213 0 obj <>stream hdRkhWD:53wUI-n  ͎ɤN2I4`"J -HIc[bEkKfл%Cp?ι|+HcS~c$9 E*s |s a؛UˈKN#՝fL WW=dYˈl=iZO2"9ef֭!n{gһ kII/n}̝l2#:4x*YnZ؃ Hq/1!]$@BJ )H"Rg&nG42L"Ra GG W7&fCރ2TP 8`:i>3lbIIޅgpe c7&@j(ΪXBKmC;(?{*pB5A'GIENiM!8YbSKPEFY _AoxCӑq bkѼkb˸ (lލS\홻_ޙVl)e:P"cſkdg]c{0HŇa^zP F\lANM^),"\΋" E=ͣ :968ޯ˛o|+Y)(A-}!իXS%@ TlM~zZks%{];G z\צ9xkhOk(r"V0AzPCB-Ѝ?UXvpC+}m^I 0bR endstream endobj 214 0 obj <>stream hT{PSWo[XژkQj-*VPE","@ $+| < D 򲁪GaF;>+L[;:'w~|?3{8/p8䦈ϣ? [潠<dzhWW8,&s|o\f.-Pʲ( #aRɅ[3,C! #rs e0A"Ȋä v!_!B"HYA[afa}D,/°Ssr!(qesq_>NGپ.% grt@o٤lb+b Vwϣ"[3erlN{arOKӖxKg}/nU@C5+ ALԳ{W5D$ ."N-KKYOIkA-ʽ @;P>X2tPkNU6W\RFV>:CZWκ7s?h>EJ J pȮ:E㵕5GU*Oɔ rUCL~}mgស2?YFX+:֜Gsm>=9uI> endstream endobj 205 0 obj <>stream hTMo0 ;hRġ*q؇F{H TB?'N;$vSmF٠Npg'Z쵁,ߢxAX`T,ǡ6'쓒w c)td_+h>stream h0y{iMVQVU{HUmV^MPM4CPYT*U|=4MSPvv|Aa6Ś'ͷtdanYԐ&/rn(4%ibDS[3FЅcV>o>ZissU| \m%aUhx%Cy(@Grw̲)u]ab/A* mY<%Ya2%]ӝL9=(e()\KSb͟24Fdo!diqXa_VɌX '큉rI#AI_BT-VJ_9t2G_ih1Gn\rl4޸4Hu+%.  7/ qO_qqdL 2A& 係̢6ӵ 0h endstream endobj 216 0 obj <>stream xmp.iid:d0842138-58f9-3c48-b98f-13cc4cf6e47d adobe:docid:indd:0ef749b8-0197-11dd-8960-baa5a32fb729 xmp.did:d0842138-58f9-3c48-b98f-13cc4cf6e47d proof:pdf xmp.iid:387da688-e536-464e-b035-55eedf9e2489 xmp.did:387da688-e536-464e-b035-55eedf9e2489 adobe:docid:indd:0ef749b8-0197-11dd-8960-baa5a32fb729 proof:pdf converted from application/x-indesign to application/pdf Adobe InDesign CC 2015 (Macintosh) / 2021-03-26T20:32:06+05:30 saved xmp.iid:387da688-e536-464e-b035-55eedf9e2489 2021-03-29T17:30:50+05:30 Adobe Illustrator CC 22.1 (Windows) / converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:d0842138-58f9-3c48-b98f-13cc4cf6e47d 2021-04-03T17:37:42+05:30 Adobe Illustrator 25.2 (Windows) / 2021-04-03T17:37:42+05:30 2021-04-03T17:37:42+05:30 2021-04-03T17:37:42+05:30 Adobe Illustrator 25.2 (Windows) 256 80 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoK DBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxscHx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8f Hx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8f/8AAEQgAUAEAAwER AAIRAQMRAf/EAaIAAAAHAQEBAQEAAAAAAAAAAAQFAwIGAQAHCAkKCwEAAgIDAQEBAQEAAAAAAAAA AQACAwQFBgcICQoLEAACAQMDAgQCBgcDBAIGAnMBAgMRBAAFIRIxQVEGE2EicYEUMpGhBxWxQiPB UtHhMxZi8CRygvElQzRTkqKyY3PCNUQnk6OzNhdUZHTD0uIIJoMJChgZhJRFRqS0VtNVKBry4/PE 1OT0ZXWFlaW1xdXl9WZ2hpamtsbW5vY3R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo+Ck5SVlpeYmZ qbnJ2en5KjpKWmp6ipqqusra6voRAAICAQIDBQUEBQYECAMDbQEAAhEDBCESMUEFURNhIgZxgZEy obHwFMHR4SNCFVJicvEzJDRDghaSUyWiY7LCB3PSNeJEgxdUkwgJChgZJjZFGidkdFU38qOzwygp 0+PzhJSktMTU5PRldYWVpbXF1eX1RlZmdoaWprbG1ub2R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo +DlJWWl5iZmpucnZ6fkqOkpaanqKmqq6ytrq+v/aAAwDAQACEQMRAD8A9QamupNYTjS3hj1Aofqz 3KPJCH7c0Ro2I+TDFXz357/PP84vJ/nBfLF1Y6Fd3cwia1mhhuwkiznin27kcTyBBril7n5XTzot tIfNU2nS3LFTCumRTxIop8YczySlt+lAMUJ1irsVdirsVdirsVdirsVdirsVdirsVdirG/zEs/MF z5R1D9A6u2i6jBE86XSRpLyEcbMYjzB4hzT41+IdsVeV/wDOJuo6hqOieZLzULmW8u5r6Npbid2k kZvS6szEk4pL3jFDsVdirsVdirx7UZb782fMfmLy5ZazPpHlTy8yWly9iVE97ePy58nINIYvTK8R 9o7/ACVZd+Vn5a235faDcaRbahNqEc9y10HmUJw5IqcVUEj9ipPfFWZ4q7FXYq7FXYq7FXYq7FXy h/zkP/5PbQ/+MOn/APUS+KX1fihjfmL8x/JPl28Sx1bVYob+QApYxLJcXJB6H0IFlk7fy4qp6D+a HkLXr/8AR2m6xE2o1oLGdZLW4JHYQ3CxSE99hiqd6trejaNafXNXv7fTrTkE+sXcqQx8jUheUhUV NOmKoXQPN/lfzF6/6C1W21P6rw+s/VpFk9P1OXDlxJpy4NT5Yqpap568k6TK8Op6/p1lPGSHhnuo Y5AV6jgzBqivSmKptY31nf2cF7ZTJcWlyiy288ZDI6OKqysOoIxVKLbz35Our/ULG31e2luNKi9f UuDgxwR1IrJL/dilNxyqO+KoXyr+Z3kTzXd3Vn5f1eK+ubNfUuIgskZCA8S6+qqc1BIBZajceOKo uy88+UL7WZ9FstXtrrUrWBrq5ghcSCKGNlR2d1qi0LrUFq4qx67/AD4/KO1vxYy+ZLczk8eUSTSx V6bzRo8Q/wCCxVnNvcQXNvFcW8izW8yLJDKhDI6MKqysNiCDUHFUFr3mTQfL9g1/rd/Dp9ou3qzu FqfBR1Y+yiuKpJ5U/Nf8vPNd0bPQdbhuruhItmWSCVgBUlI51jZqDrxBxVO/Mv8Ayjmq/wDMHcf8 mmxV4f8A84e/8oz5g/5jYv8Ak1ikvoHFDsVYnq35r/l/pWoPptzq6y38W01rZxT3skZHXmtrHMUp /lYqjPLP5geTPM7OmhatBezRislsCUnUdKtDIEkH0riqY67rFjo2j3ep3txHbW1rE0jTTNxQECoB 3HU7UG5xV87f84w+evK2iaJrw8w6za2F1d3qTKLqVY2krH8TDkRXfFJfSGnajYalYw3+n3CXVlcL zguImDI6nurDqMUIjFXYq7FXYq7FXYq7FXYq+UP+ch//ACe2h/8AGHT/APqJfFL3383vOk3k3yBq et2oBvkVYLGoqBNMwRWI/wAipb3pihhX/OMvlWJPKcvnTUK3ev8AmGeZ5L6b4pRDHI0fHk1T8ciM zHvt4DFSiP8AnJTyLZ6v5Im8yW0Yi13QONzDdx/DI0AYCRCw3ooPqL4EbdTioTD8jfNzef8A8tk/ T6Jf3dnK9hfmdVcTcEVkkZSKEtHIAT3NcVLzr/nDX/pr/wDt3f8AY1ikp9/zlX5b0BfI6a2mnwJq /wBehiN+karMyOj8lZwAWHwjrioZ3+XejadrX5NeX9K1KIzWN5pNvHcRB3jLKYx0eMqw+g4oeAfk 1+X+l65+Ynmvyrdzzjy7ZvL9Zskco10lrdenDHLIvFuAJ5njSpAxSXuXlz/nH78t9BvtUubW1nmi 1W3azlsriYyQxwSMrOkeyyfEUG7Ox98UPEfyg8heXb787fNnlq6jlk0XTF1COO09V1WWO2v4oo45 yhUyJSjFTsWArikvVfz5/LvyRF+Vuq3tpotnZXmmRxyWVxawxwun71FK1RRVSpIIP68UJn/zjleX dz+TujmRvUkhNzDDzNPhS4kCKTvsOnyxUof8uPy216e+1bzD+Z1ta6rr15NwsI5it1FbWw/YhjYG OMMf5d6depxV5j+ZXlfQfLX/ADkN5L/QEMdhFfXenS3NpbURElN76b0RaBA8dPhAp18cUvpPzL/y jmq/8wdx/wAmmxQ8P/5w9/5RnzB/zGxf8msUl9A4oeTf85Jef9Q8p+SI7fS5Wg1LWpTbR3KGjxQq vKZkPZtwoPateuKhOvyO8lWHlf8AL3SxFEo1HU4I77Urggeo8s6iQIzDtGrcQOnfucVec/8AOTvl VtFk0r8xfL5On6zbXSwXlzBRGYspMMreJXgUav2gQDtikPQ9L/w9+Z35Y6Vreu6dDeGS2ef0pASk d1GGhlZBt+2jUxQ8h/5xh8heTvM2ga1Pr2kwajNb3caQvMpJVTHUgUI74pL6W0vS9P0rT4NO06Bb axtl4W9umyoo7DFCKxV2KuxV2KuxV2KuxV2KvlD/AJyH/wDJ7aH/AMYdP/6iXxS9k/5yK8uXmufl ZqUdlEZrmweK+WJQSxWFqSUA60jZm+jFCXf84weZLbVPywttNEgN5os0ttcJ+0ElkaaJqeBV+I/1 TipT7899atNK/KnzBJcMA13bmygTu0lwfTAHyBLfIYqx3/nFzyze6P8Alt9bvFaN9ZunvYI2FKQc Ejjan+XwLD2IxSWD/wDOHNxDHd+bLN243MiWMiRHZisTXCuaf5JkUH54qWW/85Y39lH+XNvZPPGt 5PfwyQ25YeoyIknJgvUhaipxQGe/lF/5K/yt/wBsy2/5NjFXjf8Azj1/5Orz587v/qPGKS+ksUPm v8kv/WkfP3/b2/7qkWKS9V/Pv/yUPmT/AIwR/wDJ+PFCRf8AOPOoQ6d+RtrqE4Jgs/r9xKF3bhFN I7UHjQYqUr/LrXfNX5wpqWqalqsuh+WrS4+qxaLpMnozyngHJuLr++48XA+DiG38MVYX+Znl3yr5 d/PTyFYaDBDaqt3p8l8iOZJPUa/BDTO7PIWKUNXPTFIfSfmX/lHNV/5g7j/k02KHh/8Azh7/AMoz 5g/5jYv+TWKS+gcUPBv+cufLl5feVNI1u3jMkekXEiXXGvwRXSqOZHSnOJV+nFIel/lN5ktvMX5d 6FqMDh3FpHb3QB3WeBRFKD4fEtR7EYoYD/zlhrVpa/l7a6UzA3mp3sfoxDrwgBd3p4AlV+nFIZj+ V/lu88t/lDpekXqsl3FYzS3ET/aR7lpLhkPuhl4/Rih5z/zh7/yjPmD/AJjYv+TWKS+gcUOxV2Ku xV2KuxV2KuxVaskbOyKwLpTmoIqK9Kj3xV8vfnNYSaz/AM5IeXtNtlLyEackoHZVmaWQ7dlj+I4p fUZAIodwcUPNZfyS0/TvMcvmPyVqs/lbUrgEXUEMaXFlKGNSGtpOIpXegYAdqYqvu/yek8xalaXv nzXZvMcdg3O10yOBLGxD1+08KNI0h7fE/t02xV6NHGkaLHGoREAVEUUAA2AAGKvFtU/5xotf8Wy+ Y/LHma88uSTyvNJDbpzZWkPJ1ikWSIqhP7LBh26Yraaa7/zj15d1by+dOm1K7l1Oe4inv/MF4frd 9MsQYekruQI0q9QFFPY9cVTvQ/yrbQPLq6Lo/mnWbdU4CO4klhnMaJyPpxRyRNGity7L2GKpDoH/ ADj7b+X9Wu9X0fzZq9rqV8GF3cj6q7Sc39RuQeFhu4r0xV6DNoepSeWxpK63dxXwVF/TSrB9ZJVw xbiYzDVgOJ+DocVee6P/AM4+W2ja/d+YdM82avbazfer9cvF+qlpPXcSScg0JU8nAbp1xVlPnz8u 5PONh+jbnX7+x0ySFYruztRBwnKvzDuXjd61A+yQMVQXkf8AKS38p2TaVDrt/f6C6TRvo90IDAfr Ao5qkaydzsGpirFNG/5xxufL2r3Nx5Z86alo+mXe09lDGpkKg1UesX4/DWisYiRiqv5v/wCcafLO tfo6bTNSudJ1Gycvc6i1bq4umZg5klkd0f1QRs9dvDYYqy+X8uJv8MR6Fa+ZNVt+RkbUNQMiXFzd GZeL+o9wkvEeAQLTFUo8gfknbeRrrno3mLUvqckiy3enyC3MMxUEDn+65jr+yRir0rFVG8s7S9tJ rO8hS4tbhGjngkUMjowoysp2IIxV5xpX5MT+Vr67uPInmO40G2vSGn0u4gTULTkP2kR2idTTavOv vTbFUbpn5QWT+ZofNPmzU5/M+u2wAsmuESC0t+JqDDax1UEE1+Jjvv13xVkPm7yxqGvwR29tr17o sQSWO4FiIKzLKAPiM0chXiAacadflirC/KH5EJ5QWWPy/wCbNWsoLh1kuIQLRkcpsK84Wptttir1 PFXYq7FXYq7FXYq7FXYq8EbRNT0H8zdW85eUvOPly5g1vkLyx1a7KcQxVgqtD6leDL8JqNtqYqzj yP8Alf8AUfNN7571+/j1fzRqa0SW3UpaW8JUKEt1Yux+BQvMnp8ySq9DxVKZ/N/lK3mkgn1uwini YpLE91Crq6mjKylqgg9Riqtp/mLy/qUzQadqdpezqpdoreeOVwgIBYqjMaVI3xVMMVdirsVdirsV dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVeD/8AOS35b+XJPKdtq+la bb2etJfQWySW8aQ+styxThJxCqfjIIZun04qEj/IT85brRrxfy986F7aS3k+q6Zcz7NDIDx+qzV7 ctkbt9npSikvpTFDy789/IXlfUvy917U20y2TVrOB7yG/jjRJw8ZDvWQDkwYAgg9fnirIvyt8raB onkrQzptjDbzy6fbtcXKRqJpXkjWR2kkA5Nyc13xVl+KuxV2KuxV2KuxV2KuxV2KuxVRvr60sLOe 9vJlt7S2RpZ5nNFREFWYn2GKrre4huLeK4hbnDMiyRuKiqsKg7+IOKqmKuxV2KuxV2KuxV2KuxV2 KuxV2KuxV2KuxV2KvN/z7/5Q2x/7bOm/9RAxCpD+fv5IR+cLN/MGgxBfM9rGA8IoovIk/YP/ABao +w3f7J7UUgpH/wA4+fnfJeel5J82TGPVIP3OmXtwSHm4mn1eYt/u1eik/a6fa6ql6p+bv/kr/NP/ AGzLn/k2cUI/yndW9p5C0a6uZFhtrfSraWeZzRURLdWZmPYACuKsG8u+b/zB/Mk3eo+Vbq38s+Vb eZrey1C5tfrt3dun2nETPFHHH+NfpoqhtB/NTzVoP5kx/l757FtczXoQ6TrlohhWX1a+mJYiSBzZ Snw9G23G+Kob8zvzY/MjyV510nSvqukT6PrMwW0m9O5acR+sEYP++RQ4V13AIr92KvVfM0vmiLTC /lqCzudSVh+5v5JIomShrRo1c8q0pXb3xV5p+UP5u+cfNvnbXvLnmHT7KwbRo3Dx2okLrPDMIZFZ 2kkRhyr9kYqgvz4/Ojzp5Iuo9O0nRlt4bof6Pr1yVljkIVWdYYlPwshah9T6FpQ4pCUedPza/Ou5 a11Lyb5dmXy25RLe8NobiS8Y9ZPT3dIX/YPEVG/LegUPQvzE/Nu18ieVNPvtUtfW8xajEgt9Hjan 7/gDLyb4iI43PGu56UxVS0nS/wA69V0lNS1DzDZaFqFwglj0eHT1nihqOQjlklk9Qt2bj07VxVJf JP51aunnaTyB5/sodP8AMKyCK0vrXkLa5ZhWMcWJKmVSChrQnainbFWG/wDOU3mT8wIbWPS3tk0/ yldTemkySq8148Y5/vFXeOMdl79T4BSGVeWdb/5yS+q6VGfL+h/on07dTMHf1fq9FHL/AHq+1w3+ z17YoS/8z/z483eWfPdj5f8A0SukaV9ahafUrmk73Nn63F5IQlVRWUHbd/8AVO2KobWfzP8Az9l8 2adLpnlaaz8uX06LaWktr6skkBYVa5kUsYWKmv7PH3pXFXpfmz8zrfTPMlr5P0S0Or+br5DJFZc/ Rggj4M/qXM1G4jiteIBJ9qjFXl3n7z//AM5Cfl7cW+sa7+ib7Rbmb0vSs42aBGILCIs4inUlVPEm o/Vil7boeu3HmHydY63piJb3Op2cdzbRXNXjR5UDBZOBUlQTQ0xQ82/Lz82fPer/AJrap5H8x2mm QrpkU7NLYJPyZonQIQ8srgqyvX7APyxVk/5peaPzD8s6Xc615f03Tr/SrKEzXn1mWVbhAlS7BBwR lA3+3X2xV35Q+fNd86+QB5gvba2XU2luIkt4PUhgYxGiAlzOy17nf5Yq82078+fzMl/NB/LN95dX nbCeJtCseMk8kwjLRlrmRgip0YuABx33xVHfmH5j/wCckPL+kTeZ2/RFrpVvxafTrMG5lhjLBQZW mQc9z8Rjb3oBiqaeUvza/MPz35Vtn8qeX4YtWoYtT1fUHMemwyqafuVXlNKxWj8QKJ0PLFWM3P5t fm75C8+6do3n/wCp32l6gyD6xZxgL6TvwMkLhYmrGequv6wcUvcvNvmzRPKmhXGt61P6FlbgVoOT u7fZjjX9pmPQfwxQ831nXvz78w6JDr/lCy07SNMmi+sWljdP62pTxMOSMwaM26c13CcqjucVVfyD /N/WfPtvqdlrlrHDqek+kXuIAUSRJS4o0bE8XUpvTY+2Kpl+fhA8mWRJoBrGmkk/8xAxCvScVeB/ 85B/kfJqok85eVYWXW4KSajZQCjXATf14wtD6y96fa/1uqkMe8vfnonmj8p/MnlnzHOB5kh0u5Fp dPsLyNIidz/v5QN/5hv1ritM8/NK/uLL/nG3nBUPNpmm27MOyTGBHr81JX6cUBK/yX/LWw1f8s9E 1CLzLr9l66Sl7XT9Tlt7dHE8isEiQUXcVPvvirKo/wAgvKH+I7DzFeajrGparps0M9tPfXpuDW3k EsasXUsUDDpXFWAf85Pf8px5A/4zv/1EQYpfRWKHzt+Rv/k/PzG/4z3/AP3UcUl3/OYv/HJ8sf8A Ge6/4hHioe/6UqrpdmqgKqwRhVGwACDYYofMv5uzLqH/ADkv5dsNSJGnwT6XDGjVKMjzCQing7vx OKX1Jih8uf8AOXECWPm3y3rFo3pag1s49VaBgbaUPE3zBkOKQn3/ADlw8knlDy1JKvCV7p2kWhFG MNSKHfrioe6eWv8AlHNK/wCYO3/5NLih8+f85EIj/nP5FR1DI31QMpFQQb41BGKX0pihg3mN/wAq vKHmWTzfrH1e08y6hGsCTVkluplVRGqw26lySQoTkiexOKvLf+ci/Neu63+XyEeW7vS9D+uwMuoa k8cE7vwfiq2YLyKpqficr8vBSHrv5Rf+Sv8AK3/bMtv+TYxQ8j/L/wD9ap82f8YLn9cGKXrn5u/+ Sv8ANP8A2zLn/k2cUMR/5xb/APJT23/MZdf8TGKlhOhf+te6l8pf+oBcUvZPzd/8lf5p/wC2Zc/8 mzihhP8Azil/5K1/+2jcf8QjxUsO/wCcyVUN5Rag5EagC3cgfVqCv04pD3jzp5b8pa/opt/NcEU2 k2si3bG4kaGON4wQHZ1aOgAYg1NPHFDHbX8z7G+jFj5D0O78xxWwEKXMAWz02MRjjw+t3HFW40/3 WrYq8w/5xZaZvOHnpp0EUxkiMsankqt68/JQ1BUA98UlG/8AOQf5iWuseXoNA8t2V9qN4l9HPdS/ UrqOKMWrE8ayRxlyz0+xtTvih6r5J/MrQfNgSG1ivLTUhB9YuLK7tLiH0wCqsPVdBC1GcCivU9aY qyzFXzP/AM5EfkV6ZuPOfla2/dkmTWdNhX7PUtcxKO3+/FH+t44pBewyeV4fNX5O23l+VhGNQ0a1 jjkYVCSiFHicj/JkVTih4L+XH5meYfyavbzyn5z0m5bSzM0sLRAF43OzPAXKxyxSUB2YUO/iMUvZ fLv5k+YvPmo2v+FNJuNL8txSrJqOvanGqmaNCG9C0hDOGMo6yE/CvatMUMG/5yz0HW5IvL3mOwga a00pp0u5EUt6LOY3jd6dEPpkE9Bt44pDKfLv/OQdr5psYYPLPl3UNS8wygLLacFjtIJKbvNdlmVI q9DTkfCuKHm35Q65qegfnD5xutX0u91Ce8ub22uZtHtJrmBboXheSg+0sdVahPTvikov/nJ7XLXz RHpGnaDBeX1zpdxdC+C2V0ioSESgeSNFfdDulRioe4eTPPvlvX1h07TpLk3sFqss0U9nd2wVU4Iw 9SeKOMkM42Vj92KHnn/OQn5R615imsfN3lZefmDSlVJbZKCSWONzJG8ddjJGxOx+0PcAFSyLyx+f Hku60VJPMt2vl3XLdANS0u/V4ZUkXZjGrLV1Yj4ab9iK4oYN/hnVvzf/ADStPNF3YzWXkPRQiWLX aGJ70RsZKpGwDcZJD8RO3EU+1iqY/wDOWui6je+SdNvrWF5odOvC92UUt6cckTD1Gp0UMACffFIT T8tPzvs/MOi6Rpul6Jf3ep28UMGrOqBLS2WJVWWZp6sKcQWRAOTdMUPN/wA5fMdn5h/M7yrrmjW1 /eaZpX1c3k4sbuOnp3RlYBJY43NE9sUvozy15z8v+ZfrP6Ilml+qcPX9e1urWnqcuPH6zFDy+wfs 1p37YofO3mHXZPI//OR135k85WM1xpM5YabecDII4njCxSQhjQmKhRgDUfEaVxSnX56+br7zz+XM 0/lzR7uTy3YTw3d3rN1G0AkpVALaFh6kir6lXkICrioZv/zj/wCeINd8l6VpVtpl7EmkWKW91qM0 araNNERGI4n5cpGIHM0Wijqa0xQ8p806zqX5Y/8AOQ175p1Sxml0XUmcrLEu0sE8ShvTZiqF43UV Unt7g4pZ357/ADN1Dzj+XmvjypotwuiDT5n1DXNTQ28PpemS0drGCXlkYdDsq9TXFCD/AOcdfN9t on5fHTdV0zVLZbSW4upb/wCozyWpiejDjJGrlm7cQtcVLEtI8x2cH/ORt75xmtr9PLkxlWO9+o3Z qDaiEN6QjMtC4/lril7F+cXmrR0/LzUbEfWJbvXtNmGlww2lzIZPUQBeRSMiL7Y2kK4oYd/zjDr9 np3ldfK2oQ3dprU97cTQQy2lysbR+kr8vW9P0l2jb7TD9WKliv8AzlLqkfmbUNFsNDtry9n0WS/h 1ErZ3KokjtCgVXeNVk3hb4kqPfFIZB/zkRqd15y/LS11Hyut3daVZahTVojb3Fu68YeSu8U0cbtG hcVYArU+2yoTvyH+d/l/UPK2m6R5V0K8vNet7aO3XRreEpbwuqheUlyf3UcNRXmTX2rih5v+Svmu 88m/mP5r0nVtHvLvW9SlKJY6fH6jevHM5IHqNGFjYS8hIxpx3xS//9k= application/postscript Adobe PDF Library 15.0 False 1.610548 0.503592 Inches 1 False False Black Default Swatch Group 0 endstream endobj 217 0 obj <> endobj 19 0 obj <>stream x\o۸WX\`EDX\ 8MivtڹsBDSXrw)[~I^ Yy;dxxHE p^ LG:(T^=ǸOɀzJ$ MS1ݕTƞI䥉=(OG:FB{: ?HP K/ S$Fd䅉Afiz—T3ZR"]31*L-Z!MD>:*D$ C`̠; ="R('(C%AF2W1U%8*KOL:@+4^i)_ TdI! "f`RQP"E$D>#S])"E̙Eģ F1HS*$UϨ6c#fb% 4PZ$0`>D0 Ց&f&~#LW!4ԃJP'I'_"=N yf] MPbEM Rk?^Vg~9^f8j=~/?P dA⇱Tj|bS(dOCڀJ)_ci9bPTWүuڟ~ŵe֫Du[~fuO9$Ll#P: :>Ak$*Dm`rDUy%zy?j@ E}oP2t.r?2z O,hJq9_*ch.!3ptb"w{$͉-29E"_G}0iv7/WstOzxf1Rcmm`sM9'{m6Emz TE.&!E@\b(q#^6 l&­¥}B>:sRɢ-7&ݥ񱹱w(϶ޞ<{"s(ۢW_~@{=ŃྟJɐ5E~LpW-mƜJ$4;!oh1S2}N- ^5\gp[: b iigjVԔhl'4`pi<0Y3` JxZӳCsr-Gi&vZ,b'"7 ĨZ&@LRzҨNEН{:s L6dĸ޻kt~|nsVwY:G o΅+:g6u>lT}kdt5@lYI;T)׶ X.)AY)Pk\bFP*oh`Vj5fzPcA8DIq[=.299քVNK=7b,"K: !:=EAyQI3>P||#FRY]}Iъ 9HR11QMA ő=F98pfT1ޣZ]3pOV1nf^5y#nϷfETf9E-c}G}J' =Bt &/NN$߈Cl DR4l-עi'v$c٢nzy.N$.X2S˲Xv) |@h/ k xEj 0}Ϋ^?T%tNTʮCXx,Nj88ݵ#:0i w&"ݿd~ \9*=V1- VªyLz QHMAs g^?6~#.&YC^sFyjUWh܍'+VցIT|ԣB,| ?%N!F=<+߉;VBn97%!-r[/u>C.} 2D\;sڑۢۛ`soY֙yt8H9J'~.@}atCw孱 ]rC R>/ 祦lH{.moi JJ/:RvIj>Spp硂uuPN xtݟ6/>VnU٬!Lz-#tlF貵$+x3+~AEyyB>N!h@kD ը=*XyV(N|-6lZhm73̉uhP.n51wKzGey9B[plucsgWhM:^Ceӷ6_c5-}]Eu5?f[KΡ,('>Lu9ΗNmn^4C!qPH\p+L&5Աi1`g$Wo fS >bx\fŢ$sXh\9mH⛛akq:/,aa2 :u6f(ÿ܄X_ hjKt^1-&?oo **ͷl117/ϹDK65‘'w 냳>=+´MKA0pRqPU0M8.7{f67ߛ(_SiøMΚq ajV>`o/E^e;O1 1t01=ԘGzc^`,^aaBXr%KtH~#GskpMZO&$ ?=TV.~I6j3 l S䠭xS3Wh}y@;&%ۺND$!@mU]<fUː \P sBq=}ȿZϜrNIKI6%#6'l딈 QArnȽ@L='O/}DuFN+ⳳEz" JIM6V=ԲY endstream endobj 218 0 obj <<6988f6af0e81fe1b3017967e77360890>]/Root 169 0 R/Length 644/Size 219>>stream x5YHQqԬR+Ͳ2MKSD64h*"nZ i!"@"Z(.lޗ|pQJQJ9JVJڧ`<cA=@G UAF="wD77FBҳճ܊ڱՇooܲϰԐ=uȧٰ<4F3L3y,GQ":q|};R":!ӓHy=Q}]f4E\uϡ-һtqMGuOVѹbJMACiϧ 긍o+y;eDD}l Q {/>2[hg;;yk=:~M~ɝa=Sp>y7! endstream endobj startxref 497022 %%EOF